WorldWideScience

Sample records for high-energy neutron therapy

  1. High energy neutron radiography

    International Nuclear Information System (INIS)

    Gavron, A.; Morley, K.; Morris, C.; Seestrom, S.; Ullmann, J.; Yates, G.; Zumbro, J.

    1996-01-01

    High-energy spallation neutron sources are now being considered in the US and elsewhere as a replacement for neutron beams produced by reactors. High-energy and high intensity neutron beams, produced by unmoderated spallation sources, open potential new vistas of neutron radiography. The authors discuss the basic advantages and disadvantages of high-energy neutron radiography, and consider some experimental results obtained at the Weapons Neutron Research (WNR) facility at Los Alamos

  2. The Clatterbridge high-energy neutron therapy facility: specification and performance

    International Nuclear Information System (INIS)

    Bonnett, D.E.; Blake, S.W.; Shaw, J.E.; Bewley, D.K.

    1988-01-01

    A high energy neutron therapy facility has been installed at the Douglas Cyclotron Centre, Clatterbridge Hospital Merseyside, to extend M.R.C. clinical trials of fast neutrons. The neutron beam is produced by bombarding a beryllium target with 62 MeV protons. The target is isocentrically mounted with potential for 360 0 rotation, with a fully variable collimator, giving a range of rectilinear field sizes from 5 cm x 5 cm to 30 cm x 30 cm. Basic neutron beam data including output, field flatness, penumbra and depth-dose data have been measured. For a 10 cm x 10 cm field, 50% depth dose occurs at 16.2 cm in water and output is 1.63 cGy μ A -1 min -1 at maximum dose depth. Effectiveness of the target shielding and neutron-induced radioactivity in the treatment head were also measured. It is concluded that the equipment meets design specifications and fully satisfies criticisms of earlier neutron therapy equipment. A full radiation survey showed that radiation levels present no significant staff hazard. (UK)

  3. Radiation protection metrology at a high-energy neutron therapy facility

    International Nuclear Information System (INIS)

    Bonnett, D.E.; Sherwin, A.G.; More, B.R.

    1991-01-01

    A radiation protection survey has been carried out at a high-energy neutron therapy facility using a combination of different detectors and counters. Included in the survey were measurements with a tissue equivalent proportional counter (TEPC), a rem meter, a large volume ionisation chamber (LVI) and a Geiger counter. Dose equivalent rates, normalised to a proton beam current of 25 μA, of between 1 μSv.h -1 and 0.7 Sv.h -1 were recorded depending on the location. In general the results confirm the tendency of the rem meter to over-read in fields consisting mainly of low energy neutrons and illustrate the advantages of the diagnostic and gamma discriminating properties of the TEPC. The LVI-Geiger system was found to be the least favourable combination of dosemeters, substantially under-reading and being unable to estimate the neutron dose rate at levels below about 32 μGy.h -1 . (author)

  4. High energy neutron dosimeter

    International Nuclear Information System (INIS)

    Rai, K.S.F.

    1994-01-01

    A device for measuring dose equivalents in neutron radiation fields is described. The device includes nested symmetrical hemispheres (forming spheres) of different neutron moderating materials that allow the measurement of dose equivalents from 0.025 eV to past 1 GeV. The layers of moderating material surround a spherical neutron counter. The neutron counter is connected by an electrical cable to an electrical sensing means which interprets the signal from the neutron counter in the center of the moderating spheres. The spherical shape of the device allows for accurate measurement of dose equivalents regardless of its positioning. 2 figures

  5. High energy neutron generator

    International Nuclear Information System (INIS)

    Barjon, R.; Breynat, G.

    1987-01-01

    This patent describes a generator of fast neutrons only slightly contaminated by neutrons of energy less than 15 MeV, comprising a source of charged particles of energy equal to at least 15 MeV, a target made of lithium deuteride, and means for cooling the target. The target comprises at least two elements placed in series in the path of the charged particles and separated from each other, the thickness of each of the elements being selected as a function of the average energy of the charged particles emitted from the source and the energy of the fast neutrons to be generated such that neutrons of energy equal to at least 15 MeV are emitted in the forward direction in response to the bombardment of the target from behind by the charged particles. The target cooling means comprises means for circulating between and around the elements a gas which does not chemically react with lithium deuteride

  6. Intercomparison of high energy neutron personnel dosimeters

    International Nuclear Information System (INIS)

    McDonald, J.C.; Akabani, G.; Loesch, R.M.

    1993-03-01

    An intercomparison of high-energy neutron personnel dosimeters was performed to evaluate the uniformity of the response characteristics of typical neutron dosimeters presently in use at US Department of Energy (DOE) accelerator facilities. It was necessary to perform an intercomparison because there are no national or international standards for high-energy neutron dosimetry. The testing that is presently under way for the Department of Energy Laboratory Accreditation Program (DOELAP) is limited to the use of neutron sources that range in energy from about 1 keV to 2 MeV. Therefore, the high-energy neutron dosimeters presently in use at DOE accelerator facilities are not being tested effectively. This intercomparison employed neutrons produced by the 9 Be(p,n) 9 B interaction at the University of Washington cyclotron, using 50-MeV protons. The resulting neutron energy spectrum extended to a maximum of approximately 50-MeV, with a mean energy of about 20-MeV. Intercomparison results for currently used dosimeters, including Nuclear Type A (NTA) film, thermoluminescent dosimeter (TLD)-albedo, and track-etch dosimeters (TEDs), indicated a wide variation in response to identical doses of high-energy neutrons. Results of this study will be discussed along with a description of plans for future work

  7. High energy radiation from neutron stars

    International Nuclear Information System (INIS)

    Ruderman, M.

    1985-04-01

    Topics covered include young rapidly spinning pulsars; static gaps in outer magnetospheres; dynamic gaps in pulsar outer magnetospheres; pulse structure of energetic radiation sustained by outer gap pair production; outer gap radiation, Crab pulsar; outer gap radiation, the Vela pulsar; radioemission; and high energy radiation during the accretion spin-up of older neutron stars. 26 refs., 10 figs

  8. Report on high energy neutron dosimetry workshop

    International Nuclear Information System (INIS)

    Alvar, K.R.; Gavron, A.

    1993-01-01

    The workshop was called to assess the performance of neutron dosimetry per the responses from ten DOE accelerator facilities to an Office of Energy Research questionnaire regarding implementation of a personnel dosimetry requirement in DRAFT DOE 5480.ACC, ''Safety of Accelerator Facilities''. The goals of the workshop were to assess the state of dosimetry at high energy accelerators and if such dosimetry requires improvement, to reach consensus on how to proceed with such improvements. There were 22 attendees, from DOE Programs and contract facilities, DOE, Office of Energy Research (ER), Office of Environmental Safety and Health (EH), Office of Fusion Energy, and the DOE high energy accelerator facilities. A list of attendees and the meeting agenda are attached. Copies of the presentations are also attached

  9. Neutron therapy

    International Nuclear Information System (INIS)

    Riesler, Rudi

    1995-01-01

    Standard radiotherapy uses Xrays or electrons which have low LET (linear energy transfer); in contrast, particles such as neutrons with high LET have different radiobiological responses. In the late 1960s, clinical trials by Mary Catterall at the Hammersmith Hospital in London indicated that fast neutron radiation had clinical advantages for certain malignant tumours. Following these early clinical trials, several cyclotron facilities were built in the 1980s for fast neutron therapy, for example at the University of Washington, Seattle, and at UCLA. Most of these newer machines use extracted cyclotron proton beams in the range 42 to 66 MeV with beam intensities of 15 to 60 microamps. The proton beams are transported to dedicated therapy rooms, where neutrons are produced from beryllium targets. Second-generation clinical trials showed that accurate neutron beam delivery to the tumour site is more critical than for photon therapy. In order to achieve precise beam geometries, the extracted proton beams have to be transported through a gantry which can rotate around the patient and deliver beams from any angle; also the neutron beam outline (''field shape'') must be adjusted to extremely irregular shapes using a flexible collimation system. A therapy procedure has to be appropriately organized, with physicians, radiotherapists, nurses, medical physicists and other staff in attendance; other specialized equipment, such as CT or MRI scanners and radiation simulators must be made available. Neutron therapy is usually performed only in radiation oncology departments of major medical centres

  10. Practical neutron dosimetry at high energies

    International Nuclear Information System (INIS)

    McCaslin, J.B.; Thomas, R.H.

    1980-10-01

    Dosimetry at high energy particle accelerators is discussed with emphasis on physical measurements which define the radiation environment and provide an immutable basis for the derivation of any quantities subsequently required for risk evaluation. Results of inter-laboratory dosimetric comparisons are reviewed and it is concluded that a well-supported systematic program is needed which would make possible detailed evaluations and inter-comparisons of instruments and techniques in well characterized high energy radiation fields. High-energy dosimetry is so coupled with radiation transport that it is clear their study should proceed concurrently

  11. Very High Energy Neutron Scattering from Hydrogen

    International Nuclear Information System (INIS)

    Cowley, R A; Stock, C; Bennington, S M; Taylor, J; Gidopoulos, N I

    2010-01-01

    The neutron scattering from hydrogen in polythene has been measured with the direct time-of flight spectrometer, MARI, at the ISIS facility of the Rutherford Appleton Laboratory with incident neutron energies between 0.5 eV and 600 eV. The results of experiments using the spectrometer, VESUVIO, have given intensities from hydrogen containing materials that were about 60% of the intensity expected from hydrogen. Since VESUVIO is the only instrument in the world that routinely operates with incident neutron energies in the eV range we have chosen to measure the scattering from hydrogen at high incident neutron energies with a different type of instrument. The MARI, direct time-of-flight, instrument was chosen for the experiment and we have studied the scattering for several different incident neutron energies. We have learnt how to subtract the gamma ray background, how to calibrate the incident energy and how to convert the spectra to an energy plot . The intensity of the hydrogen scattering was independent of the scattering angle for scattering angles from about 5 degrees up to 70 degrees for at least 3 different incident neutron energies between 20 eV and 100 eV. When the data was put on an absolute scale, by measuring the scattering from 5 metal foils with known thicknesses under the same conditions we found that the absolute intensity of the scattering from the hydrogen was in agreement with that expected to an accuracy of ± 5.0% over a wide range of wave-vector transfers between 1 and 250 A -1 . These measurements show that it is possible to measure the neutron scattering with incident neutron energies up to at least 100 eV with a direct geometry time-of-flight spectrometer and that the results are in agreement with conventional scattering theory.

  12. First observations of power MOSFET burnout with high energy neutrons

    International Nuclear Information System (INIS)

    Oberg, D.L.; Wert, J.L.; Normand, E.; Majewski, P.P.; Wender, S.A.

    1996-01-01

    Single event burnout was seen in power MOSFETs exposed to high energy neutrons. Devices with rated voltage ≥400 volts exhibited burnout at substantially less than the rated voltage. Tests with high energy protons gave similar results. Burnout was also seen in limited tests with lower energy protons and neutrons. Correlations with heavy-ion data are discussed. Accelerator proton data gave favorable comparisons with burnout rates measured on the APEX spacecraft. Implications for burnout at lower altitudes are also discussed

  13. Research activities on dosimetry for high energy neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Yamaguchi, Yasuhiro [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    2003-03-01

    The external dosimetry research group of JAERI has been calculating dose conversion coefficients for high-energy radiations using particle transport simulation codes. The group has also been developing radiation dose measurement techniques for high-energy neutrons in collaboration with some university groups. (author)

  14. High Energy Neutron Induced Gamma Production

    International Nuclear Information System (INIS)

    Brown, D.A.; Johnson, M.; Navratil, P.

    2007-01-01

    N Division has an interest in improving the physics and accuracy of the gamma data it provides to its customers. It was asked to look into major gamma producing reactions for 14 MeV incident neutrons for several low-Z materials and determine whether LLNL's processed data files faithfully represent the current state of experimental and theoretical knowledge for these reactions. To address this, we surveyed the evaluations of the requested materials, made recommendations for the next ENDL release and noted isotopes that will require further experimental study. This process uncovered several major problems in our translation and processing of the ENDF formatted evaluations, most of which have been resolved

  15. High-Energy Neutron Backgrounds for Underground Dark Matter Experiments

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Yu [Syracuse Univ., NY (United States)

    2016-01-01

    Direct dark matter detection experiments usually have excellent capability to distinguish nuclear recoils, expected interactions with Weakly Interacting Massive Particle (WIMP) dark matter, and electronic recoils, so that they can efficiently reject background events such as gamma-rays and charged particles. However, both WIMPs and neutrons can induce nuclear recoils. Neutrons are then the most crucial background for direct dark matter detection. It is important to understand and account for all sources of neutron backgrounds when claiming a discovery of dark matter detection or reporting limits on the WIMP-nucleon cross section. One type of neutron background that is not well understood is the cosmogenic neutrons from muons interacting with the underground cavern rock and materials surrounding a dark matter detector. The Neutron Multiplicity Meter (NMM) is a water Cherenkov detector capable of measuring the cosmogenic neutron flux at the Soudan Underground Laboratory, which has an overburden of 2090 meters water equivalent. The NMM consists of two 2.2-tonne gadolinium-doped water tanks situated atop a 20-tonne lead target. It detects a high-energy (>~ 50 MeV) neutron via moderation and capture of the multiple secondary neutrons released when the former interacts in the lead target. The multiplicity of secondary neutrons for the high-energy neutron provides a benchmark for comparison to the current Monte Carlo predictions. Combining with the Monte Carlo simulation, the muon-induced high-energy neutron flux above 50 MeV is measured to be (1.3 ± 0.2) ~ 10-9 cm-2s-1, in reasonable agreement with the model prediction. The measured multiplicity spectrum agrees well with that of Monte Carlo simulation for multiplicity below 10, but shows an excess of approximately a factor of three over Monte Carlo prediction for multiplicities ~ 10 - 20. In an effort to reduce neutron backgrounds for the dark matter experiment SuperCDMS SNO- LAB, an active neutron veto was developed

  16. Bench mark spectra for high-energy neutron dosimetry

    International Nuclear Information System (INIS)

    Dierckx, R.

    1986-01-01

    To monitor radiation damage experiments, activation detectors are commonly used. The precision of the results obtained by the multiple foil analysis is largely increased by the intercalibration in bench-mark spectra. This technique is already used in dosimetry measurements for fission reactors. To produce neutron spectra similar to fusion reactor and high-energy high-intensity neutron sources (d-Li or spallation), accelerators can be used. Some possible solutions as p-Be and d-D 2 O neutron sources, useful as bench-mark spectra are described. (author)

  17. Calculated intensity of high-energy neutron beams

    International Nuclear Information System (INIS)

    Mustapha, B.; Nolen, J.A.; Back, B.B.

    2004-01-01

    The flux, energy and angular distributions of high-energy neutrons produced by in-flight spallation and fission of a 400 MeV/A 238 U beam and by the break-up of a 400 MeV/A deuteron beam are calculated. In both cases very intense secondary neutron beams are produced, peaking at zero degrees, with a relatively narrow energy spread. Such secondary neutron beams can be produced with the primary beams from the proposed rare isotope accelerator driver linac. The break-up of a 400 kW deuteron beam on a liquid-lithium target can produce a neutron flux of >10 10 neutrons/cm 2 /s at a distance of 10 m from the target

  18. Fusion materials high energy-neutron studies. A status report

    International Nuclear Information System (INIS)

    Doran, D.G.; Guinan, M.W.

    1980-01-01

    The objectives of this paper are (1) to provide background information on the US Magnetic Fusion Reactor Materials Program, (2) to provide a framework for evaluating nuclear data needs associated with high energy neutron irradiations, and (3) to show the current status of relevant high energy neutron studies. Since the last symposium, the greatest strides in cross section development have been taken in those areas providing FMIT design data, e.g., source description, shielding, and activation. In addition, many dosimetry cross sections have been tentatively extrapolated to 40 MeV and integral testing begun. Extensive total helium measurements have been made in a variety of neutron spectra. Additional calculations are needed to assist in determining energy dependent cross sections

  19. Unique furnace system for high-energy-neutron experiments

    International Nuclear Information System (INIS)

    Panayotou, N.F.; Green, D.R.; Price, L.S.

    1982-03-01

    The low flux of high energy neutron sources requires optimum utilization of the available neutron field. A furnace system has been developed in support of the US DOE fusion materials program which meets this challenge. Specimens positioned in two temperature zones just 1 mm away from the outside surface of a neutron window in the furnace enclosure can be irradiated simultaneously at two independent, isothermal (+- 1 0 C) temperatures. The temperature difference between these closely spaced isothermal zones is controllable from 0 to 320 0 C and the maximum temperature is 400 0 C. The design of the system also provides a controlled specimen environment, rapid heating and cooling and easy access to heaters and thermocouples. This furnace system is in use at the Rotating Target Neutron Source-II of Lawrence Livermore National Laboratory

  20. Transport of accelerator produced high energy neutrons though concrete

    International Nuclear Information System (INIS)

    Prabhakar Rao, G.; Sarkar, P.K.

    1996-01-01

    Development of a computational system for estimating the production and transport of high energy neutrons in particle accelerators is reported. The energy-angle distribution of neutrons from accelerated ions bombarding thick targets is calculated by a hybrid nuclear reaction model code, ALICE-91, modified to suit the purpose. Subsequent transmission of these neutrons through concrete slabs is treated using the anisotropic source-flux iteration technique (ASFIT) in the framework of a coupled neutron-gamma transport. Several parameters of both the codes have been optimized to obtain the transmitted dose through concrete. The calculations are found to be accurate and at the same time faster compared to the detailed Monte Carlo calculations. (author). 8 refs., 2 figs

  1. Response function measurement of plastic scintillator for high energy neutrons

    International Nuclear Information System (INIS)

    Sanami, Toshiya; Ban, Syuichi; Takahashi, Kazutoshi; Takada, Masashi

    2003-01-01

    The response function and detection efficiency of 2''φ x 2''L plastic (PilotU) and NE213 liquid (2''NE213) scintillators, which were used for the measurement of secondary neutrons from high energy electron induced reactions, were measured at Heavy Ion Medical Accelerator in Chiba (HIMAC). High energy neutrons were produced via 400 MeV/n C beam bombardment on a thick graphite target. The detectors were placed at 15 deg with respect to C beam axis, 5 m away from the target. As standard, a 5''φ x 5''L NE213 liquid scintillator (5''NE213) was also placed at same position. Neutron energy was determined by the time-of-flight method with the beam pickup scintillator in front of the target. In front of the detectors, veto scintillators were placed to remove charged particle events. All detector signals were corrected with list mode event by event. We deduce neutron spectrum for each detectors. The efficiency curves for pilotU and 2''NE213 were determined on the bases of 5 N E213 neutron spectrum and its efficiency calculated by CECIL code. (author)

  2. Neutron Therapy Facility

    Data.gov (United States)

    Federal Laboratory Consortium — The Neutron Therapy Facility provides a moderate intensity, broad energy spectrum neutron beam that can be used for short term irradiations for radiobiology (cells)...

  3. High energy neutron source for materials research and development

    International Nuclear Information System (INIS)

    Odera, M.

    1989-01-01

    Requirements for neutron source for nuclear materials research are reviewed and ESNIT, Energy Selective Neutron Irradiation Test facility proposed by JAERI is discussed. Its principal aims of a wide neutron energy tunability and spectra peaking at each energy to enable characterization of material damage process are demanding but attractive goals which deserve detailed study. It is also to be noted that the requirements make a difference in facility design from those of FMIT, IFMIF and other high energy intense neutron sources built or planned to date. Areas of technologies to be addressed to realize the ESNIT facility are defined and discussed. In order to get neutron source having desired spectral characteristics keeping moderate intensity, projectile and target combinations must be examined including experimentation if necessary. It is also desired to minimize change of flux density and energy spectrum according to location inside irradiation chamber. Extended target or multiple targets configuration might be a solution as well as specimen rotation and choice of combination of projectile and target which has minimum velocity of the center of mass. Though relevant accelerator technology exists, it is to be stressed that considerable efforts must be paid, especially in the area of target and irradiation devices to get ESNIT goal. Design considerations to allow hands-on maintenance and future upgrading possibility are important either, in order to exploit the facility fully for nuclear materials research and development. (author)

  4. Spectral correction factors for conventional neutron dosemeters used in high-energy neutron environments

    International Nuclear Information System (INIS)

    Lee, K.W.; Sheu, R.J.

    2015-01-01

    High-energy neutrons (>10 MeV) contribute substantially to the dose fraction but result in only a small or negligible response in most conventional moderated-type neutron detectors. Neutron dosemeters used for radiation protection purpose are commonly calibrated with 252 Cf neutron sources and are used in various workplace. A workplace-specific correction factor is suggested. In this study, the effect of the neutron spectrum on the accuracy of dose measurements was investigated. A set of neutron spectra representing various neutron environments was selected to study the dose responses of a series of Bonner spheres, including standard and extended-range spheres. By comparing 252 Cf-calibrated dose responses with reference values based on fluence-to-dose conversion coefficients, this paper presents recommendations for neutron field characterisation and appropriate correction factors for responses of conventional neutron dosemeters used in environments with high-energy neutrons. The correction depends on the estimated percentage of high-energy neutrons in the spectrum or the ratio between the measured responses of two Bonner spheres (the 4P6-8 extended-range sphere versus the 6'' standard sphere). (authors)

  5. High-energy neutron irradiation of superconducting compounds

    International Nuclear Information System (INIS)

    Sweedler, A.R.; Snead, C.L.; Newkirk, L.; Valencia, F.; Geballe, T.H.; Schwall, R.H.; Matthias, B.T.; Corenswit, E.

    1975-01-01

    The effect of high-energy neutron irradiation (E greater than 1 MeV) at ambient reactor temperatures on the superconducting properties of a variety of superconducting compounds is reported. The materials studied include the A-15 compounds Nb 3 Sn, Nb 3 Al, Nb 3 Ga, Nb 3 Ge and V 3 Si, the C-15 Laves phase HfV 2 , the ternary molybdenum sulfide Mo 3 Pb 0 . 5 S 4 and the layered dichalcogenide NbSe 2 . The superconducting transition temperature has been measured for all of the above materials for neutron fluences up to 5 x 10 19 n/cm 2 . The critical current for multifilamentary Nb 3 Sn has also been determined for fields up to 16 T and fluences between 3 x 10 17 n/cm 2 and 1.1 x 10 19 n/cm 2

  6. Neutron emission and fragment yield in high-energy fission

    International Nuclear Information System (INIS)

    Grudzevich, O. T.; Klinov, D. A.

    2013-01-01

    The KRIS special library of spectra and emission probabilities in the decays of 1500 nuclei excited up to energies between 150 and 250 MeV was developed for correctly taking into account the decay of highly excited nuclei appearing as fission fragments. The emission of neutrons, protons, and photons was taken into account. Neutron emission fromprimary fragments was found to have a substantial effect on the formation of yields of postneutron nuclei. The library was tested by comparing the calculated and measured yields of products originating from the fission of nuclei that was induced by high-energy protons. The method for calculating these yields was tested on the basis of experimental data on the thermal-neutroninduced fission of 235 U nuclei

  7. Neutron scattering investigation of magnetic excitations at high energy transfers

    International Nuclear Information System (INIS)

    Loong, C.K.

    1984-01-01

    With the advance of pulsed spallation neutron sources, neutron scattering investigation of elementary excitations in magnetic materials can now be extended to energies up to several hundreds of MeV. We have measured, using chopper spectrometers and time-of-flight techniques, the magnetic response functions of a series of d and f transition metals and compounds over a wide range of energy and momentum transfer. In PrO 2 , UO 2 , BaPrO 3 and CeB 6 we observed crystal-field transitions between the magnetic ground state and the excited levels in the energy range from 40 to 260 MeV. In materials exhibiting spin-fluctuation or mixed-valent character such as Ce 74 Th 26 , on the other hand, no sharp crystal-field lines but a broadened quasielastic magnetic peak was observed. The line width of the quasielastic component is thought to be connected to the spin-fluctuation energy of the 4f electrons. The significance of the neutron scattering results in relation to the ground state level structure of the magnetic ions and the spin-dynamics of the f electrons is discussed. Recently, in a study of the spin-wave excitations in itinerant magnetic systems, we have extended the spin-wave measurements in ferromagnetic iron up to about 160 MeV. Neutron scattering data at high energy transfers are of particular interest because they provide direct comparison with recent theories of itinerant magnetism. 26 references, 7 figures

  8. Experimental investigations of the neutron contamination in high-energy photon fields at medical linear accelerators

    International Nuclear Information System (INIS)

    Brunckhorst, Elin

    2009-01-01

    The scope of this thesis was to develop a device for the detection of the photoneutron dose inside the high-energy photon field. The photoneutron contamination of a Siemens PRIMUS linear accelerator was investigated in detail in its 15 MV photon mode. The experimental examinations were performed with three ionisation chambers (a tissue equivalent chamber, a magnesium chamber and a 10 B-coated magnesium chamber) and two types of thermoluminescence detectors (enriched with 6 Li and 7 Li, respectively). The detectors have different sensitivities to photons and neutrons and their combination allows the dose separation in a mixed neutron/photon field. The application of the ionisation chamber system, as well as the present TLD system for photoneutron detection in high-energy photon beams is a new approach. The TLD neutron sensitivity was found to be too low for a measurement inside the open photon field and the further investigation focused on the ionisation chambers. The three ionisation chambers were calibrated at different photon and neutron sources and a the borated magnesium chamber showed a very high response to thermal neutrons. For a cross check of the calibration, the three chambers were also used for dose separation of a boron neutron capture therapy beam where the exact determination of the thermal neutron dose is essential. Very accurate results were achieved for the thermal neutron dose component. At the linear accelerator the chamber system was reduced to a paired chamber system utilising the two magnesium chambers, since the fast neutron component was to small to be separated. The neutron calibration of the three chambers could not be applied, instead a conversion of measured thermal neutron signal by the borated chamber to Monte Carlo simulated total neutron dose was performed. Measurements for open fields in solid water and liquid water were performed with the paired chamber system. In larger depths the neutron dose could be determined with an

  9. Experimental investigations of the neutron contamination in high-energy photon fields at medical linear accelerators

    Energy Technology Data Exchange (ETDEWEB)

    Brunckhorst, Elin

    2009-02-26

    The scope of this thesis was to develop a device for the detection of the photoneutron dose inside the high-energy photon field. The photoneutron contamination of a Siemens PRIMUS linear accelerator was investigated in detail in its 15 MV photon mode. The experimental examinations were performed with three ionisation chambers (a tissue equivalent chamber, a magnesium chamber and a {sup 10}B-coated magnesium chamber) and two types of thermoluminescence detectors (enriched with {sup 6}Li and {sup 7}Li, respectively). The detectors have different sensitivities to photons and neutrons and their combination allows the dose separation in a mixed neutron/photon field. The application of the ionisation chamber system, as well as the present TLD system for photoneutron detection in high-energy photon beams is a new approach. The TLD neutron sensitivity was found to be too low for a measurement inside the open photon field and the further investigation focused on the ionisation chambers. The three ionisation chambers were calibrated at different photon and neutron sources and a the borated magnesium chamber showed a very high response to thermal neutrons. For a cross check of the calibration, the three chambers were also used for dose separation of a boron neutron capture therapy beam where the exact determination of the thermal neutron dose is essential. Very accurate results were achieved for the thermal neutron dose component. At the linear accelerator the chamber system was reduced to a paired chamber system utilising the two magnesium chambers, since the fast neutron component was to small to be separated. The neutron calibration of the three chambers could not be applied, instead a conversion of measured thermal neutron signal by the borated chamber to Monte Carlo simulated total neutron dose was performed. Measurements for open fields in solid water and liquid water were performed with the paired chamber system. In larger depths the neutron dose could be determined

  10. Recent research on nuclear reaction using high-energy proton and neutron

    Energy Technology Data Exchange (ETDEWEB)

    Shibata, Tokushi [Tokyo Univ., Tanashi (Japan). Inst. for Nuclear Study

    1997-11-01

    The presently available high-energy neutron beam facilities are introduced. Then some interesting research on nuclear reaction using high-energy protons are reported such as the intermediate mass fragments emission and neutron spectrum measurements on various targets. As the important research using high-energy neutron, the (p,n) reactions on Mn, Fe, and Ni, the elastic scattering of neutrons, and the shielding experiments are discussed. (author)

  11. Dose levels due to neutrons in the vicinity of high energy medical accelerators

    International Nuclear Information System (INIS)

    McGinley, P.H.; Wood, M.; Sohrabi, M.; Mills, M.; Rodriguez, R.

    1976-01-01

    High energy photons are generated for use in radiation therapy by the decelleration of electrons in metal targets. Fast neutrons are also generated as a result of (γ, n) and (e, e'n) interactions in the target, beam compensator filter, and collimator material. In this work the adsorbed dose to neutrons was measured at the center of a 10 x 10 cm photon beam and 5 cm outside of the beam edge for a number of treatment units. Dose levels due to slow and fast neutrons were also established outside of the treatment rooms and a Bonner sphere neutron spectrometer system was employed to determine the neutron energy spectrum due to stray neutron radiation at each accelerator. For the linac it was found that the neutron dose at the beam center was 0.0039% of the photon dose and values of 0.049% and 0.053% were observed for the Allis Chalmers betatron and the Brown Boveri Betatron. Dose equivalent rates in the range of 0.3 to 22.5 mrem/hr were measured for points outside the treatment rooms when the accelerators were operated at a photon dose rate of 100 rad/min at the treatment position

  12. Tolerance of human spinal cord to high-energy p(66)Be(49) neutrons

    International Nuclear Information System (INIS)

    Cohen, L.; Haken, R.K.T.; Mansell, J.A.; Yalavarthi, D.; Hendrickson, F.R.; Awschalom, M.

    1985-01-01

    A total of 76 patients with cancer of the head and neck have been irradiated at the Fermilab Neutron Therapy Facility using high-energy neutrons. Dose, time and cord-length factors were determined for each patient from their individual treatment plans. Cord doses ranged from 5 to 16 Gy in 8 to 24 fractions over 6 to 70 days. The treated lengths were between 5 and 15 cm. No myelopathy was seen during follow-up periods ranging from 2 to 6 years. By comparing these observations with published data, the upper and lower limits for spinal cord tolerance to neutrons can be determined. There is no apparent risk of injury with cord doses under 13 Gy

  13. Neutron beams for therapy

    International Nuclear Information System (INIS)

    Kuplenikov, Eh.L.; Dovbnya, A.N.; Telegin, Yu.N.; Tsymbal, V.A.; Kandybej, S.S.

    2011-01-01

    It was given the analysis and generalization of the study results carried out during some decades in many world countries on application of thermal, epithermal and fast neutrons for neutron, gamma-neutron and neutron-capture therapy. The main attention is focused on the practical application possibility of the accumulated experience for the base creation for medical research and the cancer patients effective treatment.

  14. Neutron-induced electronic failures around a high-energy linear accelerator

    International Nuclear Information System (INIS)

    Kry, Stephen F.; Johnson, Jennifer L.; White, R. Allen; Howell, Rebecca M.; Kudchadker, Rajat J.; Gillin, Michael T.

    2011-01-01

    Purpose: After a new in-vault CT-on-rails system repeatedly malfunctioned following use of a high-energy radiotherapy beam, we investigated the presence and impact of neutron radiation on this electronic system, as well as neutron shielding options. Methods: We first determined the CT scanner's failure rate as a function of the number of 18 MV monitor units (MUs) delivered. We then re-examined the failure rate with both 2.7-cm-thick and 7.6-cm-thick borated polyethylene (BPE) covering the linac head for neutron shielding. To further examine shielding options, as well as to explore which neutrons were relevant to the scanner failure, Monte Carlo simulations were used to calculate the neutron fluence and spectrum in the bore of the CT scanner. Simulations included BPE covering the CT scanner itself as well as covering the linac head. Results: We found that the CT scanner had a 57% chance of failure after the delivery of 200 MUs. While the addition of neutron shielding to the accelerator head reduced this risk of failure, the benefit was minimal and even 7.6 cm of BPE was still associated with a 29% chance of failure after the delivery of 200 MU. This shielding benefit was achieved regardless of whether the linac head or CT scanner was shielded. Additionally, it was determined that fast neutrons were primarily responsible for the electronic failures. Conclusions: As illustrated by the CT-on-rails system in the current study, physicists should be aware that electronic systems may be highly sensitive to neutron radiation. Medical physicists should therefore monitor electronic systems that have not been evaluated for potential neutron sensitivity. This is particularly relevant as electronics are increasingly common in the therapy vault and newer electronic systems may exhibit increased sensitivity.

  15. Localized Unresectable Pancreatic Cancer Treated with High Energy Neutrons and Chemotherapy at Fermilab - Preliminary Results

    Energy Technology Data Exchange (ETDEWEB)

    Saroja, K. R. [Unlisted, US, IL; Cohen, Lionel [Unlisted, US, IL; Hendrickson, Frank R. [Unlisted, US, IL; Mansell, JoAnne [Fermilab

    1990-01-01

    Between January 1985 and July 1989 a total of thirty-eight patients with locally advanced pancreatic cancer were treated with high energy neutrons at Fermilab. Twenty-one patients received only neutrons and seventeen were given chemotherapy in addition, either concurrently or subsequently following the completion of neutron irradiation. This is a retrospective study. Data were analyzed for tolerance, complications and survival. Three of the twenty-one (14%) patients who received only neutron beam therapy developed Grade ID or greater complications in the RTOG/EORTC scale. The median survival was 6.4 months. One of these patients is alive 10 months post treatment. Of seventeen patients who also received chemotherapy, five (29%) had severe complications. However, median survival was 13.5 months. Four of these seventeen patients are still alive at the time of this analysis. The preliminary results show that there is improvement in the survival of patients treated with combined neutron irradiation and chemotherapy. A pilot study to further evaluate these results in a larger group of patients is underway. Details of complications and chemotherapy regimen will be preseqted.

  16. High energy neutron dosimetry for the fusion program

    International Nuclear Information System (INIS)

    Barr, D.W.; Norris, A.E.

    1977-01-01

    Neutron dosimetry by the foil activation method offers a flexible technique for characterizing neutron spectra ranging from thermal energies to 30 MeV with the potential for extension to higher neutron energies as investigated by the Los Alamos Radiochemistry Group at the Los Alamos Meson Physics Facility and in the Apollo-Soyuz Test Project. The use of this method for the neutron flux description in thermal, resonance, and fission spectrum assemblies has been demonstrated. An extension of the method to environments involving thermonuclear processes was developed at Los Alamos in the early 1950's to characterize mixed fission-thermonuclear systems

  17. Neutron irradiation therapy machine

    International Nuclear Information System (INIS)

    1980-01-01

    Conventional neutron irradiation therapy machines, based on the use of cyclotrons for producing neutron beams, use a superconducting magnet for the cyclotron's magnetic field. This necessitates complex liquid He equipment and presents problems in general hospital use. If conventional magnets are used, the weight of the magnet poles considerably complicates the design of the rotating gantry. Such a therapy machine, gantry and target facilities are described in detail. The use of protons and deuterons to produce the neutron beams is compared and contrasted. (U.K.)

  18. High energy neutron recoil scattering from liquid 4He

    International Nuclear Information System (INIS)

    Holt, R.S.; Needham, L.M.; Paoli, M.P.

    1987-10-01

    The neutron recoil scattering from liquid 4 He at 4.2 K and 1.6 K has been observed for a momentum transfer of 150 A -1 using the Electron Volt Spectrometer on the pulsed neutron source, ISIS. The experiment yielded mean atomic kinetic energy values = 14.8 +- 3 K at 4.2 K and = 14.6 +- 3.2 K at 1.6 K in good agreement with values obtained at lower momentum transfers. (author)

  19. Measurement of high energy neutrons via Lu(n,xn) reactions

    International Nuclear Information System (INIS)

    Henry, E.A.; Becker, J.A.; Archer, D.E.; Younes, W.; Stoyer, M.A.; Slaughter, D.

    1997-07-01

    High energy neutrons can be assayed by the use of the nuclear diagnostic material lutetium. We are measuring the (n,xn) cross sections for natural lutetium in order to develop it as a detector material. We are applying lutetium to diagnose the high energy neutrons produced in test target/blanket systems appropriate for the Accelerator Production of Tritium Project. 3 refs., 5 figs., 1 tab

  20. The production of high energy neutrons by secondary reactions

    International Nuclear Information System (INIS)

    Nieschmidt, E.B.; Roney, T.J.; Staples, D.R.; Harmon, J.F.; Burkhart, J.H.

    1994-01-01

    The potential of using binary reactions in targets containing Be is discussed. Data are presented from the use of Be and BeF 2 targets bombarded with 1.5, 1.7, 1.8 and 1.9 MeV protons. Neutron production is enhanced by the presence of the F by factors of ∼4

  1. Neutron-proton elastic scattering at high energies

    Energy Technology Data Exchange (ETDEWEB)

    Saleem, M.; Fazal-e-Aleem (Punjab Univ., Lahore (Pakistan). Dept. of Physics)

    1980-09-06

    The most recent measurements of the differential and total cross sections of neutron-proton elastic scattering from 70 to 400 GeV/c have been explained by using rho as a simple pole and pomeron as a dipole. The predictions are also made regarding the energy dependence of dip and bump structure in angular distribution.

  2. High energy spin waves in iron measured by neutron scattering

    International Nuclear Information System (INIS)

    Boothroyd, A.T.; Paul, D.M.; Mook, H.A.

    1991-01-01

    We present new results for the spin were dispersion relation measured along the [ζζ0] direction in bcc iron (12% silicon) by time-of-flight, neutron inelastic scattering. The excitations were followed to the zone boundary, where they are spread over a range of energies around 300meV. 6 refs., 2 figs

  3. Spatial distribution of moderated neutrons along a Pb target irradiated by high-energy protons

    International Nuclear Information System (INIS)

    Fragopoulou, M.; Manolopoulou, M.; Stoulos, S.; Brandt, R.; Westmeier, W.; Kulakov, B.A.; Krivopustov, M.I.; Sosnin, A.N.; Debeauvais, M.; Adloff, J.C.; Zamani Valasiadou, M.

    2006-01-01

    High-energy protons in the range of 0.5-7.4 GeV have irradiated an extended Pb target covered with a paraffin moderator. The moderator was used in order to shift the hard Pb spallation neutron spectrum to lower energies and to increase the transmutation efficiency via (n,γ) reactions. Neutron distributions along and inside the paraffin moderator were measured. An analysis of the experimental results was performed based on particle production by high-energy interactions with heavy targets and neutron spectrum shifting by the paraffin. Conclusions about the spallation neutron production in the target and moderation through the paraffin are presented. The study of the total neutron fluence on the moderator surface as a function of the proton beam energy shows that neutron cost is improved up to 1 GeV. For higher proton beam energies it remains constant with a tendency to decline

  4. High-energy X-ray production in a boundary layer of an accreting neutron star

    International Nuclear Information System (INIS)

    Hanawa, Tomoyuki

    1991-01-01

    It is shown by Monte Carlo simulation that high-energy X-rays are produced through Compton scattering in a boundary layer of an accreting neutron star. The following is the mechanism for the high-energy X-ray production. An accreting neutron star has a boundary layer rotating rapidly on the surface. X-rays radiated from the star's surface are scattered in part in the boundary layer. Since the boundary layer rotates at a semirelativistic speed, the scattered X-ray energy is changed by the Compton effect. Some X-rays are scattered repeatedly between the neutron star and the boundary layer and become high-energy X-rays. This mechanism is a photon analog of the second-order Fermi acceleration of cosmic rays. When the boundary layer is semitransparent, high-energy X-rays are produced efficiently. 17 refs

  5. Relativistic polarized neutrons at the Laboratory of High Energy Physics, JINR

    International Nuclear Information System (INIS)

    Kirillov, A.; Komolov, L.; Kovalenko, A.; Matyushevskij, E.; Nomofilov, A.; Rukoyatkin, P.; Sharov, V.; Starikov, A.; Strunov, L.; Svetov, A.

    1996-01-01

    Using slowly extracted polarized deuterons, available at the accelerator facility of the Laboratory of High Energy Physics, JINR, polarized quasi-monochromatic neutrons with momenta from 1.1 to 4.5 GeV/c have been generated. Depending on momentum, from 10 4 to 10 6 polarized neutrons per accelerator cycle were produced. At present, the polarized neutrons are mainly intended for measuring the (n vec, p vec) total cross section differences. 6 refs., 2 figs

  6. Ceramics research in a high-energy neutron source

    International Nuclear Information System (INIS)

    Clinard, F.W. Jr.

    1989-01-01

    The studies on the irradiation effect to ceramics have added much to the basic understanding of their behavior, for example, the amorphous state of ceramics related to radiation-induced metamictization, the radiation-induced strengthening and toughening due to ultrafine defect aggregates, the in situ degradation of electrical resistivity, the role of radiation-induced defects on thermal conductivity and so on. Most of the irradiation testing on ceramics in the fields of structural and thermal properties have been carried out by using fast fission neutrons of about 1 MeV, but if this energy could be significantly changed, the size and nature of damage cascade and the quantity of transmutation gases produced would change. The significance of neutron source parameters, the special test requirement for ceramics such as the use of miniature specimens, the control of test environment, the transient reduction of electrical resistivity and so on are discussed. A special case of ceramic studies is that on new oxide superconductors. These materials can be made into amorphous state at about 1 dpa using 1 MeV electrons, and are considered to be fairly damage-sensitive. (K.I.)

  7. Gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Akine, Yasuyuki; Tokita, Nobuhiko; Tokuuye, Koichi; Satoh, Michinao; Churei, Hisahiko

    1993-01-01

    Gadolinium neutron capture therapy makes use of photons and electrons produced by nuclear reactions between gadolinium and lower-energy neutrons which occur within the tumor. The results of our studies have shown that its radiation effect is mostly of low LET and that the electrons are the significant component in the over-all dose. The dose from gadolinium neutron capture reactions does not seem to increase in proportion to the gadolinium concentration, and the Gd-157 concentration of about 100 μg/ml appears most optimal for therapy. Close contact between gadolinium and the cell is not necessarily required for cell inactivation, however, the effect of electrons released from intracellular gadolinium may be significant. Experimental studies on tumor-bearing mice and rabbits have shown that this is a very promising modality though further improvements in gadolinium delivery to tumors are needed. (author)

  8. Investigation of high-energy inelastic neutron scattering from liquid water confined in silica xerogel

    International Nuclear Information System (INIS)

    Perelli-Cippo, E.; Andreani, C.; Casalboni, M.; Dire, S.; Fernandez-Canoto, D.; Gorini, G.; Imberti, S.; Pietropaolo, A.; Prosposito, P.; Schutzmann, S.; Senesi, R.; Tardocchi, M.

    2006-01-01

    High-energy inelastic neutron scattering (HINS) employing epithermal neutrons is a new technique under development at the VESUVIO spectrometer at ISIS, aiming to access the high-energy and low wave-vector transfer region in neutron scattering experiments at eV energies. New neutron detectors have been developed for HINS based on the resonant detector (RD). These make use of the detection of prompt gammas after neutron absorption in an analyzer foil. The RD is used in the very low angle detector (VLAD) bank, which will extend the explored kinematical region to momentum transfer -1 , whilst still keeping energy transfer >300 meV. The final VLAD will cover the scattering range 1-5 o and will be installed by the end of 2005. The results obtained with prototype VLAD detectors on polycrystalline ice and liquid water in silica xerogels provide a demonstration of the feasibility of the measurements under realistic conditions

  9. Field calibration of a TLD albedo dosemeter in the high-energy neutron field of CERF

    International Nuclear Information System (INIS)

    Haninger, T.; Kleinau, P.; Haninger, S.

    2017-01-01

    The new albedo dosemeter-type AWST-TL-GD 04 has been calibrated in the CERF neutron field (CERN-EU high-energy Reference Field). This type of albedo dosemeter is based on thermoluminescent detectors (TLDs) and used by the individual monitoring service of the Helmholtz Zentrum Muenchen (AWST) since 2015 for monitoring persons, who are exposed occupationally against photon and neutron radiation. The motivation for this experiment was to gain a field specific neutron correction factor N n for workplaces at high-energy particle accelerators. N n is a dimensionless factor relative to a basic detector calibration with 137 Cs and is used to calculate the personal neutron dose in terms of H p (10) from the neutron albedo signal. The results show that the sensitivity of the albedo dosemeter for this specific neutron field is not significantly lower as for fast neutrons of a radionuclide source like 252 Cf. The neutron correction factor varies between 0.73 and 1.16 with a midrange value of 0.94. The albedo dosemeter is therefore appropriate to monitor persons, which are exposed at high-energy particle accelerators. (authors)

  10. ICF ignition capsule neutron, gamma ray, and high energy x-ray images

    Science.gov (United States)

    Bradley, P. A.; Wilson, D. C.; Swenson, F. J.; Morgan, G. L.

    2003-03-01

    Post-processed total neutron, RIF neutron, gamma-ray, and x-ray images from 2D LASNEX calculations of burning ignition capsules are presented. The capsules have yields ranging from tens of kilojoules (failures) to over 16 MJ (ignition), and their implosion symmetry ranges from prolate (flattest at the hohlraum equator) to oblate (flattest towards the laser entrance hole). The simulated total neutron images emphasize regions of high DT density and temperature; the reaction-in-flight neutrons emphasize regions of high DT density; the gamma rays emphasize regions of high shell density; and the high energy x rays (>10 keV) emphasize regions of high temperature.

  11. Single event upset and charge collection measurements using high energy protons and neutrons

    International Nuclear Information System (INIS)

    Normand, E.; Oberg, D.L.; Wert, J.L.; Ness, J.D.; Majewski, P.P.; Wender, S.; Gavron, A.

    1994-01-01

    RAMs, microcontrollers and surface barrier detectors were exposed to beams of high energy protons and neutrons to measure the induced number of upsets as well as energy deposition. The WNR facility at Los Alamos provided a neutron spectrum similar to that of the atmospheric neutrons. Its effect on devices was compared to that of protons with energies of 200, 400, 500, and 800 MeV. Measurements indicate that SEU cross sections for 400 MeV protons are similar to those induced by the atmospheric neutron spectrum

  12. Production of charm mesons by high energy neutrons

    International Nuclear Information System (INIS)

    Shipbaugh, C.L.

    1988-01-01

    The charmed mesons D/sup /plus minus//, D/sup 0/, and D/sub s//sup /plus minus//, have been observed in neutron-nucleus collisions at the FNAL Tevatron. A sample of 134 /plus minus/ 19 events as investigated in the decay D/sup /plus minus// /yields/ D/sup 0//pi//sup /plus minus// with the subsequent decay mode D/sup 0/ /yields/ K/sup +/K/sup /minus//. The cross section per nucleon for D/sup /plus minus//, at most probable energy /radical/s = 35 GeV, was measured to be 2.11 /plus minus/ .43 (plus minus/.63)/mu/b/nucleon for 0.0 < x/sub f/ < 0.14 (/bar x//sub f/ = .07). The branching ratio (BR) is defined as: BR /identical to/ Br(D /yields/ D/pi/) /times/ BR(D /yields/ K/sup +/K/sup /minus//). The dependence of the cross section per nucleus on number of nucleons in target was fit to a form A /sup /alpha// and it was found that /alpha/ = .96 /plus minus/ .17. A sample of 64 /plus minus/ 16 D/sub s//sup /plus minus// events was investigates for the decay D/sub s//sup /plus minus// /yields/ /phi//pi//sup /plus minus//. The differential cross section for D/sub s//sup /plus minus// production averaged over the particle and antiparticle states is: BR.[1/2](d/sigma/(D/sub s//sup +/)/dx/sub f/ + d/sigma/(D/sub s//sup /minus//) = 2.85 /plus minus/ 0.80 /plus minus/ .86 /mu/b/nucleon at x/sub f/ = 0.175 where the first errors is statistical and the second error is systematic. The branching fraction is defined as BR /equivalent to/ BR(D/sub s/ /yields/ /phi//pi/), and a linear A dependence was assumed. An estimate of relative cross section is: 0.19 /plus minus/ 0.09 at x/sub f/ = 0. 36 refs., 43 figs., 5 tabs

  13. High energy resolution characteristics on 14MeV neutron spectrometer for fusion experimental reactor

    Energy Technology Data Exchange (ETDEWEB)

    Iguchi, Tetsuo [Tokyo Univ., Tokai, Ibaraki (Japan). Nuclear Engineering Research Lab.; Takada, Eiji; Nakazawa, Masaharu

    1996-10-01

    A 14MeV neutron spectrometer suitable for an ITER-like fusion experimental reactor is now under development on the basis of a recoil proton counter telescope principle in oblique scattering geometry. To verify its high energy resolution characteristics, preliminary experiments are made for a prototypical detector system. The comparison results show reasonably good agreement and demonstrate the possibility of energy resolution of 2.5% in full width at half maximum for 14MeV neutron spectrometry. (author)

  14. Soil biological shield exposed to high energy neutrons; Zemlja kao bioloski stit od neutrona visokih energija

    Energy Technology Data Exchange (ETDEWEB)

    Simovic, R; Marinkovic, N [Institute of nuclear sciences Vinca, Belgrade (Yugoslavia)

    1993-04-15

    Shielding efficiency of soil biological shield exposed to high energy neutrons was investigated. Dose rate equivalents for neutrons, secondary gamma and gamma radiation were computed on the surface of soil slabs having different thicknesses. Yields of primary and secondary nuclear radiation in the total dose were evaluated. Influence of the incident neutron spectrum, water content and chemical composition of the material on its shielding efficiency was examined. It was found that the soil density and the water content determine the quality of biological shield, the influence of other factors being less important. Comparison of shielding efficiencies for soil with sand, brick and ordinary concrete shields was done.

  15. Dose conversion coefficients for high-energy photons, electrons, neutrons and protons

    International Nuclear Information System (INIS)

    Sakamoto, Yukio

    2005-01-01

    Dose conversion coefficients for photons, electrons and neutrons based on new ICRP recommendations were cited in the ICRP Publication 74, but the energy ranges of these data were limited and there are no data for high energy radiations produced in accelerator facilities. For the purpose of designing the high intensity proton accelerator facilities at JAERI, the dose evaluation code system of high energy radiations based on the HERMES code was developed and the dose conversion coefficients of effective dose were evaluated for photons, neutrons and protons up to 10 GeV, and electrons up to 100 GeV. The dose conversion coefficients of effective dose equivalent were also evaluated using quality factors to consider the consistency between radiation weighting factors and Q-L relationship. The effective dose conversion coefficients obtained in this work were in good agreement with those recently evaluated by using FLUKA code for photons and electrons with all energies, and neutrons and protons below 500 MeV. There were some discrepancy between two data owing to the difference of cross sections in the nuclear reaction models. The dose conversion coefficients of effective dose equivalents for high energy radiations based on Q-L relation in ICRP Publication 60 were evaluated only in this work. The previous comparison between effective dose and effective dose equivalent made it clear that the radiation weighting factors for high energy neutrons and protons were overestimated and the modification was required. (author)

  16. Characterisation of neutron fields around high-energy x-ray radiotherapy machines

    Czech Academy of Sciences Publication Activity Database

    Králík, M.; Turek, Karel

    2004-01-01

    Roč. 110, 1-4 (2004), s. 503-507 ISSN 0144-8420 Institutional research plan: CEZ:AV0Z1048901 Keywords : radiotherapy machines * neutron fields * high-energy Subject RIV: DN - Health Impact of the Environment Quality Impact factor: 0.617, year: 2003

  17. Resolution of the VESUVIO spectrometer for High-energy Inelastic Neutron Scattering experiments

    Energy Technology Data Exchange (ETDEWEB)

    Imberti, S. [Universita degli Studi di Roma Tre, Dipartimento di Fisica ' E.Amaldi' , Rome (Italy) and CNR-INFM, Rome (Italy)]. E-mail: silvia.imberti@roma2.infn.it; Andreani, C. [Universita degli Studi di Roma Tor Vergata, Dipartimento di Fisica, Roma 60133 (Italy); CNR-INFM, Rome (Italy); Garbuio, V. [Universita degli Studi di Roma Tor Vergata, Dipartimento di Fisica, Roma 60133 (Italy); CNR-INFM, Rome (Italy); Gorini, G. [Universita degli Studi di Milano-Bicocca, Dipartimento di Fisica ' G.Occhialini' , Milan (Italy); CNR-INFM, Milan (Italy); Pietropaolo, A. [Universita degli Studi di Roma Tor Vergata, Dipartimento di Fisica, Roma 60133 (Italy); CNR-INFM, Rome (Italy); Senesi, R. [Universita degli Studi di Roma Tor Vergata, Dipartimento di Fisica, Roma 60133 (Italy); CNR-INFM, Rome (Italy); Tardocchi, M. [Universita degli Studi di Milano-Bicocca, Dipartimento di Fisica ' G.Occhialini' , Milan (Italy); CNR-INFM, Milan (Italy)

    2005-11-01

    New perspectives for epithermal neutron spectroscopy have been opened up as a result of the development of the Resonance Detector and its use on inverse geometry time-of-flight spectrometers at spallation sources. A special application of the Resonance Detector is the Very Low Angle Detector Bank (VLAD) for the VESUVIO spectrometer at ISIS, operating in the angular range 1 deg. <2{theta}<5 deg. This equipment allows High-energy Inelastic Neutron Scattering (HINS) measurements to be performed in the (q,{omega}) kinematical region at low wavevector (q<10A{sup -1}) and high energy (unlimited) transfer -bar {omega}>500meV, a regime so far inaccessible to experimental studies on condensed matter systems. The HINS measurements complement the Deep Inelastic Neutron Scattering (DINS) measurements performed on VESUVIO in the high wavevector q(20A{sup -1}high energy transfer (-bar {omega}>1eV), where the short-time single-particle dynamics can be sampled. This paper will revise the main components of the resolution for HINS measurements of VESUVIO. Instrument performances and examples of applications for neutron scattering processes at high energy and at low wavevector transfer are discussed.

  18. The neutron dose equivalent around high energy medical electron linear accelerators

    Directory of Open Access Journals (Sweden)

    Poje Marina

    2014-01-01

    Full Text Available The measurement of neutron dose equivalent was made in four dual energy linear accelerator rooms. Two of the rooms were reconstructed after decommissioning of 60Co units, so the main limitation was the space. The measurements were performed by a nuclear track etched detectors LR-115 associated with the converter (radiator that consist of 10B and with the active neutron detector Thermo BIOREM FHT 742. The detectors were set at several locations to evaluate the neutron ambient dose equivalent and/or neutron dose rate to which medical personnel could be exposed. Also, the neutron dose dependence on collimator aperture was analyzed. The obtained neutron dose rates outside the accelerator rooms were several times smaller than the neutron dose rates inside the accelerator rooms. Nevertheless, the measured neutron dose equivalent was not negligible from the aspect of the personal dosimetry with almost 2 mSv a year per person in the areas occupied by staff (conservative estimation. In rooms with 15 MV accelerators, the neutron exposure to the personnel was significantly lower than in the rooms having 18 MV accelerators installed. It was even more pronounced in the room reconstructed after the 60Co decommissioning. This study confirms that shielding from the neutron radiation should be considered when building vaults for high energy linear accelerators, especially when the space constraints exist.

  19. Improving the neutron-to-photon discrimination capability of detectors used for neutron dosimetry in high energy photon beam radiotherapy

    International Nuclear Information System (INIS)

    Irazola, L.; Terrón, J.A.; Bedogni, R; Pola, A.; Lorenzoli, M.; Sánchez-Nieto, B.; Gómez, F.; Sánchez-Doblado, F.

    2016-01-01

    The increasing interest of the medical community to radioinduced second malignancies due to photoneutrons in patients undergoing high-energy radiotherapy, has stimulated in recent years the study of peripheral doses, including the development of some dedicated active detectors. Although these devices are designed to respond to neutrons only, their parasitic photon response is usually not identically zero and anisotropic. The impact of these facts on measurement accuracy can be important, especially in points close to the photon field-edge. A simple method to estimate the photon contribution to detector readings is to cover it with a thermal neutron absorber with reduced secondary photon emission, such as a borated rubber. This technique was applied to the TNRD (Thermal Neutron Rate Detector), recently validated for thermal neutron measurements in high-energy photon radiotherapy. The positive results, together with the accessibility of the method, encourage its application to other detectors and different clinical scenarios. - Highlights: • Neutron-to-photon discrimination of a thermal neutron detector used in radiotherapy. • Photon and anisotropic response study with distance and beam incidence of thermal neutron detector. • Borated rubber for estimating photon contribution in any thermal neutron detector.

  20. Evaluation of energy response of neutron rem monitor applied to high-energy accelerator facilities

    Energy Technology Data Exchange (ETDEWEB)

    Nakane, Yoshihiro; Harada, Yasunori; Sakamoto, Yukio [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment] [and others

    2003-03-01

    A neutron rem monitor was newly developed for applying to the high-intensity proton accelerator facility (J-PARC) that is under construction as a joint project between the Japan Atomic Energy Research Institute and the High Energy Accelerator Research Organization. To measure the dose rate accurately for wide energy range of neutrons from thermal to high-energy region, the neutron rem monitor was fabricated by adding a lead breeder layer to a conventional neutron rem monitor. The energy response of the monitor was evaluated by using neutron transport calculations for the energy range from thermal to 150 MeV. For verifying the results, the response was measured at neutron fields for the energy range from thermal to 65 MeV. The comparisons between the energy response and dose conversion coefficients show that the newly developed neutron rem monitor has a good performance in energy response up to 150 MeV, suggesting that the present study offered prospects of a practical fabrication of the rem monitor applicable to the high intensity proton accelerator facility. (author)

  1. High energy fast neutrons from the Harwell variable energy cyclotron. II. Biologic studies in mammalian systems

    International Nuclear Information System (INIS)

    Berry, R.J.; Bance, D.A.; Barnes, D.W.H.; Cox, R.; Goodhead, D.T.; Sansom, J.M.; Thacker, J.

    1977-01-01

    A high energy fast neutron beam potentially suitable for radiotherapy has been described in a companion paper. Its biologic effects have been studied in the following experimental systems: clonal survival and mutation induction after irradiation in vitro in Chinese hamster cells and human diploid fibroblasts; survival of reproductive capacity in vivo of murine hemopoietic colony-forming cells and murine intestinal crypts after irradiation in vivo; survival of reproductive capacity in vivo after irradiation in vitro or in vivo of murine lymphocytic leukemia cells; acute intestinal death following total body irradiation of mice and guinea pigs; and hemopoietic death following total body irradiation of mice and guinea pigs. The relative biologic effectiveness of these high energy neutrons varied among the different biologic systems, and in several cases varied with the size of the radiation dose. The oxygen enhancement ratio was studied in murine lymphocytic leukemia cells irradiated under aerobic or hypoxic conditions in vitro and assayed for survival of reproductive capacity in vivo. Compared with x-rays, the potential therapeutic gain factor for these neutrons was about 1.5. This work represents a ''radiobiologic calibration'' program which it is suggested should be undertaken before new and unknown fast neutron spectra are used for experimental radiotherapy. The results are compared with biologic studies carried out at high energy fast neutron generators in the United States

  2. Neutron dose to patients treated with high-energy medical accelerators

    International Nuclear Information System (INIS)

    McGinley, P.H.

    2001-01-01

    The neutron dose equivalent received by patients treated with high energy x-ray beams was measured in this research. A total of 13 different medical accelerators were evaluated in terms of the neutron dose equivalent in the patient plane and at the beam center. The neutron dose equivalent at the beam center was found to ranged from 0.02 to 9.4 mSv per Sv of x-ray dose and values from 0.029 to 2.58 mSv per Sv of x-ray were measured in the patient plane. It was concluded that the neutron levels meet the International Electrotechnical Commission standard for the patient plane. It was also concluded that when intensity modulated radiation treatment is conducted the neutron dose equivalent received by the patient will increase by a factor of 2 to 10. (author)

  3. Neutron dose measurements with the GSI ball at high energy accelerators

    International Nuclear Information System (INIS)

    Fehrenbacher, G.; Gutermuth, F.; Radon, T.; Kozlova, E.

    2005-01-01

    Full text: At high energy particle accelerators the production of neutron radiation dominates radiation protection. For the radiation survey at accelerators there is a need for reliable detection systems (passive radiation monitors), which can measure the dose for a wide range of neutron energies independently on the beam pulse structure of the produced radiation. In this work a passive neutron dosemeter for the measurement of the ambient dose equivalent is presented. The dosemeter is suitable for measurements of the emerging neutron radiation at accelerators for the whole energy range up to about 10 GeV. The dosemeter consists of a polyethylene sphere, TL elements (pairs of TLD600/700) and an additional lead layer (PE/Pb) in neutron fields at high energy accelerators is investigated in this work. Results of dose measurements which were performed in realistic neutron fields at the high energy accelerator SPS at CERN (CERF facility) and in Cave A at the heavy ion synchrotron SIS at GSI are presented. The results of these measurements are compared with the expected dose values from the neutron spectra determined for the measurement positions at CERF and in Cave A (FLUKA) and with the dosemeter response derived by the calculated response functions (FLUKA) folded with the neutron spectra. The comparisons show that the additional lead layer in the PE/Pb-sphere improves significantly the response of the dosemeter. The response of the PE/Pb-sphere is 40 to 50 % higher at CERF and Cave A in comparison to the bare PE-sphere. At CERF the dose values of the PE/Pb-sphere is about 25 % lower than the expected dose value, whilst for Cave A, a rather good agreement was found (2 % deviation). (author)

  4. Liquid lithium target as a high intensity, high energy neutron source

    Science.gov (United States)

    Parkin, Don M.; Dudey, Norman D.

    1976-01-01

    This invention provides a target jet for charged particles. In one embodiment the charged particles are high energy deuterons that bombard the target jet to produce high intensity, high energy neutrons. To this end, deuterons in a vacuum container bombard an endlessly circulating, free-falling, sheet-shaped, copiously flowing, liquid lithium jet that gushes by gravity from a rectangular cross-section vent on the inside of the container means to form a moving web in contact with the inside wall of the vacuum container. The neutrons are produced via break-up of the beam in the target by stripping, spallation and compound nuclear reactions in which the projectiles (deuterons) interact with the target (Li) to produce excited nuclei, which then "boil off" or evaporate a neutron.

  5. Liquid lithium target as a high intensity, high energy neutron source

    International Nuclear Information System (INIS)

    Parkin, D.M.; Dudey, N.D.

    1976-01-01

    The invention described provides a target jet for charged particles. In one embodiment the charged particles are high energy deuterons that bombard the target jet to produce high intensity, high energy neutrons. To this end, deuterons in a vacuum container bombard an endlessly circulating, free-falling, sheet-shaped, copiously flowing, liquid lithium jet that gushes by gravity from a rectangular cross-section vent on the inside of the container means to form a moving web in contact with the inside wall of the vacuum container. The neutrons are produced via break-up of the beam in the target by stripping, spallation and compound nuclear reactions in which the projectiles (deuterons) interact with the target (Li) to produce excited nuclei, which then ''boil off'' or evaporate a neutron

  6. High-energy neutron dosimetry at the Clinton P. Anderson Meson Physics Facility

    International Nuclear Information System (INIS)

    Mallett, M.W.; Vasilik, D.G.; Littlejohn, G.J.; Cortez, J.R.

    1990-01-01

    Neutron energy spectrum measurements performed at the Clinton P. Anderson Meson Physics Facility indicated potential areas for high energy neutron exposure to personnel. The low sensitivity of the Los Alamos thermoluminescent dosimeter (TLD) to high energy neutrons warranted issuing a NTA dosimeter in addition to the TLD badge to employees entering these areas. The dosimeter consists of a plastic holder surrounding NTA film that has been desiccated and sealed in a dry nitrogen environment. A study of the fading of latent images in NTA film demonstrated the success of this packaging method to control the phenomenon. The Los Alamos NTA dosimeter is characterized and the fading study discussed. 10 refs., 4 figs., 2 tabs

  7. Neutron capture therapy

    International Nuclear Information System (INIS)

    Jun, B. J.

    1998-11-01

    The overall state of the art related with neutron capture therapy(NCT) is surveyed. Since the field related with NCT is very wide, it is not intended to survey all related subjects in depth. The primary objective of this report is to help those working for the installation of a NCT facility and a PGNAA(prompt gamma ray neutron activation analysis) system for the boron analysis understand overall NCT at Hanaro. Therefore, while the parts of reactor neutron source and PGNAA are dealt in detail, other parts are limited to the level necessary to understand related fields. For example, the subject of chemical compound which requires intensive knowledge on chemistry, is not dealt as a separated item. However, the requirement of a compound for NCT, currently available compounds, their characteristics, etc. could be understood through this report. Although the subject of cancer treated by NCT is out of the capability of the author, it is dealt focussing its characteristics related with the success of NCT. Each detailed subject is expected to be dealt more detail by specialists in future. This report would be helpful for the researchers working for the NCT to understand related fields. (author). 128 refs., 3 tabs., 12 figs

  8. Dose determination of Neutron contamination in radiothrapy rooms equiped with high energy linear accelerators

    International Nuclear Information System (INIS)

    Shweikani, R.; Anjak, O.

    2014-03-01

    Radiotherapy represents the most widely spread technique to control and treat cancer. To increase the treatment efficiency, high-energy linear accelerators are used. However, applying high energy photon beams leads to a non-negligible dose of neutrons contaminating therapeutic beams. A high-energy (23 MV) linear accelerator (Varian 21EX) was studied. The CR-39 nuclear track detectors (NTDs) were used to study the variation of fast neutron relative intensities around a linear accelerator high energy photon beam and to determined the its variation on the patient plane at 0, 50, 100, 150 and 200 cm from the center of the photon beam was. By increasing the distance from the center of the X-ray beam towards the periphery, the photoneutron dose equivalent decreased rapidly for the fields. Photoneutron intensity and distributions at isocenter level with the field sizes of 40*40 cm'2 at SSD=100cm around 23 MV photon beam using Nuclear Track Detectors were determined. The advantages of CR-39 NTD s over active detectors: 1- there is no pulse pileup problem. 2- no photon interference with neutron measurement. 3- no electronics are required. 4 - less prone to noise and interference. The photoneutron intensities were rapidly decreased as we move away from the isocenter of linear accelerators. As the use of simulation software MCNP match in the results we have obtained through direct measurements and the modeling results using the code MCNP (author).

  9. Verification of the DUCT-III for calculation of high energy neutron streaming

    Energy Technology Data Exchange (ETDEWEB)

    Masukawa, Fumihiro; Nakano, Hideo; Nakashima, Hiroshi; Sasamoto, Nobuo [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Tayama, Ryu-ichi; Handa, Hiroyuki; Hayashi, Katsumi [Hitachi Engineering Co., Ltd., Hitachi, Ibaraki (Japan); Hirayama, Hideo [High Energy Accelerator Research Organization, Tsukuba, Ibaraki (Japan); Shin, Kazuo [Kyoto Univ., Kyoto (Japan)

    2003-03-01

    A large number of radiation streaming calculations under a variety of conditions are required as a part of shielding design for a high energy proton accelerator facility. Since sophisticated methods are very time consuming, simplified methods are employed in many cases. For accuracy evaluation of a simplified code DUCT-III for high energy neutron streaming calculations, two kinds of benchmark problems based on the experiments were analyzed. Through comparison of the DUCT-III calculations with both the measurements and the sophisticated Monte Carlo calculations, DUCT-III was seen reliable enough for applying to the shielding design for the Intense Proton Accelerator Facility. (author)

  10. Verification of the DUCT-III for calculation of high energy neutron streaming

    CERN Document Server

    Masukawa, F; Hayashi, K; Hirayama, H; Nakano, H; Nakashima, H; Sasamoto, N; Shin, K; Tayama, R I

    2003-01-01

    A large number of radiation streaming calculations under a variety of conditions are required as a part of shielding design for a high energy proton accelerator facility. Since sophisticated methods are very time consuming, simplified methods are employed in many cases. For accuracy evaluation of a simplified code DUCT-III for high energy neutron streaming calculations, two kinds of benchmark problems based on the experiments were analyzed. Through comparison of the DUCT-III calculations with both the measurements and the sophisticated Monte Carlo calculations, DUCT-III was seen reliable enough for applying to the shielding design for the Intense Proton Accelerator Facility.

  11. The very low angle detector for high-energy inelastic neutron scattering on the VESUVIO spectrometer

    International Nuclear Information System (INIS)

    Perelli Cippo, E.; Gorini, G.; Tardocchi, M.; Pietropaolo, A.; Andreani, C.; Senesi, R.; Rhodes, N.J.; Schooneveld, E.M.

    2008-01-01

    The Very Low Angle Detector (VLAD) bank has been installed on the VESUVIO spectrometer at the ISIS spallation neutron source. The new device allows for high-energy inelastic neutron scattering measurements, at energies above 1 eV, maintaining the wave vector transfer lower than 10A -1 . This opens a still unexplored region of the kinematical (q,ω) space, enabling new and challenging experimental investigations in condensed matter. This paper describes the main instrumental features of the VLAD device, including instrument design, detector response, and calibration procedure

  12. The very low angle detector for high-energy inelastic neutron scattering on the VESUVIO spectrometer

    Energy Technology Data Exchange (ETDEWEB)

    Perelli Cippo, E.; Gorini, G.; Tardocchi, M. [Dipartimento di Fisica ' G. Occhialini' , Universita degli Studi di Milano-Bicocca, Piazza della Scienza 3, 20126 Milano (Italy); Pietropaolo, A. [Dipartimento di Fisica ' G. Occhialini' , CNISM-Universita degli Studi di Milano-Bicocca, Piazza della Scienza 3, 20126 Milano (Italy); NAST Center - Nanoscienze-Nanotecnologie-Strumentazione, Universita degli Studi di Roma Tor Vergata, via della Ricerca Scientifica 1, 00133 Roma (Italy)], E-mail: antonino.pietropaolo@mib.infn.it; Andreani, C.; Senesi, R. [Dipartimento di Fisica and Centro NAST - Nanoscienze-Nanotecnologie-Strumentazione, Universita degli Studi di Roma Tor Vergata, via della Ricerca Scientifica 1, 00133 Roma (Italy); Rhodes, N.J.; Schooneveld, E.M. [ISIS Facility, Rutherford Appleton Laboratory, Chilton, Didcot, Oxfordshire 0QX OX11 (United Kingdom)

    2008-05-01

    The Very Low Angle Detector (VLAD) bank has been installed on the VESUVIO spectrometer at the ISIS spallation neutron source. The new device allows for high-energy inelastic neutron scattering measurements, at energies above 1 eV, maintaining the wave vector transfer lower than 10A{sup -1}. This opens a still unexplored region of the kinematical (q,{omega}) space, enabling new and challenging experimental investigations in condensed matter. This paper describes the main instrumental features of the VLAD device, including instrument design, detector response, and calibration procedure.

  13. The very low angle detector for high-energy inelastic neutron scattering on the VESUVIO spectrometer

    Science.gov (United States)

    Perelli Cippo, E.; Gorini, G.; Tardocchi, M.; Pietropaolo, A.; Andreani, C.; Senesi, R.; Rhodes, N. J.; Schooneveld, E. M.

    2008-05-01

    The Very Low Angle Detector (VLAD) bank has been installed on the VESUVIO spectrometer at the ISIS spallation neutron source. The new device allows for high-energy inelastic neutron scattering measurements, at energies above 1 eV, maintaining the wave vector transfer lower than 10Å-1. This opens a still unexplored region of the kinematical (q, ω) space, enabling new and challenging experimental investigations in condensed matter. This paper describes the main instrumental features of the VLAD device, including instrument design, detector response, and calibration procedure.

  14. Dose conversion coefficients for high-energy photons, electrons, neutrons and protons

    CERN Document Server

    Sakamoto, Y; Sato, O; Tanaka, S I; Tsuda, S; Yamaguchi, Y; Yoshizawa, N

    2003-01-01

    In the International Commission on Radiological Protection (ICRP) 1990 Recommendations, radiation weighting factors were introduced in the place of quality factors, the tissue weighting factors were revised, and effective doses and equivalent doses of each tissues and organs were defined as the protection quantities. Dose conversion coefficients for photons, electrons and neutrons based on new ICRP recommendations were cited in the ICRP Publication 74, but the energy ranges of theses data were limited and there are no data for high energy radiations produced in accelerator facilities. For the purpose of designing the high intensity proton accelerator facilities at JAERI, the dose evaluation code system of high energy radiations based on the HERMES code was developed and the dose conversion coefficients of effective dose were evaluated for photons, neutrons and protons up to 10 GeV, and electrons up to 100 GeV. The dose conversion coefficients of effective dose equivalent were also evaluated using quality fact...

  15. Simulation of a high energy neutron irradiation facility at beamline 11 of the China Spallation Neutron Source

    Energy Technology Data Exchange (ETDEWEB)

    Tairan, Liang [School of Physics and Electronic Information Inner Mongolia University for the Nationalities, Tongliao 028043 (China); Zhiduo, Li [Dongguan Branch, Institute of High Energy Physics, CAS, Beijing 100049 (China); Wen, Yin, E-mail: wenyin@aphy.iphy.ac.cn [Dongguan Branch, Institute of High Energy Physics, CAS, Beijing 100049 (China); Institute of Physics, CAS, P.O. Box 603, Beijing 100190 (China); Fei, Shen [Dongguan Branch, Institute of High Energy Physics, CAS, Beijing 100049 (China); Quanzhi, Yu [Dongguan Branch, Institute of High Energy Physics, CAS, Beijing 100049 (China); Institute of Physics, CAS, P.O. Box 603, Beijing 100190 (China); Tianjiao, Liang [Dongguan Branch, Institute of High Energy Physics, CAS, Beijing 100049 (China)

    2017-07-11

    The China Spallation Neutron Source (CSNS) will accommodate 20 neutron beamlines at its first target station. These beamlines serve different purposes, and beamline 11 is designed to analyze the degraded models and damage mechanisms, such as Single Event Effects in electronic components and devices for aerospace electronic systems. This paper gives a preliminary discussion on the scheme of a high energy neutron irradiation experiment at the beamline 11 shutter based on the Monte Carlo simulation method. The neutron source term is generated by calculating the neutrons scattering into beamline 11 with a model that includes the target-moderator-reflector area. Then, the neutron spectrum at the sample position is obtained. The intensity of neutrons with energy of hundreds of MeV is approximately 1E8 neutron/cm{sup 2}/s, which is useful for experiments. The displacement production rate and gas productions are calculated for common materials such as tungsten, tantalum and SS316. The results indicate that the experiment can provide irradiation dose rate ranges from 1E-5 to 1E-4 dpa per operating year. The residual radioactivity is also calculated for regular maintenance work. These results give the basic reference for the experimental design.

  16. Iodine neutron capture therapy

    Science.gov (United States)

    Ahmed, Kazi Fariduddin

    A new technique, Iodine Neutron Capture Therapy (INCT) is proposed to treat hyperthyroidism in people. Present thyroid therapies, surgical removal and 131I treatment, result in hypothyroidism and, for 131I, involve protracted treatment times and excessive whole-body radiation doses. The new technique involves using a low energy neutron beam to convert a fraction of the natural iodine stored in the thyroid to radioactive 128I, which has a 24-minute half-life and decays by emitting 2.12-MeV beta particles. The beta particles are absorbed in and damage some thyroid tissue cells and consequently reduce the production and release of thyroid hormones to the blood stream. Treatment times and whole-body radiation doses are thus reduced substantially. This dissertation addresses the first of the several steps needed to obtain medical profession acceptance and regulatory approval to implement this therapy. As with other such programs, initial feasibility is established by performing experiments on suitable small mammals. Laboratory rats were used and their thyroids were exposed to the beta particles coming from small encapsulated amounts of 128I. Masses of 89.0 mg reagent-grade elemental iodine crystals have been activated in the ISU AGN-201 reactor to provide 0.033 mBq of 128I. This activity delivers 0.2 Gy to the thyroid gland of 300-g male rats having fresh thyroid tissue masses of ˜20 mg. Larger iodine masses are used to provide greater doses. The activated iodine is encapsulated to form a thin (0.16 cm 2/mg) patch that is then applied directly to the surgically exposed thyroid of an anesthetized rat. Direct neutron irradiation of a rat's thyroid was not possible due to its small size. Direct in-vivo exposure of the thyroid of the rat to the emitted radiation from 128I is allowed to continue for 2.5 hours (6 half-lives). Pre- and post-exposure blood samples are taken to quantify thyroid hormone levels. The serum T4 concentration is measured by radioimmunoassay at

  17. Resolution of the VESUVIO spectrometer for High-energy Inelastic Neutron Scattering experiments

    International Nuclear Information System (INIS)

    Imberti, S.; Andreani, C.; Garbuio, V.; Gorini, G.; Pietropaolo, A.; Senesi, R.; Tardocchi, M.

    2005-01-01

    New perspectives for epithermal neutron spectroscopy have been opened up as a result of the development of the Resonance Detector and its use on inverse geometry time-of-flight spectrometers at spallation sources. A special application of the Resonance Detector is the Very Low Angle Detector Bank (VLAD) for the VESUVIO spectrometer at ISIS, operating in the angular range 1 deg. -1 ) and high energy (unlimited) transfer -bar ω>500meV, a regime so far inaccessible to experimental studies on condensed matter systems. The HINS measurements complement the Deep Inelastic Neutron Scattering (DINS) measurements performed on VESUVIO in the high wavevector q(20A -1 -1 ) and high energy transfer (-bar ω>1eV), where the short-time single-particle dynamics can be sampled. This paper will revise the main components of the resolution for HINS measurements of VESUVIO. Instrument performances and examples of applications for neutron scattering processes at high energy and at low wavevector transfer are discussed

  18. Characteristics of GaAs MESFET inverters exposed to high energy neutrons

    International Nuclear Information System (INIS)

    Bloss, W.L.; Yamada, W.E.; Young, A.M.; Janousek, B.K.

    1988-01-01

    GaAs MESFET circuits have been exposed to high energy neutrons with fluences ranging from 1x10/sup 14/ n/cm/sup 2/ to 2x10/sup 15/ m/cm/sup 2/. Discrete transistors, inverters, and ring oscillators were characterized at each fluence. While the MESFETs exhibit significant threshold voltage shifts and transconductance and saturation current degradation over this range of neutron fluences, the authors have observed improvement in the DC characteristics of Schottky Diode FET Logic (SDFL) inverters. This unusual result has been successfully simulated using device parameters extracted from FETs damaged by exposure to high energy neutrons. Although the decrease in device transconductance results in an increase in inverter gate delay, as reflected in ring oscillator frequency measurements, the authors conclude that GaAs ICs fabricated from this logic family will remain functional after exposure to extreme neutron fluences. This is a consequence of the observed improvement in inverter noise margin evident in both measured and simulated circuit performance

  19. Performance of a MICROMEGAS-based TPC in a high-energy neutron beam

    Science.gov (United States)

    Snyder, L.; Manning, B.; Bowden, N. S.; Bundgaard, J.; Casperson, R. J.; Cebra, D. A.; Classen, T.; Duke, D. L.; Gearhart, J.; Greife, U.; Hagmann, C.; Heffner, M.; Hensle, D.; Higgins, D.; Isenhower, D.; King, J.; Klay, J. L.; Geppert-Kleinrath, V.; Loveland, W.; Magee, J. A.; Mendenhall, M. P.; Sangiorgio, S.; Seilhan, B.; Schmitt, K. T.; Tovesson, F.; Towell, R. S.; Walsh, N.; Watson, S.; Yao, L.; Younes, W.

    2018-02-01

    The MICROMEGAS (MICRO-MEsh GAseous Structure) charge amplification structure has found wide use in many detection applications, especially as a gain stage for the charge readout of Time Projection Chambers (TPCs). Here we report on the behavior of a MICROMEGAS TPC when operated in a high-energy (up to 800 MeV) neutron beam. It is found that neutron-induced reactions can cause discharges in some drift gas mixtures that are stable in the absence of the neutron beam. The discharges result from recoil ions close to the MICROMEGAS that deposit high specific ionization density and have a limited diffusion time. For a binary drift gas, increasing the percentage of the molecular component (quench gas) relative to the noble component and operating at lower pressures generally improves stability.

  20. Resolution of the VESUVIO spectrometer for High-energy Inelastic Neutron Scattering experiments

    Science.gov (United States)

    Imberti, S.; Andreani, C.; Garbuio, V.; Gorini, G.; Pietropaolo, A.; Senesi, R.; Tardocchi, M.

    2005-11-01

    New perspectives for epithermal neutron spectroscopy have been opened up as a result of the development of the Resonance Detector and its use on inverse geometry time-of-flight spectrometers at spallation sources. A special application of the Resonance Detector is the Very Low Angle Detector Bank (VLAD) for the VESUVIO spectrometer at ISIS, operating in the angular range 1∘500 meV, a regime so far inaccessible to experimental studies on condensed matter systems. The HINS measurements complement the Deep Inelastic Neutron Scattering (DINS) measurements performed on VESUVIO in the high wavevector q(20 Å-11 eV), where the short-time single-particle dynamics can be sampled. This paper will revise the main components of the resolution for HINS measurements of VESUVIO. Instrument performances and examples of applications for neutron scattering processes at high energy and at low wavevector transfer are discussed.

  1. Neutron yield from thick lead target by the action of high-energy electrons

    International Nuclear Information System (INIS)

    Noga, V.I.; Ranyuk, Yu.N.; Telegin, Yu.N.; Sorokin, P.V.

    1978-01-01

    The results are presented of studying the complete neutron yield from a lead target bombarded by high-energy electrons. Neutrons were recorded by the method of radio-active indicators. The dependence of the neutron yield on the target thickness varying from 0.2 to 8 cm was obtained at the energies of electrons of 230 and 1200 MeV. The neutron yield for the given energies with the target of 6 cm in thickness is in the range of saturation and is 0.1 +-0.03 and 0.65+-0.22 (neutr./MeV.el.), respectively. The neutron angular distributions were measured for different thicknesses of targets at the 201, 230 and 1200 MeV electrons. Within the error limits the angular distributions are isotropic. The dependence of neutron yield on the electron energy was examined for a 3 cm thick target. In the energy range of 100-1200 MeV these values are related by a linear dependence with the proportionality coefficient C=3x10 -4 (neutr./MeV.el.)

  2. Monitor units are not predictive of neutron dose for high-energy IMRT

    Directory of Open Access Journals (Sweden)

    Hälg Roger A

    2012-08-01

    Full Text Available Abstract Background Due to the substantial increase in beam-on time of high energy intensity-modulated radiotherapy (>10 MV techniques to deliver the same target dose compared to conventional treatment techniques, an increased dose of scatter radiation, including neutrons, is delivered to the patient. As a consequence, an increase in second malignancies may be expected in the future with the application of intensity-modulated radiotherapy. It is commonly assumed that the neutron dose equivalent scales with the number of monitor units. Methods Measurements of neutron dose equivalent were performed for an open and an intensity-modulated field at four positions: inside and outside of the treatment field at 0.2 cm and 15 cm depth, respectively. Results It was shown that the neutron dose equivalent, which a patient receives during an intensity-modulated radiotherapy treatment, does not scale with the ratio of applied monitor units relative to an open field irradiation. Outside the treatment volume at larger depth 35% less neutron dose equivalent is delivered than expected. Conclusions The predicted increase of second cancer induction rates from intensity-modulated treatment techniques can be overestimated when the neutron dose is simply scaled with monitor units.

  3. Neutron therapy: The historical background

    International Nuclear Information System (INIS)

    Svensson, H.; Landberg, T.

    1994-01-01

    Neutron therapy was first introduced by Stone et al. in 1938, i.e. more than 10 years earlier than electron beam therapy and only 6 years after the discovery of neutrons. In spite of the impressive accomplishment in generating an adequate therapy beam, time was also found for careful radiobiological studies of neutron beams. However, it was not considered that for a certain early reaction the late effects were much greater with neutrons than with X-rays. The severe late sequelae in proportion to the few good results motivated the closure of this therapy. Neutron therapy was again introduced in Hammersmith hospital at the end of the 1960's. The major reason seems to have been to overcome the oxygen effect. Encouraging results were reported. It was argued that the very favourable statistics on local tumour control were obtained at the expense of more frequent and more severe complications. A clinical trial in Edinburgh seemed to indicate this, but it was not proved in the end as the two trials differed regarding fractionation. Today about 16000 patients have been treated with neutrons. The neutron beams now used differ significantly, both regarding dose distributions and microdosimetrical properties, from those utilized earlier. The advantage of neutrons is still, however, controversial. There are indications that neutron treatment may be favourable for some tumours. A careful cost-benefit study ought to be performed before the creation of a neutron therapy centre in Sweden as the group of patients suitable for neutrons is limited, and there may be new possibilities for improvement of photon and electron treatment with much smaller resources. (orig.)

  4. Experimental characterization of the neutron spectra generated by a high-energy clinical LINAC

    Energy Technology Data Exchange (ETDEWEB)

    Amgarou, K., E-mail: khalil.amgarou@uab.e [Institut de Radioprotection et de Surete Nucleaire (IRSN), Laboratoire de Metrologie et de Dosimetrie des Neutrons, F-13115 Saint Paul-Lez-Durance (France); Lacoste, V.; Martin, A. [Institut de Radioprotection et de Surete Nucleaire (IRSN), Laboratoire de Metrologie et de Dosimetrie des Neutrons, F-13115 Saint Paul-Lez-Durance (France)

    2011-02-11

    The production of unwanted neutrons by electron linear accelerators (LINACs) has attracted a special attention since the early 50s. The renewed interest in this topic during the last years is due mainly to the increased use of such machines in radiotherapy. Specially, in most of developing countries where many old teletherapy irradiators, based on {sup 60}Co and {sup 137}Cs radioactive sources, are being replaced with new LINAC units. The main objective of this work is to report the results of an experimental characterization of the neutron spectra generated by a high-energy clinical LINAC. Measurements were carried out, considering four irradiation configurations, by means of our recently developed passive Bonner sphere spectrometer (BSS) using pure gold activation foils as central detectors. This system offers the possibility to measure neutrons over a wide energy range (from thermal up to a few MeV) at pulsed, intense and complex mixed n-{gamma} fields. A two-step unfolding method that combines the NUBAY and MAXED codes was applied to derive the final neutron spectra as well as their associated integral quantities (in terms of total neutron fluence and ambient dose equivalent rates) and fluence-averaged energies.

  5. FLUKA simulations of a moderated reduced weight high energy neutron detection system

    Energy Technology Data Exchange (ETDEWEB)

    Biju, K., E-mail: bijusivolli@gmail.com [Health Physics Division, Bhabha Atomic Research Centre, Mumbai 400085 (India); Tripathy, S.P.; Sunil, C.; Sarkar, P.K. [Health Physics Division, Bhabha Atomic Research Centre, Mumbai 400085 (India)

    2012-08-01

    Neutron response of the systems containing high density polyethylene (HDPE) spheres coupled with different external metallic converters has been studied using the FLUKA Monte Carlo simulation code. A diameter of 17.8 cm (7 in.) of the moderating sphere is found to be optimum to obtain the maximum response when used with the neutron converter shells like W, Pb and Zr. Enhancement ratios of the neutron response due to the induced (n, xn) reactions in the outer converters made of W, Pb and Zr are analyzed. It is observed that the enhancement in the response by 1 cm thick Zr shell is comparable to that of 1 cm thick Pb in the energy region of 10-50 MeV. An appreciable enhancement is observed in the case of Zr converter for the higher energy neutrons. Thus, by reducing the dimension of the moderating sphere and using a Zr converter shell, the weight of the system reduces to 10 kg which is less compared to the presently available extended high energy neutron rem meters. The normalized energy dependent ambient dose equivalent response of the zirconium based rem counter (ZReC) at high energies is found to be in good agreement with the energy differential H{sup Low-Asterisk }(10) values suggested by the International Commission on Radiological Protection (ICRP). Based on this study, it is proposed that a rem meter made of 17.8 cm diameter HDPE sphere with 1 cm thick Zr can be used effectively and conveniently for routine monitoring in the accelerator environment.

  6. High energy proton simulation of 14-MeV neutron damage in Al2O3

    International Nuclear Information System (INIS)

    Muir, D.W.; Bunch, J.M.

    1975-01-01

    High-energy protons are a potentially useful tool for simulating the radiation damage produced by 14-MeV neutrons in CTR materials. A comparison is given of calculations and measurements of the relative damage effectiveness of these two types of radiation in single-crystal Al 2 O 3 . The experiments make use of the prominent absorption band at 206 nm as an index to lattice damage, on the assumption that peak absorption is proportional to the concentration of lattice vacancies. The induced absorption is measured for incident proton energies ranging from 5 to 15 MeV and for 14-MeV neutrons. Recoil-energy spectra are calculated for elastic and inelastic scattering using published angular distributions. Recoil-energy spectra also are calculated for the secondary alpha particles and 12 C nuclei produced by (p,p'α) reactions on 16 O. The recoil spectra are converted to damage-energy spectra and then integrated to yield the damage-energy cross section at each proton energy and for 14 MeV neutrons. A comparison of the calculations with experimental results suggests that damage energy, at least at high energies, is a reasonable criterion for estimating this type of radiation damage. (auth)

  7. Development of integrated-type dosimeter responsive to high energy neutrons (2)

    Energy Technology Data Exchange (ETDEWEB)

    Sawamura, Teruko; Murai, Ikuo; Abe, Masashi; Uoyama, Kazuya; Das, Mala [Hokkaido Univ., Sapporo, Hokkaido (Japan); Tuda, Shuichi [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    2003-03-01

    The response of superheated drop detectors or bubble detectors (BDs) was measured for quasi-monoenergetic neutron beams in the 40-75 MeV range. The experiments were performed at the AVF cyclotron facility, TAKASAKI Ion Accelerator for Advanced Radiation Application (TIARA) of Japan Atomic Energy Research Institute (JAERI). The measured dose sensitivities showed to be lowered to about a half the nominal sensitivity. A lead-breeder introduced to extend response to the high energy region were investigated and compared with Monte Carlo calculations by MCNPX code. (author)

  8. Contribution to the development of a primary standard for high energy neutron beams

    International Nuclear Information System (INIS)

    Mancaux, M.

    1983-12-01

    A tissue equivalent calorimeter, made of Shonka A-150 plastic, has been constructed in order to create a primary standard for high energy neutrons and to establish a calibration procedure for ionization chambers used in neutrontherapy. After a detailed description of the calorimeter and the associated measuring system, the preliminary tests are presented, in particular, the evolution of the response as a function of accumulated dose. The measurements of the total absorbed dose (n + γ) by calorimetry in a neutron beam, in order to determine chambers' calibration factors in terms of absorbed dose to A-150 plastic, have been performed at the Neutrontherapy Unit of the Centre Hospitalier Regional d'Orleans. The uncertainty in the determination of the total absorbed dose to the tissu equivalent material using the new procedure is 3% lower than that obtained with the usual procedure, derived from an exposure calibration [fr

  9. Comparison of neutron and high-energy X-ray dual-beam radiography for air cargo inspection

    International Nuclear Information System (INIS)

    Liu, Y.; Sowerby, B.D.; Tickner, J.R.

    2008-01-01

    Dual-beam radiography techniques utilising various combinations of high-energy X-rays and neutrons are attractive for screening bulk cargo for contraband such as narcotics and explosives. Dual-beam radiography is an important enhancement to conventional single-beam X-ray radiography systems in that it provides additional information on the composition of the object being imaged. By comparing the attenuations of transmitted dual high-energy beams, it is possible to build a 2D image, colour coded to indicate material. Only high-energy X-rays, gamma-rays and neutrons have the required penetration to screen cargo containers. This paper reviews recent developments and applications of dual-beam radiography for air cargo inspection. These developments include dual high-energy X-ray techniques as well as fast neutron and gamma-ray (or X-ray) radiography systems. High-energy X-ray systems have the advantage of generally better penetration than neutron systems, depending on the material being interrogated. However, neutron systems have the advantage of much better sensitivity to material composition compared to dual high-energy X-ray techniques. In particular, fast neutron radiography offers the potential to discriminate between various classes of organic material, unlike dual energy X-ray techniques that realistically only offer the ability to discriminate between organic and metal objects

  10. High energy nuclear data evaluations for neutron-, proton-, and photon-induced reactions at KAERI

    International Nuclear Information System (INIS)

    Lee, Young Ouk; Chang, Jong Hwa; Kim, Doo Hwan; Lee, Jeong Yeon; Han, Yinlu; Sukhovitski, Efrem Sh.

    2001-01-01

    The Korea Atomic Energy Research Institute (KAERI) is building high energy neutron-, proton-, and photon-induced nuclear data libraries for energies up to hundreds MeV in response to nuclear data needs from various R and Ds and applications. The librares provide nuclear data needed for the accelerator-driven transmutation of nuclear waste and radiation transport simulations of cancer radiotherapy. The neutron library currently has 10 isotopes such as C-12, N-14, O-16, Al-27, Si-28, Ca-40, Fe-56, Ni-58, Zr-90, Sn-120, and Pb-208 for energies from 20 up to 400 MeV. The proton nuclear data were evaluated in a consistent manner with the neutron case, using the same nuclear model parameters. In addition to the same isotopes included in the neutron library, the proton library has 70 extra isotopes of 24 elements ranging from nitrogen to lead up to 150 MeV for which the evaluations are focused on the medical and activation analyses applications. The photonuclear data library has been built along with international collaboration by participating in the IAEA's Coordinated Research Project (CRP) which ended last year. Currently the KAERI photonuclear library includes 143 isotopes of 39 elements

  11. Monte Carlo simulation for neutron yield produced by bombarding thick targets with high energy heavy ions

    Energy Technology Data Exchange (ETDEWEB)

    Oranj, Leila Mokhtari; Oh, Joo Hee; Yoon, Moo Hyun; Lee, Hee Seock [POSTECH, Pohang (Korea, Republic of)

    2013-04-15

    One of radiation shielding issues at heavy-ion accelerator facilities is to estimate neutron production by primary heavy ions. A few Monte Carlo transport codes such as FLUKA and PHITS can work with primary heavy ions. Recently IBS/RISP((Rare Isotope Science Project) started to design a high-energy, high-power rare isotope accelerator complex for nuclear physics, medical and material science and applications. There is a lack of experimental and simulated data about the interaction of major beam, {sup 238}U with materials. For the shielding design of the end of first accelerating section section, we calculate a differential neutron yield using the FLUKA code for the interaction of 18.5 MeV/u uranium ion beam with thin carbon stripper of 1.3 μm). The benchmarking studies were also done to prove the yield calculation for 400 MeV/n {sup 131}Xe and other heavy ions. In this study, the benchmarking for Xe-C, Xe-Cu, Xe-Al, Xe-Pb and U-C, other interactions were performed using the FLUKA code. All of results show that the FLUKA can evaluate the heavy ion induced reaction with good uncertainty. For the evaluation of neutron source term, the calculated neutron yields are shown in Fig. 2. The energy of Uranium ion beam is only 18.5 MeV/u, but the energy of produced secondary neutrons was extended over 100 MeV. So the neutron shielding and the damage by those neutrons is expected to be serious. Because of thin stripper, the neutron intensity at forward direction was high. But the the intensity of produced secondary photons was relatively low and mostly the angular property was isotropic. For the detail shielding design of stripper section of RISP rare istope accelerator, the benchmarking study and preliminary evaluation of neutron source term from uranium beam have been carried out using the FLUKA code. This study is also compared with the evaluation results using the PHITS code performed coincidently. Both studies shows that two monte carlo codes can give a good results for

  12. Neutron dosimetry in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Miola, U.J.; Ettinger, K.V.

    1981-01-01

    The recent development of various borated compounds and the utilization of one of these (Na 2 B 12 H 11 SH) to treat brain tumors in clinical studies in Japan has renewed interest in neutron capture therapy. In these procedures thermal neutrons interact with 10 B in boron containing cells through the 10 B(n,α) 7 Li reaction producing charged particles with a maximum range of approx. 10μm in tissue. Borated analogs of chlorpromazine, porphyrin, thiouracil and deoxyuridine promise improved tumor uptake and blood clearance. The therapy beam from the Medical Research Reactor in Brookhaven contains neutrons from a modified and filtered fission spectrum and dosimetric consequences of the use of the above mentioned compounds in conjunction with thermal and epithermal fluxes are discussed in the paper. One of the important problems of radiation dosimetry in capture therapy is determination of the flux profile and, hence, the dose profile in the brain. This has been achieved by constructing a brain phantom made of TE plastic. The lyoluminescence technique provides a convenient way of monitoring the neutron flux distributions; the detectors for this purpose utilize 6 Li and 10 B compounds. Such compounds have been synthesized specially for the purpose of dosimetry of thermal and epithermal beams. In addition, standard lyoluminescent phosphors, like glutamine, could be used to determine the collisional component of the dose as well as the contribution of the 14 N(n,p) 14 C reaction. Measurements of thermal flux were compared with calculations and with measurements done with activation foils

  13. Inter-comparison of High Energy Files (neutron-induced, from 20 to 150 MeV)

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Young-Ouk; Fukahori, Tokio [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-11-01

    Recent new applications using accelerator-driven system require well-tested nuclear data when modeling the interaction of neutrons above 20 MeV. This work is aimed to review evaluation methods applied in currently available neutron high energy files above 20 to 150 MeV, to inter-compare their evaluated cross sections on some important isotopes, and to analyze resulting discrepancies. Through out these, integrities and consistencies of the high energy files are checked, applicability of physics models and evaluation methodologies are assessed, and some directions are derived to improve and expand current JENDL High Energy File. (author)

  14. Health physics considerations at a neutron therapy facility cyclotron

    International Nuclear Information System (INIS)

    Kleck, J.H.; Krueger, D.J.; Mc Laughlin, J.E.; Smathers, J.B.

    1987-01-01

    The U.C.L.A. Neutron Therapy Facility (NTF) is one of four such facilities in the United States currently involved in NCI sponsored trials of neutron therapy and reflects the present interest in the use of high energy neutron beams for treating certain types of human cancers. The NTF houses a CP-45 negative ion cyclotron which accelerates a 46 MeV proton beam for production of neutrons from a beryllium target. In addition to patient treatment, the NTF is involved in the production of positron emitting radioisotopes for diagnostic use in Positron Emission Tomography (PET). The activation of therapy treatment collimators, positron and neutron target systems, and a high and rapidly varying external radiation environment in a clinical setting have contributed to the need for a comprehensive radiation control program in which patient care is balanced with the maintenance of occupational exposures to ALARA levels

  15. In vivo transcriptome modulation after low dose of high energy neutron irradiation

    Energy Technology Data Exchange (ETDEWEB)

    Amendola, R; Fratini, E; Piscitelli, M; Sallustio, D E [ENEA, BAS BIOTEC MED, Roma (Italy); Angelone, M; Pillon, M [ENEA, FUS TEC, Frascati (Italy); Chiani, F; Licursi, V; Negri, R [Universita La Sapienza, Roma (Italy). Dip. Biologia Cellulare e dello Sviluppo

    2007-07-01

    Complete text of publication follows. Objective: This project aims to the identification of an hypothetical transcriptome modulation of mouse peripheral blood lymphocytes and skin after exposure to high energy neutron in vivo. Positive candidate genes isolated from mice in in vivo experiments will be selected and evaluated for both radioprotection issues dealing with cosmic ray exposure, and for biomedical issues mainly for low doses and non-cancer effects. Methods: High energy neutron irradiation is performed at the ENEA Frascati, neutron generator facilities (FNG), specifically dedicated to biological samples. FNG is a linear electrostatic accelerator that produces up to 1.0 x 10{sup 11} n/s 14 MeV neutrons via the D-T nuclear reaction. The dose-rate applied for this study is of 0.7 cGy/min. The functional genomic approach has been performed on six animals for each experimental points: un-irradiated; 20 cGy, 6 hours and 24 hours delayed time after exposure. Preliminarily, a pool of total RNA is evaluated on commercial micro-arrays containing large collections of mus musculus cDNAs. Statistical filtering and functional clustering of the data is carried out using dedicated software packages. Results: Candidate genes are selected on the basis of responsiveness to 20 cGy of exposure, with a defined temporal regulation. We plan to organize a systematic screen focused on genes responding to our selection criteria, in in vivo mouse experiments, and correlate their differential expression to the human counterparts. A specific cross species database will be created with all the functional information available in standardized format (MIAME: minimal information about micro-arrays experiments). Conclusions: A lack of information on in vivo experiments is still evident for low doses exposure, especially for neutron of cosmic interest. Individual susceptibility, extensive number of animals to be processed, lack of standardization methodologies are among problems to be solved

  16. Pilot study for the implantation of a high-energy neutrons field

    International Nuclear Information System (INIS)

    Pinto, Jose Julio de O.; Mendes, Adriane C.; Federico, Claudio A.; Passaro, Angelo; Gaspar, Felipe de B.; Pazianotto, Mauricio T.

    2013-01-01

    In this work a theoretical study is presented for the implementation of a high-energy neutron field (14.1 MeV) produced by a neutron generator type DT (deuterium-tritium), to be installed in the premises of the Laboratorio de Radiacoes Ionizantes (LRI) of the Instituto de Estudos Avancados (IEAv). This evaluation was performed by means of computer simulation by Monte Carlo method, using the computer code MCNP5 (Monte Carlo N-Particle). The neutron spectra were simulated computationally for pre-selected points of the installation, allowing to estimate the beam quality in the positions provided for use of the direct beam. These simulations also allow assist the basement of a project to install the consistent D-T generator with the guidelines for radiation protection and radiation safety standards determined by the Comissao Nacional de Energia Nuclear (CNEN), by estimating the dose rates provided in accessible points to Individuals Occupationally Exposed (IOE) in the facility. The computational determination of spectra, fluxes and doses produced in different positions previously selected within and outside the laboratory, will serve as guidance from previous studies for the future installation of this generator in the physical facilities of the LRI

  17. Personal dosimetry in a mixed field of high energy muons and neutrons

    International Nuclear Information System (INIS)

    Cossairt, J.D.; Elwyn, A.J.

    1986-11-01

    High energy accelerators quite often emit muons. These particles behave in matter as would heavy electrons and are thus difficult to attenuate with shielding in many situations. Hence, these muons can be a source of radiation exposure to personnel and suitable methods of measuring the absorbed dose received to these people is obviously required. In practical situations, such muon radiation fields are often mixed with neutrons, well-known to be an even more troublesome particle species with respect to dosimetry. In this paper, we report on fluence measurements made in such a mixed radiation field and a comparison of dosimeter responses. We conclude that commercial self-reading dosimeters and film badges provided an adequate measure of the absorbed dose due to muons

  18. The Biological Effect of Fast Neutrons and High-Energy Protons

    International Nuclear Information System (INIS)

    Moskalev, Ju.I.; Petrovich, I.K.; Strel'cova, V.N.

    1964-01-01

    The paper gives the results of comparative experiments on the effects of fast neutrons and high-energy protons (500 MeV) on life expectancy, peripheral blood, incidence and rate of appearance of tumours in the rat as a function of administered dose and time of observation. The neutron experiment was performed on 573 and the proton experiment on 490 white rats. The animals irradiated with fast neutrons were given doses between 8.5 and 510 rad, and those irradiated with protons received doses between 28 and 1008 rad. The effective doses for the acute, sub-acute and chronic forms of sickness were established for fast neutrons and for protons. LD 50/30 for neutrons was 408 and for protons 600 rad, and the corresponding LD 50 / 120 values were 380 and 600 rad. The conditions governing rat mortality were analysed both in the early and the later stages of the experiment. It is shown that the average life expectancy of rats irradiated with fast neutrons does not depend on sex. The shape of the dose-effect curve for the various peripheral-blood indexes is strongly dependent not only on the radiosensitivity of the blood cells in question but also on the time of observation. It may change greatly in time for one and the same index. A considerable time after irradiation with either fast neutrons or protons, benign and malignant tumours appear in different tissues of the rats, including the haemopoeitic tissues, mammary glands, pituitary, uterus, ovaries, prostate gland, testicles, liver, kidneys, lungs, gastro-intestinal tract, subcutaneous tissue, lymph nodes, urinary bladder, etc. The over-all incidence of tumours and the number of cases of multi centred neoplasms in females are two to three times higher than in males. The minimum tumour dose for the mammary glands with neutron irradiation is apparently rather less than 42.5 rad. The maximum incidence of tumours of the pituitary is found after irradiation with a dose of 42.5 rad.- At this same dose leucosis and tumour of the

  19. High-energy extracorporeal shock wave therapy as a treatment for chronic noninsertional Achilles tendinopathy.

    Science.gov (United States)

    Furia, John P

    2008-03-01

    High-energy extracorporeal shock wave therapy has been shown to be an effective treatment for chronic insertional Achilles tendinopathy. The results of high-energy shock wave therapy for chronic noninsertional Achilles tendinopathy have not been determined. Shock wave therapy is an effective treatment for noninsertional Achilles tendinopathy. Case control study; Level of evidence, 3. Thirty-four patients with chronic noninsertional Achilles tendinopathy were treated with a single dose of high-energy shock wave therapy (shock wave therapy group; 3000 shocks; 0.21 mJ/mm(2); total energy flux density, 604 mJ/mm(2)). Thirty-four patients with chronic noninsertional Achilles tendinopathy were treated not with shock wave therapy but with additional forms of nonoperative therapy (control group). All shock wave therapy procedures were performed using regional anesthesia. Evaluation was by change in visual analog score and by Roles and Maudsley score. One month, 3 months, and 12 months after treatment, the mean visual analog scores for the control and shock wave therapy groups were 8.4 and 4.4 (P wave therapy and control groups were 12 and 0 (P wave therapy group than in the control group (P wave therapy is an effective treatment for chronic noninsertional Achilles tendinopathy.

  20. High-energy neutron yields in interactions of carbon ions with 114Sn and 124Sn nuclei

    International Nuclear Information System (INIS)

    Blinov, M.B.; Gavrilov, B.P.; Kovalenko, S.S.; Kozulin, Eh.M.; Mozhaev, A.N.; Oganesyan, Yu.Ts.; Penionzhkevich, Yu.Eh.

    1984-01-01

    The measurements of the yields of neutrons (energy more than 5 MeV) emitted in the interactions of carbon-12 ions (9 MeV/nucl.) with nuclei of two tin isotopes are conducted. The results obtained prove the effect of nucleon composition of a nucleus on the process of formation of high-energy neutrons. To clarify the concrete interaction mechanism it is necessary to perform systematic research for a number of isotopes differing in the relation of the number of neutrons and protons and binding energies of the last neutron

  1. A Benchmarking Study of High Energy Carbon Ion Induced Neutron Using Several Monte Carlo Codes

    Energy Technology Data Exchange (ETDEWEB)

    Kim, D. H.; Oh, J. H.; Jung, N. S.; Lee, H. S. [Pohang Accelerator Laboratory, Pohang (Korea, Republic of); Shin, Y. S.; Kwon, D. Y.; Kim, Y. M. [Catholic Univ., Gyeongsan (Korea, Republic of); Oranj, L. Mokhtari [POSTECH, Pohang (Korea, Republic of)

    2014-10-15

    In this study, the benchmarking study was done for the representative particle interaction of the heavy ion accelerator, especially carbon-induced reaction. The secondary neutron is an important particle in the shielding analysis to define the source term and penetration ability of radiation fields. The performance of each Monte Carlo codes were verified for selected codes: MCNPX 2.7, PHITS 2.64 and FLUKA 2011.2b.6. For this benchmarking study, the experimental data of Kurosawa et al. in the SINBAD database of NEA was applied. The calculated results of the differential neutron yield produced from several materials irradiated by high energy carbon beam reproduced the experimental data well in small uncertainty. But the MCNPX results showed large discrepancy with experimental data, especially at the forward angle. The calculated results were lower a little than the experimental and it was clear in the cases of lower incident carbon energy, thinner target and forward angle. As expected, the influence of different model was found clearly at forward direction. In the shielding analysis, these characteristics of each Monte Carlo codes should be considered and utilized to determine the safety margin of a shield thickness.

  2. A Benchmarking Study of High Energy Carbon Ion Induced Neutron Using Several Monte Carlo Codes

    International Nuclear Information System (INIS)

    Kim, D. H.; Oh, J. H.; Jung, N. S.; Lee, H. S.; Shin, Y. S.; Kwon, D. Y.; Kim, Y. M.; Oranj, L. Mokhtari

    2014-01-01

    In this study, the benchmarking study was done for the representative particle interaction of the heavy ion accelerator, especially carbon-induced reaction. The secondary neutron is an important particle in the shielding analysis to define the source term and penetration ability of radiation fields. The performance of each Monte Carlo codes were verified for selected codes: MCNPX 2.7, PHITS 2.64 and FLUKA 2011.2b.6. For this benchmarking study, the experimental data of Kurosawa et al. in the SINBAD database of NEA was applied. The calculated results of the differential neutron yield produced from several materials irradiated by high energy carbon beam reproduced the experimental data well in small uncertainty. But the MCNPX results showed large discrepancy with experimental data, especially at the forward angle. The calculated results were lower a little than the experimental and it was clear in the cases of lower incident carbon energy, thinner target and forward angle. As expected, the influence of different model was found clearly at forward direction. In the shielding analysis, these characteristics of each Monte Carlo codes should be considered and utilized to determine the safety margin of a shield thickness

  3. A shielding design for an accelerator-based neutron source for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Hawk, A.E.; Blue, T.E. E-mail: blue.1@osu.edu; Woollard, J.E

    2004-11-01

    Research in boron neutron capture therapy (BNCT) at The Ohio State University Nuclear Engineering Department has been primarily focused on delivering a high quality neutron field for use in BNCT using an accelerator-based neutron source (ABNS). An ABNS for BNCT is composed of a proton accelerator, a high-energy beam transport system, a {sup 7}Li target, a target heat removal system (HRS), a moderator assembly, and a treatment room. The intent of this paper is to demonstrate the advantages of a shielded moderator assembly design, in terms of material requirements necessary to adequately protect radiation personnel located outside a treatment room for BNCT, over an unshielded moderator assembly design.

  4. Middle Atlantic neutron therapy trail

    International Nuclear Information System (INIS)

    Rogers, C.

    1975-01-01

    A consortium of therapeutic radiologists in the Middle Atlantic States and physicists at the Naval Research Laboratory has been established to investigate the use of fast neutron beams in the control of some tumors. Many radiobiology experiments have indicated that neutron beams may have an advantage in the control of local tumors over that of conventional forms of radiotherapy. In preparation for clinical radiotherapy trials, extensive measurements have quantified the various physical characteristics of the NRL cyclotron-produced neutron beam. Techniques have been developed for the absolute determination of delivered dose at depth in tissue for this beam, accounting for the relatively small component of dose delivered by gamma rays, as well as that by the neutrons. A collimator system has been designed to allow the precise field definition necessary for optimum therapy treatment planning. A dose control and monitor unit has been engineered and has demonstrated a reproducibility of 0.2 percent. The relative biological effectiveness of this neutron bean has been studied with several biological systems to aid in determining proper radiotherapeutic dose levels. The objective of these studies is a full-scale clinical radiotherapy trial to test neutron effectiveness as compared to that of conventional radiotherapy, after a pilot study in man

  5. Towards gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Stalpers, L.; Kuipers, S.; Vroegindeweij, C.; Stecher-Rasmussen, F.; Slotman, B.

    2000-01-01

    As glioblastoma multiforme has macroscopic areas with poor vascularisation, and thereby poor uptake of an NCT-agent, the long-range γ-rays from GdNCT might enhance dose deposition compared to BNCT and to conformal photon therapy. Multicellular spheroids from a human glioblastoma cell line (Gli-6) were irradiated with conventional X-rays, with neutrons only (from the NRG Argonaut Reactor, LFR), and with neutrons (from the LFR) + 157 Gd-DTPA (240 ppm 157 Gd). Preliminary results demonstrate that after neutron irradiation in the presence of 157 Gd, the spheroids showed growth arrest. By 3D treatment planning calculations on MRI's from patients with brain tumours, dose volume histograms (DVH) for GdNCT were compared to DVH for conventional conformal radiotherapy. The calculations indicate that GdNCT on patients with large, deep-seated tumours yields better tumour/brain dose distribution than conformal radiotherapy. (author)

  6. Radiobiology of boron neutron capture therapy

    International Nuclear Information System (INIS)

    Bond, V.P.

    1986-01-01

    The author addresses the question of single session versus protracted therapy in the application of boron neutron therapy to tumors. As background he discusses the reasoning behind the current use of fractionated therapy with conventional low-LET radiations and difference which may obtain for neutron therapy. Several aspects of dose rates and dose levels are then addressed

  7. High energy dosimetry

    International Nuclear Information System (INIS)

    Ruhm, W.

    2010-01-01

    Full text: Currently, quantification of doses from high-energy radiation fields is a topical issue. This is so because high-energy neutrons play an important role for radiation exposure of air crew members and personnel outside the shielding of ion therapy facilities. In an effort to study air crew exposure from cosmic radiation in detail, two Bonner Sphere Spectrometers (BSSs) have recently been installed to measure secondary neutrons from cosmic radiation, one at the environmental research station 'Schneefernerhaus' at an altitude of 2650 m on the Zugspitze mountain, Germany, the other at the Koldewey station close to the North Pole on Spitsbergen. Based on the measured neutron fluence distributions and on fluence-to-dose conversion coefficients, mean ambient dose equivalent rate values of 75.0 ± 2.9 nSv/h and 8.7 ± 0.6 nSv/h were obtained for October 2008, respectively. Neutrons with energies above about 20 MeV contribute about 50% to dose, at 2650 m. Ambient dose equivalent rates measured by means of a standard rem counter and an extended rem counter at the Schneefernerhaus confirm this result. In order to study the response of state-of-the-art radiation instrumentation in such a high-energy radiation field, a benchmark exercise that included both measurements in and simulation of the stray neutron radiation field at the high-energy particle accelerator at GSI, Germany, were performed. This CONRAD (COordinated Network for RAdiation Dosimetry) project was funded by the European Commission, and the organizational framework was provided by the European Radiation Dosimetry Group, EURADOS. The Monte Carlo simulations of the radiation field and the experimental determination of the neutron spectra with various Bonner Sphere Spectrometers suggest the neutron fluence distributions to be very similar to those of secondary neutrons from cosmic radiation. The results of this intercomparison exercise in terms of ambient dose equivalent are also discussed

  8. Measurement assurance studies of high-energy electron and photon dosimetry in radiation-therapy applications

    Energy Technology Data Exchange (ETDEWEB)

    Ehrlich, M; Soares, C G [National Bureau of Standards, Washington, DC (USA)

    1981-08-01

    This is a brief review of surveys on the dosimetry of radiation-therapy beams by the National Bureau of Standards (NBS). Covered are the NBS ferrous-sulfate (Fricke) dosimetry service, a recently completed survey carried out with thermoluminescence dosimeters (TLD) on the dosimetry in cobalt-60 teletherapy beams, and plans for a TLD survey of dosimetry in high-energy bremsstrahlung beams.

  9. Applicability of the two-angle differential method to response measurement of neutron-sensitive devices at the RCNP high-energy neutron facility

    Energy Technology Data Exchange (ETDEWEB)

    Masuda, Akihiko, E-mail: aki-masuda@aist.go.jp [National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568 (Japan); Matsumoto, Tetsuro [National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568 (Japan); Iwamoto, Yosuke [Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai, Naka, Ibaraki 319-1195 (Japan); Hagiwara, Masayuki [High Energy Accelerator Research Organization (KEK), 1-1 Oho, Tsukuba, Ibaraki 305-0801 (Japan); Satoh, Daiki; Sato, Tatsuhiko [Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai, Naka, Ibaraki 319-1195 (Japan); Iwase, Hiroshi [High Energy Accelerator Research Organization (KEK), 1-1 Oho, Tsukuba, Ibaraki 305-0801 (Japan); Yashima, Hiroshi [Research Reactor Institute, Kyoto University, 2-1010 Asashiro-nishi, Kumatori, Sennan, Osaka 590-0494 (Japan); Nakane, Yoshihiro [Japan Atomic Energy Agency (JAEA), 2-4 Shirakata, Tokai, Naka, Ibaraki 319-1195 (Japan); Nishiyama, Jun [Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro, Tokyo 152-8550 (Japan); Shima, Tatsushi; Tamii, Atsushi; Hatanaka, Kichiji [Research Center for Nuclear Physics (RCNP), Osaka University, 10-1 Mihogaoka, Ibaraki, Osaka 567-0047 (Japan); Harano, Hideki [National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568 (Japan); Nakamura, Takashi [Cyclotron and Radioisotope Center (CYRIC), Tohoku University, 6-3 Aramaki, Aoba, Sendai, Miyagi 980-8578 (Japan)

    2017-03-21

    Quasi-monoenergetic high-energy neutron fields induced by {sup 7}Li(p,n) reactions are used for the response evaluation of neutron-sensitive devices. The quasi-monoenergetic high-energy field consists of high-energy monoenergetic peak neutrons and unwanted continuum neutrons down to the low-energy region. A two-angle differential method has been developed to compensate for the effect of the continuum neutrons in the response measurements. In this study, the two-angle differential method was demonstrated for Bonner sphere detectors, which are typical examples of moderator-based neutron-sensitive detectors, to investigate the method's applicability and its dependence on detector characteristics. Experiments were performed under 96–387 MeV quasi-monoenergetic high-energy neutron fields at the Research Center for Nuclear Physics (RCNP), Osaka University. The measurement results for large high-density polyethylene (HDPE) sphere detectors agreed well with Monte Carlo calculations, which verified the adequacy of the two-angle differential method. By contrast, discrepancies were observed in the results for small HDPE sphere detectors and metal-induced sphere detectors. The former indicated that detectors that are particularly sensitive to low-energy neutrons may be affected by penetrating neutrons owing to the geometrical features of the RCNP facility. The latter discrepancy could be consistently explained by a problem in the evaluated cross-section data for the metals used in the calculation. Through those discussions, the adequacy of the two-angle differential method was experimentally verified, and practical suggestions were made pertaining to this method.

  10. Response of CR-39 SSNTD to high energy neutrons using zirconium convertors - a Monte Carlo and experimental study

    International Nuclear Information System (INIS)

    Pal, Rupali; Sapra, B.K.; Bakshi, A.K.; Datta, D.; Biju, K.; Suryanarayana, S.V.; Nayak, B.K.

    2016-01-01

    Neutron dosimetry in ion accelerators is a challenging field as the neutron spectrum varies from thermal, to fast and high-energy neutrons usually extending beyond 20 MeV. Solid-state Nuclear Track Detectors (SSNTDs) have been increasingly used in numerous fields related to nuclear physics. Extensive work has also been carried out on determining the response characteristics of such detectors as nuclear spectrometers. In nuclear reaction studies, identification of reaction products according to their type and energy is frequently required. For normally incident particles, energy-dispersive track-diameter methods have become useful scientific tools using CR-39 SSNTD. CR-39 along with 1 mm polyethylene convertor can cover a neutron energy range from 100 keV to 10 MeV. The neutron interacts with the hydrogen in CR-39 producing recoil protons from elastic collisions. This detectable neutron energy range can be increased by modification in the radiator/convertor used along with CR-39. CR39 detectors placed in conjunction with judiciously chosen thicknesses of a polyethylene radiator and a lead absorber (or degrader) are used to increase energy range upto 19 MeV. A portable neutron counter has been proposed for high-energy neutron measurement with 1 cm thick Zirconium (Zr) as the converter outside a spherical HDPE shell of 7 inch diameter. Zr metal has been found to show (n,2n) cross section for energies above 10 MeV starting from 0.01 barns for 8 MeV upto 1 barns for 22 MeV. Above these energies, the experimental data is scarce. In this paper, Zr was used in conjunction with CR-39 which showed an enhancement of track density on the CR-39. This paper demonstrates the enhancement of neutron response using Zr on CR-39 with both theoretical and experimental studies

  11. Workshop on neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Fairchild, R.G.; Bond, V.P. (eds.)

    1986-01-01

    Potentially optimal conditions for Neutron Capture Therapy (NCT) may soon be in hand due to the anticipated development of band-pass filtered beams relatively free of fast neutron contaminations, and of broadly applicable biomolecules for boron transport such as porphyrins and monoclonal antibodies. Consequently, a number of groups in the US are now devoting their efforts to exploring NCT for clinical application. The purpose of this Workshop was to bring these groups together to exchange views on significant problems of mutual interest, and to assure a unified and effective approach to the solutions. Several areas of preclinical investigation were deemed to be necessary before it would be possible to initiate clinical studies. As neither the monomer nor the dimer of sulfhydryl boron hydride is unequivocally preferable at this time, studies on both compounds should be continued until one is proven superior.

  12. Workshop on neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Bond, V.P.

    1986-01-01

    Potentially optimal conditions for Neutron Capture Therapy (NCT) may soon be in hand due to the anticipated development of band-pass filtered beams relatively free of fast neutron contaminations, and of broadly applicable biomolecules for boron transport such as porphyrins and monoclonal antibodies. Consequently, a number of groups in the US are now devoting their efforts to exploring NCT for clinical application. The purpose of this Workshop was to bring these groups together to exchange views on significant problems of mutual interest, and to assure a unified and effective approach to the solutions. Several areas of preclinical investigation were deemed to be necessary before it would be possible to initiate clinical studies. As neither the monomer nor the dimer of sulfhydryl boron hydride is unequivocally preferable at this time, studies on both compounds should be continued until one is proven superior

  13. Neutron capture therapy with thermal neutrons at IRT MIFI

    International Nuclear Information System (INIS)

    Zajtsev, K.N.; Portnov, A.A.; Savkin, V.A.; Kulakov, V.N.; Khokhlov, V.F.; Shejno, I.N.; Vajnson, A.A.; Kozlovskaya, N.G.; Meshcherikova, V.V.; Mitin, V.N.; Yarmonenko, S.P.

    2001-01-01

    Combined preclinical investigations into neutron capture therapy are conducted. Malignant melanoma was adopted as the line of investigation; boron-containing and gadolinium-containing preparations were used during the neutron capture therapy working off. Preparations produce secondary varying radiations when used in tumor. Dogs with spontaneous melanoma were used for the experiments. Procedures for the irradiation of dogs by neutron beam as the stage before use for the treatment of oncology patients were finished off; efficiency of neutron beam influence on normal tissues during the irradiation of dogs with melanoma (and without it) in antitumor and side effect sense was estimated [ru

  14. Neutron capture therapy for melanoma

    Energy Technology Data Exchange (ETDEWEB)

    Coderre, J.A.; Glass, J.D.; Micca, P.; Fairchild, R.G.

    1988-01-01

    The development of boron-containing compounds which localize selectively in tumor may require a tumor-by-tumor type of approach that exploits any metabolic pathways unique to the particular type of tumor. Melanin-producing melanomas actively transport and metabolize aromatic amino acids for use as precursors in the synthesis of the pigment melanin. It has been shown that the boron-containing amino acid analog p-borono-phenylalanine (BPA) is selectively accumulated in melanoma tissue, producing boron concentrations in tumor that are within the range estimated to be necessary for successful boron neutron capture therapy (BNCT). We report here the results of therapy experiments carried out at the Brookhaven Medical Research Reactor (BMRR). 21 refs., 5 figs., 3 tabs.

  15. Neutron capture therapy for melanoma

    International Nuclear Information System (INIS)

    Coderre, J.A.; Glass, J.D.; Micca, P.; Fairchild, R.G.

    1988-01-01

    The development of boron-containing compounds which localize selectively in tumor may require a tumor-by-tumor type of approach that exploits any metabolic pathways unique to the particular type of tumor. Melanin-producing melanomas actively transport and metabolize aromatic amino acids for use as precursors in the synthesis of the pigment melanin. It has been shown that the boron-containing amino acid analog p-borono-phenylalanine (BPA) is selectively accumulated in melanoma tissue, producing boron concentrations in tumor that are within the range estimated to be necessary for successful boron neutron capture therapy (BNCT). We report here the results of therapy experiments carried out at the Brookhaven Medical Research Reactor (BMRR). 21 refs., 5 figs., 3 tabs

  16. Utilizing horizontal reactors channels for neutron therapy

    International Nuclear Information System (INIS)

    Stankovsky, E.Yu.; Kurachenko, Yu.A.

    2000-01-01

    Two experimental heterogeneous reactors have been considered. The reactors may be applied in neutron capture therapy and in a conventional manner. The channel out of the core serves as the neutron source. At each of these facilities, both fast and epithermal neutron fluxes for BNCT research, human clinical trials, and characterized common computational techniques have been evaluated. (authors)

  17. New measurement system for on line in core high-energy neutron flux monitoring in materials testing reactor conditions

    Science.gov (United States)

    Geslot, B.; Vermeeren, L.; Filliatre, P.; Lopez, A. Legrand; Barbot, L.; Jammes, C.; Bréaud, S.; Oriol, L.; Villard, J.-F.

    2011-03-01

    Flux monitoring is of great interest for experimental studies in material testing reactors. Nowadays, only the thermal neutron flux can be monitored on line, e.g., using fission chambers or self-powered neutron detectors. In the framework of the Joint Instrumentation Laboratory between SCK-CEN and CEA, we have developed a fast neutron detector system (FNDS) capable of measuring on line the local high-energy neutron flux in fission reactor core and reflector locations. FNDS is based on fission chambers measurements in Campbelling mode. The system consists of two detectors, one detector being mainly sensitive to fast neutrons and the other one to thermal neutrons. On line data processing uses the CEA depletion code DARWIN in order to disentangle fast and thermal neutrons components, taking into account the isotopic evolution of the fissile deposit. The first results of FNDS experimental test in the BR2 reactor are presented in this paper. Several fission chambers have been irradiated up to a fluence of about 7 × 1020 n/cm2. A good agreement (less than 10% discrepancy) was observed between FNDS fast flux estimation and reference flux measurement.

  18. New measurement system for on line in core high-energy neutron flux monitoring in materials testing reactor conditions

    Energy Technology Data Exchange (ETDEWEB)

    Geslot, B.; Filliatre, P.; Barbot, L.; Jammes, C.; Breaud, S.; Oriol, L.; Villard, J.-F. [CEA, DEN, Cadarache, SPEx/LDCI, F-13108 Saint-Paul-lez-Durance (France); Vermeeren, L. [SCK-CEN, Boeretang 200, B-2400 Mol (Belgium); Lopez, A. Legrand [CEA, DEN, Saclay, SIREN/LECSI, F-91400 Saclay (France)

    2011-03-15

    Flux monitoring is of great interest for experimental studies in material testing reactors. Nowadays, only the thermal neutron flux can be monitored on line, e.g., using fission chambers or self-powered neutron detectors. In the framework of the Joint Instrumentation Laboratory between SCK-CEN and CEA, we have developed a fast neutron detector system (FNDS) capable of measuring on line the local high-energy neutron flux in fission reactor core and reflector locations. FNDS is based on fission chambers measurements in Campbelling mode. The system consists of two detectors, one detector being mainly sensitive to fast neutrons and the other one to thermal neutrons. On line data processing uses the CEA depletion code DARWIN in order to disentangle fast and thermal neutrons components, taking into account the isotopic evolution of the fissile deposit. The first results of FNDS experimental test in the BR2 reactor are presented in this paper. Several fission chambers have been irradiated up to a fluence of about 7 x 10{sup 20} n/cm{sup 2}. A good agreement (less than 10% discrepancy) was observed between FNDS fast flux estimation and reference flux measurement.

  19. New measurement system for on line in core high-energy neutron flux monitoring in materials testing reactor conditions

    International Nuclear Information System (INIS)

    Geslot, B.; Filliatre, P.; Barbot, L.; Jammes, C.; Breaud, S.; Oriol, L.; Villard, J.-F.; Vermeeren, L.; Lopez, A. Legrand

    2011-01-01

    Flux monitoring is of great interest for experimental studies in material testing reactors. Nowadays, only the thermal neutron flux can be monitored on line, e.g., using fission chambers or self-powered neutron detectors. In the framework of the Joint Instrumentation Laboratory between SCK-CEN and CEA, we have developed a fast neutron detector system (FNDS) capable of measuring on line the local high-energy neutron flux in fission reactor core and reflector locations. FNDS is based on fission chambers measurements in Campbelling mode. The system consists of two detectors, one detector being mainly sensitive to fast neutrons and the other one to thermal neutrons. On line data processing uses the CEA depletion code DARWIN in order to disentangle fast and thermal neutrons components, taking into account the isotopic evolution of the fissile deposit. The first results of FNDS experimental test in the BR2 reactor are presented in this paper. Several fission chambers have been irradiated up to a fluence of about 7 x 10 20 n/cm 2 . A good agreement (less than 10% discrepancy) was observed between FNDS fast flux estimation and reference flux measurement.

  20. Measurement assurance studies of high-energy electron and photon dosimetry in radiation-therapy applications

    International Nuclear Information System (INIS)

    Ehrlich, M.; Soares, C.G.

    1981-01-01

    This is a brief review of surveys on the dosimetry of radiation-therapy beams by the National Bureau of Standards (NBS). Covered are the NBS ferrous-sulfate (Fricke) dosimetry service, a recently completed survey carried out with thermoluminescence dosimeters (TLD) on the dosimetry in cobalt-60 teletherapy beams, and plans for a TLD survey of dosimetry in high-energy bremsstrahlung beams. (author)

  1. The Efficiency of the BC-720 Scintillator in a High-Energy (20--800 MeV) Accelerator Neutron Field

    Energy Technology Data Exchange (ETDEWEB)

    Miles, Leslie H. [Univ. of Missouri, Columbia, MO (United States)

    2005-12-01

    High-energy neutron doses (>20 MeV) are of little importance to most radiation workers. However, space and flight crews, and people working around medical and scientific accelerators receive over half of their radiation dose from high-energy neutrons. Unfortunately, neutrons are difficult to measure, and no suitable dosimetry has yet been developed to measure this radiation. In this paper, basic high-energy neutron interactions, characteristics of high-energy neutron environments, present neutron dosimetry, and quantities used in neutron dosimetry are discussed before looking into the potential of the BC-720 scintillator to improve dosimetry. This research utilized 800 MeV protons impinging upon the WNR Facility spallation neutron source at Los Alamos National Laboratory. Time-of-flight methods and a U-238 Fission Chamber were used to aid evaluation of the efficiency of the BC-720. Results showed that the efficiency is finite over the 20–650 MeV energy region studied, although it decreases by a factor of ten between 40 and 100 MeV. This limits the use of this dosimeter to measure doses at sitespecific locations. It also encourages modifications to use this dosimeter for any unknown neutron field. As such, this dosimeter has the potential for a small, lightweight, real-time dose measurement, which could impact neutron dosimetry in all high-energy neutron environments.

  2. Accelerator based neutron source for neutron capture therapy

    International Nuclear Information System (INIS)

    Salimov, R.; Bayanov, B.; Belchenko, Yu.; Belov, V.; Davydenko, V.; Donin, A.; Dranichnikov, A.; Ivanov, A.; Kandaurov, I; Kraynov, G.; Krivenko, A.; Kudryavtsev, A.; Kursanov, N.; Savkin, V.; Shirokov, V.; Sorokin, I.; Taskaev, S.; Tiunov, M.

    2004-01-01

    Full text: The Budker Institute of Nuclear Physics (Novosibirsk) and the Institute of Physics and Power Engineering (Obninsk) have proposed an accelerator based neutron source for neutron capture and fast neutron therapy for hospital. Innovative approach is based upon vacuum insulation tandem accelerator (VITA) and near threshold 7 Li(p,n) 7 Be neutron generation. Pilot accelerator based neutron source for neutron capture therapy is under construction now at the Budker Institute of Nuclear Physics, Novosibirsk, Russia. In the present report, the pilot facility design is presented and discussed. Design features of facility components are discussed. Results of experiments and simulations are presented. Complete experimental tests are planned by the end of the year 2005

  3. Monte Carlo codes use in neutron therapy

    International Nuclear Information System (INIS)

    Paquis, P.; Mokhtari, F.; Karamanoukian, D.; Pignol, J.P.; Cuendet, P.; Iborra, N.

    1998-01-01

    Monte Carlo calculation codes allow to study accurately all the parameters relevant to radiation effects, like the dose deposition or the type of microscopic interactions, through one by one particle transport simulation. These features are very useful for neutron irradiations, from device development up to dosimetry. This paper illustrates some applications of these codes in Neutron Capture Therapy and Neutron Capture Enhancement of fast neutrons irradiations. (authors)

  4. Nuclear data needed for neutron therapy

    International Nuclear Information System (INIS)

    Okamoto, K.

    1988-03-01

    This is the summary report of the First Research Co-ordination Meeting of the IAEA Co-ordinated Research Programme (CRP) on Nuclear Data Needed for Neutron Therapy, convened by the IAEA Nuclear Data Section in Vienna, from 17 to 20 November 1987. The main objectives of the CRP are to improve the present state of nuclear data for neutron therapy. (author)

  5. A hospital-based proton linac for neutron therapy and radioisotope production

    International Nuclear Information System (INIS)

    Lennox, A.J.

    1988-10-01

    Fermilab's Alvarez proton linac has been used routinely for neutron therapy since 1976. The Neutron Therapy Facility (NTF) operates in a mode parasitic to the laboratory's high energy physics program, which uses the linac as an injector for a synchrotron. Parasitic operation is possible because the linac delivers /approximately/1.2 /times/ 10 13 protons per pulse at a 15 Hz rate, while the high energy physics program requires beam at a rate not greater than 0.5 Hz. Protons not needed for physics experiments strike a beryllium target to produce neutrons for neutron therapy. Encouraging clinical results from NTF have led to a study of the issues involved in providing hospitals with a neutron beam of the type available at Fermilab. This paper describes the issues addressed by that study. 12 refs., 1 fig., 1 tab

  6. Study of particle size distribution and formation mechanism of radioactive aerosols generated in high-energy neutron fields

    CERN Document Server

    Endo, A; Noguchi, H; Tanaka, S; Iida, T; Furuichi, S; Kanda, Y; Oki, Y

    2003-01-01

    The size distributions of sup 3 sup 8 Cl, sup 3 sup 9 Cl, sup 8 sup 2 Br and sup 8 sup 4 Br aerosols generated by irradiations of argon and krypton gases containing di-octyl phthalate (DOP) aerosols with 45 MeV and 65 MeV quasi-monoenergetic neutrons were measured in order to study the formation mechanism of radioactive particles in high energy radiation fields. The effects of the size distribution of the radioactive aerosols on the size of the added DOP aerosols, the energy of the neutrons and the kinds of nuclides were studied. The observed size distributions of the radioactive particles were explained by attachment of the radioactive atoms generated by the neutron-induced reactions to the DOP aerosols. (author)

  7. A parametric model to describe neutron spectra around high-energy electron accelerators and its application in neutron spectrometry with Bonner Spheres

    Science.gov (United States)

    Bedogni, Roberto; Pelliccioni, Maurizio; Esposito, Adolfo

    2010-03-01

    Due to the increased interest of the scientific community in the applications of synchrotron light, there is an increasing demand of high-energy electron facilities, testified by the construction of several new facilities worldwide. The radiation protection around such facilities requires accurate experimental methods to determine the dose due to prompt radiation fields. Neutron fields, in particular, are the most complex to measure, because they extend in energy from thermal (10 -8 MeV) up to hundreds MeV and because the responses of dosemeters and survey meters usually have large energy dependence. The Bonner Spheres Spectrometer (BSS) is in practice the only instrument able to respond over the whole energy range of interest, and for this reason it is frequently used to derive neutron spectra and dosimetric quantities in accelerator workplaces. Nevertheless, complex unfolding algorithms are needed to derive the neutron spectra from the experimental BSS data. This paper presents a parametric model specially developed for the unfolding of the experimental data measured with BSS around high-energy electron accelerators. The work consists of the following stages: (1) Generation with the FLUKA code, of a set of neutron spectra representing the radiation environment around accelerators with different electron energies; (2) formulation of a parametric model able to describe these spectra, with particular attention to the high-energy component (>10 MeV), which may be responsible for a large part of the dose in workplaces; and (3) implementation of this model in an existing unfolding code.

  8. A parametric model to describe neutron spectra around high-energy electron accelerators and its application in neutron spectrometry with Bonner Spheres

    International Nuclear Information System (INIS)

    Bedogni, Roberto; Pelliccioni, Maurizio; Esposito, Adolfo

    2010-01-01

    Due to the increased interest of the scientific community in the applications of synchrotron light, there is an increasing demand of high-energy electron facilities, testified by the construction of several new facilities worldwide. The radiation protection around such facilities requires accurate experimental methods to determine the dose due to prompt radiation fields. Neutron fields, in particular, are the most complex to measure, because they extend in energy from thermal (10 -8 MeV) up to hundreds MeV and because the responses of dosemeters and survey meters usually have large energy dependence. The Bonner Spheres Spectrometer (BSS) is in practice the only instrument able to respond over the whole energy range of interest, and for this reason it is frequently used to derive neutron spectra and dosimetric quantities in accelerator workplaces. Nevertheless, complex unfolding algorithms are needed to derive the neutron spectra from the experimental BSS data. This paper presents a parametric model specially developed for the unfolding of the experimental data measured with BSS around high-energy electron accelerators. The work consists of the following stages: (1) Generation with the FLUKA code, of a set of neutron spectra representing the radiation environment around accelerators with different electron energies; (2) formulation of a parametric model able to describe these spectra, with particular attention to the high-energy component (>10 MeV), which may be responsible for a large part of the dose in workplaces; and (3) implementation of this model in an existing unfolding code.

  9. Research of accelerator-based neutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Li Changkai; Ma Yingjie; Tang Xiaobin; Xie Qin; Geng Changran; Chen Da

    2013-01-01

    Background: 7 Li (p, n) reaction of high neutron yield and low threshold energy has become one of the most important neutron generating reactions for Accelerator-based Boron Neutron Capture Therapy (BNCT). Purpose Focuses on neutron yield and spectrum characteristics of this kind of neutron generating reaction which serves as an accelerator-based neutron source and moderates the high energy neutron beams to meet BNCT requirements. Methods: The yield and energy spectrum of neutrons generated by accelerator-based 7 Li(p, n) reaction with incident proton energy from 1.9 MeV to 3.0 MeV are researched using the Monte Carlo code-MCNPX2.5.0. And the energy and angular distribution of differential neutron yield by 2.5-MeV incident proton are also given in this part. In the following part, the character of epithermal neutron beam generated by 2.5-MeV incident protons is moderated by a new-designed moderator. Results: Energy spectra of neutrons generated by accelerator-based 7 Li(p, n) reaction with incident proton energy from 1.9 MeV to 3.0 MeV are got through the simulation and calculation. The best moderator thickness is got through comparison. Conclusions: Neutron beam produced by accelerator-based 7 Li(p, n) reaction, with the bombarding beam of 10 mA and the energy of 2.5 MeV, can meet the requirement of BNCT well after being moderated. (authors)

  10. Calculation of efficiency of high-energy neutron detection by plastic scintillators

    International Nuclear Information System (INIS)

    Telegin, Yu.N.

    1977-01-01

    A computer was used to calculate neutron (5-30O MeV) registration effeciencies with plastic scintillators 2,5,10, 20,30,40 and 50 cm thick. The results are shown in the form of tables. The contributions to efficiency of various processes have been analysed. The calculation results may be used in planning experiments with neutron counters

  11. Neutron therapy in the 21. century

    International Nuclear Information System (INIS)

    Kroc, Thomas K.; Welsh, James S.

    2015-01-01

    The question of whether or not neutron therapy works has been answered. It is a qualified yes, as is the case with all of radiation therapy. But, neutron therapy has not kept pace with the rest of radiation therapy in terms of beam delivery techniques. Modern photon and proton based external beam radiotherapy routinely implements image-guidance, beam intensity-modulation and 3-dimensional treatment planning. The current iteration of fast neutron radiotherapy does not. Addressing these deficiencies, however, is not a matter of technology or understanding, but resources. The future of neutron therapy lies in better understanding the interaction processes of radiation with living tissue. A combination of radiobiology and computer simulations is required in order to optimise the use of neutron therapy. The questions that need to be answered are: Can we connect the macroscopic with the microscopic? What is the optimum energy? What is the optimum energy spectrum? Can we map the sensitivity of the various tissues of the human body and use that knowledge to our advantage? And once we gain a better understanding of the above radiobiological issues will we be able to capitalise on this understanding by precisely and accurately delivering fast neutrons in a manner comparable to what is now possible with photons and protons? This presentation will review the accomplishments to date. It will then lay out the questions that need to be answered for neutron therapy to truly be a 21. century therapy. (authors)

  12. Experience with high-energy electron beam therapy at the University of Chicago

    International Nuclear Information System (INIS)

    Griem, M.L.; Kuchnir, F.T.; Lanzl, L.H.; Skaggs, L.S.; Sutton, H.G.; Tokars, R.

    1979-01-01

    Current utilization of the linear accelerator as well as 5-year cumulative experience in radiotherapy is presented. Cutaneous lymphomas and mammary gland carcinomas were the prime experience region; however, cancers at other locations were treated with mixed-beam therapy; employing fast neutrons and photon beams. The technique appears promising for abdominal tumors and deep-seated malignancies. Carcinoma of the pancreas responds favorably to this technique

  13. The relative biological effectiveness of a high energy neutron beam for micronuclei induction in T-lymphocytes of different individuals

    Energy Technology Data Exchange (ETDEWEB)

    Slabbert, J.P., E-mail: jps@tlabs.ac.z [NRF iThemba LABS (Laboratory for Accelerated Based Sciences), Somerset West (South Africa); Dept. of Medical Imaging and Clinical Oncology, University of Stellenbosch (South Africa); August, L. [NRF iThemba LABS (Laboratory for Accelerated Based Sciences), Somerset West (South Africa); Vral, A. [Dept. of Basic Medical Sciences, Ghent University (Belgium); Symons, J. [NRF iThemba LABS (Laboratory for Accelerated Based Sciences), Somerset West (South Africa)

    2010-12-15

    In assessing the radiation risk of personnel exposed to cosmic radiation fields as it pertains to radiological damage during travel in civilian aircrafts, it is particularly important to know the relative biological effectiveness (RBE) for high energy neutrons. It has been the subject of numerous investigations in recent years using different neutron energies and cytogenetic examinations. Variations in the radiosensitivity of white blood cells for different individuals are likely to influence the estimate of the relative biological effectiveness for high energy neutrons. This as such observations have been noted in the response of different cancer cell lines with varying inherent sensitivities. In this work the radiosensitivities of T-lymphocytes of different individuals to the p(66)/Be neutron beam at iThemba LABS were measured using micronuclei formations and compared to that noted following exposure to {sup 60}Co {gamma}-rays. The principle objective of this investigation was to establish if a relationship between neutron RBE and variation in biological response to {sup 60}Co {gamma}-rays for lymphocytes from different individuals could be determined. Peripheral blood samples were collected from four healthy donors and isolated lymphocytes were exposed to different doses of {sup 60}Co {gamma}-rays (1-5 Gy) and p(66)/Be neutrons (0.5-2.5 Gy). One sample per donor was not exposed to radiation and served as a control. Lymphocytes were stimulated using PHA and cultured to induce micronuclei in cytokinesis-blocked cells. Micronuclei yields were numerated using fluorescent microscopy. Radiosensitivities and RBE values were calculated from the fitted parameters describing the micronuclei frequency dose response data. Dissimilar dose response curves for different donors were observed reflecting varying inherent sensitivities to both neutron and gamma radiation. A clear reduction in the dose limiting RBE{sub M} is noted for donors with lymphocytes more sensitive to

  14. High-energy Neutron-induced Fission Cross Sections of Natural Lead and Bismuth-209

    CERN Document Server

    Tarrio, D; Carrapico, C; Eleftheriadis, C; Leeb, H; Calvino, F; Herrera-Martinez, A; Savvidis, I; Vlachoudis, V; Haas, B; Koehler, P; Vannini, G; Oshima, M; Le Naour, C; Gramegna, F; Wiescher, M; Pigni, M T; Audouin, L; Mengoni, A; Quesada, J; Becvar, F; Plag, R; Cennini, P; Mosconi, M; Rauscher, T; Couture, A; Capote, R; Sarchiapone, L; Vlastou, R; Domingo-Pardo, C; Dillmann, I; Pavlopoulos, P; Karamanis, D; Krticka, M; Jericha, E; Ferrari, A; Martinez, T; Trubert, D; Oberhummer, H; Karadimos, D; Plompen, A; Isaev, S; Terlizzi, R; Cortes, G; Cox, J; Cano-Ott, D; Pretel, C; Colonna, N; Berthoumieux, E; Vaz, P; Heil, M; Lopes, I; Lampoudis, C; Walter, S; Calviani, M; Gonzalez-Romero, E; Embid-Segura, M; Stephan, C; Igashira, M; Papachristodoulou, C; Aerts, G; Tavora, L; Berthier, B; Rudolf, G; Andrzejewski, J; Villamarin, D; Ferreira-Marques, R; Tain, J L; O'Brien, S; Reifarth, R; Kadi, Y; Neves, F; Poch, A; Kerveno, M; Rubbia, C; Lazano, M; Dahlfors, M; Wisshak, K; Salgado, J; Dridi, W; Ventura, A; Andriamonje, S; Assimakopoulos, P; Santos, C; Voss, F; Ferrant, L; Patronis, N; Chiaveri, E; Guerrero, C; Perrot, L; Vicente, M C; Lindote, A; Praena, J; Baumann, P; Kappeler, F; Rullhusen, P; Furman, W; David, S; Marrone, S; Tassan-Got, L; Gunsig, F; Alvarez-Velarde, F; Massimi, C; Mastinu, P; Pancin, J; Papadopoulos, C; Tagliente, G; Haight, R; Chepel, V; Kossionides, E; Badurek, G; Marganiec, J; Lukic, S; Pavlik, A; Goncalves, I; Duran, I; Alvarez, H; Abbondanno, U; Fujii, K; Milazzo, P M; Moreau, C

    2011-01-01

    The CERN Neutron Time-Of-Flight (n\\_TOF) facility is well suited to measure small neutron-induced fission cross sections, as those of subactinides. The cross section ratios of (nat)Pb and (209)Bi relative to (235)U and (238)U were measured using PPAC detectors. The fragment coincidence method allows to unambiguously identify the fission events. The present experiment provides the first results for neutron-induced fission up to 1 GeV for (nat)Pb and (209)Bi. A good agreement with previous experimental data below 200 MeV is shown. The comparison with proton-induced fission indicates that the limiting regime where neutron-induced and proton-induced fission reach equal cross section is close to 1 GeV.

  15. Direct integration multiple collision integral transport analysis method for high energy fusion neutronics

    International Nuclear Information System (INIS)

    Koch, K.R.

    1985-01-01

    A new analysis method specially suited for the inherent difficulties of fusion neutronics was developed to provide detailed studies of the fusion neutron transport physics. These studies should provide a better understanding of the limitations and accuracies of typical fusion neutronics calculations. The new analysis method is based on the direct integration of the integral form of the neutron transport equation and employs a continuous energy formulation with the exact treatment of the energy angle kinematics of the scattering process. In addition, the overall solution is analyzed in terms of uncollided, once-collided, and multi-collided solution components based on a multiple collision treatment. Furthermore, the numerical evaluations of integrals use quadrature schemes that are based on the actual dependencies exhibited in the integrands. The new DITRAN computer code was developed on the Cyber 205 vector supercomputer to implement this direct integration multiple-collision fusion neutronics analysis. Three representative fusion reactor models were devised and the solutions to these problems were studied to provide suitable choices for the numerical quadrature orders as well as the discretized solution grid and to understand the limitations of the new analysis method. As further verification and as a first step in assessing the accuracy of existing fusion-neutronics calculations, solutions obtained using the new analysis method were compared to typical multigroup discrete ordinates calculations

  16. The Edinburgh experience of fast neutron therapy

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Orr, J.A.; Kerr, G.R.

    1982-01-01

    The Edinburgh experience is based on a d(15 + Be) neutron beam generated by a compact CS 30 Cyclotron. Neutron therapy alone given in 20 daily fractions over four weeks has been compared with photon therapy given in the same fractionation schedule. Since clinical studies began in March, 1977, over 500 patients have been treated by fast neutrons. Almost all patients are now admitted to randomly controlled trials. In the head and neck trial conducted in collaboration with collegues in Amsterdam and Essen, 192 patients are available for analysis. Most patients had T3 lesions and about 50% had involved nodes. The cumulative regression rate at six months is similar after neutrons and photons (75%). Later recurrence rates (36%) are also similar. The early radiation morbidity is similar in both groups, but the late reactions are greater after neutrons (15%) than photons (6%). Overall survival is better after photon therapy. A trial of patients with glioblastoma has also shown a better survival after photon therapy. Neutron therapy was associated with demyelinization in three of 18 patients. Patients with transitional cell cancer of the bladder have also been the subject of study. Local tumor control was similar (53%) after neutrons and photons. Late radiation morbidity was much greater after neutrons (20%), compared with photons (2%). In a trial of advanced carcinoma of the rectum, the local tumor control was also similar after neutrons and photons (30%), but morbidity was greater after neutrons. Soft tissue sarcomas have shown response rates (37%) that may be expected after photon therapy. Salivary gland tumors have shown a similar experience, although slow growing tumors such as adenoid cystic carcinoma may respond better to neutrons

  17. A technique for determining fast and thermal neutron flux densities in intense high-energy (8-30 MeV) photon fields

    International Nuclear Information System (INIS)

    Price, K.W.; Holeman, G.R.; Nath, R.

    1978-01-01

    A technique for measuring fast and thermal neutron fluxes in intense high-energy photon fields has been developed. Samples of phorphorous pentoxide are exposed to a mixed photon-neutron field. The irradiated samples are then dissolved in distilled water and their activation products are counted in a liquid scintillation spectrometer at 95-97% efficiency. The radioactive decay characteristics of the samples are then analyzed to determine fast and thermal neutron fluxes. Sensitivity of this neutron detector to high energy photons has been measured and found to be small. (author)

  18. High-altitude cosmic ray neutrons: probable source for the high-energy protons of the earth's radiation belts

    International Nuclear Information System (INIS)

    Hajnal, F.; Wilson, J.

    1992-01-01

    'Full Text:' Several High-altitude cosmic-ray neutron measurements were performed by the NASA Ames Laboratory in the mid-to late-1970s using airplanes flying at about 13km altitude along constant geomagnetic latitudes of 20, 44 and 51 degrees north. Bonner spheres and manganese, gold and aluminium foils were used in the measurements. In addition, large moderated BF-3 counters served as normalizing instruments. Data analyses performed at that time did not provide complete and unambiguous spectral information and field intensities. Recently, using our new unfolding methods and codes, and Bonner-sphere response function extensions for higher energies, 'new' neutron spectral intensities were obtained, which show progressive hardening of neutron spectra as a function of increasing geomagnetic latitude, with substantial increases in the energy region iron, 1 0 MeV to 10 GeV. For example, we found that the total neutron fluences at 20 and 51 degrees magnetic north are in the ratio of 1 to 5.2 and the 10 MeV to 10 GeV fluence ratio is 1 to 18. The magnitude of these ratios is quite remarkable. From the new results, the derived absolute neutron energy distribution is of the correct strength and shape for the albedo neutrons to be the main source of the high-energy protons trapped in the Earth's inner radiation belt. In addition, the results, depending on the extrapolation scheme used, indicate that the neutron dose equivalent rate may be as high as 0.1 mSv/h near the geomagnetic north pole and thus a significant contributor to the radiation exposures of pilots, flight attendants and the general public. (author)

  19. Proton linacs for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Lennox, A.J.

    1993-08-01

    Recent advances in the ability to deliver boron-containing drugs to brain tumors have generated interest in ∼4 MeV linacs as sources of epithermal neutrons for radiation therapy. In addition, fast neutron therapy facilities have been studying methods to moderate their beams to take advantage of the high cross section for epithermal neutrons on boron-10. This paper describes the technical issues involved in each approach and presents the motivation for undertaking such studies using the Fermilab linac. the problems which must be solved before therapy can begin are outlined. Status of preparatory work and results of preliminary measurements are presented

  20. Design of hyper-thermal neutron irradiation fields for neutron capture therapy in KUR-heavy water neutron irradiation facility. Mounting of hyper-thermal neutron converter in therapeutic collimator

    International Nuclear Information System (INIS)

    Sakurai, Y.; Kobayashi, T.

    2001-01-01

    Neutron capture therapy (NCP) using thermal neutron needs to improve of depth dose distribution in a living body. Epi-thermal neutron following moderation of fast neutron is usually used for improving of the depth dose distribution. The moderation method of fast neutron, however, gets mixed some of high energy neutron which give some of serious effects to a living body, and involves the difficulty for collimation of thermal neutron to the diseased part. Hyper-thermal neutrons, which are in an energy range of 0.1-3 eV at high temperature side of thermal neutron, are under consideration for application to the NCP. The hyper-thermal neutrons can be produced by up-scattering of thermal neutron in a high temperature material. Fast neutron components in collimator for the NCP reduce on application of the up-scattering method. Graphite at high temperature (>1000k) is used as a hyper-thermal neutron converter. The hyper-thermal neutron converter is planted to mount on therapeutic collimator which is located at the nearest side of patient for the NCP. Total neutron flux, ratio of hyper-thermal neutron to total neutron, and ratio of gamma-ray dose to neutron flux are calculated as a function of thickness of the graphite converter using monte carlo code MCNP-V4B. (M. Suetake)

  1. Preclinical studies on gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Akine, Yasuyuki

    1994-01-01

    Gadolinium neutron capture therapy is based on radiations (photons and electrons) produced in the tumor by a nuclear reaction between gadolinium and lower-energy neutrons. Studies with Chinese hamster cells have shown that the radiation effect resulting from gadolinium neutron capture reactions is mostly of low LET and that released electrons are the significant component in the over-all dose. Biological dosimetry revealed that the dose does not seem to increase in proportion to the gadolinium concentration, leading to a conclusion that there is a range of gadolinium concentrations most efficient for gadolinium neutron capture therapy. The in vivo studies with transplantable tumors in mice and rabbits have revealed that close contact between gadolinium and the cell is not necessarily required for cell inactivation and that gadolinium delivery selective to tumors is crucial. The results show that the potential of gadolinium neutron capture therapy as a therapeutic modality appears very promising. (author)

  2. The importance of anisotropic scattering in high energy neutron transport problems

    International Nuclear Information System (INIS)

    Prillinger, G.; Mattes, M.

    1984-01-01

    To describe the highly anisotropic scattering of very fast neutrons adequately the transport code ANISN has been improved. Fokker-Planck terms have been introduced into the transport equation which accurately describe the small changes in energy and angle. The new code has been tested for a d(50)-Be neutron source in a deep penetration iron problem. The influence of the forward peaked elastic scattering on the fast neutron spectrum is shown to be significant and can be handled efficiently in the new ANISN version. Since common cross-section libraries are limited by Legendre expansion, or by their upper energy boundary, or exclude elastic scattering above 20 MeV a special library has been created. (Auth.)

  3. The Edinburgh experience of fast neutron therapy

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Orr, J.A.; Kerr, G.R.

    1982-01-01

    The Edinburgh experience is based on a d(15 + Be) neutron beam generated by a compact CS 30 Cyclotron. The facility has an iso-center treatment head providing 240 0 of rotation. The most important limitation of the beam is its poor penetrating quality. We have compared neutron therapy alone given in 20 daily fractions over four weeks with photon therapy given in the same fractionation schedule. Since clinical studies began in March, 1977, over 500 patients have been treated by fast neutrons. Almost all patients are now admitted to randomly controlled trials. In the head and neck trial conducted in collaboraton with colleagues in Amsterdam and Essen, 92 patients are available for analysis. Most patients had T3 lesions and about 50% had involved nodes. The cumulative regression rate at six months is similar after neutrons and photons (75%). Later recurrence rates (36%) are also similar. The early radiation morbidity is similar in both groups, but the late reactions are greater after neutrons (15%) than photons (6%). Overall survival is better after photon therapy. A trial of patients with glioblastoma has also shown a better survival after photon therapy. Neutron therapy was associated with demelinization in three of 18 patients. Patients with transitional cell cancer of the bladder have also been the subject of study. Local tumor control was similar (53%) after neutrons and photons. Late radiation morbidity was much greater after neutrons (20%), compared with photons (2%). In a trial of advanced carcinoma of the rectum, the local tumor control was also similar after neutrons and photons (30%), but morbidity was greater after neutrons. Soft tissue sarcomas have shown response rates (37%) that may be expected after photon therapy

  4. Hyper-thermal neutron irradiation field for neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kanda, Keiji

    1994-01-01

    The utilization of hyper-thermal neutrons, which have an energy spectrum of a Maxwell distribution higher than the room temperature of 300 K, has been studied in order to improve the thermal neutron flux distribution in a living body for a deep-seated tumor in neutron capture therapy (NCT). Simulation calculations using MCNP-V3 were carried out in order to investigate the characteristics of the hyper-thermal neutron irradiation field. From the results of simulation calculations, the following were confirmed: (i) The irradiation field of the hyper-thermal neutrons is feasible by using some scattering materials with high temperature, such as Be, BeO, C, SiC and ZrH 1.7 . Especially, ZrH 1.7 is thought to be the best material because of good characteristics of up-scattering for thermal neutrons. (ii) The ZrH 1.7 of 1200 K yields the hyper-thermal neutrons of a Maxwell-like distribution at about 2000 K and the treatable depth is about 1.5 cm larger comparing with the irradiation of the thermal neutrons of 300 K. (iii) The contamination by the secondary gamma-rays from the scattering materials can be sufficiently eliminated to the tolerance level for NCT through the bismuth layer, without the larger change of the energy spectrum of hyper-thermal neutrons. ((orig.))

  5. Precision measurements of high-energy conversion electron lines and determination of neutron binding energies

    International Nuclear Information System (INIS)

    Braumandl, F.

    1979-01-01

    The paper first discusses the energy accuracy of the BILL conversion electron spectrometer at the Grenoble high flux reactor. With an improved temperature stabilisation of the magnets, an energy accuracy of ΔE/E -5 can be reached. After this, highly exact measurements of high-energy conversion electron lines of the 200 Hg, 114 Cd, 165 Dy, 168 Er, 239 U nuclei and the 13 C, 28 Al 3 H and 92 Zr photoelectron lines were carried out. Energy calibration of the spectrometer was carried out in the 1.5 MeV to 6.5 MeV range with intensive high-energy transitions of the 200 Hg nucleus. Systematic calibration errors could be investigated by means of combinations between the calibration lines. A calibration for absolute energies was obtained by comparing low-energy gamma transitions of 200 Hg with the 411.8 keV gold standard. (orig.) [de

  6. Neutron production in lead targets by high-energy light-mass heavy ions

    International Nuclear Information System (INIS)

    Daniehl', A.V.; Lyapin, V.S.; Tsvetkov, I.O.

    1992-01-01

    The characteristics of the time-of-flight spectrometer and the double different distributions of neutrons and secondary charged particles produced by 2 GeV protons and 1 GeVXA d,α, 6 Li and 12 C ions bombarding lead targets are described. Experimental data are compared with the results of calculations by codes SITHA. 17 refs.; 10 figs.; 1 tab

  7. High-energy two-neutron removal from Be{sup 10}

    Energy Technology Data Exchange (ETDEWEB)

    Ashwood, N.I.; Freer, M.; Ahmed, S.; Clarke, N.M.; Curtis, N.; Soic, N.; Ziman, V.A. [Birmingham Univ., School of Physics and Astronomy, (United Kingdom); Millener, D.J. [Brookhaven National Lab., Upton, NY (United States); Orr, N.A.; Carstoiu, F.; Angelique, J.C.; Catford, W.N.; Lecouey, J.L.; Marques, F.M.; Normand, G.; Timis, C. [Caen Univ., Lab. de Physique Corpusculaire, ISMRA, IN2P3-CNRS, 14 (France); Carsoiu, F. [Horia Hulubei National institute of Physics and Nuclear Engineering (IFIN-HH), Bucharest-Magurele (Romania); Bouchat, V.; Hanappe, F.; Kerckx, Y.; Materna, T. [Universite Libre de Bruxelles (Belgium); Catford, W.N.; Pain, S.; Timis, C. [Surrey Univ., School of Electronics and Physical Sciences, Guildford (United Kingdom); Horoi, M. [Central Michigan Univ., Physics Dept., Mount Pleasant, MI (United States); Unshakova, A. [Joint Institute for Nuclear Research Dubna (Russian Federation)

    2005-09-15

    A kinetically complete measurement of the {sup 12}C({sup 10}Be, {alpha}+{alpha}+n) and ({sup 10}Be, {alpha}+{alpha}) reactions has been performed at a beam energy of 30 MeV/nucleon. The charged beam velocity particles were detected in an array of Si-CsI detectors placed at zero degrees, and the neutrons in an 81-element neutron array. The coincident detection of the final-state particles, produced in the breakup of {sup 10}Be, allowed the reconstruction of the excitation energy in the {sup 8}Be and {sup 9}Be systems. States in {sup 8}Be were identified, in particular the ground and first-excited states; and in {sup 9}Be, states at 1.68, 2.43, and (2.78, 3.05) MeV were observed. The population of these levels, in particular the 2.43 MeV 5/2- level, suggests that collective excitations play an important role in the neutron removal process. Distorted wave Born approximation and Glauber-type calculations have been used to model the direct neutron removal from the {sup 10}Be ground state and the two-step removal via inelastic excitations of the {sup 10}Be(2{sup +}) and {sup 9}Be(5/2{sup -}) excited states. (authors)

  8. Backward emitted high-energy neutrons in hard reactions of p and π+ on carbon

    Science.gov (United States)

    Malki, A.; Alster, J.; Asryan, G.; Averichev, Y.; Barton, D.; Baturin, V.; Bukhtoyarova, N.; Carroll, A.; Heppelmann, S.; Kawabata, T.; Leksanov, A.; Makdisi, Y.; Minina, E.; Navon, I.; Nicholson, H.; Ogawa, A.; Panebratsev, Yu.; Piasetzky, E.; Schetkovsky, A.; Shimanskiy, S.; Tang, A.; Watson, J. W.; Yoshida, H.; Zhalov, D.

    2002-01-01

    Beams of protons and pions of 5.9 GeV/c were incident on a C target. Neutrons emitted into the backward hemisphere, in the laboratory system, were detected in (triple) coincidence with two emerging particles of tranverse momenta pt>0.6 GeV/c. We determined that for (46.5+/-3.7)% of the proton-induced events and for (40.8+/-4.5)% of the pion-induced events with the two high-pt particles, there is also at least one backward emitted neutron with momentum greater than 0.32 GeV/c. This observation is in sharp contrast to a well- established universal pattern from a large variety of earlier inclusive measurements with hadrons, electrons, photons, neutrinos, and antineutrinos where the probability for backward nucleon emission was in the 5 to 10 % range. We present also a measurement of the momentum spectra for the backward going neutrons. The spectra have the same universal shape observed in the inclusive reactions. We speculate that the enhanced backward neutron emission in this semi-inclusive region could be an indication for a strong dependence of the cross section on the squared total center-of-mass energy (s) and for the importance of short-range nucleon-nucleon correlations.

  9. Time gating for energy selection and scatter rejection: High-energy pulsed neutron imaging at LANSCE

    Science.gov (United States)

    Swift, Alicia; Schirato, Richard; McKigney, Edward; Hunter, James; Temple, Brian

    2015-09-01

    The Los Alamos Neutron Science Center (LANSCE) is a linear accelerator in Los Alamos, New Mexico that accelerates a proton beam to 800 MeV, which then produces spallation neutron beams. Flight path FP15R uses a tungsten target to generate neutrons of energy ranging from several hundred keV to ~600 MeV. The beam structure has micropulses of sub-ns width and period of 1.784 ns, and macropulses of 625 μs width and frequency of either 50 Hz or 100 Hz. This corresponds to 347 micropulses per macropulse, or 1.74 x 104 micropulses per second when operating at 50 Hz. Using a very fast, cooled ICCD camera (Princeton Instruments PI-Max 4), gated images of various objects were obtained on FP15R in January 2015. Objects imaged included blocks of lead and borated polyethylene; a tungsten sphere; and a tungsten, polyethylene, and steel cylinder. Images were obtained in 36 min or less, with some in as little as 6 min. This is novel because the gate widths (some as narrow as 10 ns) were selected to reject scatter and other signal not of interest (e.g. the gamma flash that precedes the neutron pulse), which has not been demonstrated at energies above 14 MeV. This proof-of-principle experiment shows that time gating is possible above 14MeV and is useful for selecting neutron energy and reducing scatter, thus forming clearer images. Future work (simulation and experimental) is being undertaken to improve camera shielding and system design and to precisely determine optical properties of the imaging system.

  10. Neutron spectrum for neutron capture therapy in boron

    International Nuclear Information System (INIS)

    Medina C, D.; Soto B, T. G.; Baltazar R, A.; Vega C, H. R.

    2016-10-01

    Glioblastoma multiforme is the most common and aggressive of brain tumors and is difficult to treat by surgery, chemotherapy or conventional radiation therapy. One treatment alternative is the Neutron Capture Therapy in Boron, which requires a beam modulated in neutron energy and a drug with 10 B able to be fixed in the tumor. When the patients head is exposed to the neutron beam, they are captured by the 10 B and produce a nucleus of 7 Li and an alpha particle whose energy is deposited in the cancer cells causing it to be destroyed without damaging the normal tissue. One of the problems associated with this therapy is to have an epithermal neutrons flux of the order of 10 9 n/cm 2 -sec, whereby irradiation channels of a nuclear research reactor are used. In this work using Monte Carlo methods, the neutron spectra obtained in the radial irradiation channel of the TRIGA Mark III reactor are calculated when inserting filters whose position and thickness have been modified. From the arrangements studied, we found that the Fe-Cd-Al-Cd polyethylene filter yielded a ratio between thermal and epithermal neutron fluxes of 0.006 that exceeded the recommended value (<0.05), and the dose due to the capture gamma rays is lower than the dose obtained with the other arrangements studied. (Author)

  11. 90 deg.Neutron emission from high energy protons and lead ions on a thin lead target

    CERN Document Server

    Agosteo, S; Foglio-Para, A; Mitaroff, W A; Silari, Marco; Ulrici, L

    2002-01-01

    The neutron emission from a relatively thin lead target bombarded by beams of high energy protons/pions and lead ions was measured at CERN in one of the secondary beam lines of the Super Proton Synchrotron for radiation protection and shielding calculations. Measurements were performed with three different beams: sup 2 sup 0 sup 8 Pb sup 8 sup 2 sup + lead ions at 40 GeV/c per nucleon and 158 GeV/c per nucleon, and 40 GeV/c mixed protons/pions. The neutron yield and spectral fluence per incident ion on target were measured at 90 deg.with respect to beam direction. Monte-Carlo simulations with the FLUKA code were performed for the case of protons and pions and the results found in good agreement with the experimental data. A comparison between simulations and experiment for protons, pions and lead ions have shown that--for such high energy heavy ion beams--a reasonable estimate can be carried out by scaling the result of a Monte-Carlo calculation for protons by the projectile mass number to the power of 0.80-0...

  12. Spectral correction factors for conventional neutron dose meters used in high-energy neutron environments improved and extended results based on a complete survey of all neutron spectra in IAEA-TRS-403

    International Nuclear Information System (INIS)

    Oparaji, U.; Tsai, Y. H.; Liu, Y. C.; Lee, K. W.; Patelli, E.; Sheu, R. J.

    2017-01-01

    This paper presents improved and extended results of our previous study on corrections for conventional neutron dose meters used in environments with high-energy neutrons (E n > 10 MeV). Conventional moderated-type neutron dose meters tend to underestimate the dose contribution of high-energy neutrons because of the opposite trends of dose conversion coefficients and detection efficiencies as the neutron energy increases. A practical correction scheme was proposed based on analysis of hundreds of neutron spectra in the IAEA-TRS-403 report. By comparing 252 Cf-calibrated dose responses with reference values derived from fluence-to-dose conversion coefficients, this study provides recommendations for neutron field characterization and the corresponding dose correction factors. Further sensitivity studies confirm the appropriateness of the proposed scheme and indicate that (1) the spectral correction factors are nearly independent of the selection of three commonly used calibration sources: 252 Cf, 241 Am-Be and 239 Pu-Be; (2) the derived correction factors for Bonner spheres of various sizes (6''-9'') are similar in trend and (3) practical high-energy neutron indexes based on measurements can be established to facilitate the application of these correction factors in workplaces. (authors)

  13. Neutron dosimetry at a high-energy electron-positron collider

    Science.gov (United States)

    Bedogni, Roberto

    Electron-positron colliders with energy of hundreds of MeV per beam have been employed for studies in the domain of nuclear and sub-nuclear physics. The typical structure of such a collider includes an LINAC, able to produce both types of particles, an accumulator ring and a main ring, whose diameter ranges from several tens to hundred meters and allows circulating particle currents of several amperes per beam. As a consequence of the interaction of the primary particles with targets, shutters, structures and barriers, a complex radiation environment is produced. This paper addresses the neutron dosimetry issues associated with the operation of such accelerators, referring in particular to the DAΦ NE complex, operative since 1997 at INFN-Frascati National Laboratory (Italy). Special attention is given to the active and passive techniques used for the spectrometric and dosimetric characterization of the workplace neutron fields, for radiation protection dosimetry purposes.

  14. Production of the $\\Sigma^0_c$ and $\\Sigma^{++}_c$ by High-Energy Neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Ladbury, Raymond, Jr. [Colorado U.

    1988-01-01

    We present the first observation of hadroproduction of the $\\Sigma^{++}_C$ and $\\Sigma^0_c$ , decaying into $\\Lambda_{c\\pi}$. The daughter $\\Lambda_c$ is observed in the decay modes $pK \\pi$ and $pK_s\\pi\\pi$. The Experiment was conducted at a broadband neutron beam in the Proton East area of the Fermi National Accelerator Laboratory. A two - magnet multiparticle spectrometer equipped with proportional wire chambers and a high resolution MWPC vertex detector was used to momentum analyze charged particles produced in the interactions of neutrons on targets of beryllium, silicon and tungsten. Particles were identified using three Cerenkov counters. The beam energy for each event was reconstructed using hadronic and electromagnetic calorimetry....

  15. Damage parameters for non-metals in a high energy neutron environment

    International Nuclear Information System (INIS)

    Dell, G.F.; Berry, H.C.; Lazareth, O.W.; Goland, A.N.

    1980-01-01

    Simulation of radiation damage induced in monatomic and binary non-metals by FMIT and fusion neutrons is described. Damage produced by elastic scattering of recoil atoms and by ionization-assisted processes has been evaluated using the damage program DON. Displacement damage from gamma rays has been evaluated by using the technique of Oen and Holmes. A comparison of damage for an anticipated FMIT radiation environment generated by a coupled n-γ transport calculations and a fusion spectrum is made. Gamma-induced displacement damage is sufficiently small that it is dominated by neutron-induced recoil processes. Ionization-assisted displacements may be important depending upon the ionization cross section of the particular non-metal under consideration

  16. Response of pancreatic cancer to local irradiation with high-energy neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Cohen, Lionel; Woodruff, Katherine H.; Hendrickson, Frank R.; Kurup, Parvathy D.; Mansell, Joanne; Awschalom, Miguel; Rosenberg, Ivan; Ten Haken, Randall K.

    1985-09-15

    Seventy-seven patients with locally advanced, nonresectable, biopsy-proven adenocarcinoma of the pancreas were treated by palliative bypass surgery followed by intensive neutron beam irradiation of the primary tumor site. Three dose levels, under 20, 21 to 23, and 24 to 25 Gy, were studied with the use of a treatment plan that included all known disease within a limited target volume, generally under 21. Symptomatic palliation was achieved in the majority of patients. The median survival time was 6 months. One patient remained alive and well without evidence of tumor 5 years after irradiation. Two were free of tumor at autopsy (one had died of intercurrent disease and one of radiation-related complications). A common cause of death was metastatic dissemination. Complication rates were dosedependent; life-threatening complications did not exceed 12% with doses of less than 23 Gy. Autopsies from 19 patients were reviewed. In all, the pancreatic tumor site showed extensive reactive fibrosis. Local control was achieved in two patients, but most had both residual tumor in the pancreas and metastases. Six patients had centrolobular veno-occlusive liver disease. These patients had all received the higher (22–24 Gy) neutron doses. Six patients had hemorrhagic radiation gastroenteritis. Mild skin atrophy and bone marrow hypoplasia were seen in the irradiated volumes. The kidneys and spinal cord showed no radiation effects. The authors conclude that neutron irradiation can provide a good local response with marked regression and fibrosis of the tumor. This response, coupled with many deaths due to metastases, suggests that combined treatment with neutrons and chemotherapy would be worth exploring.

  17. Chemical processes in neutron capture therapy

    International Nuclear Information System (INIS)

    Brown, B.J.

    1975-01-01

    Research into the radiation chemical effects of neutron capture therapy are described. In the use of neutron capture therapy for the treatment of brain tumours, compounds containing an activatable nuclide are selectively concentrated within tumour tissue and irradiated with neutrons. Target compounds for use in therapy must accumulate selectively in high concentrations in the tumour and must be non toxic to the patient. The most suitable of these are the boron hydrides. Radiation dosages, resulting from neutron capture in normal tissue constituents are tabulated. As part of the program to study the radiation-induced chemical processes undergone by boron target compounds, the radiolytic degredation of boron hydride and phenyl boric acid system was investigated. No direct dependence between the yield of the transient radiolytic species and the concentration of the B-compound was observed. (author)

  18. Evaluation of Neutron Component in Patients under High Energy Radiotherapy By Means of an On Line and In Vivo procedure

    International Nuclear Information System (INIS)

    Exposito, M. R.; Palma, B. A.; Terron, J. A.; Gomez, F.; Domingo, C.; Barquero, R.; Sanchez-Doblado, F.

    2010-01-01

    The use of improved radiotherapy methods has raised the concern about second cancer induction. Epidemiological studies have shown a major incidence of secondary cancer in radiotherapy patients compared to patients subjected to another type of treatment. In this regard, it is important to determine the peripheral dose received by the patient during the treatment. While photon doses have been deeply contemplated, neutron contamination in high energy photon beams is still a subject of research and discussion. In the present work, we introduce a new procedure based on a digital device that allows real time neutron contamination evaluation. Several irradiations of an anthropomorphic phantom have been carried out in a variety of facilities and treatments. The purpose was to correlate the measurements from the digital detector with the neutron doses obtained in the phantom by Monte Carlo simulations and experimental measurements. A model has been designed to calculate the organ equivalent dose and risk estimates during any therapeutic session. The procedure has been used to monitor more than 1000 patients showing its applicability in clinical routine. It can be used both for inductive and retrospective studies with a reasonable uncertainty. Thus, this could provide the necessary information to complement the dosimetry of patient and estimate the treatment risk.

  19. High-energy quasi-monoenergetic neutron fields: existing facilities and future needs

    CERN Document Server

    Pomp, S; Mayer, S; Reitz, G; Rottger, S; Silari, M; Smit, F D; Vincke, H; Yasuda, H

    2014-01-01

    The argument that well-characterised quasi-monoenergetic neutron (QMN) sources reaching into the energy domain >20 MeV are needed is presented. A brief overview of the existing facilities is given, and a list of key factors that an ideal QMN source for dosimetry and spectrometry should offer is presented. The authors conclude that all of the six QMN facilities currently in existence worldwide operate in sub-optimal conditions for dosimetry. The only currently available QMN facility in Europe capable of operating at energies >40 MeV, TSL in Uppsala, Sweden, is threatened with shutdown in the immediate future. One facility, NFS at GANIL, France, is currently under construction. NFS could deliver QMN beams up to about 30 MeV. It is, however, so far not clear if and when NFS will be able to offer QMN beams or operate with only so-called white neutron beams. It is likely that by 2016, QMN beams with energies >40 MeV will be available only in South Africa and Japan, with none in Europe.

  20. Neutron cross sections for defect production by high-energy displacement cascades in copper

    International Nuclear Information System (INIS)

    Heinisch, H.L.; Mann, F.M.

    1983-08-01

    Defect production cross sections for copper have been devised, based on computer simulations of displacement cascades. One thousand cascades ranging in energy from 200 eV to 200 keV were generated with the MARLOWE computer code. The cascades were subjected to a semi-empirical cascade quenching procedure and to short-term annealing with the ALSOME computer code. Functions were fitted to the numbers of defects produced as a function of primary knock-on atom (PKA) damage energy for the following defect types: 1) the total number of point defects after quenching and after short-term annealing, 2) the numbers of free interstitials and free vacancies after shortterm annealing, and 3) the numbers and sizes of vacancy and interstitial clusters after shortterm annealing. In addition, a function describing the number of distinct damage regions (lobes) per cascade was fitted to results of a graphical analysis of the cascade configurations. The defect production functions have been folded into PKA spectra using the NJOY nuclear data processing code system with ENDF/B-V nuclear data to yield neutron cross sections for defect production in copper. The free vacancy cross section displays much less variation with neutron energy than the cross sections for damage energy or total point defects

  1. Neutron cross sections for defect production by high energy displacement cascades in copper

    International Nuclear Information System (INIS)

    Heinisch, H.L.; Mann, F.M.

    1984-01-01

    Defect production cross sections for copper have been devised, based on computer simulations of displacement cascades. One thousand cascades ranging in energy from 200 eV to 200 keV were generated with the MARLOWE computer code. The cascades were subjected to a semi-empirical cascade quenching procedure and to short-term annealing with the ALSOME computer code. Functions were fitted to the numbers of defects produced as a function of primary knock-on atom (PKA) damage energy for the following defect types: 1) the total number of point defects after quenching and after short-term annealing, 2) the numbers of free interstitials and free vacancies after short-term annealing, and 3) the numbers and sizes of vacancy and interstitial clusters after short-term annealing. In addition, a function describing the number of distinct damage regions (lobes) per cascade was fitted to results of a graphical analysis of the cascade configurations. The defect production functions have been folded into PKA spectra using the NJOY nuclear data processing code system with ENDF/B-V nuclear data to yield neutron cross sections for defect production in copper. The free vacancy cross section displays much less variation with neutron energy than the cross sections for damage energy or total point defects. (orig.)

  2. Approach to magnetic neutron capture therapy

    International Nuclear Information System (INIS)

    Kuznetsov, Anatoly A.; Podoynitsyn, Sergey N.; Filippov, Victor I.; Komissarova, Lubov Kh.; Kuznetsov, Oleg A.

    2005-01-01

    Purpose: The method of magnetic neutron capture therapy can be described as a combination of two methods: magnetic localization of drugs using magnetically targeted carriers and neutron capture therapy itself. Methods and Materials: In this work, we produced and tested two types of particles for such therapy. Composite ultradispersed ferro-carbon (Fe-C) and iron-boron (Fe-B) particles were formed from vapors of respective materials. Results: Two-component ultradispersed particles, containing Fe and C, were tested as magnetic adsorbent of L-boronophenylalanine and borax and were shown that borax sorption could be effective for creation of high concentration of boron atoms in the area of tumor. Kinetics of boron release into the physiologic solution demonstrate that ultradispersed Fe-B (10%) could be applied for an effective magnetic neutron capture therapy. Conclusion: Both types of the particles have high magnetization and magnetic homogeneity, allow to form stable magnetic suspensions, and have low toxicity

  3. Intercomparison of radiation protection devices in a high-energy stray neutron field, Part II: Bonner sphere spectrometry

    International Nuclear Information System (INIS)

    Wiegel, B.; Agosteo, S.; Bedogni, R.; Caresana, M.; Esposito, A.; Fehrenbacher, G.; Ferrarini, M.; Hohmann, E.; Hranitzky, C.; Kasper, A.; Khurana, S.; Mares, V.; Reginatto, M.; Rollet, S.; Ruehm, W.; Schardt, D.; Silari, M.; Simmer, G.; Weitzenegger, E.

    2009-01-01

    The European Commission has funded within its 6th Framework Programme a three-year project (2005-2007) called CONRAD, COordinated Network for RAdiation Dosimetry. A major task of the CONRAD Work Package 'complex mixed radiation fields at workplaces' was to organise a benchmark exercise in a workplace field at a high-energy particle accelerator where neutrons are the dominant radiation component. The CONRAD benchmark exercise took place at the Gesellschaft fuer Schwerionenforschung mbH (GSI) in Darmstadt, Germany in July 2006. In this paper, the results of the spectrometry using four extended -range Bonner sphere spectrometers of four different institutes are reported. Outside Cave A the neutron spectra were measured with three spectrometers at six selected positions and ambient dose equivalent values were derived for use in the intercomparison with other area monitors and dosemeters. At a common position all three spectrometers were used to allow a direct comparison of their results which acts as an internal quality assurance. The comparison of the neutron spectra measured by the different groups shows very good agreement. A detailed analysis presents some differences between the shapes of the spectra and possible sources of these differences are discussed. However, the ability of Bonner sphere spectrometers to provide reliable integral quantities like fluence and ambient dose equivalent is well demonstrated in this exercise. The fluence and dose results derived by the three groups agree very well within the given uncertainties, not only with respect to the total energy region present in this environment but also for selected energy regions which contribute in certain strength to the total values. In addition to the positions outside Cave A one spectrometer was used to measure the neutron spectrum at one position in the entry maze of Cave A. In this case a comparison was possible to earlier measurements.

  4. Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors.

    Science.gov (United States)

    Blue, Thomas E; Yanch, Jacquelyn C

    2003-01-01

    This paper reviews the development of low-energy light ion accelerator-based neutron sources (ABNSs) for the treatment of brain tumors through an intact scalp and skull using boron neutron capture therapy (BNCT). A major advantage of an ABNS for BNCT over reactor-based neutron sources is the potential for siting within a hospital. Consequently, light-ion accelerators that are injectors to larger machines in high-energy physics facilities are not considered. An ABNS for BNCT is composed of: (1) the accelerator hardware for producing a high current charged particle beam, (2) an appropriate neutron-producing target and target heat removal system (HRS), and (3) a moderator/reflector assembly to render the flux energy spectrum of neutrons produced in the target suitable for patient irradiation. As a consequence of the efforts of researchers throughout the world, progress has been made on the design, manufacture, and testing of these three major components. Although an ABNS facility has not yet been built that has optimally assembled these three components, the feasibility of clinically useful ABNSs has been clearly established. Both electrostatic and radio frequency linear accelerators of reasonable cost (approximately 1.5 M dollars) appear to be capable of producing charged particle beams, with combinations of accelerated particle energy (a few MeV) and beam currents (approximately 10 mA) that are suitable for a hospital-based ABNS for BNCT. The specific accelerator performance requirements depend upon the charged particle reaction by which neutrons are produced in the target and the clinical requirements for neutron field quality and intensity. The accelerator performance requirements are more demanding for beryllium than for lithium as a target. However, beryllium targets are more easily cooled. The accelerator performance requirements are also more demanding for greater neutron field quality and intensity. Target HRSs that are based on submerged-jet impingement and

  5. Results of high energy x-ray therapy of gastric carcinoma, 2. Recurrent gastric carcinoma

    Energy Technology Data Exchange (ETDEWEB)

    Asakawa, H; Otawa, H; Yamada, S [Miyagi Prefectural Adult Disease Center, Natori (Japan)

    1979-01-01

    Thirty cases with recurrent gastric carcinoma were treated with a combination of high energy x-ray and some anti-cancer drugs at Miyagi Seijinbyo Center between 1967 and 1977. Twenty three cases of them tolerated well such treatment; the irradiated dose was more than 4000 rad without any serious complication. The response of recurrent tumor to irradiation was marked in 11 lesions of 21 local recurrences and 4 metastases of the lymph node. The survival rates of those irradiated more than 4000 rad were 22% at one year, 15% at two years and 5% at three years. The median survival month was 6,9 months. These rates obtained in a combined radiation therapy seemed to be well matched for those reported by other authors in a surgical management of recurrent gastric carcinoma. As a conclusion, it was suggested that a combined radiation therapy with some anticancer drugs should be an effective procedure to prolong the life of a patient of recurrent gastric carcinoma.

  6. Intercomparison of radiation protection devices in a high-energy stray neutron field. Part III: Instrument response

    CERN Document Server

    Silari, M; Beck, P; Bedogni, R; Cale, E; Caresana, M; Domingo, C; Donadille, L; Dubourg, N; Esposito, A; Fehrenbacher, G; Fernández, F; Ferrarini, M; Fiechtner, A; Fuchs, A; García, M J; Golnik, N; Gutermuth, F; Khurana, S; Klages, Th; Latocha, M; Mares, V; Mayer, S; Radon, T; Reithmeier, H; Rollet, S; Roos, H; Rühm, W; Sandri, S; Schardt, D; Simmer, G; Spurný, F; Trompier, F; Villa-Grasa, C; Weitzenegger, E; Wiegel, B; Wielunski, M; Wissmann, F; Zechner, A; Zielczyński, M

    2009-01-01

    The European Commission has funded within its 6th Framework Programme a three-year project (2005–2007) called CONRAD, COordinated Network for RAdiation Dosimetry. The organizational framework for this project was provided by the European radiation Dosimetry Group EURADOS. Work Package 6 of CONRAD dealt with “complex mixed radiation fields at workplaces” and in this context it organised a benchmark exercise, which included both measurements and calculations, in a stray radiation field at a high-energy particle accelerator at GSI, Germany. The aim was to intercompare the response of several types of active detectors and passive dosemeters in a well-characterised workplace field. The Monte Carlo simulations of the radiation field and the experimental determination of the neutron spectra with various Bonner Sphere Spectrometers are discussed in Rollet et al. (2008) and in Wiegel et al. (2008). This paper focuses on the intercomparison of the response of the dosemeters in terms of ambient dose equivalent. Th...

  7. Development and benchmark of high energy continuous-energy neutron cross Section library HENDL-ADS/MC

    International Nuclear Information System (INIS)

    Chen Chong; Wang Minghuang; Zou Jun; Xu Dezheng; Zeng Qin

    2012-01-01

    The ADS (accelerator driven sub-critical system) has great energy spans, complex energy spectrum structures and strong physical effects. Hence, the existing nuclear data libraries can't fully meet the needs of nuclear analysis in ADS. In order to do nuclear analysis for ADS system, a point-wise data library HENDL-ADS/MC (hybrid evaluated nuclear data library) was produced by FDS team. Meanwhile, to test the availability and reliability of the HENDL-ADS/MC data library, a series of shielding and critical safety benchmarks were performed. To validate and qualify the reliability of the high-energy cross section for HENDL-ADS/MC library further, a series of high neutronics integral experiments have been performed. The testing results confirm the accuracy and reliability of HENDL-ADS/MC. (authors)

  8. (3He,α) reaction mechanism at high energy and neutron inner shell structure

    International Nuclear Information System (INIS)

    Wiele, J. van de.

    1980-01-01

    The ( 3 He,α) reaction on 12 C, 16 O, 28 Si, 58 Ni, 90 Zr, 118 Sn, 124 Sn and 208 Pb targets has been studied at Esub( 3 He) = 217 MeV (or 205 MeV) in order to investigate the reaction mechanism at high energy and large momentum transfer. The reaction yields large cross sections at very forward angles and strongly enhances the largest orbital momentum transfer. The angular distribution shapes are well reproduced in the frame-work of the Z-R- D.W.B.A. analysis if we use a unique empirical α-potential: Vsub(α)(Esub(α)) = Vsub( 3 He)(3/4 Esub(α)) + Vsub(n)(1/4 Esub(α)). The excitation energy spectra have been measured up to 100 MeV in the residual light and medium nuclei and up to about 16 MeV in heavy nuclei. In addition to the well-known low-lying levels, peaks or broad structures are observed for each nucleus at higher excitation energies. They are attributed to pick up from inner shells: 1s( 11 C and 15 O), 1p( 27 Si), 1d5/2 + 1p( 57 Ni), 1f7/2( 89 Zr) 1g9/2 117 Sn, 123 Sn and 1h11/2( 207 Pb). Selectivity and localization of direct and indirect pick up ( 3 He,α) reactions were studied. Finite range calculations show that this reaction is not very sensitive to the details of the range from function but only to D 0 coefficient and range R. A microscopic α-nucleus optical potential calculated with n-n dependent and independent density forces is able to reproduce both elastic scattering and pick up reaction angular distributions [fr

  9. Neutron therapy of resistant thyroid gland cancer

    Science.gov (United States)

    Choynzonov, E. L.; Gribova, O. V.; Startseva, Zh. A.; Lisin, V. A.; Novikov, V. A.; Musabaeva, L. I.

    2017-09-01

    The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons c. The study included 45 patients with thyroid gland cancers who received the combined modality treatment and radiation therapy alone with the use of 6.3 MeV fast neutrons generated within U-120 cyclotron. The clinical trial of neutron-photon therapy used alone and in combination with the surgery for the patients with aggressive forms of thyroid cancer showed feasibility of increasing the effectiveness of treatment due to the reduction in the incidence of local recurrences. In addition, satisfactory treatment tolerance and absence of severe specific complications dictate the necessity of prospective studies to improve treatment outcomes.

  10. Nuclear data for neutron therapy: Status and future needs

    International Nuclear Information System (INIS)

    1997-12-01

    This report discusses the status and success of neutron therapy and some of the problems in clinical neutron dosimetry. Existing neutron interaction data, in particular results of kerma factor measurements and data evaluations, are reviewed. Nuclear data relevant for neutron source reactions, collimation, and shielding are also discussed. Finally, physical aspects of the variation of biological effectiveness of neutrons with neutron energy (radiation quality) are set out. Exchange of information between neutron therapy centers is essential, since only clinical experience can determine the optimal absorbed dose, fractionation, target volume, and clinical indications/contra-indications for neutron therapy

  11. Nuclear data for neutron therapy: Status and future needs

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-12-01

    This report discusses the status and success of neutron therapy and some of the problems in clinical neutron dosimetry. Existing neutron interaction data, in particular results of kerma factor measurements and data evaluations, are reviewed. Nuclear data relevant for neutron source reactions, collimation, and shielding are also discussed. Finally, physical aspects of the variation of biological effectiveness of neutrons with neutron energy (radiation quality) are set out. Exchange of information between neutron therapy centers is essential, since only clinical experience can determine the optimal absorbed dose, fractionation, target volume, and clinical indications/contra-indications for neutron therapy. Refs, 44 figs, 19 tabs.

  12. The High-Energy Polarization-Limiting Radius of Neutron Star Magnetospheres 1, Slowly Rotating Neutron Stars

    CERN Document Server

    Heyl, J S; Lloyd, D; CERN. Geneva; Heyl, Jeremy S.; Shaviv, Nir J.; Lloyd, Don

    2003-01-01

    In the presence of strong magnetic fields, the vacuum becomes a birefringent medium. We show that this QED effect decouples the polarization modes of photons leaving the NS surface. Both the total intensity and the intensity in each of the two modes is preserved along a ray's path through the neutron-star magnetosphere. We analyze the consequences that this effect has on aligning the observed polarization vectors across the image of the stellar surface to generate large net polarizations. Counter to previous predictions, we show that the thermal radiation of NSs should be highly polarized even in the optical. When detected, this polarization will be the first demonstration of vacuum birefringence. It could be used as a tool to prove the high magnetic field nature of AXPs and it could also be used to constrain physical NS parameters, such as $R/M$, to which the net polarization is sensitive.

  13. Fast and high-energy neutron detection with nuclear track detectors: Results of the European joint experiments 1992/93

    Energy Technology Data Exchange (ETDEWEB)

    Schraube, H. [GSF - Forschungszentrum fuer Umwelt und Gesundheit Neuherberg GmbH, Oberschleissheim (Germany); Alberts, W.G. [Physikalisch-Technische Bundesanstalt, Braunschweig (Germany); Weeks, A.R. [comps.] [Nuclear Electric plc, Berkeley (United Kingdom). Berkeley Technology Centre

    1997-12-31

    Under the auspices of EURADOS, the European radiation dosimetry group, seventeen recognised laboratories engaged in the field of individual neutron dosimetry with passive track detectors participated in an international comparative experiment. A number of twenty-seven detector systems, predominantly etched track detectors with the material PADC (poly allyl diglycol carbonate), were employed by the participating laboratories. Quasi-monoenergetic neutrons were provided for irradiations free-in-air and on front of a PMMA phantom by the GSF (Forschungszentrum fuer Umwelt und Gesundheit, Neuherberg, Germany) and by the PTB (Physikalisch-Technische Bundesanstalt, Braunschweig, Germany). High energy irradiations were conducted by the PSI (Paul-Scherrer Institut, Villigen, Switzerland). The results of the on-phantom irradiations were used to derive energy and angular responses of the track detectors, those of the free-in-air irradiations to obtain data for the linearity characteristics of the response with dose. The report contains a short description and the original data of the participating laboratories, displays the irradiation and reference conditions, and provides an over-all evaluation. Emphasis is placed on the quantitative evaluation of the background characteristics and of the non-linearity observed with most of the systems employed which limits their useful dose-range of application. (orig.)

  14. Characterization of neutron-irradiated HT-UPS steel by high-energy X-ray diffraction microscopy

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Xuan, E-mail: xuanzhang@anl.gov [Nuclear Engineering Division, Argonne National Laboratory, Lemont, IL 60439 (United States); Park, Jun-Sang; Almer, Jonathan [Advanced Photon Source, Argonne National Laboratory, Lemont, IL 60439 (United States); Li, Meimei [Nuclear Engineering Division, Argonne National Laboratory, Lemont, IL 60439 (United States)

    2016-04-01

    This paper presents the first measurement of neutron-irradiated microstructure using far-field high-energy X-ray diffraction microscopy (FF-HEDM) in a high-temperature ultrafine-precipitate-strengthened (HT-UPS) austenitic stainless steel. Grain center of mass, grain size distribution, crystallographic orientation (texture), diffraction spot broadening and lattice constant distributions of individual grains were obtained for samples in three different conditions: non-irradiated, neutron-irradiated (3dpa/500 °C), and irradiated + annealed (3dpa/500 °C + 600 °C/1 h). It was found that irradiation caused significant increase in grain-level diffraction spot broadening, modified the texture, reduced the grain-averaged lattice constant, but had nearly no effect on the average grain size and grain size distribution, as well as the grain size-dependent lattice constant variations. Post-irradiation annealing largely reversed the irradiation effects on texture and average lattice constant, but inadequately restored the microstrain.

  15. Determination of workplace neutron spectra at a high energy hadron accelerator using active and passive Bonner sphere spectrometers

    International Nuclear Information System (INIS)

    Bedogni, R.; Esposito, A.; Chiti, M.

    2008-01-01

    In the framework of the 2006 experimental benchmark organized at the GSI (Darmstadt, Germany) by the EC CONRAD network, a neutron dosimetry intercomparison was performed in a workplace field around a carbon target hit by 400 MeV/u 12 C ions. The radiation protection group of the INFN-LNF participated to the intercomparison with a Bonner sphere spectrometer equipped with an active 6 LiI(Eu) scintillator and a set of passive detectors, namely MCP-6s (80mgcm -2 )/MCP-7 TLD pairs from TLD Poland. Both active and passive spectrometers, independently tested and calibrated, were used to determine the field and dosimetric quantities in the measurement point. The FRUIT unfolding code, developed at the INFN-LNF radiation protection group, was used to unfold the raw BSS data. This paper compares the results of the active or passive spectrometers, obtaining a satisfactory agreement in terms of both spectrum shape and value of the integral quantities, as the neutron fluence or the ambient dose equivalent. These results allow qualifying the BSS based on TLD pairs as a reliable passive method to be used around high energy particle accelerators even in low dose rate areas. This is particularly useful in those workplaces where the active instruments could be disturbed by the presence of pulsed fields, large photon fluence or electromagnetic noise

  16. Measurement of leakage and design for the protective barrier of the high energy radiation therapy room

    International Nuclear Information System (INIS)

    Chu, S.S.; Park, C.Y.

    1981-01-01

    The logical development of an optimum structural shielding design and the computation of protective barriers for high energy radiation therapy room, Toshiba 13 MeV are presented. We obtained following results by comparison in between the precalculating values and actual survey after complete installation of radiogenerating units. 1) The calculating formula for the protective barrier written in NCRP report no. 34(1970) was the most ideal and economic calculating methods for the construction of barrier and to determine thickness for the meeting requirements of the number of patients of 80-100 in daily treatment. 2) The precalculating values of protective barrier are 5 times more protective than that of actual measurement. It is depending on radiation workload and utilization the data most securely. 3) The dose rate during exposure are 2-10 mR/hr at out of the door and the control room. 4) The foul smelling and ozone gas production from long exposure of cancer patients cannot be estimated when the room is ill ventilated. (author)

  17. Time-dose relationship of erythema in high energy photon irradiation therapy

    Energy Technology Data Exchange (ETDEWEB)

    Kobayashi, Hidetoshi (Gifu Prefectural Tajimi Hospital (Japan)); Sakuma, Sadayuki

    1992-01-01

    Skin doses of 100 patients who were treated with high energy ionizing irradiation during conventional irradiation therapy were measured by thermoluminescence dosimeter (TLD). In 87 of the 100 patients, acute hyperemic change of the skin (erythema) of the irradiated region was observed. In the other 13 patients, alopetia of the scalp was observed. The following conclusions were reached. The time-dose relationship was linear when erythema tolerance was used as an index, but not when alopecia was used. The tolerance dose for erythema was lower than previously reported. The slope of the isoeffect curve on the log-log plot of total absorbed skin dose against total number of days after the first irradiation was 0.68 when erythema was used as an index. This number is larger than previously reported results. We considered that erythema is significantly influenced by fraction size and that hyperfractionation is a promising method of irradiation, especially in Japan. Combined use of chemotherapeutic agents, such as 5-FU, accelerated erythema. The slope of combined treatment was 0.86. Observing acute hyperemic change of skin is considered to be a useful method of investigating the combined effects of chemotherapeutic agents on irradiation. (author).

  18. Microdosimetry for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Maughan, R.L.; Kota, C.

    2000-01-01

    The specific aims of the research proposal were as follows: (1) To design and construct small volume tissue equivalent proportional counters for the dosimetry and microdosimetry of high intensity thermal and epithermal neutron beams used in BNCT, and of modified fast neutron beams designed for boron neutron capture enhanced fast neutron therapy (BNCEFNT). (2) To develop analytical methods for estimating the biological effectiveness of the absorbed dose in BNCT and BNCEFNT based on the measured microdosimetric spectra. (3) To develop an analytical framework for comparing the biological effectiveness of different epithermal neutron beams used in BNCT and BNCEFNT, based on correlated sets of measured microdosimetric spectra and radiobiological data. Specific aims (1) and (2) were achieved in their entirety and are comprehensively documented in Jay Burmeister's Ph.D. dissertation entitled ''Specification of physical and biologically effective absorbed dose in radiation therapies utilizing the boron neutron capture reaction'' (Wayne State University, 1999). Specific aim (3) proved difficult to accomplish because of a lack of sufficient radiobiological data

  19. A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226.

    Science.gov (United States)

    Melville, G; Melville, P

    2013-02-01

    Radium needles that were once implanted into tumours as a cancer treatment are now obsolete and constitute a radioactive waste problem, as their half-life is 1600 years. We are investigating the reduction of radium by transmutation by bombarding Ra-226 with high-energy neutrons from a neutron source to produce Ra-225 and hence Ac-225, which can be used as a generator to produce Bi-213 for use in 'Targeted Alpha Therapy' for cancer. This paper examines the possibility of producing Ac-225 by neutron capture using a theoretical model in which neutron energy is convoluted with the corresponding neutron cross sections of Ra-226. The total integrated yield can then be obtained. This study shows that an intense beam of high-energy neutrons could initiate neutron capture on Ra-226 to produce Ra-225 and hence practical amounts of Ac-225 and a useful reduction of Ra-226. Copyright © 2012 Elsevier Ltd. All rights reserved.

  20. Definition by modelling, optimization and characterization of a neutron spectrometry system based on Bonner spheres extended to the high-energy range

    International Nuclear Information System (INIS)

    Serre, S.

    2010-01-01

    This research thesis first describes the problematic of the effects of natural radiation on micro- and nano-electronic components, and the atmospheric-radiative stress of atmospheric neutrons from cosmic origin: issue of 'Single event upsets', present knowledge of the atmospheric radiative environment induced by cosmic rays. The author then presents the neutron-based detection and spectrometry by using the Bonner sphere technique: principle of moderating spheres, definition and mathematical formulation of neutron spectrometry using Bonner spheres, active sensors of thermal neutrons, response of a system to conventional Bonner spheres, extension to the range of high energies. Then, he reports the development of a Bonner sphere system extended to the high-energy range for the spectrometry of atmospheric neutrons: definition of a conventional system, Monte Carlo calculation of response functions, development of the response matrix, representation and semi-empirical verification of fluence response, uncertainty analysis, extension to high energies, and measurement tests of the spectrometer. He reports the use of a Monte Carlo simulation to characterize the spectrometer response in the high-energy range

  1. Development of dose delivery verification by PET imaging of photonuclear reactions following high energy photon therapy

    International Nuclear Information System (INIS)

    Janek, S; Svensson, R; Jonsson, C; Brahme, A

    2006-01-01

    A method for dose delivery monitoring after high energy photon therapy has been investigated based on positron emission tomography (PET). The technique is based on the activation of body tissues by high energy bremsstrahlung beams, preferably with energies well above 20 MeV, resulting primarily in 11 C and 15 O but also 13 N, all positron-emitting radionuclides produced by photoneutron reactions in the nuclei of 12 C, 16 O and 14 N. A PMMA phantom and animal tissue, a frozen hind leg of a pig, were irradiated to 10 Gy and the induced positron activity distributions were measured off-line in a PET camera a couple of minutes after irradiation. The accelerator used was a Racetrack Microtron at the Karolinska University Hospital using 50 MV scanned photon beams. From photonuclear cross-section data integrated over the 50 MV photon fluence spectrum the predicted PET signal was calculated and compared with experimental measurements. Since measured PET images change with time post irradiation, as a result of the different decay times of the radionuclides, the signals from activated 12 C, 16 O and 14 N within the irradiated volume could be separated from each other. Most information is obtained from the carbon and oxygen radionuclides which are the most abundant elements in soft tissue. The predicted and measured overall positron activities are almost equal (-3%) while the predicted activity originating from nitrogen is overestimated by almost a factor of two, possibly due to experimental noise. Based on the results obtained in this first feasibility study the great value of a combined radiotherapy-PET-CT unit is indicated in order to fully exploit the high activity signal from oxygen immediately after treatment and to avoid patient repositioning. With an RT-PET-CT unit a high signal could be collected even at a dose level of 2 Gy and the acquisition time for the PET could be reduced considerably. Real patient dose delivery verification by means of PET imaging seems to be

  2. Presentation of a semiempirical method for the calculation of doses due to neutrons and capture gamma rays inside high energy accelerators rooms

    International Nuclear Information System (INIS)

    Larcher, A.M.; Bonet Duran, S.M.

    1998-01-01

    Full text: Medical electron accelerators operating above 10 MeV produce radiation beams that are contaminated with neutrons. Therefore, shielding design for high energy accelerator rooms must consider the neutron component of the radiation field. In this paper a semiempirical method is presented to calculate doses due to neutrons and capture gamma rays inside the room and the maze. The calculation method is based on the knowledge of the neutron yield Q (neutrons/Gy of photons at isocenter) and the average energy of the primary beam of neutrons Eo (MeV). The method constitutes an appropriate tool for shielding facilities evaluation. The accuracy of the method has been contrasted with data obtained from the literature and an excellent correlation among the calculations and the measured values was achieved. In addition, the method has been used in the verification of experimental data corresponding to a 15 MeV linear accelerator installed in the country with similar results. (author) [es

  3. Gadolinium atom on neutron capture therapy

    International Nuclear Information System (INIS)

    Oda, Y.; Takagaki, M.; Miyatake, S.; Kikuchi, H.

    1994-01-01

    This report describes our measurements of gadolinium concentrations in several brain tumors obtained from fresh surgical specimens, as compared with corresponding concentrations in the blood. Moreover we tried to find out if the gadolinium concentration is high enough to use this compound in the treatment of brain tumors by neutron capture therapy. (J.P.N.)

  4. Neutron therapy coupling brachytherapy and boron neutron capture therapy (BNCT) techniques

    International Nuclear Information System (INIS)

    Chaves, Iara Ferreira.

    1994-12-01

    In the present dissertation, neutron radiation techniques applied into organs of the human body are investigated as oncologic radiation therapy. The proposal treatment consists on connecting two distinct techniques: Boron Neutron Capture Therapy (BNCT) and irradiation by discrete sources of neutrons, through the brachytherapy conception. Biological and radio-dosimetrical aspects of the two techniques are considered. Nuclear aspects are discussed, presenting the nuclear reactions occurred in tumoral region, and describing the forms of evaluating the dose curves. Methods for estimating radiation transmission are reviewed through the solution of the neutron transport equation, Monte Carlo methodology, and simplified analytical calculation based on diffusion equation and numerical integration. The last is computational developed and presented as a quickly way to neutron transport evaluation in homogeneous medium. The computational evaluation of the doses for distinct hypothetical situations is presented, applying the coupled techniques BNTC and brachytherapy as an possible oncologic treatment. (author). 78 refs., 61 figs., 21 tabs

  5. Radiation therapy with fast neutrons: A review

    International Nuclear Information System (INIS)

    Jones, D.T.L.; Wambersie, A.

    2007-01-01

    Because of their biological effects fast neutrons are most effective in treating large, slow-growing tumours which are resistant to conventional X-radiation. Patients are treated typically 3-4 times per week for 4-5 weeks (sometimes in combination with X-radiation) for a variety of conditions such as carcinomas of the head and neck, salivary gland, paranasal sinus and breast; soft tissue, bone and uterine sarcomas and malignant melanomas. It is estimated that about 27,000 patients have undergone fast neutron therapy to date

  6. Recent advances in neutron capture therapy (NCT)

    International Nuclear Information System (INIS)

    Fairchild, R.G.

    1985-01-01

    The application of the 10 B(n,α) 7 Li reaction to cancer radiotherapy (Neutron Capture therapy, or NCT) has intrigued investigators since the discovery of the neutron. This paper briefly summarizes data describing recently developed boronated compounds with evident tumor specificity and extended biological half-lives. The implication of these compounds to NCT is evaluated in terms of Therapeutic Gain (TG). The optimization of NCT using band-pass filtered beams is described, again in terms of TG, and irradiation times with these less intense beams are estimated. 24 refs., 3 figs., 3 tabs

  7. Intercomparison of radiation protection devices in a high-energy stray neutron field. Part III: Instrument response

    International Nuclear Information System (INIS)

    Silari, M.; Agosteo, S.; Beck, P.; Bedogni, R.; Cale, E.; Caresana, M.; Domingo, C.; Donadille, L.; Dubourg, N.; Esposito, A.; Fehrenbacher, G.; Fernandez, F.; Ferrarini, M.; Fiechtner, A.; Fuchs, A.; Garcia, M.J.; Golnik, N.; Gutermuth, F.; Khurana, S.; Klages, Th.

    2009-01-01

    The European Commission has funded within its 6th Framework Programme a three-year project (2005-2007) called CONRAD, COordinated Network for RAdiation Dosimetry. The organizational framework for this project was provided by the European radiation Dosimetry Group EURADOS. Work Package 6 of CONRAD dealt with 'complex mixed radiation fields at workplaces' and in this context it organised a benchmark exercise, which included both measurements and calculations, in a stray radiation field at a high-energy particle accelerator at GSI, Germany. The aim was to intercompare the response of several types of active detectors and passive dosemeters in a well-characterised workplace field. The Monte Carlo simulations of the radiation field and the experimental determination of the neutron spectra with various Bonner Sphere Spectrometers are discussed in Rollet et al. (2008) and in Wiegel et al. (2008). This paper focuses on the intercomparison of the response of the dosemeters in terms of ambient dose equivalent. The paper describes in detail the detectors employed in the experiment, followed by a discussion of the results. A comparison is also made with the H*(10) values predicted by the Monte Carlo simulations and those measured by the BSS systems.

  8. Characterization of the PTW 34031 ionization chamber (PMI) at RCNP with high energy neutrons ranging from 100 - 392 MeV

    Science.gov (United States)

    Theis, C.; Carbonez, P.; Feldbaumer, E.; Forkel-Wirth, D.; Jaegerhofer, L.; Pangallo, M.; Perrin, D.; Urscheler, C.; Roesler, S.; Vincke, H.; Widorski, M.; Iwamoto, Y.; Hagiwara, M.; Satoh, D.; Iwase, H.; Yashima, H.; Matsumoto, T.; Masuda, A.; Nishiyama, J.; Harano, H.; Itoga, T.; Nakamura, T.; Sato, T.; Nakane, Y.; Nakashima, H.; Sakamoto, Y.; Taniguchi, S.; Nakao, N.; Tamii, A.; Shima, T.; Hatanaka, K.

    2017-09-01

    Radiation monitoring at high energy proton accelerators poses a considerable challenge due to the complexity of the encountered stray radiation fields. These environments comprise a wide variety of different particle types and span from fractions of electron-volts up to several terra electron-volts. As a consequence the use of Monte Carlo simulation programs like FLUKA is indispensable to obtain appropriate field-specific calibration factors. At many locations of the LHC a large contribution to the particle fluence is expected to originate from high-energy neutrons and thus, benchmark experiments with mono-energetic neutron beams are of high importance to verify the aforementioned detector response calculations. This paper summarizes the results of a series of benchmark experiments with quasi mono-energetic neutrons of 100, 140, 200, 250 and 392 MeV that have been carried out at RCNP - Osaka University, during several campaigns between 2006 and 2014.

  9. Fast neutron therapy in advanced malignant tumour treatment

    International Nuclear Information System (INIS)

    Avinc, A.

    1998-01-01

    In this report the fast neutron therapy applications were examined by thoroughly consideration of the fast neutron sources and the interactions of the fast neutron by the medium. The efficacy of fast neutron radiotherapy with that of patients with locally advanced tumours were compared. Radiological data indicate that fast neutrons could bring benefit in the treatment of some tumour types especially salivary glands, paranasal sinuses, soft tissue sarcomas, prostatic adenocarcinomas, palliative treatment of melanoma and rectum. There is a significant improvement in local/regional control for the neutron group, but no improvement in the survival. The neutron therapy is suggested through which this benefit could be achieved

  10. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head.

    Science.gov (United States)

    Xie, Kai; Mao, Yuanqing; Qu, Xinhua; Dai, Kerong; Jia, Qingwei; Zhu, Zhenan; Yan, Mengning

    2018-02-02

    Nontraumatic osteonecrosis of the femoral head (ONFH) is treated with a series of methods. High-energy extracorporeal shock wave therapy (ESWT) is an option with promising mid-term outcomes. The objective of this study was to determine the long-term outcomes of ESWT for ONFH. Fifty-three hips in 39 consecutive patients were treated with ESWT in our hospital between January 2005 and July 2006. Forty-four hips in 31 patients with stage I-III nontraumatic ONFH, according to the Association Research Circulation Osseous (ARCO) system, were reviewed in the current retrospective study. The visual analog pain scale (VAS), Harris hip score, radiography, and magnetic resonance imaging were used to estimate treatment results. The progression of ONFH was evaluated by imaging examination and clinical outcomes. The results were classified as clinical success (no progression of hip symptoms) and imaging success (no progression of stage or substage on radiography and MRI). The mean follow-up duration was 130.6 months (range, 121 to 138 months). The mean VAS decreased from 3.8 before ESWT to 2.2 points at the 10-year follow-up (p < 0.001). The mean Harris hip score improved from 77.4 before ESWT to 86.9 points at the 10-year follow-up. The clinical success rates were 87.5% in ARCO stage I patients, 71.4% in ARCO stage II patients, and 75.0% in ARCO stage III patients. Imaging success was observed in all stage I hips, 64.3% of stage II hips, and 12.5% of stage III hips. Seventeen hips showed progression of the ARCO stage/substage on imaging examination. Eight hips showed femoral head collapse at the 10-year follow-up. Four hips in ARCO stage III and one hip in ARCO stage II were treated with total hip arthroplasty during the follow-up. Three were performed 1 year after ESWT, one at 2 years, and one at 5 years. The results of the current study indicated that ESWT is an effective treatment method for nontraumatic ONFH, resulting in pain relief and function restoration

  11. Neutron capture therapy. Principles and applications

    International Nuclear Information System (INIS)

    Sauerwein, Wolfgang A.G.; Moss, Raymond; Wittig, Andrea; Nakagawa, Yoshinobu

    2012-01-01

    State of the art report on neutron capture therapy. Summarizes the progress made in recent decades. Multidisciplinary approach. Written by the most experienced specialists Neutron capture therapy (NCT) is based on the ability of the non-radioactive isotope boron-10 to capture thermal neutrons with very high probability and immediately to release heavy particles with a path length of one cell diameter. This in principle allows for tumor cell-selective high-LET particle radiotherapy. NCT is exciting scientifically but challenging clinically, and a key factor in success is close collaboration among very different disciplines. This book provides a comprehensive summary of the progress made in NCT in recent years. Individual sections cover all important aspects, including neutron sources, boron chemistry, drugs for NCT, dosimetry, and radiation biology. The use of NCT in a variety of malignancies and also some non-malignant diseases is extensively discussed. NCT is clearly shown to be a promising modality at the threshold of wider clinical application. All of the chapters are written by experienced specialists in language that will be readily understood by all participating disciplines.

  12. Nuclear data needed for neutron therapy

    International Nuclear Information System (INIS)

    Okamoto, K.

    1989-03-01

    The Second Research Co-ordination Meeting (RCM) of the IAEA Co-ordinated Research Programme (CRP) on Nuclear Data Needed for Neutron Therapy was convened by the IAEA Nuclear Data Section, in Vienna, from 24 to 27 January 1989. The Summary Report of the First RCM was issued as INDC(NDS)-203/GZ (March 1988). Special emphasis was put on the discussion of the issue of the final publication of this CRP. (author). 36 refs, 8 tabs

  13. Experimental study on neutronics in bombardment of thick targets by high energy proton beams for accelerator-driven sub-critical system

    CERN Document Server

    Guo Shi Lun; Shi Yong Qian; Shen Qing Biao; Wan Jun Sheng; Brandt, R; Vater, P; Kulakov, B A; Krivopustov, M I; Sosnin, A N

    2002-01-01

    The experimental study on neutronics in the target region of accelerator-driven sub-critical system is carried out by using the high energy accelerator in Joint Institute for Nuclear Research, Dubna, Russia. The experiments with targets U(Pb), Pb and Hg bombarded by 0.533, 1.0, 3.7 and 7.4 GeV proton beams show that the neutron yield ratio of U(Pb) to Hg and Pb to Hg targets is (2.10 +- 0.10) and (1.76 +- 0.33), respectively. Hg target is disadvantageous to U(Pb) and Pb targets to get more neutrons. Neutron yield drops along 20 cm thick targets as the thickness penetrated by protons increases. The lower the energy of protons, the steeper the neutron yield drops. In order to get more uniform field of neutrons in the targets, the energy of protons from accelerators should not be lower than 1 GeV. The spectra of secondary neutrons produced by different energies of protons are similar, but the proportion of neutrons with higher energy gradually increases as the proton energy increases

  14. Evaluation of the fluence to dose conversion coefficients for high energy neutrons using a voxel phantom coupled with the GEANT4 code

    CERN Document Server

    Paganini, S

    2005-01-01

    Crews working on present-day jet aircraft are a large occupationally exposed group with a relatively high average effective dose from Galactic cosmic radiation. Crews of future high-speed commercial flying at higher altitudes would be even more exposed. To help reduce the significant uncertainties in calculations of such exposures, the male adult voxels phantom MAX, developed in the Nuclear Energy Department of Pernambuco Federal University in Brazil, has been coupled with the Monte Carlo simulation code GEANT4. This toolkit, distributed and upgraded from the international scientific community of CERN/Switzerland, simulates thermal to ultrahigh energy neutrons transport and interactions in the matter. The high energy neutrons are pointed as the component that contribute about 70% of the neutron effective dose that represent the 35% to 60% total dose at aircraft altitude. In this research calculations of conversion coefficients from fluence to effective dose are performed for neutrons of energies from 100 MeV ...

  15. High-energy extracorporeal shock-wave therapy for treating chronic calcific tendinitis of the shoulder: a systematic review.

    Science.gov (United States)

    Bannuru, Raveendhara R; Flavin, Nina E; Vaysbrot, Elizaveta; Harvey, William; McAlindon, Timothy

    2014-04-15

    Calcific and noncalcific tendinitis of the shoulder can be unresponsive to conventional therapies. Extracorporeal shock-wave therapy (ESWT) has been suggested as an alternative treatment. To assess the efficacy of ESWT in patients with calcific and noncalcific tendinitis. MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, Web of Science, and Google Scholar were searched up to 1 November 2013. Randomized, controlled trials (RCTs) comparing high-energy versus low-energy ESWT or placebo for treatment of calcific or noncalcific tendinitis of the shoulder. Outcome measures included pain (visual analogue scale score), functional assessment (Constant-Murley score), and resolution of calcifications. Three independent reviewers abstracted data and determined eligibility and quality by consensus. Twenty-eight RCTs met the inclusion criteria. Studies were heterogeneous. Twenty RCTs compared ESWT energy levels and placebo and consistently showed that high-energy ESWT was significantly better than placebo in decreasing pain and improving function and resorption of calcifications in calcific tendinitis. No significant difference was found between ESWT and placebo in treatment of noncalcific tendinitis. The number of RCTs was small, and the studies were heterogeneous. High-energy ESWT is effective for improving pain and shoulder function in chronic calcific shoulder tendinitis and can result in complete resolution of calcifications. This therapy may be underutilized for a condition that can be difficult to manage. None.

  16. Laser-Driven Very High Energy Electron/Photon Beam Radiation Therapy in Conjunction with a Robotic System

    Directory of Open Access Journals (Sweden)

    Kazuhisa Nakajima

    2014-12-01

    Full Text Available We present a new external-beam radiation therapy system using very-high-energy (VHE electron/photon beams generated by a centimeter-scale laser plasma accelerator built in a robotic system. Most types of external-beam radiation therapy are delivered using a machine called a medical linear accelerator driven by radio frequency (RF power amplifiers, producing electron beams with an energy range of 6–20 MeV, in conjunction with modern radiation therapy technologies for effective shaping of three-dimensional dose distributions and spatially accurate dose delivery with imaging verification. However, the limited penetration depth and low quality of the transverse penumbra at such electron beams delivered from the present RF linear accelerators prevent the implementation of advanced modalities in current cancer treatments. These drawbacks can be overcome if the electron energy is increased to above 50 MeV. To overcome the disadvantages of the present RF-based medical accelerators, harnessing recent advancement of laser-driven plasma accelerators capable of producing 1-GeV electron beams in a 1-cm gas cell, we propose a new embodiment of the external-beam radiation therapy robotic system delivering very high-energy electron/photon beams with an energy of 50–250 MeV; it is more compact, less expensive, and has a simpler operation and higher performance in comparison with the current radiation therapy system.

  17. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Science.gov (United States)

    2010-04-01

    ... therapy system. (a) Identification. A medical neutron radiation therapy system is a device intended to... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical neutron radiation therapy system. 892.5300... analysis and display equipment, patient and equipment support, treatment planning computer programs...

  18. High-energy extracorporeal shock-wave therapy for calcifying tendinitis of the rotator cuff: a randomised trial.

    Science.gov (United States)

    Albert, J-D; Meadeb, J; Guggenbuhl, P; Marin, F; Benkalfate, T; Thomazeau, H; Chalès, G

    2007-03-01

    In a prospective randomised trial of calcifying tendinitis of the rotator cuff, we compared the efficacy of dual treatment sessions delivering 2500 extracorporeal shock waves at either high- or low-energy, via an electromagnetic generator under fluoroscopic guidance. Patients were eligible for the study if they had more than a three-month history of calcifying tendinitis of the rotator cuff, with calcification measuring 10 mm or more in maximum dimension. The primary outcome measure was the change in the Constant and Murley Score. A total of 80 patients were enrolled (40 in each group), and were re-evaluated at a mean of 110 (41 to 255) days after treatment when the increase in Constant and Murley score was significantly greater (t-test, p = 0.026) in the high-energy treatment group than in the low-energy group. The improvement from the baseline level was significant in the high-energy group, with a mean gain of 12.5 (-20.7 to 47.5) points (p energy group. Total or subtotal resorption of the calcification occurred in six patients (15%) in the high-energy group and in two patients (5%) in the low-energy group. High-energy shock-wave therapy significantly improves symptoms in refractory calcifying tendinitis of the shoulder after three months of follow-up, but the calcific deposit remains unchanged in size in the majority of patients.

  19. Present status of fast neutron therapy for the malignant tumors

    Energy Technology Data Exchange (ETDEWEB)

    Tsunemoto, H; Morita, S; Honke, Y [National Inst. of Radiological Sciences, Chiba (Japan)

    1980-04-01

    Fast neutron therapy has been applied to the treatment of cancer of the head and the neck, prostatic cancer, osteosarcoma, and malignant melanoma, and the basic treatment schedule for this therapy for them has been almost established. The effectiveness of this therapy for squamous cell carcinoma of the uterus will be established by the results of future clinical application of this therapy. It is expected that postoperative irradiation of fast neutron will decrease local recurrence of adenocarcinoma of the uterus. Treatment schedule for fast neutron therapy for esophageal cancer and lung cancer must be established, and moreover, it is necessary to apply this therapy to the treatment of gastric and pancreatic cancer.

  20. The impact of ICRP 60 recommendations on the dose equivalent in low- and high energy neutron fields

    Energy Technology Data Exchange (ETDEWEB)

    Jakes, J; Schraube, H [GSF-Forschungszentrum Neuberg, D-85758 Oberschleissheim (Germany). Inst. fuer Strahlenschutz

    1996-12-31

    The objectives of this study was to determine the impact of the increased risk factors for neutrons after ICRP 60 on the operational dose equivalent quantities at a few neutron fields selected with the respect to cover the broad variety of neutron spectra: (1) Cadarache calibration assembly, with average neutron energy around 0.6 MeV, designed to simulate realistic neutron spectra at workplaces. This assembly is basically composed of an almost spherical {sup 238}U converter irradiated by 14.6 MeV neutrons from an accelerator target, placed at its center, and a scattering chamber consisting of a cylindrical polyethylene duct and a series of additional shieldings; (2) Neutron spectra at exposed workplaces in nuclear power plants; (3) Moderated spectra of {sup 252}Cf fission source; (4) Neutron spectra behind a shielding made of the iron (the average energy 5.,89 MeV) and concrete (the average energy 46.51 MeV), respectively; (5) Cosmic rays induced neutron spectra measured on the top of the Zugspitze (2968 m) where there is the average neutron energy around 40 MeV. From the derived neutron spectra, the mean quality factors and conversion factors h after ICRP 21 and ICRP 60, respectively, were calculated. The dose equivalent conversion factors were taken for the region below 20 MeV, and the energy region above 20 MeV. The results show that the operational quantities were affected predominately in the low energy fields, where the changes are given by a factor of 1,3 for the neutron fields given above. As has been expected, the impact of the new recommendations depends on the shape of the neutron spectra. Therefore, this factor can be much higher in the fields where the intermediate energy region is dominant, which is the case of moderated and scattered spectra at some places in the nuclear power plant and around containers with the spent fuel elements. (J.K.) 9 refs.

  1. Neutron spectrum for neutron capture therapy in boron; Espectro de neutrones para terapia por captura de neutrones en boro

    Energy Technology Data Exchange (ETDEWEB)

    Medina C, D.; Soto B, T. G. [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Programa de Doctorado en Ciencias Basicas, 98068 Zacatecas, Zac. (Mexico); Baltazar R, A. [Universidad Autonoma de Zacatecas, Unidad Academica de Ingenieria Electrica, Programa de Doctorado en Ingenieria y Tecnologia Aplicada, 98068 Zacatecas, Zac. (Mexico); Vega C, H. R., E-mail: dmedina_c@hotmail.com [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas, Zac. (Mexico)

    2016-10-15

    Glioblastoma multiforme is the most common and aggressive of brain tumors and is difficult to treat by surgery, chemotherapy or conventional radiation therapy. One treatment alternative is the Neutron Capture Therapy in Boron, which requires a beam modulated in neutron energy and a drug with {sup 10}B able to be fixed in the tumor. When the patients head is exposed to the neutron beam, they are captured by the {sup 10}B and produce a nucleus of {sup 7}Li and an alpha particle whose energy is deposited in the cancer cells causing it to be destroyed without damaging the normal tissue. One of the problems associated with this therapy is to have an epithermal neutrons flux of the order of 10{sup 9} n/cm{sup 2}-sec, whereby irradiation channels of a nuclear research reactor are used. In this work using Monte Carlo methods, the neutron spectra obtained in the radial irradiation channel of the TRIGA Mark III reactor are calculated when inserting filters whose position and thickness have been modified. From the arrangements studied, we found that the Fe-Cd-Al-Cd polyethylene filter yielded a ratio between thermal and epithermal neutron fluxes of 0.006 that exceeded the recommended value (<0.05), and the dose due to the capture gamma rays is lower than the dose obtained with the other arrangements studied. (Author)

  2. Neutron field characterization and dosimetry at the TRIUMF proton therapy facility

    International Nuclear Information System (INIS)

    Mukherjee, B.

    2002-01-01

    Full text: In 1972 the 500 MeV H' Cyclotron of the TRIUMF (Tri University Meson Factory) located in Vancouver, Canada became operational. Beside Meson Physics, high-energy protons of various energy and beam current levels from the TRIUMF Cyclotron are used for scientific research and biomedical applications. Recently, a 500 MeV proton beam from the cyclotron was used as the booster beam for the radioactive ion beam facility, ISAC (Isotope Separator Accelerator) and a second beam as primary irradiation source for the Proton Irradiation Facility (PIF). The major commercial applications of the PIF are the provision of high-energy proton beams for radiation hardness testing of electronic components used in space applications (NASA) and proton therapy of ocular tumors (British Columbia Proton Therapy Facility). The PIF vault was constructed within the main accelerator hall of the TRIUMF using stacks of large concrete blocks. An intense field of fast neutrons is produced during the interaction of high-energy proton beam with target materials, such as, beam stops, collimators and beam energy degraders. The leakage of such neutrons due to insufficient radiological shielding or through the shielding discontinuities may constitute a major share of the personnel radiation exposure of the radiation workers. The neutron energy distribution and dose equivalent near a lead beam stopper bombarded with 116 MeV and 65 MeV collimated proton beams at the Ocular Tumor irradiation facility were evaluated using a Bonner-Sphere Spectrometer and a REM counter respectively. The results were utilized to investigate efficacy of the existing radiological shielding of the PIF. This paper highlights experimental methods to analyze the high-energy accelerator produced neutron beam and basic guideline for the radiological shielding designs of irradiation vault of Proton Therapy facilities

  3. Measurement of neutron-production double-differential cross sections for high-energy pion-incident reaction

    International Nuclear Information System (INIS)

    Iwamoto, Yousuke; Iga, Kiminori; Kitsuki, Hirohiko

    2000-01-01

    Double-differential neutron-production yields for 870-MeV π + , π - and 2.1-GeV π + incident on iron and lead targets were measured with NE213 liquid scintillators by time-of-flight technique. The two-gate integration method was used for the pulse shape discrimination between neutrons and gamma-rays. Neutron detection efficiencies were derived from the calculation results of SCINFUL and CECIL codes. The experimental results were compared with the calculation including the neutron transport in the actual thickness target by the contribution use of both NMTC/JAERI97 and MCNPX. (author)

  4. Considerations for boron neutron capture therapy studies

    International Nuclear Information System (INIS)

    Faria Gaspar, P. de.

    1994-01-01

    Radiotherapy is indispensable as a mean to eradicate deeply or infiltrating tumor tissue that can not be removed surgically. Therefore, it is not selective and may also kill the surrounding health tissue. The principle of BNCT (Boron Neutron Capture Therapy) consist in targeting a tumor selectively with a boron-10 compound. This nuclide has a large capture cross section for thermal neutrons and the nuclear reaction and the delivered energy in locus will selective the tumor. Since its initial proposal in 1963 BNCT has made much progress, however it is not used in a routine treatment. In this work it was approached some complex procedures, as the obtention of selective boron compounds, the adequate set up of neutron beams, the biodistribution, the in vivo and in vitro studies, and also human patients treatments. This work provide fundamentals about BNCT to professional of different areas of knowledge since it comprises multidisciplinary study. It includes appendixes for the ones not related to the field for a better comprehension of the many aspects involved. It is also presented a glossary containing technical and basic aspects involved. It is also presented a glossary containing technical and basic terms referred in the work. (author). 174 refs, 1 fig, 12 apps

  5. Research needs for neutron capture therapy

    International Nuclear Information System (INIS)

    1995-01-01

    Key issues and questions addressed by the workshop related to optimization of Boron Neutron Capture Therapy (BNCT), in general, and to the possibility of success of the present BNCT trials at Brookhaven National Laboratory (BNL) and Massachusetts Institute of Technology (MIT), in particular. Both trials use nuclear fission reactors as neutron sources for BNCT of glioblastoma multiforme (BNL) and of deep seated melanoma (MIT). Presentations and discussions focussed on optimal boron-labeled compounds, mainly for brain tumors such as glioblastoma multiforme, and the best mode of compound delivery to the tumor. Also, optimizing neutron irradiation with dose delivery to the tumor cells and the issues of dosimetry of BNCT especially in the brain were discussed. Planning of treatment and of follow-up of patients, coordination of BNCT at various treatment sites, and the potential of delivering BNCT to various types of cancer with an appropriately tailored protocol were additional issues. The need for multicentric interdisciplinary cooperation among the different medical specialties was highlighted

  6. High energy resolution measurement of the sup 238 U neutron capture yield from 1 to 100 keV

    Energy Technology Data Exchange (ETDEWEB)

    Macklin, R.L. (Tennessee Univ., Knoxville, TN (United States). Dept. of Nuclear Engineering); Perez, R.B. (Tennessee Univ., Knoxville, TN (United States). Dept. of Nuclear Engineering Oak Ridge National Lab., TN (United States)); De Saussure, G.; Ingle, R.W. (Oak Ridge National Lab., TN (United States))

    1991-01-01

    The purpose of this work is the precise determination of the {sup 238}U neutron capture yield (i.e. the probability of neutron capture) as a function of neutron energy with the highest available neutron energy resolution. The motivation for this undertaking arises from the central role played by the {sup 238}U neutron capture process in the neutron balance of both thermal reactors and fast breeder reactors. The present measurement was performed using the Oak Ridge Electron Linear Accelerator (ORELA) facility. The pulsed beam of neutrons from the ORELA facility is collimated on a sample of {sup 238}U. The neutron capture rate in the sample is measured, as a function of neutron time-of-flight (TOF) by detecting the {gamma}-rays from the {sup 238}U(n, {gamma}){sup 239}U reaction with a large {gamma}-ray detector surrounding the {sup 238}U sample. At each energy, the capture yield is proportional to the observed capture rate divided by the measured intensity of the neutron beam. The constant of proportionality (the normalization constant) is obtained from the ratio of theoretical to experimentally measured areas under small {sup 238}U resonances where the resonance parameters have been determined from high-resolution {sup 238}U transmission measurements. The cross section for the reaction {sup 238}U(n,{gamma}){sup 239}U can be derived from the measured capture yield if one applies appropriate corrections for multiple scattering and resonance self-shielding. Some 200 {sup 238}U neutron resonances in the energy range from 250 eV to 10 keV have been observed which had not been detected in previous measurements. (author).

  7. Use of the Power Burst Facility for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Crocker, J.G.; Griebenow, M.L.; Leatham, J.

    1990-01-01

    A program is under development at the Idaho National Engineering Laboratory (INEL) that involves using the Power Burst Facility (PBF) for research into boron neutron capture therapy (BNCT). BNCT utilizes the ionizing energy from boron-neutron capture to stop reproduction of or destroy cells in cancerous tissue in a two-step process. The first step is to selectively concentrate a boron isotope within the tumor cell, that when activated by neutron capture emits highly ionizing, short range particles. The second step involves activation of the isotope only in the vicinity of the tumor with a narrow neutron beam. The ( 10 B[n, 4 He] 7 Li) reaction with thermal neutrons produces fission products with track lengths approximately equal to a cell diameter. The INEL program includes the modification of the PBF by the addition of a filter and treatment area. The filter will down-scatter high energy neutrons into the epithermal range and remove thermal neutrons and excessively damaging gamma components. The intense source of epithermal neutrons from PBF is considered necessary to achieve optimum therapy for deep-seated tumors with minimum damage to surface tissue. THe neutron filter conceptualized for PBF utilizes aluminum and heavy water to down-scatter neutrons into the proper energy range. Bismuth will be used for gamma shielding and cadmium will remove the thermal neutron contaminant from the beam. The INEL program leads to human clinical trials at PBF which are intended to prove that brain tumors can be successfully treated through noninvasive techniques. Further research into BNCT at PBF for other cancer types is also anticipated

  8. Fast neutron therapy at the end of 1988 - a survey of the clinical data

    International Nuclear Information System (INIS)

    Wambersie, A.

    1990-01-01

    The clinical results reported from the different neutron therapy centres, in USA, Europe and Asia, are reviewed. Fast neutrons were proven to be superior to photons for locally extended inoperable salivary gland tumours. The reported overall local control rates are 67% and 24% respectively. Paranasal sinuses and some tumours of the head and neck area, especially extended tumours with large fixed lymph nodes, are also indications for neutrons. By contrast, the results obtained for brain tumours were, in general, disappointing. Neutrons were shown to bring a benefit in the treatment of well differentiated slowly growing soft tissue sarcomas. The reported overall local control rates are 53% and 38% after neutron and photon irradiation respectively. Better results were also reported for bone- and chondrosarcomas. The reported local control rates are 54% for osteosarcomas and 49% for chondrosarcomas after neutron irradiation; the corresponding values are 21% and 33% respectively after photon irradiation. For locally extended prostatic adenocarcinoma, the superiority of mixed schedule (neutrons+photons) was demonstrated by a RTOG randomized trial (local control rates 77% for mixed schedule compared to 31% for photons). Neutrons were also shown to be useful for palliative treatment of melanomas. Further studies are needed in order to evaluate the benefit of fast neutrons for other localisations such as cervix, bladder, rectum. It can be concluded that fast neutrons are superior to photons for at least 10% of the radiotherapy patients. It is likely that the new high-energy hospital-based cyclotron will further extend the indications of neutron therapy. However, patient selection remains one of the main problems and there is a need for development of individual predictive tests. (orig.)

  9. Audit of high energy therapy beams in hospital oncology departments by the National Radiation Laboratory

    International Nuclear Information System (INIS)

    Smyth, V.G.

    1994-02-01

    In 1993 the output of every high energy radiotherapy beam used clinically in New Zealand was measured by National Radiation Laboratory (NRL) staff using independent dosimetry equipment. The purpose of this was to audit the dosimetry that is used by hospital physicists for the basis of patient treatments, and to uncover any errors that may be clinically significant. This report analyses the uncertainties involved in comparing the NRL and hospital measurements, and presents the results of the 1993 audit. The overall uncertainty turns out to be about 1.5%. The results for linear accelerator photon beams are consistent with a purely random variation within this uncertainty. Electron beams show some small errors beyond the expected uncertainty. Gamma beams have the potential to be the most accurately measured, but in practice are less accurately measured than linear accelerator beams. None of the disagreements indicated an error of clinical significance. 8 refs., 3 figs., 2 tabs

  10. Pulse-shape discrimination of high-energy neutrons and gamma rays in NaI(Tl)

    International Nuclear Information System (INIS)

    Share, G.H.; Kurfess, J.D.; Theus, R.B.

    1978-01-01

    Pulse-shape discrimination can be used to separate neutron and gamma-ray interactions depositing energies up to in excess of 50 MeV in NaI(Tl) crystals. The secondary alpha particles, deuterons and protons produced in the neutron interactions are also resolvable. (Auth.)

  11. Boron neutron capture therapy (BNCT) using fast neutrons: Effects in two human tumor cell lines

    International Nuclear Information System (INIS)

    Sauerwein, W.; Ziegler, W.; Szypniewski, H.; Streffer, C.

    1990-01-01

    The results demonstrate that the effect of fast neutrons on cell survival in cell culture can be enhanced by boron neutron capture reaction. Even with lower enhancement ratios, the concept of NCT assisted fast neutron therapy may successfully be applied for tumor treatment with the Essen cyclotron. (orig.)

  12. A study on measurement of neutrons generated in radiation therapy – Measurement of neurons in CR-39 detection method

    International Nuclear Information System (INIS)

    Park, Cheol-Soo; Cho, Jae-Hwan; Lee, Hae-Kag; Lee, Sun-Yeob; Jang, Hyon-Chol; Dong, Kyung-Rae; Chung, Woon-Kwan; Jin, Lee; Moon, Deog-Hwan; Lee, Kwang-Sung; Yang, Nam-Oh; Cho, Moo-Seong

    2013-01-01

    Highlights: ► To measure the neutrons generated in a linear accelerator. ► Both fast neutrons and thermal neutrons produced an increase in the dose of neutrons generated with increasing irradiation dose. ► The generation of neutrons increased when a wedge filter was used. ► When the SRS cone that required a high dose was used, more neutrons were detected. -- Abstract: The CR-39 [diethylene glycol bis-(allylcarbonate)] neuron detection method was used to measure the dose of neutrons generated in X-ray (photon) therapy conducted in a linear accelerator, and to use high-energy photons as part of the clinical applications to examine the problems associated with the dose for patients caused by the generation of neutrons from high-energy photons used for cancer therapy. According to the experimental results, 0.35 mSv, 0.65 mSv 1.82 mSv of fast neutrons on average were generated from 1 Gy, 2 Gy and 5 Gy of photon irradiation, respectively, whereas 0.26 mSv, 0.56 mSv and 1.23 mSv of thermal neutrons were generated. Both fast neutrons and thermal neutrons produced an increase in the dose of neutrons generated with increasing irradiation dose. With in regard to the dose generated within and around the irradiation area of the photon rays, it was confirmed that more neutrons were generated within the irradiation area. A wedge filer was used to measure the generation of neutrons. According to the measurement results, the generation of neutrons increased when a wedge filter was used. When the SRS cone that required a high dose was used, more neutrons were detected than those in the previous experiment. When fast neutrons were used, 2.85 mSv neutrons on average were generated from 5 Gy of photon irradiation. When thermal neutrons were used, 1.37 mSv neutrons on average were generated from 5 Gy of photon irradiation. Overall, approximately 1.6 times and 1.12 times more fast and thermal neutrons, respectively, were generated than in the case of a general treatment with 5 Gy

  13. Immediate Dose-Response Effect of High-Energy Versus Low-Energy Extracorporeal Shock Wave Therapy on Cutaneous Microcirculation.

    Science.gov (United States)

    Kraemer, Robert; Sorg, Heiko; Forstmeier, Vinzent; Knobloch, Karsten; Liodaki, Eirini; Stang, Felix Hagen; Mailaender, Peter; Kisch, Tobias

    2016-12-01

    Elucidation of the precise mechanisms and therapeutic options of extracorporeal shock wave therapy (ESWT) is only at the beginning. Although immediate real-time effects of ESWT on cutaneous hemodynamics have recently been described, the dose response to different ESWT energies in cutaneous microcirculation has never been examined. Thirty-nine Sprague-Dawley rats were randomly assigned to three groups that received either focused high-energy shock waves (group A: total of 1000 impulses, 10 J) to the lower leg of the hind limb, focused low-energy shock waves (group B: total of 300 impulses, 1 J) or placebo shock wave treatment (group C: 0 impulses, 0 J) using a multimodality shock wave delivery system (Duolith SD-1 T-Top, Storz Medical, Tägerwilen, Switzerland). Immediate microcirculatory effects were assessed with the O2C (oxygen to see) system (LEA Medizintechnik, Giessen, Germany) before and for 20 min after application of ESWT. Cutaneous tissue oxygen saturation increased significantly higher after high-energy ESWT than after low-energy and placebo ESWT (A: 29.4% vs. B: 17.3% vs. C: 3.3%; p = 0.003). Capillary blood velocity was significantly higher after high-energy ESWT and lower after low-energy ESWT versus placebo ESWT (group A: 17.8% vs. group B: -22.1% vs. group C: -5.0%, p = 0.045). Post-capillary venous filling pressure was significantly enhanced in the high-energy ESWT group in contrast to the low-energy ESWT and placebo groups (group A: 25% vs. group B: 2% vs. group C: -4%, p = 0.001). Both high-energy and low-energy ESWT affect cutaneous hemodynamics in a standard rat model. High-energy ESWT significantly increases parameters of cutaneous microcirculation immediately after application, resulting in higher tissue oxygen saturation, venous filling pressure and blood velocity, which suggests higher tissue perfusion with enhanced oxygen saturation, in contrast to low-energy as well as placebo ESWT. Low-energy ESWT also increased tissue oxygen

  14. Neutron capture therapy: Years of experimentation---Years of reflection

    International Nuclear Information System (INIS)

    Farr, L.E.

    1991-01-01

    This report describes early research on neutron capture therapy over a number of years, beginning in 1950, speaking briefly of patient treatments but dwelling mostly on interpretations of our animal experiments. This work carried out over eighteen years, beginning over forty years ago. Yet, it is only fitting to start by relating how neutron capture therapy became part of Brookhaven's Medical Research Center program

  15. Current status of neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2001-05-01

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT.

  16. Current status of neutron capture therapy

    International Nuclear Information System (INIS)

    2001-05-01

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT

  17. Neutron transmission benchmark problems for iron and concrete shields in low, intermediate and high energy proton accelerator facilities

    Energy Technology Data Exchange (ETDEWEB)

    Nakane, Yoshihiro; Sakamoto, Yukio [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Hayashi, Katsumi [and others

    1996-09-01

    Benchmark problems were prepared for evaluating the calculation codes and the nuclear data for accelerator shielding design by the Accelerator Shielding Working Group of the Research Committee on Reactor Physics in JAERI. Four benchmark problems: transmission of quasi-monoenergetic neutrons generated by 43 MeV and 68 MeV protons through iron and concrete shields at TIARA of JAERI, neutron fluxes in and around an iron beam stop irradiated by 500 MeV protons at KEK, reaction rate distributions inside a thick concrete shield irradiated by 6.2 GeV protons at LBL, and neutron and hadron fluxes inside an iron beam stop irradiated by 24 GeV protons at CERN are compiled in this document. Calculational configurations and neutron reaction cross section data up to 500 MeV are provided. (author)

  18. Dose prescription in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gupta, N.M.S.; Gahbauer, R.A.; Blue, T.E.; Wambersie, A.

    1994-01-01

    The purpose of this paper is to address some aspects of the many considerations that need to go into a dose prescription in boron neutron capture therapy (BNCT) for brain tumors; and to describe some methods to incorporate knowledge from animal studies and other experiments into the process of dose prescription. Previously, an algorithm to estimate the normal tissue tolerance to mixed high and low linear energy transfer radiations in BNCT was proposed. The authors have developed mathematical formulations and computational methods to represent this algorithm. Generalized models to fit the central axis dose rate components for an epithermal neutron field were also developed. These formulations and beam fitting models were programmed into spreadsheets to simulate two treatment techniques which are expected to be used in BNCT: a two-field bilateral scheme and a single-field treatment scheme. Parameters in these spreadsheets can be varied to represent the fractionation scheme used, the 10 B microdistribution in normal tissue, and the ratio of 10 B in tumor to normal tissue. Most of these factors have to be determined for a given neutron field and 10 B compound combination from large animal studies. The spreadsheets have been programmed to integrate all of the treatment-related information and calculate the location along the central axis where the normal tissue tolerance is exceeded first. This information is then used to compute the maximum treatment time allowable and the maximum tumor dose that may be delivered for a given BNCT treatment. The effect of different treatment variables on the treatment time and tumor dose has been shown to be very significant. It has also been shown that the location of D max shifts significantly, depending on some of the treatment variables-mainly the fractionation scheme used. These results further emphasize the fact that dose prescription in BNCT is very complicated and nonintuitive. 11 refs., 6 figs., 3 tabs

  19. Boron thermal/epithermal neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.

    1982-01-01

    The development of various particle beams for radiotherapy represents an attempt to improve dose distribution, and to provide high LET radiations which are less sensitive to ambient physical and radiobiological factors such as oxygen tension, cell cycle, and dose rate. In general, a compromise is necessary as effective RBE is reduced in order to spread the dose distribution over the anticipated tumor volume. The approach of delivering stable non-toxic isotopes to tumor, and then activating these atoms subsequently via an external radiation beam has mator advantages; problems associated with high uptake of these isotopes in competing cell pools are obviated, and the general tumor volume can be included in the treatment field of the activating beam. As long as the normal tissues supporting tumor show a low uptake of the isotope to be activated, and as long as the range of the reaction products is short, dose will be restricted to tumor, with a consequent high therapeutic ratio. Neutron Capture Therapy (NCT) is generally carried out by activating boron-10 with low energy neutrons. The range of the high LET, low OER particles from the 10 B(n, α) 7 Li reaction is approx. 10μ, or one cell diameter, a situation that is optimal for cell killing. Significant advantages may be gained by using the NCT procedure in conjunction with improved tissue penetration provided with epithermal or filtered beams, and new compounds showing physiological binding to tumor

  20. Design criteria for a high energy Compton Camera and possible application to targeted cancer therapy

    Science.gov (United States)

    Conka Nurdan, T.; Nurdan, K.; Brill, A. B.; Walenta, A. H.

    2015-07-01

    The proposed research focuses on the design criteria for a Compton Camera with high spatial resolution and sensitivity, operating at high gamma energies and its possible application for molecular imaging. This application is mainly on the detection and visualization of the pharmacokinetics of tumor targeting substances specific for particular cancer sites. Expected high resolution (animals with a human tumor xenograft which is one of the first steps in evaluating the potential utility of a candidate gene. The additional benefit of high sensitivity detection will be improved cancer treatment strategies in patients based on the use of specific molecules binding to cancer sites for early detection of tumors and identifying metastasis, monitoring drug delivery and radionuclide therapy for optimum cell killing at the tumor site. This new technology can provide high resolution, high sensitivity imaging of a wide range of gamma energies and will significantly extend the range of radiotracers that can be investigated and used clinically. The small and compact construction of the proposed camera system allows flexible application which will be particularly useful for monitoring residual tumor around the resection site during surgery. It is also envisaged as able to test the performance of new drug/gene-based therapies in vitro and in vivo for tumor targeting efficacy using automatic large scale screening methods.

  1. Statistical analysis for discrimination of prompt gamma ray peak induced by high energy neutron: Monte Carlo simulation study

    International Nuclear Information System (INIS)

    Do-Kun Yoon; Joo-Young Jung; Tae Suk Suh; Seong-Min Han

    2015-01-01

    The purpose of this research is a statistical analysis for discrimination of prompt gamma ray peak induced by the 14.1 MeV neutron particles from spectra using Monte Carlo simulation. For the simulation, the information of 18 detector materials was used to simulate spectra by the neutron capture reaction. The discrimination of nine prompt gamma ray peaks from the simulation of each detector material was performed. We presented the several comparison indexes of energy resolution performance depending on the detector material using the simulation and statistics for the prompt gamma activation analysis. (author)

  2. Integral test of niobium differential elastic scattering cross-sections of 60 and 120 degrees for high-energy neutrons

    International Nuclear Information System (INIS)

    Selvi, Saim; Shin, Kazuo; Hyodo, Tomonori

    1984-01-01

    Spectra of scattered neutrons from a niobium disc were measured at the scattering angles of 60 deg and 120 deg by an NE-213 scintillator. Comparison of the experimental data with the point-to-point Monte Carlo calculations, using the evaluated data from the ENDF/B-IV file, showed good agreement at 60 deg, but considerable discrepancy at 120 deg. (author)

  3. Neutron therapy for salivary and thyroid gland cancer

    Energy Technology Data Exchange (ETDEWEB)

    Gribova, O. V., E-mail: gribova79@mail.ru; Choynzonov, E. L., E-mail: nii@oncology.tomsk.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); National Research Tomsk Polytechnic University, Lenina Avenue 30, Tomsk, 634050 (Russian Federation); Musabaeva, L. I., E-mail: musabaevaLI@oncology.tomsk.ru; Lisin, V. A., E-mail: Lisin@oncology.tomsk.ru; Novikov, V. A., E-mail: dr.vanovikov@gmail.com [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation)

    2016-08-02

    The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons for salivary gland cancer and prognostically unfavorable thyroid gland cancer. The study group comprised 127 patients with salivary gland cancer and 46 patients with thyroid gland cancer, who received neutron therapy alone and in combination with surgery. The results obtained demonstrated that the combined modality treatment including fast neutron therapy led to encouraging local control in patients with salivary and thyroid gland cancers.

  4. General considerations for neutron capture therapy at a reactor facility

    International Nuclear Information System (INIS)

    Binney, S.E.

    2001-01-01

    In addition to neutron beam intensity and quality, there are also a number of other significant criteria related to a nuclear reactor that contribute to a successful neutron capture therapy (NCT) facility. These criteria are classified into four main categories: Nuclear design factors, facility management and operations factors, facility resources, and non-technical factors. Important factors to consider are given for each of these categories. In addition to an adequate neutron beam intensity and quality, key requirements for a successful neutron capture therapy facility include necessary finances to construct or convert a facility for NCT, a capable medical staff to perform the NCT, and the administrative support for the facility. The absence of any one of these four factors seriously jeopardizes the overall probability of success of the facility. Thus nuclear reactor facility management considering becoming involved in neutron capture therapy, should it be proven clinically successful, should take all these factors into consideration. (author)

  5. METHODS OF ASSESSMENT OF THE RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS IN NEUTRON THERAPY

    Directory of Open Access Journals (Sweden)

    V. A. Lisin

    2017-01-01

    Full Text Available The relative biological effectiveness (RBE of fast neutrons is an important factor influencing the quality of neutron therapy therefore, the assessment of RBE is of great importance. Experimental and clinical studies as well as different mathematical and radiobiological models are used for assessing RBE. Research is conducted for neutron sources differing in the method of producing particles, energy and energy spectrum. Purpose: to find and analyze the dose-dependence of fast neutron RBE in neutron therapy using the U-120 cyclotron and NG-12I generator. Material and methods: The optimal method for assessing the relative biological effectiveness of neutrons for neutron therapy was described. To analyze the dependence of the RBE on neutron dose, the multi-target model of cell survival was applied. Results: The dependence of the RBE of neutrons produced from the U-120 cyclotron and NG-120 generator on the dose level was found for a single irradiation of biological objects. It was shown that the function of neutron dose was consistent with similar dependencies found by other authors in the experimental and clinical studies.

  6. High-energy-neutron damage in Nb3Sn: changes in critical properties, and damage-energy analysis

    International Nuclear Information System (INIS)

    Snead, C.L. Jr.; Parkin, D.M.; Guinan, M.W.

    1981-01-01

    Filamentary wires of Nb 3 Sn have been irradiated with fission-reactor, 14.8-MeV, and d-Be neutrons and the changes in critical properties measured. The changes observed scale reasonably well with the calculated damage energies for the irradiations. A critical dose for operation of these conductors in fusion-magnet applications is determined to be 0.19 eV/atom damage energy or 0.0019 dpa

  7. Multipolarity analysis for 14C high-energy resonance populated by (18O,16O) two-neutron transfer reaction

    International Nuclear Information System (INIS)

    Carbone, D.; Cavallaro, M.; Bondì, M.; Agodi, C.; Cunsolo, A.; Cappuzzello, F.; Azaiez, F.; Franchoo, S.; Khan, E.; Bonaccorso, A.; Fortunato, L.; Foti, A.; Linares, R.; Lubian, J.; Scarpaci, J. A.; Vitturi, A.

    2015-01-01

    The 12 C( 18 O, 16 O) 14 C reaction at 84 MeV incident energy has been explored up to high excitation energy of the residual nucleus thanks to the use of the MAGNEX spectrometer to detect the ejectiles. In the region above the two-neutron separation energy, a resonance has been observed at 16.9 MeV. A multipolarity analysis of the cross section angular distribution indicates an L = 0 character for such a transition

  8. HIGH ENERGY NEUTRINOS PRODUCED IN THE ACCRETION DISKS BY NEUTRONS FROM NUCLEI DISINTEGRATED IN THE AGN JETS

    Energy Technology Data Exchange (ETDEWEB)

    Bednarek, W., E-mail: bednar@uni.lodz.pl [Department of Astrophysics, The University of Lodz, 90-236 Lodz, ul. Pomorska 149/153 (Poland)

    2016-12-20

    We investigate the consequences of acceleration of nuclei in jets of active galaxies not far from the surface of an accretion disk. The nuclei can be accelerated in the re-connection regions in the jet and/or at the jet boundary, between the relativistic jet and its cocoon. It is shown that the relativistic nuclei can efficiently fragment onto specific nucleons in collisions with the disk radiation. Neutrons, directed toward the accretion disk, take a significant part of energy from the relativistic nuclei. These neutrons develop a cascade in the dense accretion disk. We calculate the neutrino spectra produced in such a hadronic cascade within the accretion disk. We propose that the neutrinos produced in such a scenario, from the whole population of super-massive black holes in active galaxies, can explain the extragalactic neutrino background recently measured by the IceCube neutrino detector, provided that a 5% fraction of galaxies have an active galactic nucleus and a few percent of neutrons reach the accretion disk. We predict that the neutrino signals in the present neutrino detectors, produced in terms of such a model, will not be detectable even from the nearby radio galaxies similar to M87.

  9. SEARCH FOR SOURCES OF HIGH-ENERGY NEUTRONS WITH FOUR YEARS OF DATA FROM THE ICETOP DETECTOR

    Energy Technology Data Exchange (ETDEWEB)

    Aartsen, M. G. [Department of Physics, University of Adelaide, Adelaide, 5005 (Australia); Abraham, K. [Physik-department, Technische Universität München, D-85748 Garching (Germany); Ackermann, M. [DESY, D-15735 Zeuthen (Germany); Adams, J. [Department of Physics and Astronomy, University of Canterbury, Private Bag 4800, Christchurch (New Zealand); Aguilar, J. A.; Ansseau, I. [Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels (Belgium); Ahlers, M. [Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin, Madison, WI 53706 (United States); Ahrens, M. [Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm (Sweden); Altmann, D.; Anton, G. [Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen (Germany); Andeen, K. [Department of Physics, Marquette University, Milwaukee, WI 53201 (United States); Anderson, T. [Department of Physics, Pennsylvania State University, University Park, PA 16802 (United States); Archinger, M.; Baum, V. [Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz (Germany); Argüelles, C.; Axani, S. [Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139 (United States); Auffenberg, J. [III. Physikalisches Institut, RWTH Aachen University, D-52056 Aachen (Germany); Bai, X. [Physics Department, South Dakota School of Mines and Technology, Rapid City, SD 57701 (United States); Barwick, S. W. [Department of Physics and Astronomy, University of California, Irvine, CA 92697 (United States); Bay, R. [Department of Physics, University of California, Berkeley, CA 94720 (United States); Collaboration: IceCube Collaboration; and others

    2016-10-20

    IceTop is an air-shower array located on the Antarctic ice sheet at the geographic South Pole. IceTop can detect an astrophysical flux of neutrons from Galactic sources as an excess of cosmic-ray air showers arriving from the source direction. Neutrons are undeflected by the Galactic magnetic field and can typically travel 10 ( E /PeV) pc before decay. Two searches are performed using 4 yr of the IceTop data set to look for a statistically significant excess of events with energies above 10 PeV (10{sup 16} eV) arriving within a small solid angle. The all-sky search method covers from −90° to approximately −50° in declination. No significant excess is found. A targeted search is also performed, looking for significant correlation with candidate sources in different target sets. This search uses a higher-energy cut (100 PeV) since most target objects lie beyond 1 kpc. The target sets include pulsars with confirmed TeV energy photon fluxes and high-mass X-ray binaries. No significant correlation is found for any target set. Flux upper limits are determined for both searches, which can constrain Galactic neutron sources and production scenarios.

  10. High-energy particle production in solar flares (SEP, gamma-ray and neutron emissions). [solar energetic particles

    Science.gov (United States)

    Chupp, E. L.

    1987-01-01

    Electrons and ions, over a wide range of energies, are produced in association with solar flares. Solar energetic particles (SEPs), observed in space and near earth, consist of electrons and ions that range in energy from 10 keV to about 100 MeV and from 1 MeV to 20 GeV, respectively. SEPs are directly recorded by charged particle detectors, while X-ray, gamma-ray, and neutron detectors indicate the properties of the accelerated particles (electrons and ions) which have interacted in the solar atmosphere. A major problem of solar physics is to understand the relationship between these two groups of charged particles; in particular whether they are accelerated by the same mechanism. The paper reviews the physics of gamma-rays and neutron production in the solar atmosphere and the method by which properties of the primary charged particles produced in the solar flare can be deduced. Recent observations of energetic photons and neutrons in space and at the earth are used to present a current picture of the properties of impulsively flare accelerated electrons and ions. Some important properties discussed are time scale of production, composition, energy spectra, accelerator geometry. Particular attention is given to energetic particle production in the large flare on June 3, 1982.

  11. Utilization of RP-10 reactor for neutron therapy

    International Nuclear Information System (INIS)

    Paucar, R.; Nieto, M.; Parreno, F.; Vela, M.; Pozo, Z.

    1997-01-01

    In the Nuclear Energy Peruvian Institute, IPEN, a research area has established of Neutron Radiotherapy, know as NCT. This research joins the physics of particles (Neutrons and photons) and Medical Physics, and this one is an applied investigation where in considering the construction of a treatment hall in Huarangal (Peru) Reactor's irradiation facility, it can treat patients with brain tumors. In Neutron Therapy (NCT), it tries to use neutrons to destroy tumor cells where other therapeutic techniques are not effective. This process consist on to incise a neutrons beam of adequate characteristics over the tumor area of the patient. The neutrons used are of thermal energy and therefore irradiations are developed in experimental reactors. For this one, it is used horizontal channels prepared suitably. Before the irradiation, it is injected to the patient a substance which is absorbed by tumoral tissue. The substance components will be B-10, nuclide with an absorption cross section high to thermal neutrons (3837 b). The B-10 irradiate with thermal neutrons produce alpha particles of short reach (10 μm. on soft tissue) and with LET values (lineal energy transference) very high. The result is a cell preferential destruction which have absorbed the substance and it's next neighbors, like the cell size is 10 μm. This process as know as Boron Neutron Capture Therapy (BNCT). This work describes Peruvian RP-10 reactor and recently efforts to assess the design and feasibility of the medical neutron irradiation facility for NCT. (author). 22 refs., 6 tabs

  12. Anesthetic management of Boron Neutron Capture Therapy for glioblastoma

    International Nuclear Information System (INIS)

    Shinomura, T.; Furutani, H.; Osawa, M.; Ono, K.; Fukuda, K.

    2000-01-01

    General anesthesia was given to twenty-seven patients who received Boron Neutron Capture Therapy (BNCT) under craniotomy at Kyoto University Research Reactor from 1991 to 1999. Special considerations are required for anesthesia. (author)

  13. Dose to radiation therapists from activation at high-energy accelerators used for conventional and intensity-modulated radiation therapy

    International Nuclear Information System (INIS)

    Rawlinson, J. Alan; Islam, Mohammad K.; Galbraith, Duncan M.

    2002-01-01

    The increased beam-on times which characterize intensity-modulated radiation therapy (IMRT) could lead to an increase in the dose received by radiation therapists due to induced activity. To examine this, gamma ray spectrometry was used to identify the major isotopes responsible for activation at a representative location in the treatment room of an 18 MV accelerator (Varian Clinac 21EX). These were found to be 28 Al, 56 Mn, and 24 Na. The decay of the dose rate measured at this location following irradiation was analyzed in terms of the known half-lives to yield saturation dose rates of 9.6, 12.4, and 6.2 μSv/h, respectively. A formalism was developed to estimate activation dose (μSv/week) due to successive patient irradiation cycles, characterized by the number of 18 MV fractions per week, F, the number of MU per fraction, M, the in-room time between fractions, t d (min), and the treatment delivery time t r ' (min). The results are represented by the sum of two formulas, one for the dose from 28 Al≅1.8x10 -3 F M (1-e -0.3t r ' )/t r ' and one for the dose from the other isotopes ≅1.1x10 -6 F 1.7 Mt d . For conventional therapy doses are about 60 μ Sv/week for an 18 MV workload of 60 000 MU/week. Irradiation for QA purposes can significantly increase the dose. For IMRT as currently practiced, lengthy treatment delivery times limit the number of fractions that can be delivered per week and hence limit the dose to values similar to those in conventional therapy. However for an IMRT regime designed to maximize patient throughput, doses up to 330 μSv/week could be expected. To reduce dose it is recommended that IMRT treatments should be delivered at energies lower than 18 MV, that in multienergy IMRT, high-energy treatments should be scheduled in the latter part of the day, and that equipment manufacturers should strive to minimize activation in the design of high-energy accelerators

  14. Application of low-cost Gallium Arsenide light-emitting-diodes as kerma dosemeter and fluence monitor for high-energy neutrons

    International Nuclear Information System (INIS)

    Mukherjee, B.; Simrock, S.; Khachan, J.; Rybka, D.; Romaniuk, R.

    2007-01-01

    Displacement damage (DD) caused by fast neutrons in unbiased Gallium Arsenide (GaAs) light emitting diodes (LED) resulted in a reduction of the light output. On the other hand, a similar type of LED irradiated with gamma rays from a 60 Co source up to a dose level in excess of 1.0 kGy (1.0 x 10 5 rad) was found to show no significant drop of the light emission. This phenomenon was used to develop a low cost passive fluence monitor and kinetic energy released per unit mass dosemeter for accelerator-produced neutrons. These LED-dosemeters were used to assess the integrated fluence of photoneutrons, which were contaminated with a strong Bremsstrahlung gamma-background generated by the 730 MeV superconducting electron linac driving the free electron laser in Hamburg (FLASH) at Deutsches Elektronen-Synchrotron. The applications of GaAs LED as a routine neutron fluence monitor and DD precursor for the electronic components located in high-energy accelerator environment are highlighted. (authors)

  15. A study on the utilization of hyper-thermal neutrons for neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kanda, Keiji

    1993-01-01

    The utilization of hyper-thermal neutrons, which have an energy spectrum of a Maxwellian distribution of a higher temperature than the room temperature of 300 K, was studied in order to improve the thermal neutron flux distribution at the deeper part in a living body for neutron capture therapy. Simulation calculations were carried out using MCNP-V3 in order to confirm the characteristics of hyper-thermal neutrons, i.e., (1) depth dependence of neutron energy spectrum, and (2) depth distribution of the reaction rate in a water phantom for materials with 1/v neutron absorption. It is confirmed that the hyper-thermal neutron irradiation can improve the thermal neutron flux distribution in the deeper and wider area in a living body compared with the thermal neutron irradiation. Practically, by the incidence of the hyper-thermal neutrons with a 3000 K Maxwellian distribution, the thermal neutron flux at 5 cm depth can be given about four times larger than by the incidence of the thermal neutrons of 300 K. (author)

  16. Cross Sections for High-Energy Gamma Transitions from MeV Neutron Capture in {sup 206}Pb

    Energy Technology Data Exchange (ETDEWEB)

    Bergqvist, I; Lundberg, B; Nilsson, L

    1970-03-15

    Gamma-ray spectra from neutron capture in Pb (radiogenic lead) in the energy range 1.5 to 8.5 MeV were recorded using time-of-flight techniques. The spectrometer was a Nal (Tl) crystal, 20.8 cm long and 22.6 cm in diameter. The spectra are dominated by gamma transitions to levels with large single-particle strength, in agreement with predictions of semi-direct capture theories. The theories predict enhancements of the direct capture cross section by a factor of 10 - 15 in the region of the giant dipole resonance. The observed enhancement is about 50.

  17. Dosimetry methods in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Gambarini, G.; Artuso, E.; Felisi, M.; Regazzoni, V.; Giove, D. [Universita degli Studi di Milano, Department of Physics, Via Festa del Patrono 7, 20122 Milano (Italy); Agosteo, S.; Barcaglioni, L. [Istituto Nazionale di Fisica Nucleare, Milano (Italy); Campi, F.; Garlati, L. [Politecnico di Milano, Energy Department, Piazza Leonardo Da Vinci 32, 20133 Milano (Italy); De Errico, F. [Universita degli Studi di Pisa, Department of Civil and Industrial Engineering, Lungamo Pacinotti 43, 56126 Pisa (Italy); Borroni, M.; Carrara, M. [Fondazione IRCCS Istituto Nazionale Tumori, Medical Physics Unit, Via Venezian 1, 20133 Milano (Italy); Burian, J.; Klupak, V.; Viererbl, L.; Marek, M. [Research Centre Rez, Department of Neutron Physics, 250-68 Husinec-Rez (Czech Republic)

    2014-08-15

    Dosimetry studies have been carried out at thermal and epithermal columns of Lvr-15 research reactor for investigating the spatial distribution of gamma dose, fast neutron dose and thermal neutron fluence. Two different dosimetry methods, both based on solid state detectors, have been studied and applied and the accuracy and consistency of the results have been inspected. One method is based on Fricke gel dosimeters that are dilute water solutions and have good tissue equivalence for neutrons and also for all the secondary radiations produced by neutron interactions in tissue or water phantoms. Fricke gel dosimeters give the possibility of separating the various dose contributions, i.e. the gamma dose, the fast neutron dose and the dose due to charged particles generated during thermal neutron reactions by isotopes having high cross section, like 10-B. From this last dose, thermal neutron fluence can be obtained by means of the kerma factor. The second method is based on thermoluminescence dosimeters. In particular, the developed method draw advantage from the different heights of the peaks of the glow curve of such phosphors when irradiated with photons or with thermal neutrons. The results show that satisfactory results can be obtained with simple methods, in spite of the complexity of the subject. However, the more suitable dosimeters and principally their utilization and analysis modalities are different for the various neutron beams, mainly depending on the relative intensities of the three components of the neutron field, in particular are different for thermal and epithermal columns. (Author)

  18. Dosimetry methods in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gambarini, G.; Artuso, E.; Felisi, M.; Regazzoni, V.; Giove, D.; Agosteo, S.; Barcaglioni, L.; Campi, F.; Garlati, L.; De Errico, F.; Borroni, M.; Carrara, M.; Burian, J.; Klupak, V.; Viererbl, L.; Marek, M.

    2014-08-01

    Dosimetry studies have been carried out at thermal and epithermal columns of Lvr-15 research reactor for investigating the spatial distribution of gamma dose, fast neutron dose and thermal neutron fluence. Two different dosimetry methods, both based on solid state detectors, have been studied and applied and the accuracy and consistency of the results have been inspected. One method is based on Fricke gel dosimeters that are dilute water solutions and have good tissue equivalence for neutrons and also for all the secondary radiations produced by neutron interactions in tissue or water phantoms. Fricke gel dosimeters give the possibility of separating the various dose contributions, i.e. the gamma dose, the fast neutron dose and the dose due to charged particles generated during thermal neutron reactions by isotopes having high cross section, like 10-B. From this last dose, thermal neutron fluence can be obtained by means of the kerma factor. The second method is based on thermoluminescence dosimeters. In particular, the developed method draw advantage from the different heights of the peaks of the glow curve of such phosphors when irradiated with photons or with thermal neutrons. The results show that satisfactory results can be obtained with simple methods, in spite of the complexity of the subject. However, the more suitable dosimeters and principally their utilization and analysis modalities are different for the various neutron beams, mainly depending on the relative intensities of the three components of the neutron field, in particular are different for thermal and epithermal columns. (Author)

  19. Medical and biological requirements for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gahbauer, R.; Goodman, J.H.; Kanellitsas, C.; Clendenon, N.; Blue, J.

    1986-01-01

    In conventional radiation therapy, tumor doses applied to most solid tumors are limited by the tolerance of normal tissues. The promise of Boron Neutron Capture Therapy lies in its potential to deposit high doses of radiation very specifically to tumor tissue. Theoretically ratios of tumor to normal tissue doses can be achieved significantly higher than conventional radiotherapeutic techniques would allow. Effective dose distributions obtainable are a complex function of the neutron beam characteristics and the macro and micro distributions of boron in tumor and normal tissues. Effective RBE doses are calculated in tumors and normal tissue for thermal, epithermal and 2 keV neutrons

  20. Present status of fast neutron therapy survey of the clinical data and of the clinical research programmes

    International Nuclear Information System (INIS)

    Wambersie, A.; Richard, F.

    1989-01-01

    The clinical results reported from the different neutron therapy centres, in USA, Europe and Asia, are reviewed. Fast neutrons were proven to be superior to photons for locally extended inoperable salivary gland tumours. The reported overall local control rates are 67% and 24% respectively. Paranasal sinuses and some tumours of the head and neck area, especially extended tumours with large fixed lymph nodes, are also indications for neutrons. By contrast, the results obtained for brain tumours were, in general, disappointing. Neutrons were shown to bring a benefit in the treatment of well differentiated slowly growing soft tissue sarcomas. The reported overall local control rates were 53% and 38% after neutron and photon irradiation respectively. Better results, after neutron irradiation, were also reported for bone- and chondrosarcomas. The reported local control rates are 54% for osteosarcomas and 49% for chondrosarcomas after neutron irradiation; the corresponding values are 21% and 33% respectively after photon irradiation. For locally extended prostatic adenocarcinoma, the superiority of mixed schedule (neutrons + photons) was demonstrated by a RTOG randomized trial (local control rates 77% for mixed schedule compared to 31% for photons). Neutrons were also shown to be useful for palliative treatment of melanomas. Further studies are needed in order to definitively evaluate the benefit of fast neutrons for other localisations such as uterine cervix, bladder, and rectum. It can be concluded that fast neutrons are superior to photons for at least 10% to 20% of the radiotherapy patients. As far as the technical point of view is concerned, it is recognized that the first patient series were treated in ''suboptimal'' conditions. However, recently, important improvements were made. In particular, several high-energy hospital-based cyclotrons are now fully dedicated to neutron therapy. It is likely that these improved technical conditions will further extend the

  1. Advances in neutron capture therapy 2006. Proceedings of 12th international congress on neutron capture therapy

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Kobayashi, Tooru; Fukuda, Hiroshi

    2006-01-01

    The Twelfth International Congress on Neutron Capture Therapy (ICNCT-12) is being held from October 9th to 13th, 2006 at the Kagawa International Congress Hall in Takamatsu, Kagawa, Japan. The main theme of the congress is From the past to the Future'. Five symposiums were organized to accommodate all the contributions from the international scientific committees of the International Society for Neutron Capture Therapy (ISNCT), and two symposiums were added to balance the number of fields of specialties. The seven symposiums for ICNCT-12 are as follows: 1) Clinical Results of BNCT for Brain Tumors, 2) Dosimetry, 3) Treatment Planning system, 4) Drug Delivery System, 5) Biomedical and General Matters, 6) BNCT Systems using Accelerators, 7) New Applications and Protocols for BNCT. There are a total of 195 presentations in this congress: 3 special lectures, 34 symposium presentations, 10 presentations in two special sessions from the recipients of the Ralph G. Fairchild Award, 70 presentations in the oral parallel sessions and 78 presentations in the poster sessions. A compilation of 169 papers are published in this proceedings. The 165 of the presented papers are indexed individually. (J.P.N.)

  2. High energy x-ray and neutron studies of disordered energy-related materials at extreme conditions

    International Nuclear Information System (INIS)

    Parise, John

    2016-01-01

    The fundamental scientific accomplishments are: (1) advances in a general description of the liquid state by employing structural models constrained by measurements to interpret experimental results and extend them to liquids in general, with special emphasis on (2) The structure of the high-temperature crystal and molten UO_2 and 3) water. Specifically, samples of UO_2 and water were probed using high-energy x-rays at the Advanced Photon Source. The high Z of UO_2, and the 2-3mm diameter droplet shape of the molten sample, means that >100keV X-rays are required to minimize absorption and multiple scattering, which can distort the measured structure factor. A high flux of x-rays is also required to obtain sufficient statistical accuracy in short (a few seconds) measurement times. The scattered x-ray data were analyzed and pair distribution functions, extracted that characterize the local and long-range atomic structure of the material. The measurements of the hot UO_2 solid show a substantial increase in oxygen disorder and, upon melting, the average U-O coordination was found to decrease from 8 to 6.7±0.5. The research incorporated development of diffraction techniques, sample environment optimization and state-of-the-art simulation techniques. The symbiotic nature of the advances in simulation and experiment allowed for a more focused and informed development of future experiments, effective use of expensive beam time and generated new research agendas for the growing number of research groups, within the US and internationally, that focus on the structure of liquids. Molecular dynamics (MD) provided detailed information when combined with high-quality XN data including addressing key issues in liquids; the relationship between cooling path, structure and fictive temperature, and the trade-offs between network over connectedness in liquids containing low-coordination cations.

  3. High energy x-ray and neutron studies of disordered energy-related materials at extreme conditions

    Energy Technology Data Exchange (ETDEWEB)

    Parise, John [Stony Brook Univ., NY (United States)

    2016-05-16

    The fundamental scientific accomplishments are: (1) advances in a general description of the liquid state by employing structural models constrained by measurements to interpret experimental results and extend them to liquids in general, with special emphasis on (2) The structure of the high-temperature crystal and molten UO2 and 3) water. Specifically, samples of UO2 and water were probed using high-energy x-rays at the Advanced Photon Source. The high Z of UO2, and the 2-3mm diameter droplet shape of the molten sample, means that >100keV X-rays are required to minimize absorption and multiple scattering, which can distort the measured structure factor. A high flux of x-rays is also required to obtain sufficient statistical accuracy in short (a few seconds) measurement times. The scattered x-ray data were analyzed and pair distribution functions, extracted that characterize the local and long-range atomic structure of the material. The measurements of the hot UO2 solid show a substantial increase in oxygen disorder and, upon melting, the average U-O coordination was found to decrease from 8 to 6.7±0.5. The research incorporated development of diffraction techniques, sample environment optimization and state-of-the-art simulation techniques. The symbiotic nature of the advances in simulation and experiment allowed for a more focused and informed development of future experiments, effective use of expensive beam time and generated new research agendas for the growing number of research groups, within the US and internationally, that focus on the structure of liquids. Molecular dynamics (MD) provided detailed information when combined with high-quality XN data including addressing key issues in liquids; the relationship between cooling path, structure and fictive temperature, and the trade-offs between network over connectedness in liquids containing low-coordination cations.

  4. Neutron capture therapy beams at the MIT Research Reactor

    International Nuclear Information System (INIS)

    Choi, J.R.; Clement, S.D.; Harling, O.K.; Zamenhof, R.G.

    1990-01-01

    Several neutron beams that could be used for neutron capture therapy at MITR-II are dosimetrically characterized and their suitability for the treatment of glioblastoma multiforme and other types of tumors are described. The types of neutron beams studied are: (1) those filtered by various thicknesses of cadmium, D2O, 6Li, and bismuth; and (2) epithermal beams achieved by filtration with aluminum, sulfur, cadmium, 6Li, and bismuth. Measured dose vs. depth data are presented in polyethylene phantom with references to what can be expected in brain. The results indicate that both types of neutron beams are useful for neutron capture therapy. The first type of neutron beams have good therapeutic advantage depths (approximately 5 cm) and excellent in-phantom ratios of therapeutic dose to background dose. Such beams would be useful for treating tumors located at relatively shallow depths in the brain. On the other hand, the second type of neutron beams have superior therapeutic advantage depths (greater than 6 cm) and good in-phantom therapeutic advantage ratios. Such beams, when used along with bilateral irradiation schemes, would be able to treat tumors at any depth in the brain. Numerical examples of what could be achieved with these beams, using RBEs, fractionated-dose delivery, unilateral, and bilateral irradiation are presented in the paper. Finally, additional plans for further neutron beam development at MITR-II are discussed

  5. Accelerator Based Neutron Beams for Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Yanch, Jacquelyn C.

    2003-01-01

    The DOE-funded accelerator BNCT program at the Massachusetts Institute of Technology has resulted in the only operating accelerator-based epithermal neutron beam facility capable of generating significant dose rates in the world. With five separate beamlines and two different epithermal neutron beam assemblies installed, we are currently capable of treating patients with rheumatoid arthritis in less than 15 minutes (knee joints) or 4 minutes (finger joints) or irradiating patients with shallow brain tumors to a healthy tissue dose of 12.6 Gy in 3.6 hours. The accelerator, designed by Newton scientific Incorporated, is located in dedicated laboratory space that MIT renovated specifically for this project. The Laboratory for Accelerator Beam Applications consists of an accelerator room, a control room, a shielded radiation vault, and additional laboratory space nearby. In addition to the design, construction and characterization of the tandem electrostatic accelerator, this program also resulted in other significant accomplishments. Assemblies for generating epithermal neutron beams were designed, constructed and experimentally evaluated using mixed-field dosimetry techniques. Strategies for target construction and target cooling were implemented and tested. We demonstrated that the method of submerged jet impingement using water as the coolant is capable of handling power densities of up to 6 x 10(sup 7) W/m(sup 2) with heat transfer coefficients of 10(sup 6)W/m(sup 2)-K. Experiments with the liquid metal gallium demonstrated its superiority compared with water with little effect on the neutronic properties of the epithermal beam. Monoenergetic proton beams generated using the accelerator were used to evaluate proton RBE as a function of LET and demonstrated a maximum RBE at approximately 30-40 keV/um, a finding consistent with results published by other researchers. We also developed an experimental approach to biological intercomparison of epithermal beams and

  6. Study on the dose distribution of the mixed field with thermal and epi-thermal neutrons for neutron capture therapy

    International Nuclear Information System (INIS)

    Kobayashi, Tooru; Sakurai, Yoshinori; Kanda, Keiji

    1994-01-01

    Simulation calculations using DOT 3.5 were carried out in order to confirm the characteristics of depth-dependent dose distribution in water phantom dependent on incident neutron energy. The epithermal neutrons mixed to thermal neutron field is effective improving the thermal neutron depth-dose distribution for neutron capture therapy. A feasibility study on the neutron energy spectrum shifter was performed using ANISN-JR for the KUR Heavy Water Facility. The design of the neutron spectrum shifter is feasible, without reducing the performance as a thermal neutron irradiation field. (author)

  7. Slow neutron capture therapy for malignant glioma (boron or lithium neutron capture therapy)

    International Nuclear Information System (INIS)

    Hatanaka, Hiroshi

    1981-01-01

    In recurrent glioblastoma, the mean survival period is approx. 6 months by the routine methods of treatment, but is extended more than 3-fold by neutron capture therapy. This method and a routine method with 60 Co or an accelerator were used for comparison in the clinical treatment of 26 patients with supratentorial malignant glioma. There were no significant differences as for prognostic factors of the group treated by this method and those of the control group; No. of cases 14 and 12, the mean age 46 and 53.5 yr, and the stage (TNM) 3.14 and 2.83, respectively. As of the end of Feb. 1980, this method showed a lifeprolonging effect 3 times that of the control, the mean survival period being 67 weeks for this method and 21 for the control. Although 100% improvement was observed in about one half of the cases by this method, the control group showed improvement of only 80% at maximum. It is also possible to treat any deep portion of the brain with thermal neutrons. As a Boron compound, mercaptoundecahydrododecarborate with a low toxicity has been put into practical use for brain tumors, and as Li, the use of 6 LiCl for lung cancer is under examination. (Chiba, N.)

  8. Physical engineering and medical physics on boron neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori

    2011-01-01

    The contents of physical engineering and medical physics that support boron neutron capture therapy (BNCT) can be roughly classified to the four items, (1) neutron irradiation system, (2) development and improvement of dose assessment techniques, (3) development and improvement of dose planning system, and (4) quality assurance and quality control. This paper introduces the BNCT at Kyoto University Research Reactor Institute, with a focus on the basic physics of BNCT, thermal neutron irradiation and epithermal neutron irradiation, heavy water neutron irradiation facilities of KUR, and medical irradiation system of KUR. It also introduces the world's first BNCT clinical cyclotron irradiation system (C-BENS) of Kyoto University Research Reactor Institute, BNCT dose assessment techniques, dose planning system, and quality assurance and quality control. (A.O.)

  9. Beam neutron energy optimization for boron neutron capture therapy using monte Carlo method

    International Nuclear Information System (INIS)

    Pazirandeh, A.; Shekarian, E.

    2006-01-01

    In last two decades the optimal neutron energy for the treatment of deep seated tumors in boron neutron capture therapy in view of neutron physics and chemical compounds of boron carrier has been under thorough study. Although neutron absorption cross section of boron is high (3836b), the treatment of deep seated tumors such as glioblastoma multiform requires beam of neutrons of higher energy that can penetrate deeply into the brain and thermalized in the proximity of the tumor. Dosage from recoil proton associated with fast neutrons however poses some constraints on maximum neutron energy that can be used in the treatment. For this reason neutrons in the epithermal energy range of 10eV-10keV are generally to be the most appropriate. The simulation carried out by Monte Carlo methods using MCBNCT and MCNP4C codes along with the cross section library in 290 groups extracted from ENDF/B6 main library. The ptimal neutron energy for deep seated tumors depends on the sue and depth of tumor. Our estimated optimized energy for the tumor of 5cm wide and 1-2cm thick stands at 5cm depth is in the range of 3-5keV

  10. Commissioning of accelerator based boron neutron capture therapy system

    International Nuclear Information System (INIS)

    Nakamura, S.; Wakita, A.; Okamoto, H.; Igaki, H.; Itami, J.; Ito, M.; Abe, Y.; Imahori, Y.

    2017-01-01

    Boron neutron capture therapy (BNCT) is a treatment method using a nuclear reaction of 10 B(n, α) 7 Li. BNCT can be deposited the energy to a tumor since the 10 B which has a higher cross-section to a neutron is high is concentrated on the tumor. It is different from conventional radiation therapies that BNCT expects higher treatment effect to radiation resistant tumors since the generated alpha and lithium particles have higher radiological biological effectiveness. In general, BNCT has been performed in research nuclear reactor. Thus, BNCT is not widely applied in a clinical use. According to recent development of accelerator-based boron neutron capture therapy system, the system has an adequate flux of neutrons. Therefore, National Cancer Canter Hospital, Tokyo, Japan is planning to install accelerator based BNCT system. Protons with 2.5 MeV are irradiated to a lithium target system to generate neutrons. As a result, thermal load of the target is 50 kW since current of the protons is 20.0 mA. Additionally, when the accelerator-based BNCT system is installed in a hospital, the facility size is disadvantage in term of neutron measurements. Therefore, the commissioning of the BNCT system is being performed carefully. In this article, we report about the commissioning. (author)

  11. Phantom models for neutron capture therapy

    International Nuclear Information System (INIS)

    Storr, G.J.

    1990-08-01

    The development of a two-dimensional phantom model using the neutron and photon transport code DOT-IV is detailed. The effects of varying basic parameters such as aperture width, neutron source energy and tissue composition have been studied. One important conclusion from the study is that narrow beam apertures will give little or no advantage for tumour dose over tissue dose even in the 'ideal beam' range of 2-7 keV. The model may be used for future filter and beam studies with confidence. 10 refs., 7 tabs., 13 figs

  12. Role of gel dosimeters in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Khajeali, Azim; Farajollahi, Ali Reza; Khodadadi, Roghayeh; Kasesaz, Yaser; Khalili, Assef

    2015-01-01

    Gel dosimeters have acquired a unique status in radiotherapy, especially with the advent of the new techniques in which there is a need for three-dimensional dose measurement with high spatial resolution. One of the techniques in which the use of gel dosimeters has drawn the attention of the researchers is the boron neutron capture therapy. Exploring the history of gel dosimeters, this paper sets out to study their role in the boron neutron capture therapy dosimetric process. - Highlights: • Gel dosimeters have been investigated. • Conventional dosimetric proses of BNCT has been investigated. • Role of gel dosimeters in BNCT has been investigated

  13. A neutron dynamic therapy with a boron tracedrug UTX-51 using a compact neutron generator.

    Science.gov (United States)

    Hori, Hitoshi; Tada, Ryu; Uto, Yoshihiro; Nakata, Eiji; Morii, Takashi; Masuda, Kai

    2014-08-01

    We are developing a neutron dynamic therapy (NDT) with boron tracedrugs for a new mechanical-clearance treatment of pathotoxic misfolded, aggregated, and self-propagating prion-associated disease proteins. We present a compact neutron generator-based NDT using a boron tracedrug UTX-51. Our NDT is based on the weak thermal neutron-bombarded destructive action of UTX-51 on bovine serum albumin (BSA) using the neutron beams produced from a compact inertial electrostatic confinement fusion (IECF) neutron generator. BSA as an NDT molecular target was subjected to thermal neutron irradiation for eight hours using a compact neutron generator. The sodium dodecyl sulfate-polyacrylamide gel electrophoresis pattern showed no protein band when 2 nmoles of BSA were irradiated with more than 100 nmoles of UTX-51, while BSA was not affected when irradiated without UTX-51. For the first time, we have succeeded in the molecular destruction of a prion-disease model protein, BSA, by NDT with a boron tracedrug, UTX-51, using a compact neutron generator. Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  14. Design of a boron neutron capture enhanced fast neutron therapy assembly

    Energy Technology Data Exchange (ETDEWEB)

    Wang, Zhonglu [Georgia Inst. of Technology, Atlanta, GA (United States)

    2006-12-01

    The use of boron neutron capture to boost tumor dose in fast neutron therapy has been investigated at several fast neutron therapy centers worldwide. This treatment is termed boron neutron capture enhanced fast neutron therapy (BNCEFNT). It is a combination of boron neutron capture therapy (BNCT) and fast neutron therapy (FNT). It is believed that BNCEFNT may be useful in the treatment of some radioresistant brain tumors, such as glioblastoma multiform (GBM). A boron neutron capture enhanced fast neutron therapy assembly has been designed for the Fermilab Neutron Therapy Facility (NTF). This assembly uses a tungsten filter and collimator near the patient's head, with a graphite reflector surrounding the head to significantly increase the dose due to boron neutron capture reactions. The assembly was designed using Monte Carlo radiation transport code MCNP version 5 for a standard 20x20 cm2 treatment beam. The calculated boron dose enhancement at 5.7-cm depth in a water-filled head phantom in the assembly with a 5x5 cm2 collimation was 21.9% per 100-ppm 10B for a 5.0-cm tungsten filter and 29.8% for a 8.5-cm tungsten filter. The corresponding dose rate for the 5.0-cm and 8.5-cm thick filters were 0.221 and 0.127 Gy/min, respectively; about 48.5% and 27.9% of the dose rate of the standard 10x10 cm2 fast neutron treatment beam. To validate the design calculations, a simplified BNCEFNT assembly was built using four lead bricks to form a 5x5 cm2 collimator. Five 1.0-cm thick 20x20 cm2 tungsten plates were used to obtain different filter thicknesses and graphite bricks/blocks were used to form a reflector. Measurements of the dose enhancement of the simplified assembly in a water-filled head phantom were performed using a pair of tissue-equivalent ion chambers. One of the ion chambers is loaded with 1000-ppm natural boron (184-ppm 10B) to measure dose due to boron neutron capture. The

  15. Very high-energy electron (VHEE) beams in radiation therapy; Treatment plan comparison between VHEE, VMAT, and PPBS.

    Science.gov (United States)

    Schüler, Emil; Eriksson, Kjell; Hynning, Elin; Hancock, Steven L; Hiniker, Susan M; Bazalova-Carter, Magdalena; Wong, Tony; Le, Quynh-Thu; Loo, Billy W; Maxim, Peter G

    2017-06-01

    The aim of this study was to evaluate the performance of very high-energy electron beams (VHEE) in comparison to clinically derived treatment plans generated with volumetric modulated arc therapy (VMAT) and proton pencil beam scanning (PPBS) technology. We developed a custom optimization script that could be applied automatically across modalities to eliminate operator bias during IMRT optimization. Four clinical cases were selected (prostate cancer, lung cancer, pediatric brain tumor, and head and neck cancer (HNC)). The VHEE beams were calculated in the EGSnrc/DOSXYZnrc Monte Carlo code for 100 and 200 MeV beams. Treatment plans with VHEE, VMAT, and PPBS were optimized in a research version of RayStation using an in-house developed script to minimize operator bias between the different techniques. The in-house developed script generated similar or superior plans to the clinically used plans. In the comparisons between the modalities, the integral dose was lowest for the PPBS-generated plans in all cases. For the prostate case, the 200 MeV VHEE plan showed reduced integral dose and reduced organ at risk (OAR) dose compared to the VMAT plan. For all other cases, both the 100 and the 200 MeV VHEE plans were superior to the VMAT plans, and the VHEE plans showed better conformity and lower spinal cord dose in the pediatric brain case and lower brain stem dose in the HNC case when compared to the PPBS plan. The automated optimization developed in this study generated similar or superior plans as compared to the clinically used plan and represents an unbiased approach to compare treatment plans generated for different modalities. In the present study, we also show that VHEE plans are similar or superior to VMAT plans with reduced mean OAR dose and increased target conformity for a variety of clinical cases, and VHEE plans can even achieve reductions in OAR doses compared to PPBS plans for shallow targets. With increased VHEE energy, better conformity and even higher

  16. High energy

    International Nuclear Information System (INIS)

    Bonner, B.E.; Roberts, J.B. Jr.

    1990-01-01

    We report here on the considerable progress that we made for the year beginning November 1, 1989, for DOE Contract No. AS05-76ERO5096. One of our Fermilab experiments, E704 -- polarization studies with 200 GeV protons, was run from February through August of this year. This experiment has been in the planning, construction, and commissioning stages for over ten years. In this report we detail just what measurements we managed to complete during the run. Our other Fermilab experiment, E683 -- photoproduction of jets, has had parasitic test beam during most of the same period. There was also a one week engineering test run in June. The schedule calls for a three month data run beginning in January, 1991. We also had three test runs for our CERN experiment, NA47 (SMC) -- spin dependent structure functions for the proton and neutron. We are in the midst of major apparatus construction for this experiment. More of our plans for the future are included in the accompanying Renewal Proposal. As in recent years, the format we follow in both the Progress Report and the Renewal Proposal is to have a brief writeup on each individual experiment and to include in the appendices copies of published papers which provide much greater detail. For manuscripts that have been submitted for publication and experimental proposals, we provide only the cover and abstract page. The aim is to concentrate on the physics goals, results and their significance in the main body of the report. For our two Fermilab experiments and the SMC experiment, exhaustive reports of the physics goals have been provided in previous years and are not repeated here

  17. Microdosimetric investigations at the fast neutron therapy facility at Fermilab

    International Nuclear Information System (INIS)

    Langen, K.M.

    1997-01-01

    Microdosimetry was used to investigate three issues at the neutron therapy facility (NTF) at Fermilab. Firstly, the conversion factor from absorbed dose in A-150 tissue equivalent plastic to absorbed dose in ICRU tissue was determined. For this, the effective neutron kerma factor ratios, i.e., oxygen tissue equivalent plastic and carbon to A-150 tissue equivalent plastic, were measured in the neutron beam. An A-150 tissue equivalent plastic to ICRU tissue absorbed dose conversion factor of 0.92 ± 0.04 was determined. Secondly, variations in the radiobiological effectiveness (RBE) in the beam were mapped by determining variations in two related quantities, e * and R, with field size and depth in tissue. Maximal variation in e * and R of 9% and 15% respectively were determined. Lastly, the feasibility of utilizing the boron neutron capture reaction on boron-10 to selectively enhance the tumor dose in the NTF beam was investigated

  18. The Swedish facility for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Skoeld, K.; Capala, J. [Studsvik Medical AB (Sweden); Kierkegaard, J.; Haakansson, R. [Studsvik Nuclear AB (Sweden); Gudowska, I. [Karolinska Institute (Sweden)

    2000-10-01

    A BNCT (Boron Neutron Capture Therapy) facility has been constructed at the R2-0 reactor at Studsvik, Sweden. R2-0 is a 1 MW, open core, pool reactor. The reactor core is suspended on a movable tower and can be positioned anywhere in the pool. The BNCT facility includes two adjacent, parallel filter/moderator configurations and the reactor core is positioned in front of any of them as appropriate. One of the resulting neutron beams has been optimized for clinical irradiations with a filter/moderator system that allows easy variation of the neutron spectrum from the thermal to the epithermal energy range and with an extended collimator for convenient patient positioning. The other beam has been designed for radiobiological research and is equipped with a heavy water moderator and a large irradiation cavity with a uniform field of thermal neutrons. (author)

  19. The Swedish facility for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Skoeld, K.; Capala, J.; Kierkegaard, J.; Haakansson, R.; Gudowska, I.

    2000-01-01

    A BNCT (Boron Neutron Capture Therapy) facility has been constructed at the R2-0 reactor at Studsvik, Sweden. R2-0 is a 1 MW, open core, pool reactor. The reactor core is suspended on a movable tower and can be positioned anywhere in the pool. The BNCT facility includes two adjacent, parallel filter/moderator configurations and the reactor core is positioned in front of any of them as appropriate. One of the resulting neutron beams has been optimized for clinical irradiations with a filter/moderator system that allows easy variation of the neutron spectrum from the thermal to the epithermal energy range and with an extended collimator for convenient patient positioning. The other beam has been designed for radiobiological research and is equipped with a heavy water moderator and a large irradiation cavity with a uniform field of thermal neutrons. (author)

  20. Expanding options in radiation oncology: neutron beam therapy

    International Nuclear Information System (INIS)

    Cohen, L.

    1982-01-01

    Twelve years experience with neutron beam therapy in Britain, the USA, Europe and Japan shows that local control is achievable in late-stage epidermoid cancer somewhat more frequently than with conventional radiotherapy. Tumours reputed to be radioresistant (salivary gland, bladder, rectosigmoid, melanoma, bone and soft-tissue sarcomas) have proved to be particularly responsive to neutrons. Pilot studies in brain and pancreatic tumours suggest promising new approaches to management of cancer in these sites. The availability of neutron therapy in the clinical environment opens new prospects for irradiation of 'radioresistant' tumours, permits more conservative cancer surgery, expands the use of elective chemotherapy and provides a wider range of options for cancer patients. (author)

  1. European protocol for neutron dosimetry for external beam therapy

    International Nuclear Information System (INIS)

    Broerse, J.J.; Mijnheer, B.J.; Williams, J.R.

    1981-01-01

    The paper attempts to serve the needs of European centres participating in the High LET Therapy Project Group set up under the sponsorship of The European Organization for Research on Treatment of Cancer, to promote cooperation between physicists involved in fast neutron therapy and establish a common basis for neutron dosimetry. Differences in dosimetry procedures between European and American Groups are indicated if relevant. The subject is dealt with under the following main headings: principles of dosimetry of neutron fields, dosimetric methods, physical parameters, determination of absorbed dose at a reference point, determination of absorbed dose at any point, check of absorbed dose given to a patient, dosimetry intercomparisons between institutes. There is an ample bibliography. (U.K.)

  2. Estimation dose of secondary neutrons in proton therapy

    International Nuclear Information System (INIS)

    Urban, T.

    2014-01-01

    Most of proton therapy centers for cancer treatment are still based on the passive scattering, in some of them there is system of the active scanning installed as well. The aim of this study is to compare secondary neutron doses in and around target volumes in proton therapy for both treatment techniques and for different energies and profile of incident proton beam. The proton induced neutrons have been simulated in the very simple geometry of tissue equivalent phantom (imitate the patient) and scattering and scanning nozzle, respectively. In simulations of the scattering nozzle, different types of scattering filters and brass collimators have been used as well. 3D map of neutron doses in and around the chosen/potential target volume in the phantom/patient have been evaluated and compared in the context of the dose deposited in the target volume. Finally, the simulation results have been compared with published data. (author)

  3. Proceedings of the first international symposium on neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Brownell, G.L.

    1982-01-01

    This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration

  4. Proceedings of the first international symposium on neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Fairchild, R.G.; Brownell, G.L. (eds.)

    1982-01-01

    This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration.

  5. FERMILAB: operation resumes in meson area; fast neutron therapy

    International Nuclear Information System (INIS)

    Anon.

    1979-01-01

    Improvements and modifications in the Meson Area at Fermilab are described. The target train was rebuilt and energy range of some beams raised to 400 GeV with provisions for Tevatron beams of 1000 GeV in the future. The work of the fast neutron therapy facility is summarised. (W.D.L.).

  6. Clinical considerations for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Madoc-Jones, H.; Wazer, D.E.; Zamenhof, R.G.; Harling, O.K.; Bernard, J.A. Jr.

    1990-01-01

    The radiotherapeutic management of primary brain tumors and metastatic melanoma in brain has had disappointing clinical results for many years. Although neutron capture therapy was tried in the US in the 1950s and 1960s, the results were not as hoped. However, with the newly developed capability to measure boron concentrations in blood and tissue both quickly and accurately, and with the advent of epithermal neutron beams obviating the need for scalp and skull reflection, it should not be possible to mount such a clinical trial of NCT again and avoid serious complications. As a prerequisite, it will be important to demonstrate the differential uptake of boron compound in brain tumor as compared with normal brain and its blood supply. If this can be done, then a trial of boron neutron capture therapy for brain tumors should be feasible. Because boronated phenylalanine has been demonstrated to be preferentially taken up by melanoma cells through the biosynthetic pathway for melanin, there is special interest in a trial of boron neutron capture therapy for metastatic melanoma in brain. Again, the use of an epithermal beam would make this a practical possibility. However, because any epithermal (or thermal) beam must contain a certain contaminating level of gamma rays, and because even a pure neutron beam cases gamma rays to be generated when it interacts with tissue, they think that it is essential to deliver treatments with an epithermal beam for boron neutron capture therapy in fractions in order to minimize the late-effects of low-LET gamma rays in the normal tissue

  7. Boron neutron capture therapy (BNCT). Recent aspect, a change from thermal neutron to epithermal neutron beam and a new protocol

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu

    1999-01-01

    Since 1968, One-hundred seventy three patients with glioblastoma (n=81), anaplastic astrocytoma (n=44), low grade astrocytoma (n=16) or other types of tumor (n=32) were treated by boron-neutron capture therapy (BNCT) using a combination of thermal neutron and BSH in 5 reactors (HTR n=13, JRR-3 n=1, MuITR n=98, KUR n=28, JRR-2 n=33). Out of 101 patients with glioma treated by BNCT under the recent protocol, 33 (10 glioblastoma, 14 anaplastic astrocytoma, 9 low grade astrocytoma) patients lived or have lived longer than 3 years. Nine of these 33 lived or have lived longer than 10 years. According to the retrospective analysis, the important factors related to the clinical results were tumor dose radiation dose and maximum radiation dose in thermal brain cortex. The result was not satisfied as it was expected. Then, we decided to introduce mixed beams which contain thermal neutron and epithermal neutron beams. KUR was reconstructed in 1996 and developed to be available to use mixed beams. Following the shutdown of the JRR-2, JRR-4 was renewed for medical use in 1998. Both reactors have capacity to yield thermal neutron beam, epithermal neutron beam and mixed beams. The development of the neutron source lead us to make a new protocol. (author)

  8. Application of generalized perturbation theory to sensitivity analysis in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Garcia, Vanessa S. [Universidade Federal Fluminense (EEIMVR/UFF-RJ), Volta Redonda, RJ (Brazil). Escola de Engenharia Industrial e Metalurgica. Programa de Pos-Graduacao em Modelagem Computacional em Ciencia e Tecnologia; Silva, Fernando C.; Silva, Ademir X., E-mail: fernando@con.ufrj.b, E-mail: ademir@con.ufrj.b [Coordenacao dos Programas de Pos-Graduacao de Engenharia (PEN/COPPE/UFRJ), Rio de Janeiro, RJ (Brazil). Programa de Engenharia Nuclear; Alvarez, Gustavo B. [Universidade Federal Fluminense (EEIMVR/UFF-RJ), Volta Redonda, RJ (Brazil). Escola de Engenharia Industrial e Metalurgica. Dept. de Ciencias Exatas

    2011-07-01

    Boron neutron capture therapy - BNCT - is a binary cancer treatment used in brain tumors. The tumor is loaded with a boron compound and subsequently irradiated by thermal neutrons. The therapy is based on the {sup 10}B (n, {alpha}) {sup 7}Li nuclear reaction, which emits two types of high-energy particles, {alpha} particle and the {sup 7}Li nuclei. The total kinetic energy released in this nuclear reaction, when deposited in the tumor region, destroys the cancer cells. Since the success of the BNCT is linked to the different selectivity between the tumor and healthy tissue, it is necessary to carry out a sensitivity analysis to determinate the boron concentration. Computational simulations are very important in this context because they help in the treatment planning by calculating the lowest effective absorbed dose rate to reduce the damage to healthy tissue. The objective of this paper is to present a deterministic method based on generalized perturbation theory (GPT) to perform sensitivity analysis with respect to the {sup 10}B concentration and to estimate the absorbed dose rate by patients undergoing this therapy. The advantage of the method is a significant reduction in computational time required to perform these calculations. To simulate the neutron flux in all brain regions, the method relies on a two-dimensional neutron transport equation whose spatial, angular and energy variables are discretized by the diamond difference method, the discrete ordinate method and multigroup formulation, respectively. The results obtained through GPT are consistent with those obtained using other methods, demonstrating the efficacy of the proposed method. (author)

  9. Application of generalized perturbation theory to sensitivity analysis in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Garcia, Vanessa S.; Silva, Fernando C.; Silva, Ademir X.; Alvarez, Gustavo B.

    2011-01-01

    Boron neutron capture therapy - BNCT - is a binary cancer treatment used in brain tumors. The tumor is loaded with a boron compound and subsequently irradiated by thermal neutrons. The therapy is based on the 10 B (n, α) 7 Li nuclear reaction, which emits two types of high-energy particles, α particle and the 7 Li nuclei. The total kinetic energy released in this nuclear reaction, when deposited in the tumor region, destroys the cancer cells. Since the success of the BNCT is linked to the different selectivity between the tumor and healthy tissue, it is necessary to carry out a sensitivity analysis to determinate the boron concentration. Computational simulations are very important in this context because they help in the treatment planning by calculating the lowest effective absorbed dose rate to reduce the damage to healthy tissue. The objective of this paper is to present a deterministic method based on generalized perturbation theory (GPT) to perform sensitivity analysis with respect to the 10 B concentration and to estimate the absorbed dose rate by patients undergoing this therapy. The advantage of the method is a significant reduction in computational time required to perform these calculations. To simulate the neutron flux in all brain regions, the method relies on a two-dimensional neutron transport equation whose spatial, angular and energy variables are discretized by the diamond difference method, the discrete ordinate method and multigroup formulation, respectively. The results obtained through GPT are consistent with those obtained using other methods, demonstrating the efficacy of the proposed method. (author)

  10. Optimal Neutron Source and Beam Shaping Assembly for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Vujic, J.; Greenspan, E.; Kastenber, W.E.; Karni, Y.; Regev, D.; Verbeke, J.M.; Leung, K.N.; Chivers, D.; Guess, S.; Kim, L.; Waldron, W.; Zhu, Y.

    2003-01-01

    There were three objectives to this project: (1) The development of the 2-D Swan code for the optimization of the nuclear design of facilities for medical applications of radiation, radiation shields, blankets of accelerator-driven systems, fusion facilities, etc. (2) Identification of the maximum beam quality that can be obtained for Boron Neutron Capture Therapy (BNCT) from different reactor-, and accelerator-based neutron sources. The optimal beam-shaping assembly (BSA) design for each neutron source was also to e obtained. (3) Feasibility assessment of a new neutron source for NCT and other medical and industrial applications. This source consists of a state-of-the-art proton or deuteron accelerator driving and inherently safe, proliferation resistant, small subcritical fission assembly

  11. Alanine and TLD coupled detectors for fast neutron dose measurements in neutron capture therapy (NCT)

    Energy Technology Data Exchange (ETDEWEB)

    Cecilia, A.; Baccaro, S.; Cemmi, A. [ENEA-FIS-ION, Casaccia RC, Via Anguillarese 301, 00060 Santa Maria di Galeria, Rome (Italy); Colli, V.; Gambarini, G. [Dept. of Physics of the Univ., INFN, Via Celoria 16, 20133 Milan (Italy); Rosi, G. [ENEA-FIS-ION, Casaccia RC, Via Anguillarese 301, 00060 Santa Maria di Galeria, Rome (Italy); Scolari, L. [Dept. of Physics of the Univ., INFN, Via Celoria 16, 20133 Milan (Italy)

    2004-07-01

    A method was investigated to measure gamma and fast neutron doses in phantoms exposed to an epithermal neutron beam designed for neutron capture therapy (NCT). The gamma dose component was measured by TLD-300 [CaF{sub 2}:Tm] and the fast neutron dose, mainly due to elastic scattering with hydrogen nuclei, was measured by alanine dosemeters [CH{sub 3}CH(NH{sub 2})COOH]. The gamma and fast neutron doses deposited in alanine dosemeters are very near to those released in tissue, because of the alanine tissue equivalence. Couples of TLD-300 and alanine dosemeters were irradiated in phantoms positioned in the epithermal column of the Tapiro reactor (ENEA-Casaccia RC). The dosemeter response depends on the linear energy transfer (LET) of radiation, hence the precision and reliability of the fast neutron dose values obtained with the proposed method have been investigated. Results showed that the combination of alanine and TLD detectors is a promising method to separate gamma dose and fast neutron dose in NCT. (authors)

  12. Aspects of OER and RBE relevant to neutron therapy

    International Nuclear Information System (INIS)

    Field, S.B.; Hornsey, S.

    1979-01-01

    This chapter contains information concerning the mechanisms involved in neutron radiotherapy. Early studies on the attempts of using neutrons in radiotherapy are described. The rationale for fast neutron therapy is discussed as well as the relationships between OER and LET. Tissue responses include: repopulation of surviving cells; repair of sublethal damage; and slow repair. These mechanisms are considered separately. The relationships between RBE and dose per fraction for damage to skin, intestine, esophagus, lungs, hemopoietic tissue, and nerve tissue are discussed. Factors governing the effects of fractionation of dose in neutron radiotherapy are presented. Observations on mammalian cells and tissues show a general reduction in RBE with increasing neutron energy. The benefits of using mixed treatments, part with neutrons and the remainder with photons, are discussed. Problems with this approach include uncertainties of how the combination will effect normal tissue, how it effects slow repair, or its potentially lethal damage. Tumor response, as compared with x rays, to single and multiple doses of radiation is described. Clinical results are given

  13. Computer aided design of fast neutron therapy units

    International Nuclear Information System (INIS)

    Gileadi, A.E.; Gomberg, H.J.; Lampe, I.

    1980-01-01

    Conceptual design of a radiation-therapy unit using fusion neutrons is presently being considered by KMS Fusion, Inc. As part of this effort, a powerful and versatile computer code, TBEAM, has been developed which enables the user to determine physical characteristics of the fast neutron beam generated in the facility under consideration, using certain given design parameters of the facility as inputs. TBEAM uses the method of statistical sampling (Monte Carlo) to solve the space, time and energy dependent neutron transport equation relating to the conceptual design described by the user-supplied input parameters. The code traces the individual source neutrons as they propagate throughout the shield-collimator structure of the unit, and it keeps track of each interaction by type, position and energy. In its present version, TBEAM is applicable to homogeneous and laminated shields of spherical geometry, to collimator apertures of conical shape, and to neutrons emitted by point sources or such plate sources as are used in neutron generators of various types. TBEAM-generated results comparing the performance of point or plate sources in otherwise identical shield-collimator configurations are presented in numerical form. (H.K.)

  14. Current status of accelerator-based boron neutron capture therapy

    International Nuclear Information System (INIS)

    Kreiner, A. J.; Bergueiro, J.; Di Paolo, H.; Castell, W.; Vento, V. Thatar; Cartelli, D.; Kesque, J.M.; Valda, A.A.; Ilardo, J.C.; Baldo, M.; Erhardt, J.; Debray, M.E.; Somacal, H.R.; Estrada, L.; Sandin, J.C. Suarez; Igarzabal, M.; Huck, H.; Padulo, J.; Minsky, D.M.

    2011-01-01

    The direct use of proton and heavy ion beams for radiotherapy is a well established cancer treatment modality, which is becoming increasingly widespread due to its clear advantages over conventional photon-based treatments. This strategy is suitable when the tumor is spatially well localized. Also the use of neutrons has a long tradition. Here Boron Neutron Capture Therapy (BNCT) stands out, though on a much smaller scale, being a second-generation promising alternative for tumors which are diffuse and infiltrating. On this sector, so far only nuclear reactors have been used as neutron sources. In this paper we describe the current situation worldwide as far as the use of accelerator-based neutron sources for BNCT is concerned (so-called Accelerator-Based (AB)-BNCT). In particular we discuss the present status of an ongoing project to develop a folded Tandem-ElectroStatic-Quadrupole (TESQ) accelerator at the Atomic Energy Commission of Argentina. The project goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the 7 Li(p,n) 7 Be reaction. These are the specifications needed to produce sufficiently intense and clean epithermal neutron beams to perform BNCT for deep-seated tumors in less than an hour. (author)

  15. Experience of boron neutron capture therapy in Japan

    International Nuclear Information System (INIS)

    Kanda, K.

    2004-01-01

    Four research reactors are currently licensed for medical application in Japan. As of July 1995, approximately 210 clinical irradiations using these research reactors have been done for brain and skin tumors as shown. The number of chief medical doctors certified by the Government is eleven so far. Among them, eight doctors have already treated tumor patients using the Kyoto University Reactor (KUR, 5MW). Recently in USA clinical trials have been restarted using epithermal neutrons at MIT and BNL. In this paper, the experience of clinical trials of boron neutron capture therapy (BNCT) which have been performed in Japan, mainly physics studies, are reviewed, and current studies are also introduced

  16. Development of inverse-planning system for neutron capture therapy

    International Nuclear Information System (INIS)

    Kumada, Hiroaki; Yamamoto, Kazuyoshi; Maruo, Takeshi

    2006-01-01

    To lead proper irradiation condition effectively, Japan Atomic Energy Agency (JAEA) is developing an inverse-planning system for neutron capture therapy (NCT-IPS) based on the JAEA computational dosimetry system (JCDS) for BNCT. The leading methodology of an optimum condition in the NCT-IPS has been applied spatial channel theory with adjoint flux solution of Botzman transport. By analyzing the results obtained from the adjoint flux calculations according to the theory, optimum incident point of the beam against the patient can be found, and neutron spectrum of the beam which can generate ideal distribution of neutron flux around tumor region can be determined. The conceptual design of the NCT-IPS was investigated, and prototype of NCT-IPS with JCDS is being developed. (author)

  17. Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams

    Energy Technology Data Exchange (ETDEWEB)

    Kosunen, A

    1999-08-01

    In radiation therapy using electron and photon beams the dosimetry chain consists of several sequential phases starting by the realisation of the dose quantity in the Primary Standard Dosimetry Laboratory and ending to the calculation of the dose to a patient. A similar procedure can be described for the dosimetry of epithermal neutron beams in boron neutron capture therapy (BNCT). To achieve the required accuracy of the dose delivered to a patient the quality of all steps in the dosimetry procedure has to be considered. This work is focused on two items in the dosimetry chains: the determination of the dose in the reference conditions and the evaluation of the accuracy of dose calculation methods. The issues investigated and discussed in detail are: a)the calibration methods of plane parallel ionisation chambers used in electron beam dosimetry, (b) the specification of the critical dosimetric parameter i.e. the ratio of stopping powers for water to air, (S I ?){sup water} {sub air}, in photon beams, (c) the feasibility of the twin ionization chamber technique for dosimetry in epithermal neutron beams applied to BNCT and (d) the determination accuracy of the calculated dose distributions in phantoms in electron, photon, and epithermal neutron beams. The results demonstrate that up to a 3% improvement in the consistency of dose determinations in electron beams is achieved by the calibration of plane parallel ionisation chambers in high energy electron beams instead of calibrations in {sup 60}Co gamma beams. In photon beam dosimetry (S I ?){sup water} {sub air} can be determined with an accuracy of 0.2% using the percentage dose at the 10 cm depth, %dd(10), as a beam specifier. The use of %odd(10) requires the elimination of the electron contamination in the photon beam. By a twin ionisation chamber technique the gamma dose can be determined with uncertainty of 6% (1 standard deviation) and the total neutron dose with an uncertainty of 15 to 20% (1 standard deviation

  18. Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams

    International Nuclear Information System (INIS)

    Kosunen, A.

    1999-08-01

    In radiation therapy using electron and photon beams the dosimetry chain consists of several sequential phases starting by the realisation of the dose quantity in the Primary Standard Dosimetry Laboratory and ending to the calculation of the dose to a patient. A similar procedure can be described for the dosimetry of epithermal neutron beams in boron neutron capture therapy (BNCT). To achieve the required accuracy of the dose delivered to a patient the quality of all steps in the dosimetry procedure has to be considered. This work is focused on two items in the dosimetry chains: the determination of the dose in the reference conditions and the evaluation of the accuracy of dose calculation methods. The issues investigated and discussed in detail are: a)the calibration methods of plane parallel ionisation chambers used in electron beam dosimetry, (b) the specification of the critical dosimetric parameter i.e. the ratio of stopping powers for water to air, (S I ?) water air , in photon beams, (c) the feasibility of the twin ionization chamber technique for dosimetry in epithermal neutron beams applied to BNCT and (d) the determination accuracy of the calculated dose distributions in phantoms in electron, photon, and epithermal neutron beams. The results demonstrate that up to a 3% improvement in the consistency of dose determinations in electron beams is achieved by the calibration of plane parallel ionisation chambers in high energy electron beams instead of calibrations in 60 Co gamma beams. In photon beam dosimetry (S I ?) water air can be determined with an accuracy of 0.2% using the percentage dose at the 10 cm depth, %dd(10), as a beam specifier. The use of %odd(10) requires the elimination of the electron contamination in the photon beam. By a twin ionisation chamber technique the gamma dose can be determined with uncertainty of 6% (1 standard deviation) and the total neutron dose with an uncertainty of 15 to 20% (1 standard deviation). To improve the accuracy

  19. Status of nuclear data for use in neutron therapy

    International Nuclear Information System (INIS)

    White, R.M.

    1992-03-01

    Optimization of neutron therapy requires nuclear cross section data for: (1) the selection of source reaction for neutron production, (2) the design of collimators and shields, (3) the calculation of absorbed dose in the irradiation tissues, including heterogeneity corrections, (4) microdosimetry, and (5) studies of the influence of radiation quality on biological effects. Under the auspices of the International Atomic Energy Agency (IAEA), a Coordinated Research Program (CRP) has been underway since 1987 to assess the status of these nuclear data, to coordinate research efforts, to report recent progress, and to recommend acceptance of appropriate data and further research where necessary. In this paper, we outline the results of the CRP's final report to be published and evaluate the status of the most critical nuclear data needs for therapy, i.e., kerma calculations and measurements, from low neutron energies to 70 MeV. Recommended values for (n,p) kerma and the carbon-to-oxygen neutron kerma factor ratios up to 70 MeV are given with estimates of their current uncertainties

  20. High-energy versus low-energy extracorporeal shock wave therapy for calcifying tendinitis of the shoulder: which is superior? A meta-analysis.

    Science.gov (United States)

    Verstraelen, F U; In den Kleef, N J H M; Jansen, L; Morrenhof, J W

    2014-09-01

    There are several treatment options for calcifying tendinitis of the shoulder. The next step treatment after conservative treatment fails is still a matter of dispute. Extracorporeal shock wave therapy (ESWT) has been shown to be a good alternative to surgery, but the best treatment intensity remains unknown. High-energy ESWT is much more painful, more expensive, and usually is done in an inpatient setting, whereas low-energy ESWT can be performed in an outpatient setting by a physical therapist. A systematic review and meta-analysis of randomized trials was performed to answer two clear research questions: (1) Is there a greater increase in the Constant-Murley score in patients treated with high-energy ESWT compared with those treated with low-energy ESWT by 3 months and by 6 months? (2) Is there a greater chance of complete resorption of the calcifications in patients treated with high-energy ESWT compared with those treated with low-energy ESWT by 3 months and by 6 months? Five relevant electronic online databases, Medline (through PubMed), EMBASE (through OVID), Cinahl (through EBSCO), Web of Science, and the Cochrane Central Register of Controlled Trials, were systematically searched. We also crosschecked the reference lists of articles and reviews for possible relevant studies. Eligible for inclusion were all randomized controlled trials (RCTs) that compared high-energy ESWT (> 0.28 mJ/mm(2)) with low-energy ESWT (energy ESWT compared with patients treated with low-energy ESWT at 3 and 6 months. The 3-month mean difference was 9.88 (95% CI, 9.04-10.72, p energy ESWT more often resulted in complete resorption of the deposits at 3 months. The corresponding odds ratio was 3.40 (95% CI, 1.35-8.58) and p = 0.009 (6-month data could not be pooled). When shock wave therapy is chosen, high-energy shock wave therapy is more likely to result in improved Constant-Murley score and resorption of the deposits compared with low-energy therapy. Level I, therapeutic study

  1. Recombination methods for boron neutron capture therapy dosimetry

    International Nuclear Information System (INIS)

    Golnik, N.; Tulik, P.; Zielczynski, M.

    2003-01-01

    The radiation effects of boron neutron capture therapy (BNCT) are associated with four-dose-compartment radiation field - boron dose (from 10 B(n,α) 7 Li) reaction), proton dose from 14 N(n,p) 14 C reaction, neutron dose (mainly fast and epithermal neutrons) and gamma-ray dose (external and from capture reaction 1 H(n,γ) 2 D). Because of this the relation between the absorbed dose and the biological effects is very complex and all the above mentioned absorbed dose components should be determined. From this point of view, the recombination chambers can be very useful instruments for characterization of the BNCT beams. They can be used for determination of gamma and high-LET dose components for the characterization of radiation quality of mixed radiation fields by recombination microdosimetric method (RMM). In present work, a graphite high-pressure recombination chamber filled with nitrogen, 10 BF 3 and tissue equivalent gas was used for studies on application of RMM for BNCT dosimetry. The use of these gases or their mixtures opens a possibility to design a recombination chamber for determination of the dose fractions due to gamma radiation, fast neutrons, neutron capture on nitrogen and high LET particles from (n, 10 B) reaction in simulated tissue with different content of 10 B. (author)

  2. Development of lithium target for accelerator based neutron capture therapy

    International Nuclear Information System (INIS)

    Taskaev, Sergey; Bayanov, Boris; Belov, Victor; Zhoorov, Eugene

    2006-01-01

    Pilot innovative accelerator based neutron source for neutron capture therapy of cancer is now of the threshold of its operation at the BINP, Russia. One of the main elements of the facility is lithium target producing neutrons via threshold 7 Li(p,n) 7 Be reaction at 25 kW proton beam with energies 1.915 MeV or 2.5 MeV. The main problems of lithium target were determined to be: 7 Be radioactive isotope activation keeping lithium layer solid, presence of photons due to proton inelastic scattering on lithium nuclei, and radiation blistering. The results of thermal test of target prototype were presented as previous NCT Congress. It becomes clear that water is preferable for cooling the target, and that lithium target 10 cm in diameter is able to run before melting. In the present report, the conception of optimal target is proposed: thin metal disk 10 cm in diameter easy for detaching, with evaporated thin layer of pure lithium from the side of proton beam exposure, its back being intensively cooled with turbulent water flow to maintain lithium layer solid. Design of the target for the neutron source constructed at BINP is shown. The results of investigation of radiation blistering and lithium layer are presented. Target unit of facility is under construction now, and obtaining neutrons is expected in nearest future. (author)

  3. Irradiation system for neutron capture therapy using the small accelerator

    International Nuclear Information System (INIS)

    Kobayashi, Tooru; Hoshi, Masaharu

    2002-01-01

    Neutron capture therapy (NCT) is to kill tumor cells that previously incorporated the stable isotope which generates heavy charged particles with a short range and a high linear energy transfer (LET) on neutron irradiation. Boron-10 is ordinarily used as such an isotope. The tumor tissue is neutron-irradiated at craniotomy after preceding craniotomy for tumor extraction: therefore two surgeries are required for the present NCT in Japan. The reactions 10 B(n, αγ) 7 Li and 7 Li (p, n) 7 Be are thought preferential for patients and doctors if a convenient small accelerator, not the reactor used at present, is available in the hospital because only one craniotomy is sufficient. Authors' examinations of the system for NCT using the small accelerator involve irradiation conditions, desirable energy spectrum of neutron, characterization of thermal and epi-thermal neutrons, social, practical and technical comparison of the reactor and accelerator, and usefulness of the reaction 7 Li (p, n) 7 Be. The system devoted to the NCT is awaited in future. (K.H.)

  4. Design of a cryogenic deuterium gas target for neutron therapy

    International Nuclear Information System (INIS)

    Kuchnir, F.T.; Waterman, F.M.; Forsthoff, H.; Skaggs, L.S.; Vander Arend, P.C.; Stoy, S.

    1976-01-01

    A cryogenic deuterium gas target operating at 80 0 K and 10 atm pressure has been designed for use with a small cyclotron; the D(d,n) reaction is used to produce a neutron beam suitable for radiation therapy. The target is cooled by circulation of the gas in a closed loop between the target and an external heat exchanger immersed in liquid nitrogen

  5. Preliminary investigations of Monte Carlo Simulations of neutron energy and LET spectra for fast neutron therapy facilities

    International Nuclear Information System (INIS)

    Kroc, T.K.

    2009-01-01

    No fast neutron therapy facility has been built with optimized beam quality based on a thorough understanding of the neutron spectrum and its resulting biological effectiveness. A study has been initiated to provide the information necessary for such an optimization. Monte Carlo studies will be used to simulate neutron energy spectra and LET spectra. These studies will be bench-marked with data taken at existing fast neutron therapy facilities. Results will also be compared with radiobiological studies to further support beam quality ptimization. These simulations, anchored by this data, will then be used to determine what parameters might be optimized to take full advantage of the unique LET properties of fast neutron beams. This paper will present preliminary work in generating energy and LET spectra for the Fermilab fast neutron therapy facility.

  6. High energy (42-66 MeV reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities

    International Nuclear Information System (INIS)

    Griffin, T.W.; Laramore, G.E.; Maor, M.H.; Hendrickson, F.R.; Parker, R.G.; Davis, L.W.

    1990-01-01

    550 Patients were entered into a set of dose-searching studies designed to determine normal tissue tolerances to high energy (42-66 MeV reactions) fast neutrons delivered in 12 equal fractions over 4 weeks. Patients were stratified by treatment facility and then randomized to receive 16, 18 or 20 Gy for tumors located in the upper abdomen or pelvis, and 18, 20 or 22 Gy for tumors located in the head and neck, thorax or extremities. Following completion of the randomized protocols, additional patients were studied at the 20.4 Gy level in the head and neck, thorax and pelvis. Normal tissue effect scoring was accomplished using the RTOG-EORTC acute and late normal tissue effect scales. Acute Grade 3+ toxicity rates in the head and neck were 19 per cent for 20/20.4 Gy and 20 per cent for 22 Gy. Time adjusted late toxicity rates in the head and neck at 12 months were 15 per cent for 20/20.4 Gy and 0 per cent for 22 Gy. The 18 Gy treatment arm of the head and neck protocol was dropped early in the study after only two patients were accrued. For cases treated in the thorax, acute Grade 3+ toxicity rates were 6 per cent for 18 Gy, 15 per cent for 20/20.4 Gy and 7 per cent for 22 Gy. Late toxicity rates at 12 months were 0 per cent for 18 Gy, 11 per cent for 20/20.4 Gy and 18 per cent for 22 Gy. Acute Grade 3+ toxicity rates in the upper abdomen were 0 per cent for 16 Gy, 18 per cent for 18 Gy and 12 per cent for 20 Gy. There were no Grade 3+ late toxicities in the upper abdomen. In the pelvis acute Grade 3+ toxicity rates were 0 per cent for 16 Gy, 3 per cent for 18 Gy and 3 per cent for 20/20.4 Gy. Late Grade 3+ toxicities at 24 months were 20 per cent for 16 Gy, 5 per cent for 18 Gy and 24 per cent for 20/20.4 Gy. In the extremities, acute Grade 3+ toxicity rates were 7 per cent for 20 Gy and 21 per cent for 22 Gy, while at 12 months, late Grade 3+ toxicity rates were 14 and 35 per cent respectively. The 18 Gy treatment arm of the extremities protocol was dropped early

  7. Preliminary results of neutron spectroscopy in proton therapy treatment room in Ithemba Labs (South Africa); Resultados preliminares de espectrometria de neutrones en la sala de tratamiento de protonterapia en Ithemba Labs (Sudafrica)

    Energy Technology Data Exchange (ETDEWEB)

    Domingo, C.; Garcia-Fuste, M. J.; Amgarou, K.; Sanchez-Doblado, F.; Nieto-Camero, J.

    2011-07-01

    Proton beams originating from accelerators high energy hadrons lead to the production of neutrons when protons interact with the elements present in the beam line. Furthermore, when these protons are used for proton therapy treatments, their interaction with the patient also involves production of neutrons, mainly due to interactions with the C, O and N. This represents a source of unwanted radiation that increases the risk of developing second cancers by the patient. Assessment of risk factors is one of the goals of our project.

  8. Research on neutron capture therapy in the USSR

    International Nuclear Information System (INIS)

    Ryabukhin, Y.

    1988-01-01

    Research on neutron capture therapy in the USSR began in 1964. Towards 1975 prime knowledge in physics, pharmacology and radiobiology had been accumulated. It was realized that inherent to NCT is a variety of modalities as to the type and location of the tumor, the energy and source of neutrons, the nature and transportation of the nuclide-carrying agent (NCA), etc. Thus, it became likely that some modalities would turn out to be clinically feasible. At the end of the 70s, studies of boron derivatives began at the All-Union Oncological Research Center, Moscow. These studies were stimulated by the clinical trials in Japan. Still, neutron capturing nuclides (NCN) other than 10 b are regarded as promising. Research was aimed at clinical trials that could ensure sufficient safety, convenience and conclusiveness. Hence, new requirements emerged, such as the pre-clinical modeling of NCT in big animals and the monitoring of tumor response to each fraction of NCT. Usual requirements are also to be met, that is: tailoring neutron beams with an adequate intensity and energy, choosing NCNs and finding suitable NCAs, physical and radiobiological planning including adoption of tentative RBEs and time-fractionation regimen, selecting tumors as candidates for NCT, and developing techniques for monitoring NCNs in vivo

  9. Boron neutron capture therapy for malignant brain tumor in Japan

    Energy Technology Data Exchange (ETDEWEB)

    Nakagawa, Yoshinobu [National Kagawa Children`s Hospital, Takamatsu, Kagawa (Japan)

    1998-03-01

    Since 1968, we have treated 149 patients and performed boron-neutron capture therapy (BNCT) on 164 occasions using 5 reactors in Japan. There were 64 patients with glioblastoma, 39 patients with anaplastic astrocytoma and 17 patients with low grade astrocytoma (grade 1 or 2). There were 30 patients with other types of tumor. The overall response rate in the glioma patients was 64%. Seven patients (12%) of glioblastoma, 22 patients (56%) of anaplastic astrocytoma and 8 patients (62%) of low grade astrocytoma lived more than 2 years Median survival time of glioblastoma was 640 days. Median survival times of patients with anaplastic astrocytoma was 1811 days, and 1669 days in low grade astrocytoma. Six patients (5 glioblastoma and one anaplastic astrocytoma) died within 90 days after BNCT. Six patients lived more than 10 years. Histological grading, age of the patients, neutron fluence at the target point and target depth or size of the tumor were proved to be important factors. BNCT is an effective treatment for malignant brain tumors. We are now became able to radiate the tumor more correctly with a high enough dose of neutron beam even if we use thermal neutron beam. (author)

  10. Computational Dosimetry and Treatment Planning Considerations for Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Nigg, David Waler

    2003-01-01

    Specialized treatment planning software systems are generally required for neutron capture therapy (NCT) research and clinical applications. The standard simplifying approximations that work well for treatment planning computations in the case of many other modalities are usually not appropriate for application to neutron transport. One generally must obtain an explicit three-dimensional numerical solution of the governing transport equation, with energy-dependent neutron scattering completely taken into account. Treatment planning systems that have been successfully introduced for NCT applications over the past 15 years rely on the Monte Carlo stochastic simulation method for the necessary computations, primarily because of the geometric complexity of human anatomy. However, historically, there has also been interest in the application of deterministic methods, and there have been some practical developments in this area. Most recently, interest has turned toward the creation of treatment planning software that is not limited to any specific therapy modality, with NCT as only one of several applications. A key issue with NCT treatment planning has to do with boron quantification, and whether improved information concerning the spatial biodistribution of boron can be effectively used to improve the treatment planning process. Validation and benchmarking of computations for NCT are also of current developmental interest. Various institutions have their own procedures, but standard validation models are not yet in wide use

  11. High-energy X-ray detection using organic luminescent materials: a novel application for radiation therapy

    International Nuclear Information System (INIS)

    Schimitberger, Thiago; Ferreira, Giovana Ribeiro; Silva, Mariana de Melo; Saraiva, M.F.; Bianchi, Rodrigo Fernando

    2010-01-01

    In this work, it is presented the characterization and fabrication of a novel ionizing radiation sensor for high energy X-ray (6 MeV). It is used organic luminescent materials usually applied in light-emitting and nanostructure device, but still few explored in radiation dosimetry. Organic solutions of tris(8-hydroxyquinolinato) aluminum - Alq_3 and poly[2-methoxy-5-(2'-ethylhexyloxy)-p-phenylene vinylene] - MEH-PPV were prepared to better study the impact of spectral overlap between the Alq_3 emission and MEH-PPV absorption. It is observed a blue-shift on the photoluminescence of the MEH-PPV/Alq_3 solution system from red-orange (λ_m_a_x = 598 nm) to green (λ_m_a_x = 545 nm) when the radiation dose changes from 0 to 100 Gy. This effect is attributed to the photooxidation process of MEH-PPV and was employed to design dose accumulation sensors in order to represent easily the radiation dose for cancer treatment. (author)

  12. Neutron capture therapy of ocular melanoma: dosimetry and microdosimetry approaches

    International Nuclear Information System (INIS)

    Pignol, J.P.; Methlin, G.; Abbe, J.C.; Lefebvre, O.; Sahel, J.

    1994-01-01

    Neutron capture therapy (NCT) aims at destroying cancerous cells with the α and 7 Li particles produced by the neutron capture reaction on 10 B. This note reports on the study of the boron distribution in tissues on an animal model (nude mice) xenografted with a human ocular melanoma after an i.p.injection of 2g/kg of 10 B-BPA and in cells cultured in the presence of 530 μmol/l of 10 B-BPA. A concentration of 64 ppm of 10 B in the active part of the tumour with a ratio of concentrations versus the skin of 3.7 are observed. Investigations on cells reveal the presence of boron in the cytoplasm. The biological, dosimetric and microdosimetric consequences of these findings are discussed. (authors). 15 refs., 2 tabs., 2 figs

  13. Neutron therapy planning: Principles and practice in Edinburgh

    International Nuclear Information System (INIS)

    Duncan, W.; Williams, J.R.; Redpath, A.T.; Arnott, S.J.

    1981-01-01

    The principles of treatment planning using beams of fast neutron irradiation are the same as that involved in X-ray therapy. The optimum treatment technique to be employed and the standard of dose distribution depend on the penetration of the beam, the sophistication of the treatment head and certain clinical constraints. These inter-related factors are briefly discussed. The Edinburgh Cyclotron produces d(15)+Be neutrons and compared to megavoltage X-rays it is necessary to use a greater number of fields, respect greater restraints on planning and, when wedge filters are used, accept relatively higher doses in 'hot spots'. With careful and detailed planning satisfactory dose distributions can be achieved. The procedures followed in clinical planning, field selection and dose computation are described. (orig.)

  14. Characteristics of neutron irradiation facility and dose estimation method for neutron capture therapy at Kyoto University research reactor institute

    International Nuclear Information System (INIS)

    Kobayashi, T.; Sakurai, Y.; Kanda, K.

    2001-01-01

    The neutron irradiation characteristics of the Heavy Water Neutron Irradiation Facility (HWNIF) at the Kyoto University Research Reactor Institute (KIJRRI) for boron neutron capture therapy (BNCT), is described. The present method of dose measurement and its evaluation at the KURRI, is explained. Especially, the special feature and noticeable matters were expounded for the BNCT with craniotomy, which has been applied at present only in Japan. (author)

  15. Measurement of the tissue to A-150 tissue equivalent plastic kerma ratio at two p(66)Be neutron therapy facilities

    International Nuclear Information System (INIS)

    Langen, K M; Binns, P J; Schreuder, A N; Lennox, A J; Deluca, P M Jr.

    2003-01-01

    The ICRU tissue to A-150 tissue equivalent plastic kerma ratio is needed for neutron therapy dosimetry. The current ICRU protocol for neutron dosimetry recommends using a common conversion factor of 0.95 at all high-energy neutron therapy facilities. In an effort to determine facility specific ICRU tissue to A-150 plastic kerma ratios, an experimental approach was pursued. Four low pressure proportional counters that differed in wall materials (i.e. A-150, carbon, zirconium and zirconium-oxide) were used as dosimeters and integral kerma ratios were determined directly in the clinical beam. Measurements were performed at two p(66)Be facilities: iThemba LABS near Cape Town and Fermilab near Chicago. At the iThemba facility the clinical neutron beam is routinely filtered by a flattening and hardening filter combination. The influence of beam filtration on the kerma ratio was evaluated. Using two recent gas-to-wall dose conversion factor (r m,g value) evaluations a mean ICRU tissue to A-150 plastic kerma ratio of 0.93 ± 0.05 was determined for the clinical beam at iThemba LABS. The respective value for the Fermilab beam is 0.95 ± 0.05. The experimentally determined ICRU tissue to A-150 plastic kerma ratios for the two clinical beams are in agreement with theoretical evaluations. Beam filtration reduces the kerma ratio by 3 ± 2%

  16. Evaluation of moderator assemblies for use in an accelerator-based neutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Woollard, J.E.; Blue, T.E.; Gupta, N.; Gahbauer, R.A.

    1998-01-01

    The neutron fields produced by several moderator assemblies were evaluated using both in-phantom and in-air neutron field assessment parameters. The parameters were used to determine the best moderator assembly, from among those evaluated, for use in the accelerator-based neutron source for boron neutron capture therapy. For a 10-mA proton beam current and the specified treatment parameters, a moderator assembly consisting of a BeO moderator and a Li 2 CO 3 reflector was found to be the best moderator assembly whether the comparison was based on in-phantom or in-air neutron field assessment parameters. However, the parameters were discordant regarding the moderator thickness. The in-phantom neutron field assessment parameters predict 20 cm of BeO as the best moderator thickness, whereas the in-air neutron field assessment parameters predict 25 cm of BeO as the best moderator thickness

  17. Extracorporeal shockwave therapy for atrophic and oligotrophic nonunion of tibia and femur in high energy trauma patients. Case series

    Directory of Open Access Journals (Sweden)

    Carlos Sandoval

    2017-01-01

    Conclusions: ESWT induced bone healing in an average 60% of cases, which is consistent with current reported literature. CT studies gave some clues to patients' real condition of fracture anatomy before treatment, allowing a better decision in the orientation of ESWT application for each case. Volumetric Fracture Analysis for Winquist Classification shown that ESWT was able to induce significant bone regeneration in fractures with high volume. This kind of therapy was well accepted in reluctant patients to invasive methods.

  18. Carborane derivative development for boron neutron capture therapy. Final report

    International Nuclear Information System (INIS)

    Barnum, Beverly A.; Yan Hao; Moore, Roger; Hawthorne, M. Frederick; Baum, Kurt

    1999-01-01

    Boron Neutron Capture Therapy [BNCT] is a binary method of cancer therapy based on the capture of neutrons by a boron-10 atom [ 10 B]. Cytotoxic 7 Li nuclei and α-particles are emitted, with a range in tissue of 9 and 5 microm, respectively, about one cell diameter. The major obstacle to clinically viable BNCT is the selective localization of 5-30 ppm 10 B in tumor cells required for effective therapy. A promising approach to BNCT is based on hydrophilic boron-rich oligomeric phosphate diesters, or ''trailers'' that have been shown to concentrate selectively in tumor tissue. Examples of these compounds were prepared previously at high cost using an automated DNA synthesizer. Direct synthesis methods are needed for the production of gram-scale quantities for further biological evaluation. The work accomplished as a result of the collaboration between Fluorochem, Inc. and UCLA demonstrates that short oligomers containing at least five carborane units with four phosphodiester linkages can be prepared in substantial quantities. This work was accomplished by the application of standard phosphoramidite coupling chemistry

  19. High energy electron beams characterization using CaSO{sub 4}:Dy+PTFE Phosphors for clinical therapy applications

    Energy Technology Data Exchange (ETDEWEB)

    Rivera, T., E-mail: trivera@ipn.mx [Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada-Legaria, IPN. Av. Legaria 694, Col. Irrigacion. 11500 Mexico DF (Mexico); Espinoza, A.; Von, S.M. [Centro Estatal de Cancerologia de los Servicios de Salud de Nayarit, Enfermeria S/n, Fracc, Fray Junipero Serra, 63169 Tepic Nay (Mexico); Alvarez, R.; Jimenez, Y. [Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada-Legaria, IPN. Av. Legaria 694, Col. Irrigacion. 11500 Mexico DF (Mexico)

    2012-07-15

    In the present work high energy electron beam dosimetry from linear accelerator (LINACs) for clinical applications using dysprosium doped calcium sulfate embedded in polytetrafluorethylene (CaSO{sub 4}:Dy+PTFE) was studied. The irradiations were carried out using high electron beams (6 to 18 MeV) from a linear accelerator (LINAC) Varian, CLINAC 2300C/D, for clinical practice purpose. The electron irradiations were obtained using the water solid in order to guarantee electronic equilibrium conditions (EEC). Field shaping for electron beams was obtained with electron cones. Glow curve and other thermoluminescent characteristics of CaSO{sub 4}:Dy+PTFE were conducted under high electrons beams irradiations. The TL response of the pellets showed an intensity peak centered at around 215 Degree-Sign C. TL response of CaSO{sub 4}:Dy+PTFE as a function of high electron absorbed dose showed a linearity in a wide range. To obtain reproducibility characteristic, a set of pellets were exposed repeatedly for the same electron absorbed dose. The results obtained in this study can suggest the applicability of CaSO{sub 4}:Dy+PTFE pellets for high electron beam dosimetry, provided fading is correctly accounted for. - Highlights: Black-Right-Pointing-Pointer Developing of CaSO{sub 4}:Dy to electron beams dosimetry. Black-Right-Pointing-Pointer Characterization of caSO{sub 4}:Dy to radiation safety in LINACs. Black-Right-Pointing-Pointer TL characteristics of CaSO{sub 4}:Dy for electron beams quality control.

  20. Results of two randomised clinical trials of neutron therapy in rectal adenocarcinoma

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Jack, W.J.L.; Orr, J.A.; Kerr, G.R.; Williams, J.R.

    1987-01-01

    Two clinical trials of neutron therapy were instituted to compare fast neutron therapy with megavoltage therapy in inoperable adenocarcinoma of the rectum and in postoperative recurrent adenocarcinoma of the rectum and to evaluate local tumour control, radiation morbidity and survival rates. In both rectal trials, complete local regression and persistent local control of tumour were similar in each treatment group. Survival was poor and so there is little long-term experience of tumour control and morbidity. The possibility that the relatively poor penetration of the neutron beam had an adverse effect on the results of neutron therapy should be considered. (Auth.)

  1. Study on high speed lithium jet for neutron source of boron neutron capture therapy (BNCT)

    International Nuclear Information System (INIS)

    Takahashi, Minoru; Kobayashi, Tooru; Zhang, Mingguang; Mak, Michael; Stefanica, Jiri; Dostal, Vaclav; Zhao Wei

    2012-01-01

    The feasibility study of a liquid lithium type proton beam target was performed for the neutron source of the boron neutron capture therapy (BNCT). As the candidates of the liquid lithium target, a thin sheet jet and a thin film flow on a concave wall were chosen, and a lithium flow experiment was conducted to investigate the hydrodynamic stability of the targets. The surfaces of the jets and film flows with a thickness of 0.5 mm and a width of 50 mm were observed by means of photography. It has been found that a stable sheet jet and a stable film flow on a concave wall can be formed up to certain velocities by using a straight nozzle and a curved nozzle with the concave wall, respectively. (author)

  2. Novel amino-carboxy-dihydroboranes for neutron capture therapy

    International Nuclear Information System (INIS)

    Boehmel, T.

    1985-01-01

    The thesis discusses the following topics: I. Synthesis of boron compounds for the neutron capture therapy which are to meet the following requirements: 1. Low toxicity; 2. High boron content; 3. High enrichment and long retention time in the neoplastic tissue and simultaneous low concentration in blood and normal tissue; 4. Independent cytostatic effects; 5. Functional groups which allow a connection with polymers. II. Presentation of compounds with increased 10 B content. III. Examination of the distribution of boric substances in living organisms by means of a quantitative analysis of the boron content. (orig./PW) [de

  3. Dose modification factors in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Allen, B.J. (Australian Nuclear Science and Technology Organization (ANSTO), Menai (Australia))

    1993-01-01

    The effective treatment depth and therapeutic ratio in boron neutron capture therapy (BNCT) depend on a number of macroscopic dose factors such as boron concentrations in the tumor, normal tissue and blood. However, the role of various microscopic dose modification factors can be of critical importance in the evaluation of normal tissue tolerance levels. An understanding of these factors is valuable in designing BNCT experiments and the selection of appropriate boron compounds. These factors are defined in this paper and applied to the case of brain tumors with particular attention to capillary endothelial cells and oligodendrocytes. (orig.).

  4. Ultrastructural changes in tumor cells following boron neutron capture therapy

    International Nuclear Information System (INIS)

    Barkla, D.H.; Brown, J.K.; Meriaty, H.; Allen, B.J.

    1992-01-01

    In a previous study the authors reported on morphological changes in two human melanoma cell lines treated with 10 B-phenylalanine(BPA) and Boron Neutron Capture Therapy(BNCT). The present study describes morphological changes in melanoma and glioma cell lines treated with boron-tetraphenyl porphyrin(BTPP) and BNCT. Porphyrin compounds are selectively taken up by tumor cells and have been used clinically in phototherapy treatment of cancer patients. Boronated porphyrins show good potential as therapeutic agents in BNCT treatment of human cancer patients

  5. Boron neutron capture therapy: Brain Tumor Treatment Evaluation Program

    International Nuclear Information System (INIS)

    Griebenow, M.L.; Dorn, R.V. III; Gavin, P.R.; Spickard, J.H.

    1988-01-01

    The United States (US) Department of Energy (DOE) recently initiated a focused, multidisciplined program to evaluate Boron Neutron Capture Therapy (BNCT) for the treatment of brain tumors. The program, centered at the DOE/endash/Idaho National Engineering Laboratory (INEL), will develop the analytical, diagnostic and treatment tools, and the database required for BNCT technical assessment. The integrated technology will be evaluated in a spontaneously-occurring canine brain-tumor model. Successful animal studies are expected to lead to human clinical trials within four to five years. 2 refs., 3 figs

  6. Gadolinium neutron capture therapy for brain tumors. Biological aspects

    International Nuclear Information System (INIS)

    Takagaki, Masao; Oda, Yoshifumi; Matsumoto, Masato; Kikuchi, Haruhiko; Kobayashi, Tooru; Kanda, Keiji; Ujeno, Yowri.

    1994-01-01

    This study investigated the tumoricidal effect of gadolinium neutron capture therapy (Gd-NCT) in in vitro and in vivo systems using Gd-DTPA. In in vitro study, a certain amount of Gd-DTPA, yielding 5000 ppm Gd-n, was added to human glioma cells, T98G, upon which thermal neutrons were exposed. After irradiation, the cells were incubated and the colonies were counted 10 days later. In in vivo study, Fisher-344 rats with experimentally induced gliosarcoma cells (9L) were exposed to thermal neutrons at a fluence rate of 3E+9/s for 1 h immediately after iv injection of Gd-DTPA. Two weeks after irradiation, brain samples were histologically examined. Tumor clearance of Gd-DTPA was also determined. In vitro analysis showed that a 1% survival level was obtained at 3.75E+12 (n/cm 2 ) for the Gd (+) medium and 2.50E+13 (n/cm 2 ) for the Gd (-) medium. In in vivo analysis, the concentration of Gd in 9L-rat brain tumor after iv injection of 0.2 mg/kg Gd-DTPA was found to be less than 100 ppm, but Gd-NCT on 9L-rat brain tumor administered with a ten-fold dose showed a substantial killing effect on tumor without serious injury to the normal brain structure. The killing effect of Gd-NCT was confirmed in in vitro and in vivo systems. (N.K.)

  7. In vivo study on influence of the heterogeneity of tissues in the dose distribution in high energy X ray therapy

    International Nuclear Information System (INIS)

    Aldred, M.A.

    1987-01-01

    Several authors investigated the effect of the heterogeneity of tissue in the dose distribution in a radiation-therapy. Practically all of them carried out ''in vitro'' measurements using a solid body immersed in a water phantom, in order to simulate the inhomogeneity, such as bone, air cavity, etc. In the present work, ''in vivo'' measurements were performed utilizing thermoluminescent dosimeters, whose appropriateness and convenience are well known. Eight patients at Instituto de Radioterapia Oswaldo Cruz were selected, that were under irradiation treatments in their pelvic region. The ratio between body entry radiation dose and the corresponding exit dose, when compared to the same ratio for a homogeneous phantom, gives the influence of the heterogeneity of the tissue the radiation crosses. The results found in those eight patients have shown that ''in vivo'' measurements present a ratio about 8% smaller that in homogeneous phantom case. (author) [pt

  8. A conceptual design of neutron tumor therapy reactor facility with a YAYOI based fast neutron source reactor

    International Nuclear Information System (INIS)

    Wakabayashi, Hiroaki; An, Shigehiro.

    1983-01-01

    Fast neutron is known as one of useful radiations for radiation therapy of tumors. Boron neutron capture therapy (BNCT) of tumors which makes use of 10 B(n, α) 7 Li reaction of 10 B compounds selectively attached to tumor cells with thermal and intermediate neutrons is another way of neutron based radiation therapy which is, above all, attractive enough to kill tumor cells selectively sparing normal tissue. In Japan, BNCT has already been applied and leaned to be effective. After more than a decade operational experiences and the specific experiments designed for therapeutical purposes, in this paper, a conceptual design of a special neutron therapy reactor facility based on YAYOI - fast neutron source reactor of Nuclear Engineering Research Laboratory, Faculty of Engineering, the University of Tokyo - modified to provide an upward beam of fast and intermediate neutrons is presented. Emphasis is placed on the in-house nature of facility and on the coordinating capability of biological and physical researches as well as maintenances of the facility. (author)

  9. The radiation biology of Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Coderre, J.A.

    2003-01-01

    Boron Neutron Capture Therapy (BNCT) produces a complex mixture of high and low-LET radiations in tissue. Using data on the biological effectiveness of these various dose components, derived primarily in small animals irradiated with thermal neutrons, it has been possible to express clinical BNCT doses in photon-equivalent units. The accuracy of these calculated doses in normal tissue and tumor will be reviewed. Clinical trials are underway at a number of centers. There are differences in the neutron beams at these centers, and differences in the details of the clinical protocols. Ideally, data from all centers using similar boron compounds and treatment protocols should be compared and combined, if appropriate, in a multi-institutional study in order to strengthen statistical analysis. An international dosimetry exchange is underway that will allow the physical doses from the various treatment centers to be quantitatively compared. As a first step towards the comparison of the clinical data, the normal brain tolerance data from the patients treated in the initial Brookhaven National Laboratory and the Harvard/MIT BNCT clinical trials have been compared. The data provide a good estimate of the normal brain tolerance for a somnolence syndrome endpoint, and provide guidance for setting normal brain tolerance limits in ongoing and future clinical trials. Escalation of the dose in BNCT can be accomplished by increasing the amount of the boron compound administered, increasing the duration of the neutron exposure, or both. The dose escalations that have been carried out to date at the various treatment centers will be compared and contrasted. Possible future clinical trials using BNCT in combination with other modalities will be discussed

  10. A standardized method for beam design in neutron capture therapy

    International Nuclear Information System (INIS)

    Storr, G.J.: Harrington, B.V.

    1993-01-01

    A desirable end point for a given beam design for Neutron Capture Therapy (NCT) should be quantitative description of tumour control probability and normal tissue damage. Achieving this goal will ultimately rely on data from NCT human clinical trials. Traditional descriptions of beam designs have used a variety of assessment methods to quantify proposed or installed beam designs. These methods include measurement and calculation of open-quotes free fieldclose quotes parameters, such as neutron and gamma flux intensities and energy spectra, and figures-of-merit in tissue equivalent phantoms. The authors propose here a standardized method for beam design in NCT. This method would allow all proposed and existing NCT beam facilities to be compared equally. The traditional approach to determining a quantitative description of tumour control probability and normal tissue damage in NCT research may be described by the following path: Beam design → dosimetry → macroscopic effects → microscopic effects. Methods exist that allow neutron and gamma fluxes and energy dependence to be calculated and measured to good accuracy. By using this information and intermediate dosimetric quantities such as kerma factors for neutrons and gammas, macroscopic effect (absorbed dose) in geometries of tissue or tissue-equivalent materials can be calculated. After this stage, for NCT the data begins to become more sparse and in some areas ambiguous. Uncertainties in the Relative Biological Effectiveness (RBE) of some NCT dose components means that beam designs based on assumptions considered valid a few years ago may have to be reassessed. A standard method is therefore useful for comparing different NCT facilities

  11. Boron containing compounds and their preparation and use in neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Gabel, D.

    1992-09-01

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  12. Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma

    Energy Technology Data Exchange (ETDEWEB)

    Gabel, D.

    1991-06-04

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  13. Boron neutron capture therapy for malignant melanoma: An experimental approach

    Energy Technology Data Exchange (ETDEWEB)

    Larsson, B.S.; Larsson, B.; Roberto, A. (Uppsala Univ. (Sweden))

    1989-07-01

    Previous studies have shown that some thioamides, e.g., thiouracil, are incorporated as false precursors into melanin during its synthesis. If boronated analogs of the thioamides share this property, the melanin of melanotic melanomas offers a possibility for specific tumoural uptake and retention of boron as a basis for neutron capture therapy. We report on the synthesis of boronated 1H-1,2,4-triazole-3-thiol (B-TZT), boronated 5-carboxy-2-thiouracil (B-CTU), and boronated 5-diethylaminomethyl-2-thiouracil (B-DEAMTU) and the localization of these substances in melanotic melanomas transplanted to mice. The distribution in the mice was studied by boron neutron capture radiography. B-TZT and B-CTU showed the highest tumour:normal tissue concentration ratios, with tumour:liver ratios of about 4 and tumour:muscle ratios of about 14; B-DEAMTU showed corresponding ratios of 1.4 and 5, respectively. The absolute concentration of boron in the tumours, however, was more than three times higher in the mice injected with B-TZT, compared with B-CTU. The results suggest that B-TZT may be the most promising compound of the three tested with regard to possible therapy of melanotic melanomas.

  14. Why high energy physics

    International Nuclear Information System (INIS)

    Diddens, A.N.; Van de Walle, R.T.

    1981-01-01

    An argument is presented for high energy physics from the point of view of the practitioners. Three different angles are presented: The cultural consequence and scientific significance of practising high energy physics, the potential application of the results and the discovery of high energy physics, and the technical spin-offs from the techniques and methods used in high energy physics. (C.F.)

  15. Studies on the optimal collimation of fast neutrons for neutron therapy

    International Nuclear Information System (INIS)

    Pfister, G.

    1973-08-01

    Optimal dimensions and materials of collimators for the neutron therapy installations under construction in Hamburg and Heidelberg were investigated by computer simulation of clinical irradiations. The neutron transport from the source through collimator and phantom was calculated by numerical solution of the Boltzmann equation by the Ssub(N) method with first collision correction. It was shown that the collimater quantity can be the same for both installations if the same materials are used. With homogeneous distribution of the materials in the collimator, tungsten was found to be most suitable, but almost the same results were achieved with nickel. Alloys of various elements did not improve W/Fe and Fe/(CH 2 )sub(n) distribution significantly improved the collimator quantity. The radiation scattering component is reduced by filters, by smaller beam cross sections, and by longer collimators. The γ quanta which are due to nuclear excitation and by the isotopes produced in the collimator are not dangerous to the patient. Long-term activation of the collimator material should, however, be allowed for in order to ensure radiation protection of the operating personnel. A hardening of the neutron energy spectra on the sides of the useful radiation beam could be determined. (orig./AK) [de

  16. Monte Carlo codes use in neutron therapy; Application de codes Monte Carlo en neutrontherapie

    Energy Technology Data Exchange (ETDEWEB)

    Paquis, P.; Mokhtari, F.; Karamanoukian, D. [Hopital Pasteur, 06 - Nice (France); Pignol, J.P. [Hopital du Hasenrain, 68 - Mulhouse (France); Cuendet, P. [CEA Centre d' Etudes de Saclay, 91 - Gif-sur-Yvette (France). Direction des Reacteurs Nucleaires; Fares, G.; Hachem, A. [Faculte des Sciences, 06 - Nice (France); Iborra, N. [Centre Antoine-Lacassagne, 06 - Nice (France)

    1998-04-01

    Monte Carlo calculation codes allow to study accurately all the parameters relevant to radiation effects, like the dose deposition or the type of microscopic interactions, through one by one particle transport simulation. These features are very useful for neutron irradiations, from device development up to dosimetry. This paper illustrates some applications of these codes in Neutron Capture Therapy and Neutron Capture Enhancement of fast neutrons irradiations. (authors)

  17. Possibility of construction in Bulgaria of a fast neutron therapy center on the base of the U-250 isochronous cyclotron

    International Nuclear Information System (INIS)

    Angelov, V.A.; Enchevich, I.B.

    1985-01-01

    Development of oncological disease treatment by fast neutrons in the world practice is reviewed. Main radiobiological results, which point to peculiarities of neutron therapy in comparison with standard X-ray therapy are considered. Main requirements for devices to be met, used in fast neutron therapy, are enumerated. On the basis of it, the possibility of construction in Bulgaria a fast neutron therapy center using the U-250 multipurpose cyclotron has been made. The conclusion is made that the main parameters of a proton beam in combination with an isocentrical head as a fast neutron source will create the conditions for realization of high-efficiency neutron therapy

  18. ESR-dosimetry in thermal and epithermal neutron fields for application in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Schmitz, Tobias

    2016-01-22

    Dosimetry is essential for every form of radiotherapy. In Boron Neutron Capture Therapy (BNCT) mixed neutron and gamma fields have to be considered. Dose is deposited in different neutron interactions with elements in the penetrated tissue and by gamma particles, which are always part of a neutron field. The therapeutic dose in BNCT is deposited by densely ionising particles, originating from the fragmentation of the isotope boron-10 after capture of a thermal neutron. Despite being investigated for decades, dosimetry in neutron beams or fields for BNCT remains complex, due to the variety in type and energy of the secondary particles. Today usually ionisation chambers combined with metal foils are used. The applied techniques require extensive effort and are time consuming, while the resulting uncertainties remain high. Consequently, the investigation of more effective techniques or alternative dosimeters is an important field of research. In this work the possibilities of ESR-dosimeters in those fields have been investigated. Certain materials, such as alanine, generate stable radicals upon irradiation. Using Electron Spin Resonance (ESR) spectrometry the amount of radicals, which is proportional to absorbed dose, can be quantified. Different ESR detector materials have been irradiated in the thermal neutron field of the research reactor TRIGA research reactor in Mainz, Germany, with five setups, generating different secondary particle spectra. Further irradiations have been conducted in two epithermal neutron beams. The detector response, however, strongly depends on the dose depositing particle type and energy. It is hence necessary to accompany measurements by computational modelling and simulation. In this work the Monte Carlo code FLUKA was used to calculate absorbed doses and dose components. The relative effectiveness (RE), linking absorbed dose and detector response, has been calculated using amorphous track models. For the simulation, detailed models of

  19. Determination of the fission-neutron averaged cross sections of some high-energy threshold reactions of interest for reactor dosimetry

    International Nuclear Information System (INIS)

    Arribere, M.A.; Kestelman, A.J.; Korochinsky, S.; Blostein, J.J.

    2003-01-01

    For three high threshold reactions, we have measured the cross sections averaged over a 235 U fission neutron spectrum. The measured reactions, and corresponding averaged cross sections found, are: 127 I(n,2n) 126 I, (1.36±0.12) mb; 90 Zr(n,2n) 89m Zr, (13.86±0.83) μb; and 58 Ni(n,d+np+pn) 57 Co, (274±15) μb; all referred to the well known standard of (111±3) mb for the 58 Ni(n,p) 58m+g Co averaged cross section. The measured cross sections are of interest in nuclear engineering for the characterization of the fast neutron component in the energy distribution of reactor neutrons. (author)

  20. Dose Determination using alanine detectors in a Mixed Neutron and Gamma Field for Boron Neutron Capture Therapy of Liver Malignancies

    DEFF Research Database (Denmark)

    Schmitz, T.; Blaickner, M.; Ziegner, M.

    2011-01-01

    Introduction Boron Neutron Capture Therapy for liver malignancies is being investigated at the University of Mainz. One important aim is the set-up of a reliable dosimetry system. Alanine dosimeters have previously been applied for dosimetry of mixed radiation fields in antiproton therapy, and ma...

  1. Performance of the SciBar cosmic ray telescope (SciCRT) toward the detection of high-energy solar neutrons in solar cycle 24

    Science.gov (United States)

    Sasai, Yoshinori; Nagai, Yuya; Itow, Yoshitaka; Matsubara, Yutaka; Sako, Takashi; Lopez, Diego; Itow, Tsukasa; Munakata, Kazuoki; Kato, Chihiro; Kozai, Masayoshi; Miyazaki, Takahiro; Shibata, Shoichi; Oshima, Akitoshi; Kojima, Hiroshi; Tsuchiya, Harufumi; Watanabe, Kyoko; Koi, Tatsumi; Valdés-Galicia, Jose Francisco; González, Luis Xavier; Ortiz, Ernesto; Musalem, Octavio; Hurtado, Alejandro; Garcia, Rocio; Anzorena, Marcos

    2014-12-01

    We plan to observe solar neutrons at Mt. Sierra Negra (4,600 m above sea level) in Mexico using the SciBar detector. This project is named the SciBar Cosmic Ray Telescope (SciCRT). The main aims of the SciCRT project are to observe solar neutrons to study the mechanism of ion acceleration on the surface of the sun and to monitor the anisotropy of galactic cosmic-ray muons. The SciBar detector, a fully active tracker, is composed of 14,848 scintillator bars, whose dimension is 300 cm × 2.5 cm × 1.3 cm. The structure of the detector enables us to obtain the particle trajectory and its total deposited energy. This information is useful for the energy reconstruction of primary neutrons and particle identification. The total volume of the detector is 3.0 m × 3.0 m × 1.7 m. Since this volume is much larger than the solar neutron telescope (SNT) in Mexico, the detection efficiency of the SciCRT for neutrons is highly enhanced. We performed the calibration of the SciCRT at Instituto Nacional de Astrofisica, Optica y Electronica (INAOE) located at 2,150 m above sea level in Mexico in 2012. We installed the SciCRT at Mt. Sierra Negra in April 2013 and calibrated this detector in May and August 2013. We started continuous observation in March 2014. In this paper, we report the detector performance as a solar neutron telescope and the current status of the SciCRT.

  2. Designing an Epithermal Neutron Beam for Boron Neutron Capture Therapy for the Fusion Reactions 2H(d,n)3He and 3H(d,n)4He1

    International Nuclear Information System (INIS)

    Verbeke, J.M.; Costes, S.V.; Bleuel, D.; Vujic, J.; Leung, K.N.

    1998-01-01

    A beam shaping assembly has been designed to moderate high energy neutrons from the fusion reactions 2 H(d,N) 3 He and 3 H(d,n) 4 He for use fin boron neutron capture therapy. The low neutron yield of the 2 H(d,n) 3 He reaction led to unacceptably long treatment times. However, a 160 mA deuteron beam of energy 400 keV led to a treatment time of 120 minutes with the reaction 3 H(d,n) 4 He. Equivalent doses of 9.6 Gy-Eq and 21.9 Gy-Eq to the skin and to a 8 cm deep tumor respectively have been computed

  3. High energy neutron cross-sections and kerma values of biomedical interest calculated with a nuclear model applicable to light nuclei

    International Nuclear Information System (INIS)

    Brenner, D.J.

    1984-01-01

    A model has been developed for calculating fast neutron cross sections (E > 14 MeV) for light nuclei of biomedical interest. The model explicitly includes experimental nuclear structure information. Some calculations for 12 C, 14 N, and 16 O are presented

  4. Search for High-energy Neutrinos from Binary Neutron Star Merger GW170817 with ANTARES, IceCube, and the Pierre Auger Observatory

    NARCIS (Netherlands)

    Albert, A.; Andre, M.; Anghinolfi, M.; Ardid, M.; Aubert, J. -J.; Aublin, J.; Avgitas, T.; Baret, B.; Barrios-Marti, J.; Basa, S.; Belhorma, B.; Bertin, V.; Biagi, S.; Bormuth, R.; Bourret, S.; Bouwhuis, M. C.; Branzas, H.; Bruijn, R.; Brunner, J.; Busto, J.; Capone, A.; Caramete, L.; Carr, J.; Celli, S.; El Moursli, R. Cherkaoui; Chiarusi, T.; Circella, M.; Coelho, J. A. B.; Coleiro, A.; Coniglione, R.; Costantini, H.; Coyle, P.; Creusot, A.; Diaz, A. F.; Deschamps, A.; De Bonis, G.; Distefano, C.; Di Palma, I.; Domi, A.; Donzaud, C.; Dornic, D.; Drouhin, D.; Eberl, T.; El Bojaddaini, I.; El Khayati, N.; Elsaesser, D.; Enzenhofer, A.; Ettahiri, A.; Fassi, F.; Felis, I.; Fusco, L. A.; Gay, P.; Giordano, V.; Glotin, H.; Gregoire, T.; Ruiz, R. Gracia; Graf, K.; Hallmann, S.; van Haren, H.; Heijboer, A. J.; Hello, Y.; Hernandez-Rey, J. J.; Hoessl, J.; Hofestaedt, J.; Illuminati, G.; James, C. W.; de Jong, M.; Jongen, M.; Kadler, M.; Kalekin, O.; Katz, U.; Kiessling, D.; Kouchner, A.; Kreter, M.; Kreykenbohm, I.; Kulikovskiy, V.; Lachaud, C.; Lahmann, R.; Lefevre, D.; Leonora, E.; Lotze, M.; Loucatos, S.; Marcelin, M.; Margiotta, A.; Marinelli, A.; Martinez-Mora, J. A.; Mele, R.; Melis, K.; Michael, T.; Migliozzi, P.; Moussa, A.; Navas, S.; Nezri, E.; Organokov, M.; Pavalas, G. E.; Pellegrino, C.; Perrina, C.; Piattelli, P.; Popa, V.; Pradier, T.; Quinn, L.; Racca, C.; Riccobene, G.; Sanchez-Losa, A.; Saldana, M.; Salvadori, I.; Samtleben, D. F. E.; Sanguineti, M.; Sapienza, P.; Schussler, F.; Sieger, C.; Spurio, M.; Stolarczyk, Th.; Taiuti, M.; Tayalati, Y.; Trovato, A.; Turpin, D.; Tonnis, C.; Vallage, B.; Van Elewyck, V.; Versari, F.; Vivolo, D.; Vizzoca, A.; Wilms, J.; Zornoza, J. D.; Zuniga, J.; Aartsen, M. G.; Ackermann, M.; Adams, J.; Aguilar, J. A.; Ahlers, M.; Ahrens, M.; Al Samarai, I.; Altmann, D.; Andeen, K.; Anderson, T.; Ansseau, I.; Anton, G.; Arguelles, C.; Auffenberg, J.; Axani, S.; Bagherpour, H.; Bai, X.; Barron, J. P.; Barwick, S. W.; Baum, V.; Bay, R.; Beatty, J. J.; Tjus, J. Becker; Becker, K. H.; BenZvi, S.; Berley, D.; Bernardini, E.; Besson, D. Z.; Binder, G.; Bindig, D.; Blaufuss, E.; Blot, S.; Bohm, C.; Boerner, M.; Bos, F.; Bose, D.; Boeser, S.; Botner, O.; Bourbeau, E.; Bourbeau, J.; Bradascio, F.; Braun, J.; Brayeur, L.; Brenzke, M.; Bretz, H. -P.; Bron, S.; Brostean-Kaiser, J.; Burgman, A.; Carver, T.; Casey, J.; Casier, M.; Cheung, E.; Chirkin, D.; Christov, A.; Clark, K.; Classen, L.; Coenders, S.; Collin, G. H.; Conrad, J. M.; Cowen, D. F.; Cross, R.; Day, M.; de Andre, J. P. A. M.; De Clercq, C.; DeLaunay, J. J.; Dembinski, H.; De Ridder, S.; Desiati, P.; de Vries, K. D.; de Wasseige, G.; de With, M.; DeYoung, T.; Diaz-Velez, J. C.; di Lorenzo, V.; Dujmovic, H.; Dumm, J. P.; Dunkman, M.; Dvorak, E.; Eberhardt, B.; Ehrhardt, T.; Eichmann, B.; Eller, P.; Evenson, P. A.; Fahey, S.; Fazel, A. R.; Felde, J.; Filimonov, K.; Finley, C.; Flis, S.; Franckowiak, A.; Friedman, E.; Fuchs, T.; Gaisser, T. K.; Gallagher, J.; Gerhardt, L.; Ghorbani, K.; Giang, W.; Glauch, T.; Glsenkamp, T.; Goldschmidt, A.; Gonzalez, J. G.; Grant, D.; Griffith, Z.; Haack, C.; Hallgren, A.; Halzen, F.; Hanson, K.; Hebecker, D.; Heereman, D.; Helbing, K.; Hellauer, R.; Hickford, S.; Hignight, J.; Hill, G. C.; Hoffman, K. D.; Hoffmann, R.; Hokanson-Fasig, B.; Hoshina, K.; Huang, F.; Huber, M.; Hultqvist, K.; Huennefeld, M.; In, S.; Ishihara, A.; Jacobi, E.; Japaridze, G. S.; Jeong, M.; Jero, K.; Jones, B. J. P.; Kalaczynski, P.; Kang, W.; Kappes, A.; Karg, T.; Karle, A.; Katz, U.; Kauer, M.; Keivani, A.; Kelley, J. L.; Kheirandish, A.; Kim, J.; Kim, M.; Kintscher, T.; Kiryluk, J.; Kittler, T.; Klein, S. R.; Kohnen, G.; Koirala, R.; Kolanoski, H.; Kopke, L.; Kopper, C.; Kopper, S.; Koschinsky, J. P.; Koskinen, D. J.; Kowalski, M.; Krings, K.; Kroll, M.; Kruckl, G.; Kunnen, J.; Kunwar, S.; Kurahashi, N.; Kuwabara, T.; Kyriacou, A.; Labare, M.; Lanfranchi, J. L.; Larson, M. J.; Lauber, F.; Lesiak-Bzdak, M.; Leuermann, M.; Liu, Q. R.; Lu, L.; Lunemann, J.; Luszczak, W.; Madsen, J.; Maggi, G.; Mahn, K. B. M.; Mancina, S.; Maruyama, R.; Mase, K.; Maunu, R.; McNally, F.; Meagher, K.; Medici, M.; Meier, M.; Menne, T.; Merino, G.; Meures, T.; Miarecki, S.; Micallef, J.; Momente, G.; Montaruli, T.; Moore, R. W.; Moulai, M.; Nahnhauer, R.; Nakarmi, P.; Naumann, U.; Neer, G.; Niederhausen, H.; Nowicki, S. C.; Nygren, D. R.; Pollmann, A. Obertacke; Olivas, A.; O'Murchadha, A.; Palczewski, T.; Pandya, H.; Pankova, D. V.; Peiffer, P.; Pepper, J. A.; de Los Heros, C. Perez; Pieloth, D.; Pinat, E.; Plum, M.; Pranav, D.; Price, P. B.; Przybylski, G. T.; Raab, C.; Raedel, L.; Rameez, M.; Rawlins, K.; Rea, I. C.; Reimann, R.; Relethford, B.; Relich, M.; Resconi, E.; Rhode, W.; Richman, M.; Robertson, S.; Rongen, M.; Rott, C.; Ruhe, T.; Ryckbosch, D.; Rysewyk, D.; Saelzer, T.; Herrera, S. E. Sanchez; Sandrock, A.; Sandroos, J.; Santander, M.; Sarkar, S.; Sarkar, S.; Satalecka, K.; Schlunder, P.; Schmidt, T.; Schneider, A.; Schoenen, S.; Schoeneberg, S.; Schumacher, L.; Seckel, D.; Seunarine, S.; Soedingrekso, J.; Soldin, D.; Song, M.; Spiczak, G. M.; Spiering, C.; Stachurska, J.; Stamatikos, M.; Stanev, T.; Stasik, A.; Stettner, J.; Steuer, A.; Stezelberger, T.; Stokstad, R. G.; Stossl, A.; Strotjohann, N. L.; Stuttard, T.; Sullivan, G. W.; Sutherland, M.; Taboada, I.; Tatar, J.; Tenholt, F.; Ter-Antonyan, S.; Terliuk, A.; Tesic, G.; Tilav, S.; Toale, P. A.; Tobin, M. N.; Toscano, S.; Tosi, D.; Tselengidou, M.; Tung, C. F.; Turcati, A.; Turley, C. F.; Ty, B.; Unger, E.; Usner, M.; Vandenbroucke, J.; Van Driessche, W.; van Eijndhoven, N.; Vanheule, S.; van Santen, J.; Vehring, M.; Vogel, E.; Vraeghe, M.; Walck, C.; Wallace, A.; Wallraff, M.; Wandler, F. D.; Wandkowsky, N.; Waza, A.; Weaver, C.; Weiss, M. J.; Wendt, C.; Werthebach, J.; Westerhoff, S.; Whelan, B. J.; Wiebe, K.; Wiebusch, C. H.; Wille, L.; Williams, D. R.; Wills, L.; Wolf, M.; Wood, J.; Wood, T. R.; Woolsey, E.; Woschnagg, K.; Xu, D. L.; Xu, X. W.; Xu, Y.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Yuan, T.; Zoll, M.; Aab, A.; Abreu, P.; Aglietta, M.; Albuquerque, I. F. M.; Albury, J. M.; Allekotte, I.; Almela, A.; Alvarez Castillo, J.; Alvarez-Muniz, J.; Anastasi, G. A.; Anchordoqui, L.; Andrada, B.; Andringa, S.; Aramo, C.; Arsene, N.; Asorey, H.; Assis, P.; Avila, G.; Badescu, A. M.; Balaceanu, A.; Barbato, F.; Barreira Luz, R. J.; Beatty, J. J.; Becker, K. H.; Bellido, J. A.; Berat, C.; Bertaina, M. E.; Bertou, X.; Biermann, P. L.; Biteau, J.; Blaess, S. G.; Blanco, A.; Blazek, J.; Bleve, C.; Bohacova, M.; Bonifazi, C.; Borodai, N.; Botti, A. M.; Brack, J.; Brancus, I.; Bretz, T.; Bridgeman, A.; Briechle, F. L.; Buchholz, P.; Bueno, A.; Buitink, S.; Buscemi, M.; Caballero-Mora, K. S.; Caccianiga, L.; Cancio, A.; Canfora, F.; Caruso, R.; Castellina, A.; Catalani, F.; Cataldi, G.; Cazon, L.; Chavez, A. G.; Chinellato, J. A.; Chudoba, J.; Clay, R. W.; Cobos Cerutti, A. C.; Colalillo, R.; Coleman, A.; Collica, L.; Coluccia, M. R.; Conceicao, R.; Consolati, G.; Contreras, F.; Cooper, M. J.; Coutu, S.; Covault, C. E.; Cronin, J.; D'Amico, S.; Daniel, B.; Dasso, S.; Daumiller, K.; Dawson, B. R.; Day, J. A.; de Almeida, R. M.; de Jong, S. J.; De Mauro, G.; de Mello Neto, J. R. T.; De Mitri, I.; de Oliveira, J.; de Souza, V.; Debatin, J.; Deligny, O.; Diaz Castro, M. L.; Diogo, F.; Dobrigkeit, C.; D'Olivo, J. C.; Dorosti, Q.; dos Anjos, R. C.; Dova, M. T.; Dundovic, A.; Ebr, J.; Engel, R.; Erdmann, M.; Erfani, M.; Escobar, C. O.; Espadanal, J.; Etchegoyen, A.; Falcke, H.; Farmer, J.; Farrar, G.; Fauth, A. C.; Fazzini, N.; Feldbusch, F.; Fenu, F.; Fick, B.; Figueira, J. M.; Filipcic, A.; Freire, M. M.; Fujii, T.; Fuster, A.; Gaior, R.; Garcia, B.; Gate, F.; Gemmeke, H.; Gherghel-Lascu, A.; Ghia, P. L.; Giaccari, U.; Giammarchi, M.; Giller, M.; Glas, D.; Glaser, C.; Golup, G.; Gomez Berisso, M.; Gomez Vitale, P. F.; Gonzalez, N.; Gorgi, A.; Gottowik, M.; Grillo, A. F.; Grubb, T. D.; Guarino, F.; Guedes, G. P.; Halliday, R.; Hampel, M. R.; Hansen, P.; Harari, D.; Harrison, T. A.; Harvey, V. M.; Haungs, A.; Hebbeker, T.; Heck, D.; Heimann, P.; Herve, A. E.; Hill, G. C.; Hojvat, C.; Holt, E.; Homola, P.; Horandel, J. R.; Horvath, P.; Hrabovsky, M.; Huege, T.; Hulsman, J.; Insolia, A.; Isar, P. G.; Jandt, I.; Johnsen, J. A.; Josebachuili, M.; Jurysek, J.; Kaeaepae, A.; Kampert, K. H.; Keilhauer, B.; Kemmerich, N.; Kemp, J.; Kieckhafer, R. M.; Klages, H. O.; Kleifges, M.; Kleinfeller, J.; Krause, R.; Krohm, N.; Kuempel, D.; Mezek, G. Kukec; Kunka, N.; Awad, A. Kuotb; Lago, B. L.; LaHurd, D.; Lang, R. G.; Lauscher, M.; Legumina, R.; Leigui de Oliveira, M. A.; Letessier-Selvon, A.; Lhenry-Yvon, I.; Link, K.; Lo Presti, D.; Lopes, L.; Lopez, R.; Lopez Casado, A.; Lorek, R.; Luce, Q.; Lucero, A.; Malacari, M.; Mallamaci, M.; Mandat, D.; Mantsch, P.; Mariazzi, A. G.; Maris, I. C.; Marsella, G.; Martello, D.; Martinez, H.; Martinez Bravo, O.; Masias Meza, J. J.; Mathes, H. J.; Mathys, S.; Matthews, J.; Matthiae, G.; Mayotte, E.; Mazur, P. O.; Medina, C.; Medina-Tanco, G.; Melo, D.; Menshikov, A.; Merenda, K. -D.; Michal, S.; Micheletti, M. I.; Middendorf, L.; Miramonti, L.; Mitrica, B.; Mockler, D.; Mollerach, S.; Montanet, F.; Morello, C.; Morlino, G.; Mostafa, M.; Mueller, A. L.; Mueller, G.; Muller, M. A.; Mueller, S.; Mussa, R.; Naranjo, I.; Nellen, L.; Nguyen, P. H.; Niculescu-Oglinzanu, M.; Niechciol, M.; Niemietz, L.; Niggemann, T.; Nitz, D.; Nosek, D.; Novotny, V.; Nozka, L.; Nunez, L. A.; Oikonomou, F.; Olinto, A.; Palatka, M.; Pallotta, J.; Papenbreer, P.; Parente, G.; Parra, A.; Paul, T.; Pech, M.; Pedreira, F.; Pekala, J.; Pelayo, R.; Pena-Rodriguez, J.; Pereira, L. A. S.; Perlin, M.; Perrone, L.; Peters, C.; Petrera, S.; Phuntsok, J.; Pierog, T.; Pimenta, M.; Pirronello, V.; Platino, M.; Plum, M.; Poh, J.; Porowski, C.; Prado, R. R.; Privitera, P.; Prouza, M.; Quel, E. J.; Querchfeld, S.; Quinn, S.; Ramos-Pollan, R.; Rautenberg, J.; Ravignani, D.; Ridky, J.; Riehn, F.; Risse, M.; Ristori, P.; Rizi, V.; Rodrigues de Carvalho, W.; Fernandez, G. Rodriguez; Rodriguez Rojo, J.; Roncoroni, M. J.; Roth, M.; Roulet, E.; Rovero, A. C.; Ruehl, P.; Saffi, S. J.; Saftoiu, A.; Salamida, F.; Salazar, H.; Saleh, A.; Salina, G.; Sanchez, F.; Sanchez-Lucas, P.; Santos, E. M.; Santos, E.; Sarazin, F.; Sarmento, R.; Sarmiento-Cano, C.; Sato, R.; Schauer, M.; Scherini, V.; Schieler, H.; Schimp, M.; Schmidt, D.; Scholten, O.; Schovanek, P.; Schroeder, F. G.; Schroeder, S.; Schulz, A.; Schumacher, J.; Sciutto, S. J.; Segreto, A.; Shadkam, A.; Shellard, R. C.; Sigl, G.; Silli, G.; Smida, R.; Snow, G. R.; Sommers, P.; Sonntag, S.; Soriano, J. F.; Squartini, R.; Stanca, D.; Stanic, S.; Stasielak, J.; Stassi, P.; Stolpovskiy, M.; Strafella, F.; Streich, A.; Suarez, F.; Suarez Duran, M.; Sudholz, T.; Suomijarvi, T.; Supanitsky, A. D.; Supik, J.; Swain, J.; Szadkowski, Z.; Taboada, A.; Taborda, O. A.; Timmermans, C.; Todero Peixoto, C. J.; Tomankova, L.; Tome, B.; Torralba Elipe, G.; Travnicek, P.; Trini, M.; Tueros, M.; Ulrich, R.; Unger, M.; Urban, M.; Valdes Galicia, J. F.; Valino, I.; Valore, L.; van Aar, G.; van Bodegom, P.; van den Berg, A. M.; van Vliet, A.; Varela, E.; Vargas Cardenas, B.; Vazquez, R. A.; Veberic, D.; Ventura, C.; Vergara Quispe, I. D.; Verzi, V.; Vicha, J.; Villasenor, L.; Vorobiov, S.; Wahlberg, H.; Wainberg, O.; Walz, D.; Watson, A. A.; Weber, M.; Weindl, A.; Wiedenski, M.; Wiencke, L.; Wilczynski, H.; Wirtz, M.; Wittkowski, D.; Wundheiler, B.; Yang, L.; Yushkov, A.; Zas, E.; Zavrtanik, D.; Zavrtanik, M.; Zepeda, A.; Zimmermann, B.; Ziolkowski, M.; Zong, Z.; Zuccarello, F.; Abbott, B. P.; Abbott, R.; Abbott, T. D.; Acernese, F.; Ackley, K.; Adams, C.; Adams, T.; Addesso, P.; Adhikari, R. X.; Adya, V. B.; Affeldt, C.; Afrough, M.; Agarwal, B.; Agathos, M.; Agatsuma, K.; Aggarwal, N.; Aguiar, O. D.; Aiello, L.; Ain, A.; Ajith, P.; Allen, B.; Allen, G.; Allocca, A.; Altin, P. A.; Amato, A.; Ananyeva, A.; Anderson, S. B.; Anderson, W. G.; Angelova, S. V.; Antier, S.; Appert, S.; Arai, K.; Araya, M. C.; Areeda, J. S.; Arnaud, N.; Arun, K. G.; Ascenzi, S.; Ashton, G.; Ast, M.; Aston, S. M.; Astone, P.; Atallah, D. V.; Aufmuth, P.; Aulbert, C.; AultONeal, K.; Austin, C.; Avila-Alvarez, A.; Babak, S.; Bacon, P.; Bader, M. K. M.; Bae, S.; Baker, P. T.; Baldaccini, F.; Ballardin, G.; Ballmer, S. W.; Banagiri, S.; Barayoga, J. C.; Barclay, S. E.; Barish, B. C.; Barker, D.; Barkett, K.; Barone, F.; Barr, B.; Barsotti, L.; Barsuglia, M.; Barta, D.; Bartlett, J.; Bartos, I.; Bassiri, R.; Basti, A.; Batch, J. C.; Bawaj, M.; Bayley, J. C.; Bazzan, M.; Becsy, B.; Beer, C.; Bejger, M.; Belahcene, I.; Bell, A. S.; Berger, B. K.; Bergmann, G.; Bero, J. J.; Berry, C. P. L.; Bersanetti, D.; Bertolini, A.; Betzwieser, J.; Bhagwat, S.; Bhandare, R.; Bilenko, I. A.; Billingsley, G.; Billman, C. R.; Birch, J.; Birney, R.; Birnholtz, O.; Biscans, S.; Biscoveanu, S.; Bisht, A.; Bitossi, M.; Biwer, C.; Bizouard, M. A.; Blackburn, J. K.; Blackman, J.; Blair, C. D.; Blair, D. G.; Blair, R. M.; Bloemen, S.; Bock, O.; Bode, N.; Boer, M.; Bogaert, G.; Bohe, A.; Bondu, F.; Bonilla, E.; Bonnand, R.; Boom, B. A.; Bork, R.; Boschi, V.; Bose, S.; Bossie, K.; Bouffanais, Y.; Bozzi, A.; Bradaschia, C.; Brady, P. R.; Branchesi, M.; Brau, J. E.; Briant, T.; Brillet, A.; Brinkmann, M.; Brisson, V.; Brockill, P.; Broida, J. E.; Brooks, A. F.; Brown, D. A.; Brown, D. D.; Brunett, S.; Buchanan, C. C.; Buikema, A.; Bulik, T.; Bulten, H. J.; Buonanno, A.; Buskulic, D.; Buy, C.; Byer, R. L.; Cabero, M.; Cadonati, L.; Cagnoli, G.; Cahillane, C.; Bustillo, J. Calderon; Callister, T. A.; Calloni, E.; Camp, J. B.; Canepa, M.; Canizares, P.; Cannon, K. C.; Cao, H.; Cao, J.; Capano, C. D.; Capocasa, E.; Carbognani, F.; Caride, S.; Carney, M. F.; Diaz, J. Casanueva; Casentini, C.; Caudill, S.; Cavaglia, M.; Cavalier, F.; Cavalieri, R.; Cella, G.; Cepeda, C. B.; Cerda-Duran, P.; Cerretani, G.; Cesarini, E.; Chamberlin, S. J.; Chan, M.; Chao, S.; Charlton, P.; Chase, E.; Chassande-Mottin, E.; Chatterjee, D.; Cheeseboro, B. D.; Chen, H. Y.; Chen, X.; Chen, Y.; Cheng, H. -P.; Chia, H.; Chincarini, A.; Chiummo, A.; Chmiel, T.; Cho, H. S.; Cho, M.; Chow, J. H.; Christensen, N.; Chu, Q.; Chua, A. J. K.; Chua, S.; Chung, A. K. W.; Chung, S.; Ciani, G.; Ciolfi, R.; Cirelli, C. E.; Cirone, A.; Clara, F.; Clark, J. A.; Clearwater, P.; Cleva, F.; Cocchieri, C.; Coccia, E.; Cohadon, P. -F.; Cohen, D.; Colla, A.; Collette, C. G.; Cominsky, L. R.; Constancio, M., Jr.; Conti, L.; Cooper, S. J.; Corban, P.; Corbitt, T. R.; Cordero-Carrion, I.; Corley, K. R.; Cornish, N.; Corsi, A.; Cortese, S.; Costa, C. A.; Coughlin, M. W.; Coughlin, S. B.; Coulon, J. -P.; Countryman, S. T.; Couvares, P.; Covas, P. B.; Cowan, E. E.; Coward, D. M.; Cowart, M. J.; Coyne, D. C.; Coyne, R.; Creighton, J. D. E.; Creighton, T. D.; Cripe, J.; Crowder, S. G.; Cullen, T. J.; Cumming, A.; Cunningham, L.; Cuoco, E.; Dal Canton, T.; Dalya, G.; Danilishin, S. L.; D'Antonio, S.; Danzmann, K.; Dasgupta, A.; Costa, C. F. Da Silva; Dattilo, V.; Dave, I.; Davier, M.; Davis, D.; Daw, E. J.; Day, B.; De, S.; DeBra, D.; Degallaix, J.; De laurentis, M.; Deleglise, S.; Del Pozzo, W.; Demos, N.; Denker, T.; Dent, T.; De Pietri, R.; Dergachev, V.; De Rosa, R.; DeRosa, R. T.; De Rossi, C.; DeSalvo, R.; de Varona, O.; Devenson, J.; Dhurandhar, S.; Diaz, M. C.; Di Fiore, L.; Di Giovanni, M.; Di Girolamo, T.; Di Lieto, A.; Di Pace, S.; Di Palma, I.; Di Renzo, F.; Doctor, Z.; Dolique, V.; Donovan, F.; Dooley, K. L.; Doravari, S.; Dorrington, I.; Douglas, R.; Alvarez, M. Dovale; Downes, T. P.; Drago, M.; Dreissigacker, C.; Driggers, J. C.; Du, Z.; Ducrot, M.; Dupej, P.; Dwyer, S. E.; Edo, T. B.; Edwards, M. C.; Effler, A.; Eggenstein, H. -B.; Ehrens, P.; Eichholz, J.; Eikenberry, S. S.; Eisenstein, R. A.; Essick, R. C.; Estevez, D.; Etienne, Z. B.; Etzel, T.; Evans, M.; Evans, T. M.; Factourovich, M.; Fafone, V.; Fair, H.; Fairhurst, S.; Fan, X.; Farinon, S.; Farr, B.; Farr, W. M.; Fauchon-Jones, E. J.; Favata, M.; Fays, M.; Fee, C.; Fehrmann, H.; Feicht, J.; Fejer, M. M.; Fernandez-Galiana, A.; Ferrante, I.; Ferreira, E. C.; Ferrini, F.; Fidecaro, F.; Finstad, D.; Fiori, I.; Fiorucci, D.; Fishbach, M.; Fisher, R. P.; Fitz-Axen, M.; Flaminio, R.; Fletcher, M.; Fong, H.; Font, J. A.; Forsyth, P. W. F.; Forsyth, S. S.; Fournier, J. -D.; Frasca, S.; Frasconi, F.; Frei, Z.; Freise, A.; Frey, R.; Frey, V.; Fries, E. M.; Fritschel, P.; Frolov, V. V.; Fulda, P.; Fyffe, M.; Gabbard, H.; Gadre, B. U.; Gaebel, S. M.; Gair, J. R.; Gammaitoni, L.; Ganija, M. R.; Gaonkar, S. G.; Garcia-Quiros, C.; Garufi, F.; Gateley, B.; Gaudio, S.; Gaur, G.; Gayathri, V.; Gehrels, N.; Gemme, G.; Genin, E.; Gennai, A.; George, D.; George, J.; Gergely, L.; Germain, V.; Ghonge, S.; Ghosh, Abhirup; Ghosh, Archisman; Ghosh, S.; Giaime, J. A.; Giardina, K. D.; Giazotto, A.; Gill, K.; Glover, L.; Goetz, E.; Goetz, R.; Gomes, S.; Goncharov, B.; Gonzalez, G.; Castro, J. M. Gonzalez; Gopakumar, A.; Gorodetsky, M. L.; Gossan, S. E.; Gosselin, M.; Gouaty, R.; Grado, A.; Graef, C.; Granata, M.; Grant, A.; Gras, S.; Gray, C.; Greco, G.; Green, A. C.; Gretarsson, E. M.; Groot, P.; Grote, H.; Grunewald, S.; Gruning, P.; Guidi, G. M.; Guo, X.; Gupta, A.; Gupta, M. K.; Gushwa, K. E.; Gustafson, E. K.; Gustafson, R.; Halim, O.; Hall, B. R.; Hall, E. D.; Hamilton, E. Z.; Hammond, G.; Haney, M.; Hanke, M. M.; Hanks, J.; Hanna, C.; Hannam, M. D.; Hannuksela, O. A.; Hanson, J.; Hardwick, T.; Harms, J.; Harry, G. M.; Harry, I. W.; Hart, M. J.; Haster, C. -J.; Haughian, K.; Healy, J.; Heidmann, A.; Heintze, M. C.; Heitmann, H.; Hello, P.; Hemming, G.; Hendry, M.; Heng, I. S.; Hennig, J.; Heptonstall, A. W.; Heurs, M.; Hild, S.; Hinderer, T.; Hoak, D.; Hofman, D.; Holt, K.; Holz, D. E.; Hopkins, P.; Horst, C.; Hough, J.; Houston, E. A.; Howell, E. J.; Hreibi, A.; Hu, Y. M.; Huerta, E. A.; Huet, D.; Hughey, B.; Husa, S.; Huttner, S. H.; Huynh-Dinh, T.; Indik, N.; Inta, R.; Intini, G.; Isa, H. N.; Isac, J. -M.; Isi, M.; Iyer, B. R.; Izumi, K.; Jacqmin, T.; Jani, K.; Jaranowski, P.; Jawahar, S.; Jimenez-Forteza, F.; Johnson, W. W.; Jones, D. I.; Jones, R.; Jonker, R. J. G.; Ju, L.; Junker, J.; Kalaghatgi, C. V.; Kalogera, V.; Kamai, B.; Kandhasamy, S.; Kang, G.; Kanner, J. B.; Kapadia, S. J.; Karki, S.; Karvinen, K. S.; Kasprzack, M.; Katolik, M.; Katsavounidis, E.; Katzman, W.; Kaufer, S.; Kawabe, K.; Kefelian, F.; Keitel, D.; Kemball, A. J.; Kennedy, R.; Kent, C.; Key, J. S.; Khalili, F. Y.; Khan, I.; Khan, S.; Khan, Z.; Khazanov, E. A.; Kijbunchoo, N.; Kim, Chunglee; Kim, J. C.; Kim, K.; Kim, W.; Kim, W. S.; Kim, Y. -M.; Kimbrell, S. J.; King, E. J.; King, P. J.; Kinley-Hanlon, M.; Kirchhoff, R.; Kissel, J. S.; Kleybolte, L.; Klimenko, S.; Knowles, T. D.; Koch, P.; Koehlenbeck, S. M.; Koley, S.; Kondrashov, V.; Kontos, A.; Korobko, M.; Korth, W. Z.; Kowalska, I.; Kozak, D. B.; Kramer, C.; Kringel, V.; Krishnan, B.; Krolak, A.; Kuehn, G.; Kumar, P.; Kumar, R.; Kumar, S.; Kuo, L.; Kutynia, A.; Kwang, S.; Lackey, B. D.; Lai, K. H.; Landry, M.; Lang, R. N.; Lange, J.; Lantz, B.; Lanza, R. K.; Lartaux-Vollard, A.; Lasky, P. D.; Laxen, M.; Lazzarini, A.; Lazzaro, C.; Leaci, P.; Leavey, S.; Lee, C. H.; Lee, H. M.; Lee, H. W.; Lee, K.; Lehmann, J.; Lenon, A.; Leonardi, M.; Leroy, N.; Letendre, N.; Levin, Y.; Li, T. G. F.; Linker, S. D.; Littenberg, T. B.; Liu, J.; Lo, R. K. L.; Lockerbie, N. A.; London, L. T.; Lord, J. E.; Lorenzini, M.; Loriette, V.; Lormand, M.; Losurdo, G.; Lough, J. D.; Lousto, C. O.; Lovelace, G.; Lueck, H.; Lumaca, D.; Lundgren, A. P.; Lynch, R.; Ma, Y.; Macas, R.; Macfoy, S.; Machenschalk, B.; MacInnis, M.; Macleod, D. M.; Hernandez, I. Magana; Magana-Sandoval, F.; Zertuche, L. Magana; Magee, R. M.; Majorana, E.; Maksimovic, I.; Man, N.; Mandic, V.; Mangano, V.; Mansell, G. L.; Manske, M.; Mantovani, M.; Marchesoni, F.; Marion, F.; Marka, S.; Marka, Z.; Markakis, C.; Markosyan, A. S.; Markowitz, A.; Maros, E.; Marquina, A.; Martelli, F.; Martellini, L.; Martin, I. W.; Martin, R. M.; Martynov, D. V.; Mason, K.; Massera, E.; Masserot, A.; Massinger, T. J.; Masso-Reid, M.; Mastrogiovanni, S.; Matas, A.; Matichard, F.; Matone, L.; Mavalvala, N.; Mazumder, N.; McCarthy, R.; McClelland, D. E.; McCormick, S.; McCuller, L.; McGuire, S. C.; McIntyre, G.; McIver, J.; McManus, D. J.; McNeill, L.; McRae, T.; McWilliams, S. T.; Meacher, D.; Meadors, G. D.; Mehmet, M.; Meidam, J.; Mejuto-Villa, E.; Melatos, A.; Mendell, G.; Mercer, R. A.; Merilh, E. L.; Merzougui, M.; Meshkov, S.; Messenger, C.; Messick, C.; Metzdorff, R.; Meyers, P. M.; Miao, H.; Michel, C.; Middleton, H.; Mikhailov, E. E.; Milano, L.; Miller, A. L.; Miller, B. B.; Miller, J.; Millhouse, M.; Milovich-Goff, M. C.; Minazzoli, O.; Minenkov, Y.; Ming, J.; Mishra, C.; Mitra, S.; Mitrofanov, V. P.; Mitselmakher, G.; Mittleman, R.; Moffa, D.; Moggi, A.; Mogushi, K.; Mohan, M.; Mohapatra, S. R. P.; Montani, M.; Moore, C. J.; Moraru, D.; Moreno, G.; Morriss, S. R.; Mours, B.; Mow-Lowry, C. M.; Mueller, G.; Muir, A. W.; Mukherjee, Arunava; Mukherjee, D.; Mukherjee, S.; Mukund, N.; Mullavey, A.; Munch, J.; Muniz, E. A.; Muratore, M.; Murray, P. G.; Napier, K.; Nardecchia, I.; Naticchioni, L.; Nayak, R. K.; Neilson, J.; Nelemans, G.; Nelson, T. J. N.; Nery, M.; Neunzert, A.; Nevin, L.; Newport, J. M.; Newton, G.; Ng, K. K. Y.; Nguyen, T. T.; Nichols, D.; Nielsen, A. B.; Nissanke, S.; Nitz, A.; Noack, A.; Nocera, F.; Nolting, D.; North, C.; Nuttall, L. K.; Oberling, J.; O'Dea, G. D.; Ogin, G. H.; Oh, J. J.; Oh, S. H.; Ohme, F.; Okada, M. A.; Oliver, M.; Oppermann, P.; Oram, Richard J.; O'Reilly, B.; Ormiston, R.; Ortega, L. F.; O'Shaughnessy, R.; Ossokine, S.; Ottaway, D. J.; Overmier, H.; Owen, B. J.; Pace, A. E.; Page, J.; Page, M. A.; Pai, A.; Pai, S. A.; Palamos, J. R.; Palashov, O.; Palomba, C.; Pal-Singh, A.; Pan, Howard; Pan, Huang-Wei; Pang, B.; Pang, P. T. H.; Pankow, C.; Pannarale, F.; Pant, B. C.; Paoletti, F.; Paoli, A.; Papa, M. A.; Parida, A.; Parker, W.; Pascucci, D.; Pasqualetti, A.; Passaquieti, R.; Passuello, D.; Patil, M.; Patricelli, B.; Pearlstone, B. L.; Pedraza, M.; Pedurand, R.; Pekowsky, L.; Pele, A.; Penn, S.; Perez, C. J.; Perreca, A.; Perri, L. M.; Pfeiffer, H. P.; Phelps, M.; Piccinni, O. J.; Pichot, M.; Piergiovanni, F.; Pierro, V.; Pillant, G.; Pinard, L.; Pinto, I. M.; Pirello, M.; Pitkin, M.; Poe, M.; Poggiani, R.; Popolizio, P.; Porter, E. K.; Post, A.; Powell, J.; Prasad, J.; Pratt, J. W. W.; Pratten, G.; Predoi, V.; Prestegard, T.; Prijatelj, M.; Principe, M.; Privitera, S.; Prodi, G. A.; Prokhorov, L. G.; Puncken, O.; Punturo, M.; Puppo, P.; Puerrer, M.; Qi, H.; Quetschke, V.; Quintero, E. A.; Quitzow-James, R.; Raab, F. J.; Rabeling, D. S.; Radkins, H.; Raffai, P.; Raja, S.; Rajan, C.; Rajbhandari, B.; Rakhmanov, M.; Ramirez, K. E.; Ramos-Buades, A.; Rapagnani, P.; Raymond, V.; Razzano, M.; Read, J.; Regimbau, T.; Rei, L.; Reid, S.; Reitze, D. H.; Ren, W.; Reyes, S. D.; Ricci, F.; Ricker, P. M.; Rieger, S.; Riles, K.; Rizzo, M.; Robertson, N. A.; Robie, R.; Robinet, F.; Rocchi, A.; Rolland, L.; Rollins, J. G.; Roma, V. J.; Romano, R.; Romel, C. L.; Romie, J. H.; Rosinska, D.; Ross, M. P.; Rowan, S.; Ruediger, A.; Ruggi, P.; Rutins, G.; Ryan, K.; Sachdev, S.; Sadecki, T.; Sadeghian, L.; Sakellariadou, M.; Salconi, L.; Saleem, M.; Salemi, F.; Samajdar, A.; Sammut, L.; Sampson, L. M.; Sanchez, E. J.; Sanchez, L. E.; Sanchis-Gual, N.; Sandberg, V.; Sanders, J. R.; Sassolas, B.; Saulson, P. R.; Sauter, O.; Savage, R. L.; Sawadsky, A.; Schale, P.; Scheel, M.; Scheuer, J.; Schmidt, J.; Schmidt, P.; Schnabel, R.; Schofield, R. M. S.; Schoenbeck, A.; Schreiber, E.; Schuette, D.; Schulte, B. W.; Schutz, B. F.; Schwalbe, S. G.; Scott, J.; Scott, S. M.; Seidel, E.; Sellers, D.; Sengupta, A. S.; Sentenac, D.; Sequino, V.; Sergeev, A.; Shaddock, D. A.; Shaffer, T. J.; Shah, A. A.; Shahriar, M. S.; Shaner, M. B.; Shao, L.; Shapiro, B.; Shawhan, P.; Sheperd, A.; Shoemaker, D. H.; Shoemaker, D. M.; Siellez, K.; Siemens, X.; Sieniawska, M.; Sigg, D.; Silva, A. D.; Singer, L. P.; Singh, A.; Singhal, A.; Sintes, A. M.; Slagmolen, B. J. J.; Smith, B.; Smith, R. J. E.; Smith, R. J. E.; Somala, S.; Son, E. J.; Sonnenberg, J. A.; Sorazu, B.; Sorrentino, F.; Souradeep, T.; Spencer, A. P.; Srivastava, A. K.; Staats, K.; Staley, A.; Steinke, M.; Steinlechner, J.; Steinlechner, S.; Steinmeyer, D.; Stevenson, S. P.; Stone, R.; Stops, D. J.; Strain, K. A.; Stratta, G.; Strigin, S. E.; Strunk, A.; Sturani, R.; Stuver, A. L.; Summerscales, T. Z.; Sun, L.; Sunil, S.; Suresh, J.; Sutton, P. J.; Swinkels, B. L.; Szczepanczyk, M. J.; Tacca, M.; Tait, S. C.; Talbot, C.; Talukder, D.; Tanner, D. B.; Tapai, M.; Taracchini, A.; Tasson, J. D.; Taylor, J. A.; Taylor, R.; Tewari, S. V.; Theeg, T.; Thies, F.; Thomas, E. G.; Thomas, M.; Thomas, P.; Thorne, K. A.; Thrane, E.; Tiwari, S.; Tiwari, V.; Tokmakov, K. V.; Toland, K.; Tonelli, M.; Tornasi, Z.; Torres-Forne, A.; Torrie, C. I.; Toyra, D.; Travasso, F.; Traylor, G.; Trinastic, J.; Tringali, M. C.; Trozzo, L.; Tsang, K. W.; Tse, M.; Tso, R.; Tsukada, L.; Tsuna, D.; Tuyenbayev, D.; Ueno, K.; Ugolini, D.; Unnikrishnan, C. S.; Urban, A. L.; Usman, S. A.; Vahlbruch, H.; Vajente, G.; Valdes, G.; van Bakel, N.; van Beuzekom, M.; van den Brand, J. F. J.; Van Den Broeck, C.; Vander-Hyde, D. C.; van der Schaaf, L.; van Heijningen, J. V.; van Veggel, A. A.; Vardaro, M.; Varma, V.; Vass, S.; Vasuth, M.; Vecchio, A.; Vedovato, G.; Veitch, J.; Veitch, P. J.; Venkateswara, K.; Venugopalan, G.; Verkindt, D.; Vetrano, F.; Vicere, A.; Viets, A. D.; Vinciguerra, S.; Vine, D. J.; Vinet, J. -Y.; Vitale, S.; Vo, T.; Vocca, H.; Vorvick, C.; Vyatchanin, S. P.; Wade, A. R.; Wade, L. E.; Wade, M.; Walet, R.; Walker, M.; Wallace, L.; Walsh, S.; Wang, G.; Wang, H.; Wang, J. Z.; Wang, W. H.; Wang, Y. F.; Ward, R. L.; Warner, J.; Was, M.; Watchi, J.; Weaver, B.; Wei, L. -W.; Weinert, M.; Weinstein, A. J.; Weiss, R.; Wen, L.; Wessel, E. K.; Wessels, P.; Westerweck, J.; Westphal, T.; Wette, K.; Whelan, J. T.; Whiting, B. F.; Whittle, C.; Wilken, D.; Williams, D.; Williams, R. D.; Williamson, A. R.; Willis, J. L.; Willke, B.; Wimmer, M. H.; Winkler, W.; Wipf, C. C.; Wittel, H.; Woan, G.; Woehler, J.; Wofford, J.; Wong, K. W. K.; Worden, J.; Wright, J. L.; Wu, D. S.; Wysocki, D. M.; Xiao, S.; Yamamoto, H.; Yancey, C. C.; Yang, L.; Yap, M. J.; Yazback, M.; Yu, Hang; Yu, Haocun; Yvert, M.; Zadrozny, A.; Zanolin, M.; Zelenova, T.; Zendri, J. -P.; Zevin, M.; Zhang, L.; Zhang, M.; Zhang, T.; Zhang, Y. -H.; Zhao, C.; Zhou, M.; Zhou, Z.; Zhu, S. J.; Zhu, X. J.; Zucker, M. E.; Zweizig, J.

    2017-01-01

    The Advanced LIGO and Advanced Virgo observatories recently discovered gravitational waves from a binary neutron star inspiral. A short gamma-ray burst (GRB) that followed the merger of this binary was also recorded by the Fermi Gamma-ray Burst Monitor (Fermi-GBM), and the Anti-Coincidence Shield

  5. Radiation Transport Simulation for Boron Neutron Capture Therapy (BNCT)

    Energy Technology Data Exchange (ETDEWEB)

    Ziegner, M.; Blaickner, M. [AIT Austrian Institute of Technology GmbH, Health and Environment Department, Molecular Medicine, Muthgasse 11, 1190 Wien (Austria); Ziegner, M.; Khan, R.; Boeck, H. [Vienna University of Technology, Institute of Atomic and Subatomic Physics, Stadionallee 2, 1020 Wien (Austria); Bortolussi, S.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, National Institute of Nuclear Physics (INFN) Pavia Section, Pavia (Italy); Schmitz, T.; Hampel, G. [Nuclear Chemistry, University of Mainz, Fritz Strassmann Weg 2, 55099 Mainz (Germany)

    2011-07-01

    This work is part of a larger project initiated by the University of Mainz and aiming to use the university's TRIGA reactor to develop a treatment for liver metastases based on Boron Neutron Capture Therapy (BNCT). Diffuse distribution of cancerous cells within the organ makes complete resection difficult and the vicinity to radiosensitive organs impedes external irradiation. Therefore the method of 'autotransplantation', first established at the University of Pavia, is used. The liver is taken out of the body, irradiated in the thermal column of the reactor, therewith purged of metastases and then reimplanted. A highly precise dosimetry system is to be developed by means of measurements at the University of Mainz and computational calculations at the AIT. The stochastic MCNP-5 Monte Carlo-Code, developed by Los Alamos Laboratories, is applied. To verify the calculations of the flux and the absorbed dose in matter a number of measurements are performed irradiating different phantoms and liver sections in a 20cm x 20cm beam tube, which was created by removing graphite blocks from the thermal column of the reactor. The detector material consists of L- {alpha} -alanine pellets which are thought to be the most suitable because of their good tissue equivalence, small size and their wide response range. Another experiment focuses on the determination of the relative biological effectiveness (RBE-factor) of the neutron and photon dose for liver cells. Therefore cell culture plates with the cell medium enriched with {sup 157}Gd and {sup 10}B at different concentrations are irradiated. With regard to the alanine pellets MCNP-5 calculations give stable results. Nevertheless the absorbed dose is underestimated compared to the measurements, a phenomenon already observed in previous works. The cell culture calculations showed the enormous impact of the added isotopes with high thermal neutron cross sections, especially {sup 157}Gd, on the absorbed dose

  6. Optimization study for an epithermal neutron beam for boron neutron capture therapy at the University of Virginia Research Reactor

    International Nuclear Information System (INIS)

    Burns, T.D. Jr.

    1995-05-01

    The non-surgical brain cancer treatment modality, Boron Neutron Capture Therapy (BNCT), requires the use of an epithermal neutron beam. This purpose of this thesis was to design an epithermal neutron beam at the University of Virginia Research Reactor (UVAR) suitable for BNCT applications. A suitable epithermal neutron beam for BNCT must have minimal fast neutron and gamma radiation contamination, and yet retain an appreciable intensity. The low power of the UVAR core makes reaching a balance between beam quality and intensity a very challenging design endeavor. The MCNP monte carlo neutron transport code was used to develop an equivalent core radiation source, and to perform the subsequent neutron transport calculations necessary for beam model analysis and development. The code accuracy was validated by benchmarking output against experimental criticality measurements. An epithermal beam was designed for the UVAR, with performance characteristics comparable to beams at facilities with cores of higher power. The epithermal neutron intensity of this beam is 2.2 x 10 8 n/cm 2 · s. The fast neutron and gamma radiation KERMA factors are 10 x 10 -11 cGy·cm 2 /n epi and 20 x 10 -11 cGy·cm 2 /n epi , respectively, and the current-to-flux ratio is 0.85. This thesis has shown that the UVAR has the capability to provide BNCT treatments, however the performance characteristics of the final beam of this study were limited by the low core power

  7. Boron neutron capture therapy in cancer: past, present and future

    Energy Technology Data Exchange (ETDEWEB)

    Pisarev, Mario A.; Dagrosa, Maria Alejandra; Juvenal, Guilermo J. [National Atomic Energy Commission, Buenos Aires (Argentina). Div. of Nuclear Biochemistry; University of Buenos Aires (Argentina). School of Medicine. Dept. of Human Biochemistry

    2007-07-15

    Undifferentiated thyroid cancer (UTC) is a very aggressive tumor with no effective treatment, since it lacks iodine uptake and does not respond to radio or chemotherapy. The prognosis of these patients is bad, due to the rapid growth of the tumor and the early development of metastasis. Boron neutron capture therapy (BNCT) is based on the selective uptake of certain boron non-radioactive compounds by a tumor, and the subsequent irradiation of the area with an appropriate neutron beam. {sup 10}B is then activated to {sup 11}B, which will immediately decay releasing alpha particles and {sup 7}Li, of high linear energy transfer (LET) and limited reach. Clinical trials are being performed in patients with glioblastoma multiform and melanoma. We have explored its possible application to UTC. Our results demonstrated that a cell line of human UTC has a selective uptake of borophenylalanine (BPA) both in vitro and after transplantation to nude mice. Treatment of mice by BNCT led to a complete control of growth and cure of 100% of the animals. Moreover dogs with spontaneous UTC also have a selective uptake of BPA. At the present we are studying the biodistribution of BPA in patients with UTC before its application in humans. (author)

  8. Boron-containing thioureas for neutron capture therapy

    International Nuclear Information System (INIS)

    Ketz, H.

    1993-01-01

    Melanin is produced in large amounts in malignant melanotic melanomas. Because thiourea compounds are covalently incorporated into melanin during its biosynthesis, the preparation of boronated thiourea-derivatives is of particular interest for the BNCT (Boron Neutron Capture Therapy). Accumulation of boron in tumors by means of boronated thiourea-derivatives may therefore provide levels of 10 B which are useful for BNCT. In BNCT the tumor containing the boron compound is irradiated with epithermal neutrons to generate He- and Li-nuclei from the 10 B which can then destroy the tumor cells. Because of the short ranges of these particles (approximately one cell diameter) the damage will be almost exclusively confined to the tumor leaving normal tissue unharmed. High accumulation of 2-mercapto-1-methylimidazole (methimazole) in melanotic melanomas has been described in the literature. Boronated derivatives of methimazole were therefore synthesized. Boron was in the form of a boronic acid, a nido-carbonate and a mercaptoundeca hydro-closo-dodecaborate (BSH). The synthesis of the boron cluster derivatives of methimazole (nido-carborate- and BSH-derivatives) with 9 resp. 12 boron atoms in the molecule were expected to achieve higher concentrations of boron in the tumor than in the case of the boronic acid compound with its single boron atom. (orig.) [de

  9. Possible application of boron neutron capture therapy to canine osteosarcoma

    International Nuclear Information System (INIS)

    Takeuchi, Akira

    1985-01-01

    Possibility for successful treatment of canine osteosarcoma by boron neutron capture therapy (BNCT) was demonstrated based upon an uptake study of the boron compound and an experimental treatment by BNCT. In the up take study following intravenous administration of Na 2 B 12 H 11 SH, satisfactorily higher boron concentration with some variation between tumors is likely to be obtained 12 hours after the administration, together with significantly lower boron levels in blood and bone. Based upon these results, osteosarcoma of a mongrel dog was successfully treated by BNCT. The tumor received approximately 3800 rads with single neutron irradiation (approximately 1.4 x 10 13 n./cm 2 ) about 12 hours after intravenous infusion of Na 2 B 12 H 11 SH of 96 % enriched 10 B in the ratio of 50 mg 10 B/kg. Clinical and radiographical improvements were remarkable and no neoplastic cell was found in any part of the original neoplastic lesion and its surrounding tissue at the time of autopsy after 30 days. (author)

  10. Boron neutron capture therapy for children with malignant brain tumor

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Komatsu, Hisao; Kageji, Teruyoshi; Tsuji, Fumio; Matsumoto, Keizo; Kitamura, Katsuji; Hatanaka, Hiroshi; Minobe, Takashi.

    1993-01-01

    Among the 131 cases with brain tumors treated by boron-neutron capture therapy (BNCT), seventeen were children. Eight supratentorial tumors included five astrocytomas(grade 2-4), two primitive neuroectodermal tumors (PNET) and one rhabdomyosarcoma. Seven pontine tumors included one astrocytoma, one PNET and 5 unverified gliomas. Two cerebellar tumors (PNET and astrocytoma) were also treated. All pontine tumors showed remarkable decrease in size after BNCT. However, most of them showed regrowth of the tumors because the neutrons were insufficient due to the depth. Four cases with cerebral tumor died of remote cell dissemination, although they all responded to BNCT. One of them survived 7 years after repeated BNCTs. An 11 years old girl with a large astrocytoma in the right frontal lobe has lived more than 11 years and is now a draftswoman at a civil engineering company after graduating from a technical college. An 8 years old girl with an astrocytoma in the left occipital lobe has no recurrence of the tumor for 2 years and attends on elementary school without mental and physical problems. Two children (one year old girl and four years old boy) with cerebellar tumors have shown showed an excellent growth after BNCT and had no neurological deficits. Mental and physical development in patients treated by BNCT is usually better than that in patients treated by conventional radiotherapy. (author)

  11. New approaches to novel boronated porphyrins for neutron capture therapy

    International Nuclear Information System (INIS)

    Kahl, S.B.

    1986-01-01

    The use of boon compounds in the treatment of human cancer is based on the unique ability of nonradioactive 10 B nuclei to absorb thermal neutrons. The prompt nuclear reactions, which occur in neutron absorption, deliver a dose of nearly 2.8 MeV only in the vicinity of boron-containing cells, since the nuclear garments produced (alpha particles and recoil lithium atoms) travel only 10 to 15 μm. The practical, clinical use of this technique to date has been limited by the authors inability to target boron-containing compounds specifically to tumor cells in amounts sufficient for therapy and in a chemical form that has an acceptable level of toxicity. Porphyrins are one important and large class of compounds that are known to accumulate in practically all tumor systems yet examined. Such site-specific accumulation is not known to be based on any currently identifiable selective transport mechanism and yet is observed for both natural and synthetic porphyrins. Tetraphenylporphine sulfonate (TPPS) has been shown by Fairchild et al. to be an ideal model compound for assessing porphyrin uptake, and suitably boronated tetraphenyl porphine might be expected to behave similarly. This report describes the synthesis, properties, and preliminary biodistribution of such compounds

  12. A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part I: boron neutron capture therapy models.

    Science.gov (United States)

    Culbertson, C N; Wangerin, K; Ghandourah, E; Jevremovic, T

    2005-08-01

    The goal of this study was to evaluate the COG Monte Carlo radiation transport code, developed and tested by Lawrence Livermore National Laboratory, for neutron capture therapy related modeling. A boron neutron capture therapy model was analyzed comparing COG calculational results to results from the widely used MCNP4B (Monte Carlo N-Particle) transport code. The approach for computing neutron fluence rate and each dose component relevant in boron neutron capture therapy is described, and calculated values are shown in detail. The differences between the COG and MCNP predictions are qualified and quantified. The differences are generally small and suggest that the COG code can be applied for BNCT research related problems.

  13. Potential use of superconducting magnets for neutron therapy

    Energy Technology Data Exchange (ETDEWEB)

    Duthil, R; Kircher, F; Lottin, J C; Palanque, S [CEA/Saclay, 91 - Gif-sur-Yvette (France); Aucouturier, J; Fache, P [DT, CGR MeV, 78 Buc (France)

    1984-01-01

    The results of a feasibility study on the use of superconducting magnets for neutron therapy devices will be reported. Two possibilities can be foreseen: - SC magnets used in the isocentric primary beam transport line. The advantage is to increase the energy of the particles which can be transported (up to 70 MeV for protons), compared to existing systems, with a lower weight. This solution could be used very quickly. - A SC isocentric cyclotron, working at on average field of 4.7 T for accelerating deuterons up to 30 MeV. The feasibility of such a machine is fairly established but technical developments are needed, mainly in view of the rotation and of the miniaturisation of the cyclotron.

  14. Boron compounds in neutron capture therapy of tumors

    International Nuclear Information System (INIS)

    Strouf, O.; Gregor, V.

    1986-01-01

    In the selective incorporation of a sufficient amount of a compound containing boron isotope 10 B in the tumor tissue for neutron capture therapy, high efficiency is achieved in tumor destruction while sparing the surrounding tissues. In the treatment of brain tumors, 4-carboxy phenylboric acid and the disodium salt of mercaptoundecahydrododecaborate were successfully tested. The use of the compounds minimizes radiation damage to the blood stream of the brain. In case of melanomas the L-DOPA-borate complex, boronophenylalanine and chlorpromazine preparations containing 10 B are used. In the treatment of cancer of the reproductive organs, boron derivatives of estradiol and testosterone have been proven. The immunobiological procedure, i.e., the use of antibodies with bound boron compounds, is being intensively studied. (M.D.)

  15. Neutron therapy for malignant tumours of the salivary glands

    International Nuclear Information System (INIS)

    Duncan, W.; Orr, J.A.; Arnott, S.J.; Jack, W.J.L.

    1987-01-01

    A group of 28 patients with malignant tumours of the salivary glands have been treated by d(15)+Be neutron irradiation. Nineteen patients had inoperable cancers. Three had gross recurrent cancer and three had measurable residual cancer after surgery. Three patients were treated post-operatively for microscopic residual disease. Seven different histological types of tumour were included. Six out of 8 patients with adenoid cystic carcinomas have lasting local tumour control. 54% of the gross tumours were locally controlled. All three of those classified as microscopic residual disease have no evidence of local recurrence. 11/14 cancers given 16.0 Gy or more in 20 fractions in 4 weeks were controlled compared with only 1/8 given a lower dose. 12/19 cancers less than 10.0 cm maximum diameter were controlled. The radiation-related morbidity was similar to that observed after photon therapy. (Auth.)

  16. Physico-technical progress in neutron-capture therapy method

    International Nuclear Information System (INIS)

    Kanda, Keiji; Furubayashi, Toru; Aoki, Kazuhiko

    1985-01-01

    This paper describes mainly development studies on the determination method of in vivo 10 B for the purpose of employment for neutron capture therapy for malignant melanoma and other tumors. To darify the efficacy of the neutron capture therapy, it is necessary to determine 10 B concentration in the diseased part. This study aimed at in vivo 10 B concention determination in living sample to the level of ppm order with 10 % of analytical error within 1 hour, and these determination conditions were satified by prompt γ-ray (478 keV) determination of 10 B (n, αγ) 7 Li reaction. This method required no sample pretreatment. Further, data normalization by γ-ray of H(n, γ)D reaction permitted no disturbance by sample shape or size. Lower limit of detection of the proposed method was estimated in terms of measuring time and statistical error by the equations of 10 B concentration and error analysis derived by the authors. As for the effect of prompt γ-rays of 23 Na(n, γ) 24 Na and 6 Li(n, γ) 7 Li reactions, it was clarified that the former showed no disturbance but some correction was necessary in case of less than 0.1 g of smaple size owing to the latter reaction. In vivo sample determination showed the proposed method was practical. In this paper some results of phantom experiment for in vivo non-destructive 10 B measurement and related simulation calculation, and examination of effect of (γ, n) reaction in heavy water of biomedical irradiation equipment on radiation quality were also described. (Takagi, S.)

  17. Adjuvant neutron therapy in complex treatment of patients with locally advanced breast cancer

    Science.gov (United States)

    Lisin, V. A.; Velikaya, V. V.; Startseva, Zh. A.; Popova, N. O.; Goldberg, V. E.

    2017-09-01

    The study included 128 patients with stage T2-4N0-3M0 locally advanced breast cancer. All patients were divided into two groups. Group I (study group) consisted of 68 patients, who received neutron therapy, and group II (control group) comprised 60 patients, who received electron beam therapy. Neutron therapy was well tolerated by the patients and 1-2 grade radiation skin reactions were the most common. Neutron therapy was shown to be effective in multimodality treatment of the patients with locally advanced breast cancer. The 8-year recurrence-free survival rate in the patients with locally advanced breast cancer was 94.5 ± 4.1% after neutron therapy and 81.4 ± 5.9% after electron beam therapy (p = 0.05).

  18. IMPROVED COMPUTATIONAL CHARACTERIZATION OF THE THERMAL NEUTRON SOURCE FOR NEUTRON CAPTURE THERAPY RESEARCH AT THE UNIVERSITY OF MISSOURI

    Energy Technology Data Exchange (ETDEWEB)

    Stuart R. Slattery; David W. Nigg; John D. Brockman; M. Frederick Hawthorne

    2010-05-01

    Parameter studies, design calculations and initial neutronic performance measurements have been completed for a new thermal neutron beamline to be used for neutron capture therapy cell and small-animal radiobiology studies at the University of Missouri Research Reactor. The beamline features the use of single-crystal silicon and bismuth sections for neutron filtering and for reduction of incident gamma radiation. The computational models used for the final beam design and performance evaluation are based on coupled discrete-ordinates and Monte Carlo techniques that permit detailed modeling of the neutron transmission properties of the filtering crystals with very few approximations. This is essential for detailed dosimetric studies required for the anticipated research program.

  19. Design of neutron beams at the Argonne Continuous Wave Linac (ACWL) for boron neutron capture therapy and neutron radiography

    International Nuclear Information System (INIS)

    Zhou, X.L.; McMichael, G.E.

    1994-01-01

    Neutron beams are designed for capture therapy based on p-Li and p-Sc reactions using the Argonne Continuous Wave Linac (ACWL). The p-Li beam will provide a 2.5 x 10 9 n/cm 2 s epithermal flux with 7 x 10 5 γ/cm 2 s contamination. On a human brain phantom, this beam allows an advantage depth (AD) of 10 cm, an advantage depth dose rate (ADDR) of 78 cGy/min and an advantage ratio (AR) of 3.2. The p-Sc beam offers 5.9 x 10 7 n/cm 2 s and a dose performance of AD = 8 cm and AR = 3.5, suggesting the potential of near-threshold (p,n) reactions such as the p-Li reaction at E p = 1.92 MeV. A thermal radiography beam could also be obtained from ACWL

  20. High energy resolution measurement of the 238U neutron capture yield in the energy region between 1 and 100 keV

    International Nuclear Information System (INIS)

    Machlin, R.L.; Perez, R.B.; de Saussure, G.; Ingle, R.W.

    1988-01-01

    A measurement of the 238 U neutron capture yield was performed at the 150 meter flight-path of the ORELA facility on two 238 U samples (0.01224 and 0.0031 atomsbarn). The capture yeild data were normalized by Moxon's small resonance method. The energy resolution achieved in this measurement frequently resulted in doublet and triplet splittings of what appeared to be single resonance in previous measurements. This resolution should allow extension of the resolved resonance energy region in 238 U from the present 4-keV limit up to 15 or 20 keV incident neutron energy. Some 200 small resonances of the ( 238 U /plus/ n) compound nucleus have been observed which had not been detected in transmission measurement, in the energy range from 250 eV to 10 keV

  1. Search for High-energy neutrinos from binary neutron star merger GW170817 with ANTARES, iceCube, and the Pierre Auger observatory

    Czech Academy of Sciences Publication Activity Database

    Albert, A.; André, M.; Anghinolfi, M.; Blažek, Jiří; Boháčová, Martina; Chudoba, Jiří; Ebr, Jan; Juryšek, Jakub; Mandát, Dušan; Palatka, Miroslav; Pech, Miroslav; Prouza, Michael; Řídký, Jan; Martins dos Santos, Eva M.; Schovánek, Petr; Trávníček, Petr; Vícha, Jakub; Yushkov, Alexey

    2017-01-01

    Roč. 850, č. 2 (2017), s. 1-18, č. článku L35. ISSN 2041-8205 R&D Projects: GA MŠk LM2015038; GA MŠk LG15014; GA MŠk EF16_013/0001402 Grant - others:OP VVV - AUGER-CZ(XE) CZ.02.1.01/0.0/0.0/16_013/0001402 Institutional support: RVO:68378271 Keywords : gamma-ray burst * general * gravitational waves * neutrinos Subject RIV: BF - Elementary Particles and High Energy Physics OBOR OECD: Particles and field physics Impact factor: 5.522, year: 2016

  2. New compounds for neutron capture therapy (NCT) and their significance

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Bond, V.P.

    1982-01-01

    Clearly the most effective tumor therapy would be obtained by the selective targeting of cytotoxic agents to tumor cells. Although many biomolecules are known to be taken up in tumors, the targeting of cytotoxic agents to tumors is limited by the fact that other essential cell pools compete with equal or even greater effectiveness. The approach of delivering stable non-toxic isotopes to tumor, with activation by means of an external radiation beam, is advantageous for two reasons: (1) it obviates problems associated with high uptake of isotopes in normal tissues, as these cell pools can be excluded from the radiation field, and (2) the general tumor area can be included in the activating beam field; thus, the possibility exists that all microscopic tumor extensions can be irradiated. As long as range of reaction products is short, dose will be restricted to the tumor, with a resultant high therapeutic ratio. This method can be accomplished with either photon activation therapy (PAT) or Neutron Capture Therapy (NCT), the latter will be emphasized here. The range of the high LET, low OER particles from the 10 B(n,α) 7 Li reaction is approx. 10 μm, or one cell diameter; hence this reaction is optimal for cell killing. A number of biomolecules have been investigated as possible vehicles for transport of boron to tumors, including phenothiazines, thiouracils, porphyrins, nucleosides, and amino acids. Biodistributions of these compounds show selective concentration in tumor adequate for therapy. The biological halflives are in the order of days, allowing the possibility of fractionated or protracted irradiations. The radiobiological and physical implication of these parameters on NCT are discussed. The possibility of using an approximately-monoenergetic, scandium-filtered beam of about 2 keV, to reduce the dose from background radiations by about 85%, is also discussed

  3. Investigation on the neutron beam characteristics for boron neutron capture therapy with 3D and 2D transport calculations

    International Nuclear Information System (INIS)

    Kodeli, I.; Diop, C.M.; Nimal, J.C.

    1994-01-01

    In the framework of future Boron Neutron Capture Therapy (BNCT) experiments, where cells and animals irradiations are planned at the research reactor of Strasbourg University, the feasibility to obtain a suitable epithermal neutron beam is investigated. The neutron fluence and spectra calculations in the reactor are performed using the 3D Monte Carlo code TRIPOLI-3 and the 2D SN code TWODANT. The preliminary analysis of Al 2 O 3 and Al-Al 2 O 3 filters configurations are carried out in an attempt to optimize the flux characteristics in the beam tube facility. 7 figs., 7 refs

  4. Neutron dose equivalent next to the target shield of a neutron therapy facility using an LET counter

    International Nuclear Information System (INIS)

    Stinchcomb, T.G.; Kuchnir, F.T.

    1981-01-01

    The use of a spherical tissue-equivalent proportional counter for measurements of the lineal energy (y) and derivations of the linear energy transfer (LET) for fast neutrons has the advantage of giving distributions of dose and dose equivalent as functions of either LET or y. A measurement next to the target shielding of the neutron therapy facility at the University of Chicago Hospitals and Clinics (UCHC) is described, and the data processing is outlined. The distributions are presented and compared to those from measurements in the neutron beam. The average quality factors are presented

  5. A test-type hyper-thermal neutron generator for neutron capture therapy - estimation of neutron energy spectrum by simulation calculations and TOF experiments

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kobayashi, Katsuhei

    1999-01-01

    In order to clarify the irradiation characteristics of hyper-thermal neutrons and the feasibility of a hyper-thermal neutron irradiation field for neutron capture therapy, a 'test-type' hyper-thermal neutron generator was designed and made. Graphite of 6 cm thickness and 21 cm diameter was selected as the high temperature scatterer. The scatterer is heated up to 1200 deg. C maximum using molybdenum heaters. The radiation heat is shielded by reflectors of molybdenum and stainless steel. The temperature is measured using three R-type thermo-couples and controlled by a program controller. The total thickness of the generator is designed to be as thin as possible, 20 cm in maximum, in the standing point of the neutron beam intensity. The thermal stability, controllability and safety of the generator at high temperature employment were confirmed by the heating tests. As one of the experiments for the characteristics estimation, the neutron energy spectrum dependent on the scatterer temperature was measured by the TOF (time of flight) method using the LINAC neutron generator. The estimations by simulation calculations were also performed. From the experiment and calculation results, it was confirmed that the neutron temperature shifted higher as the scatterer temperature was higher. The prospect of the feasibility of the 'hyper-thermal neutron irradiation field for NCT' was opened from the estimation results of the generator characteristics by the simulation calculations and experiments

  6. Extracting the cross section angular distributions for 15C high-energy resonance excited via the (18O,16O two-neutron transfer reaction

    Directory of Open Access Journals (Sweden)

    Carbone D.

    2016-01-01

    Full Text Available The 13C(18O,16O15C reaction has been studied at 84 MeV incident energy. The ejectiles have been momentum analized by the MAGNEX spectrometer and 15C excitation energy spectra have been obtained up to about 20 MeV. In the region above the two-neutron separation energy, a bump has been observed at 13.7 MeV. The extracted cross section angular distribution for this structure, obtained by using different models for background, displays a clear oscillating pattern, typical of resonant state of the residual nucleus.

  7. Multipolarity analysis for {sup 14}C high-energy resonance populated by ({sup 18}O,{sup 16}O) two-neutron transfer reaction

    Energy Technology Data Exchange (ETDEWEB)

    Carbone, D., E-mail: carboned@lns.infn.it; Cavallaro, M.; Bondì, M.; Agodi, C.; Cunsolo, A. [INFN-Laboratori Nazionali del Sud, Catania (Italy); Cappuzzello, F. [INFN-Laboratori Nazionali del Sud, Catania (Italy); Dipartimento di Fisica e Astronomia, Università di Catania, Catania (Italy); Azaiez, F.; Franchoo, S.; Khan, E. [Institut de Physique Nucleaire, Universitè Paris-Sud, Orsay (France); Bonaccorso, A. [INFN-Sezione di Pisa, Pisa (Italy); Fortunato, L. [Dipartimento di Fisica e Astronomia, Università di Padova, Padova (Italy); INFN-Sezione di Padova, Padova (Italy); Foti, A. [Dipartimento di Fisica e Astronomia, Università di Catania, Catania (Italy); INFN-Sezione di Catania, Catania (Italy); Linares, R.; Lubian, J. [Instituto de Fisica, Universidade Federal Fluminense, Niteroi (Brazil); Scarpaci, J. A. [Centre de Sciences Nucleaires et de Sciences de Matieres, Universitè Paris-Sud, Orsay (France); Vitturi, A. [INFN-Sezione di Padova, Padova (Italy); INFN-Sezione di Catania, Catania (Italy)

    2015-10-15

    The {sup 12}C({sup 18}O,{sup 16}O){sup 14}C reaction at 84 MeV incident energy has been explored up to high excitation energy of the residual nucleus thanks to the use of the MAGNEX spectrometer to detect the ejectiles. In the region above the two-neutron separation energy, a resonance has been observed at 16.9 MeV. A multipolarity analysis of the cross section angular distribution indicates an L = 0 character for such a transition.

  8. (n,xn cross section measurements for Y-89 foils used as detectors for high energy neutron measurements in the deeply subcritical assembly “QUINTA”

    Directory of Open Access Journals (Sweden)

    Bielewicz Marcin

    2017-01-01

    Full Text Available Study of the deep subcritical systems (QUINTA using relativistic beams is performed within the project “Energy and Transmutation of Radioactive Wastes” (E&T – RAW. The experiment assembly was irradiated by deuteron/proton beam (Dubna NUCLOTRON. We calculated the neutron energy spectrum inside the whole assembly by using threshold energy (n,xn reactions in yttrium (Y-89 foils. There are almost no experimental cross section data for those reactions. New Y-89(n,xn cross section measurements were carried out at The Svedberg laboratory (TSL in Uppsala, Sweden in 2015. In this paper we present preliminary results of those experiments.

  9. Dynamics of oxygen ordering in YBa2CU3O6+x studied by neutron and high-energy synchrotron x-ray diffiaction.

    Science.gov (United States)

    Frello, T.; Andersen, N. H.; Madsen, J.; Ka¨ll, M.; von Zimmermann, M.; Schmidt, O.; Poulsen, H. F.; Schneider, J. R.; Wolf, Th.

    1997-08-01

    The dynamics of the ortho-II oxygen structure in a high purity YBa 2Cu 3O 6+ x single crystal with x=0.50 has been studied by neutron and by X-ray diffraction with a photon energy of 100 keV. Our data show that the oxygen order develops on two different time-scales, one of the order of seconds and a much slower of the order of weeks and months. The mechanism dominating the slow time-scale is related to oxygen diffusion, while the fast mechanism may result from a temperature-dependent change in the average oxygen chain length.

  10. MCNP speed advances for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Goorley, J.T.; McKinney, G.; Adams, K.; Estes, G.

    1998-04-01

    The Boron Neutron Capture Therapy (BNCT) treatment planning process of the Beth Israel Deaconess Medical Center-M.I.T team relies on MCNP to determine dose rates in the subject's head for various beam orientations. In this time consuming computational process, four or five potential beams are investigated. Of these, one or two final beams are selected and thoroughly evaluated. Recent advances greatly decreased the time needed to do these MCNP calculations. Two modifications to the new MCNP4B source code, lattice tally and tracking enhancements, reduced the wall-clock run times of a typical one million source neutrons run to one hour twenty five minutes on a 200 MHz Pentium Pro computer running Linux and using the GNU FORTRAN compiler. Previously these jobs used a special version of MCNP4AB created by Everett Redmond, which completed in two hours two minutes. In addition to this 30% speedup, the MCNP4B version was adapted for use with Parallel Virtual Machine (PVM) on personal computers running the Linux operating system. MCNP, using PVM, can be run on multiple computers simultaneously, offering a factor of speedup roughly the same as the number of computers used. With two 200 MHz Pentium Pro machines, the run time was reduced to forty five minutes, a 1.9 factor of improvement over the single Linux computer. While the time of a single run was greatly reduced, the advantages associated with PVM derive from using computational power not already used. Four possible beams, currently requiring four separate runs, could be run faster when each is individually run on a single machine under Windows NT, rather than using Linux and PVM to run one after another with each multiprocessed across four computers. It would be advantageous, however, to use PVM to distribute the final two beam orientations over four computers

  11. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?

    Science.gov (United States)

    De Stasio, Gelsomina; Rajesh, Deepika; Casalbore, Patrizia; Daniels, Matthew J; Erhardt, Robert J; Frazer, Bradley H; Wiese, Lisa M; Richter, Katherine L; Sonderegger, Brandon R; Gilbert, Benjamin; Schaub, Sebastien; Cannara, Rachel J; Crawford, John F; Gilles, Mary K; Tyliszczak, Tolek; Fowler, John F; Larocca, Luigi M; Howard, Steven P; Mercanti, Delio; Mehta, Minesh P; Pallini, Roberto

    2005-06-01

    Gadolinium neutron capture therapy (GdNCT) is a potential treatment for malignant tumors based on two steps: (1) injection of a tumor-specific (157)Gd compound; (2) tumor irradiation with thermal neutrons. The GdNC reaction can induce cell death provided that Gd is proximate to DNA. Here, we studied the nuclear uptake of Gd by glioblastoma (GBM) tumor cells after treatment with two Gd compounds commonly used for magnetic resonance imaging, to evaluate their potential as GdNCT agents. Using synchrotron X-ray spectromicroscopy, we analyzed the Gd distribution at the subcellular level in: (1) human cultured GBM cells exposed to Gd-DTPA or Gd-DOTA for 0-72 hours; (2) intracerebrally implanted C6 glioma tumors in rats injected with one or two doses of Gd-DOTA, and (3) tumor samples from GBM patients injected with Gd-DTPA. In cell cultures, Gd-DTPA and Gd-DOTA were found in 84% and 56% of the cell nuclei, respectively. In rat tumors, Gd penetrated the nuclei of 47% and 85% of the tumor cells, after single and double injection of Gd-DOTA, respectively. In contrast, in human GBM tumors 6.1% of the cell nuclei contained Gd-DTPA. Efficacy of Gd-DTPA and Gd-DOTA as GdNCT agents is predicted to be low, due to the insufficient number of tumor cell nuclei incorporating Gd. Although multiple administration schedules in vivo might induce Gd penetration into more tumor cell nuclei, a search for new Gd compounds with higher nuclear affinity is warranted before planning GdNCT in animal models or clinical trials.

  12. Microstructural evolution in modified 9Cr-1Mo ferritic/martensitic steel irradiated with mixed high-energy proton and neutron spectra at low temperatures

    International Nuclear Information System (INIS)

    Sencer, B.H.; Garner, F.A.; Gelles, D.S.; Bond, G.M.; Maloy, S.A.

    2002-01-01

    Modified 9Cr-1Mo ferritic/martensitic steel was exposed at 32-57 deg. C to a mixed proton/neutron particle flux and spectrum at the Los Alamos Neutron Science Center. The microstructure of unirradiated 9Cr-1Mo consists of laths, dislocations and carbides. Examination of electron diffraction patterns obtained from extraction replicas of unirradiated 9Cr-1Mo revealed that the precipitate microstructure was primarily dominated by M 23 C 6 carbides. The post-irradiation microstructure contained black-spot damage in addition to precipitates and dislocations. Examination of electron diffraction patterns revealed diffuse rings from M 23 C 6 carbides, indicating amorphization and/or nanocrystallinity. Crystalline MC carbides were also found. No cavity formation was found although a significant amount of helium and hydrogen generation had been generated. TEM-EDS examination of extraction replicas for carbides from unirradiated and irradiated samples did not show any detectable changes in composition of either M 23 C 6 or MC carbides. There was also no evident change in carbide size. Lattice images of M 23 C 6 carbides revealed an amorphous microstructure following irradiation, but MC carbides were still crystalline

  13. OPTIMIZATION OF THE EPITHERMAL NEUTRON BEAM FOR BORON NEUTRON CAPTURE THERAPY AT THE BROOKHAVEN MEDICAL RESEARCH REACTOR.

    Energy Technology Data Exchange (ETDEWEB)

    HU,J.P.; RORER,D.C.; RECINIELLO,R.N.; HOLDEN,N.E.

    2002-08-18

    Clinical trials of Boron Neutron Capture Therapy for patients with malignant brain tumor had been carried out for half a decade, using an epithermal neutron beam at the Brookhaven's Medical Reactor. The decision to permanently close this reactor in 2000 cut short the efforts to implement a new conceptual design to optimize this beam in preparation for use with possible new protocols. Details of the conceptual design to produce a higher intensity, more forward-directed neutron beam with less contamination from gamma rays, fast and thermal neutrons are presented here for their potential applicability to other reactor facilities. Monte Carlo calculations were used to predict the flux and absorbed dose produced by the proposed design. The results were benchmarked by the dose rate and flux measurements taken at the facility then in use.

  14. Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.; Brenner, J.F.; Wazer, D.E.; Madoc-Jones, H.; Clement, S.D.; Harling, O.K.; Yanch, J.C.

    1990-01-01

    Monte Carlo based dosimetry and computer-aided treatment planning for neutron capture therapy have been developed to provide the necessary link between physical dosimetric measurements performed on the MITR-II epithermal-neutron beams and the need of the radiation oncologist to synthesize large amounts of dosimetric data into a clinically meaningful treatment plan for each individual patient. Monte Carlo simulation has been employed to characterize the spatial dose distributions within a skull/brain model irradiated by an epithermal-neutron beam designed for neutron capture therapy applications. The geometry and elemental composition employed for the mathematical skull/brain model and the neutron and photon fluence-to-dose conversion formalism are presented. A treatment planning program, NCTPLAN, developed specifically for neutron capture therapy, is described. Examples are presented illustrating both one and two-dimensional dose distributions obtainable within the brain with an experimental epithermal-neutron beam, together with beam quality and treatment plan efficacy criteria which have been formulated for neutron capture therapy. The incorporation of three-dimensional computed tomographic image data into the treatment planning procedure is illustrated

  15. Boron neutron capture therapy for recurrent head and neck malignancies

    International Nuclear Information System (INIS)

    Kato, Itsuro; Ono, Koji; Sakurai, Yoshinori

    2006-01-01

    To avoid severe impairment of oro-facial structures and functions, it is necessary to explore new treatments for recurrent head and neck malignancies (HNM). Boron neutron capture therapy (BNCT) is tumor-cell targeted radiotherapy that has significant superiority over conventional radiotherapies in principle. So far for 4 years and 3 months, we have treated with 37 times of BNCT for 21 patients (14 squamous cell carcinomas (SCC), 4 salivary gland carcinomas and 3 sarcomas) with a recurrent and far advanced HNM since 2001. Results are (1) 10 B concentration of tumor/normal tissue ratio (T/N ratio) of FBPA-PET studies were SCC: 1.8-5.7, sarcoma: 2.5-4.0, parotid tumor: 2.5-3.7. (2) Therapeutic effects were CR: 6cases, PR: 11cases, PD: 3cases NE (not evaluated): 1case. Response rate was 81%. (3) Improvement of QOL such as a relief of severe pain, bleeding, and exudates at the local lesion, improvement of PS, disappearance of ulceration, covered with normal skin and preserved oral and maxillofacial functions and tissues. (4) Survival periods after BNCT were 1-51 months (mean: 9.8 months). 4-year survival rate was 39% by Kaplan-Meier analysis. (5) A few adverse-effects such as transient mucositis, alopecia were recognized. These results indicate that BNCT represents a new and promising treatment approach for advanced HNM. (author)

  16. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma

    International Nuclear Information System (INIS)

    Kageji, T.; Mizobuchi, Y.; Nagahiro, S.; Nakagawa, Y.; Kumada, H.

    2011-01-01

    The purpose of this study was to evaluate the clinical outcome of BSH-based intra-operative BNCT (IO-BNCT) and BSH and BPA-based non-operative BNCT (NO-BNCT). We have treated 23 glioblastoma patients with BNCT without any additional chemotherapy since 1998. The median survival time (MST) of BNCT was 19.5 months, and 2-year, 3-year and 5-year survival rates were 26.1%, 17.4% and 5.8%, respectively. This clinical result of BNCT in patients with GBM is superior to that of single treatment of conventional radiotherapy compared with historical data of conventional treatment. - Highlights: ► In this study, we evaluate the clinical outcome of boron neutron capture therapy (BNCT) for malignant brain tumors. ► We have treated 23 glioblastoma (GBM) patients with BNCT without any additional chemotherapy. ► Clinical results of BNCT in patients with GBM are superior to that of single treatment of conventional radiotherapy compared with historical data of conventional treatment.

  17. Commercial Clinical Application of Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    1999-01-01

    CRADA No. 95-CR-09 among the LITCO--now Bechtel BWXT Idaho, LLC; a private company, Neutron Therapies Limited Liability Company, NTL formerly Ionix Corporation; and Washington State University was established in 1996 to further the development of BNCT. NTL has established a laboratory for the synthesis, under US FDA approved current Good Manufacturing Practices (cGMP) guidelines, of key boron intermediates and final boron agents for BNCT. The company has focused initially on the development of the compound GB-10 (Na 2 B 10 H 10 ) as the first boron agent of interest. An Investigational New Drug (IND) application for GB-10 has been filed and approved by the FDA for a Phase I human biodistribution trial in patients with non-small cell lung cancer and glioblastoma multiforme at UW under the direction of Professor Keith Stelzer, Principal Investigator (PI). These trials are funded by NTL under a contract with the UW, Department of Radiation Oncology, and the initial phases are nearing completion. Initial results show that boron-10 concentrations on the order of 100 micrograms per gram (100 ppm) can be achieved and maintained in blood with no indication of toxicity

  18. High energy hadron scattering

    International Nuclear Information System (INIS)

    Johnson, R.C.

    1980-01-01

    High energy and small momentum transfer 2 'yields' 2 hadronic scattering processes are described in the physical framework of particle exchange. Particle production in high energy collisions is considered with emphasis on the features of inclusive reactions though with some remarks on exclusive processes. (U.K.)

  19. The high energy galaxy

    International Nuclear Information System (INIS)

    Cesarsky, C.J.

    1986-08-01

    The galaxy is host to a wide variety of high energy events. I review here recent results on large scale galactic phenomena: cosmic-ray origin and confinement, the connexion to ultra high energy gamma-ray emission from X-ray binaries, gamma ray and synchrotron emission in interstellar space, galactic soft and hard X-ray emission

  20. Very high energy colliders

    International Nuclear Information System (INIS)

    Richter, B.

    1986-03-01

    The luminosity and energy requirements are considered for both proton colliders and electron-positron colliders. Some of the basic design equations for high energy linear electron colliders are summarized, as well as design constraints. A few examples are given of parameters for very high energy machines. 4 refs., 6 figs

  1. Study of the radiation around a high energy accelerator. Production and scattering of cascade neutrons; Etude du rayonnement autour d'un accelerateur de haute energie. Production et diffusion des neutrons de cascade

    Energy Technology Data Exchange (ETDEWEB)

    Tardy-Joubert, P [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires

    1966-03-01

    The cascade induced in protective screens by a 3 GeV proton beam has been studied using activation detectors; the results have been compared with the cosmic neutron spectrum in the atmosphere. A study of the secondary neutron spectrum has made, it possible to obtain the distribution of the dose and to determine the maximum permissible fluxes expressed in terms of the energy, taking into account all the daughter products present. The dose calculated has been checked experimentally. The proportion of cascade neutrons has been studied using the idea of an imaginary source. The parameters which have to be introduced into the general equations to take into account scattering in the the air have been determined. (author) [French] La cascade induite dans les ecrans de protection par un faisceau de protons de 3 GeV a ete etudiee au moyen de detecteurs a activation et la comparaison a ete faite avec le spectre des neutrons cosmiques dans l'atmosphere. L'etude du spectre des neutrons secondaires a permis de preciser la distribution de la dose et de determiner les flux maximaux admissibles qui sont exprimes en fonction de l'energie, en tenant compte de l'ensemble des descendants presents. La dose calculee a ete verifiee experimentalement. La propagation des neutrons de cascade a ete etudiee en introduisant la notion de source fictive. Les parametres a introduire dans les equations generales pour rendre compte de la diffusion dans l'air ont ete determines. (auteur)

  2. Biological effects of high-energy radiation

    International Nuclear Information System (INIS)

    Curtis, S.B.

    1976-01-01

    The biological effects of high-energy radiation are reviewed, with emphasis on the effects of the hadronic component. Proton and helium ion effects are similar to those of the more conventional and sparsely ionizing x- and γ-radiation. Heavy-ions are known to be more biologically effective, but the long term hazard from accumulated damage has yet to be assessed. Some evidence of widely varying but dramatically increased effectiveness of very high-energy (approximately 70 GeV) hadron beams is reviewed. Finally, the importance of the neutron component in many situations around high-energy accelerators is pointed out

  3. Boron neutron capture therapy of intracerebral rat gliosarcomas

    International Nuclear Information System (INIS)

    Joel, D.D.; Fairchild, R.G.; Laissue, J.A.; Saraf, S.K.; Kalef-Ezra, J.A.; Slatkin, D.N.

    1990-01-01

    The efficacy of boron neutron capture therapy (BNCT) for the treatment of intracerebrally implanted rat gliosarcomas was tested. Preferential accumulation of 10B in tumors was achieved by continuous infusion of the sulfhydryl borane dimer, Na4(10)B24H22S2, at a rate of 45-50 micrograms of 10B per g of body weight per day from day 11 to day 14 after tumor initiation (day 0). This infusion schedule resulted in average blood 10B concentrations of 35 micrograms/ml in a group of 12 gliosarcoma-bearing rats and 45 micrograms/ml in a group of 10 similar gliosarcoma-bearing rats treated by BNCT. Estimated tumor 10B levels in these two groups were 26 and 34 micrograms/g, respectively. On day 14, boron-treated and non-boron-treated rats were exposed to 5.0 or 7.5 MW.min of radiation from the Brookhaven Medical Research Reactor that yielded thermal neutron fluences of approximately 2.0 x 10(12) or approximately 3.0 x 10(12) n/cm2, respectively, in the tumors. Untreated rats had a median postinitiation survival time of 21 days. Reactor radiation alone increased median postinitiation survival time to 26 (5.0 MW.min) or 28 (7.5 MW.min) days. The 12 rats that received 5 MW.min of BNCT had a median postinitiation survival time of 60 days. Two of these animals survived greater than 15 months. In the 7.5 MW.min group, the median survival time is not calculable since 6 of the 10 animals remain alive greater than 10 months after BNCT. The estimated radiation doses to tumors in the two BNCT groups were 14.2 and 25.6 Gy equivalents, respectively. Similar gliosarcoma-bearing rats treated with 15.0 or 22.5 Gy of 250-kilovolt peak x-rays had median survival times of only 26 or 31 days, respectively, after tumor initiation

  4. TU-F-CAMPUS-T-01: Dose and Energy Spectra From Neutron Induced Radioactivity in Medical Linear Accelerators Following High Energy Total Body Irradiation

    International Nuclear Information System (INIS)

    Keehan, S; Taylor, M; Franich, R; Smith, R; Dunn, L; Kron, T

    2015-01-01

    Purpose: To assess the risk posed by neutron induced activation of components in medical linear accelerators (linacs) following the delivery of high monitor unit 18 MV photon beams such as used in TBI. Methods: Gamma spectroscopy was used to identify radioisotopes produced in components of a Varian 21EX and an Elekta Synergy following delivery of photon beams. Dose and risk estimates for TBI were assessed using dose deliveries from an actual patient treatment. A 1 litre spherical ion chamber (PTW, Germany) has been used to measure the dose at the beam exit window and at the total body irradiation (TBI) treatment couch following large and small field beams with long beam-on times. Measurements were also made outside of the closed jaws to quantify the benefit of the attenuation provided by the jaws. Results: The radioisotopes produced in the linac head have been identified as 187 W, 56 Mn, 24 Na and 28 Al, which have half-lives from between 2.3 min to 24 hours. The dose at the beam exit window following an 18 MV 2197 MU TBI beam delivery was 12.6 µSv in ten minutes. The dose rate at the TBI treatment couch 4.8 m away is a factor of ten lower. For a typical TBI delivered in six fractions each consisting of four beams and an annual patient load of 24, the annual dose estimate for a staff member at the treatment couch for ten minutes is 750 µSv. This can be further reduced by a factor of about twelve if the jaws are closed before entering the room, resulting in a dose estimate of 65 µSv. Conclusion: The dose resulting from the activation products for a representative TBI workload at our clinic of 24 patients per year is 750 µSv, which can be further reduced to 65 µSv by closing the jaws

  5. A parameter study to determine the optimal source neutron energy in boron neutron capture therapy of brain tumours

    Energy Technology Data Exchange (ETDEWEB)

    Nievaart, V A [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Moss, R L [Joint Research Centre of the European Commission, Postbus 2, 1755ZG Petten (Netherlands); Kloosterman, J L [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Hagen, T H J J van der [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Dam, H van [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands)

    2004-09-21

    The values of the parameters used in boron neutron capture therapy (BNCT) to calculate a given dose to human tissue vary with patients due to different physical, biological and/or medical circumstances. Parameters include the tissue dimensions, the {sup 10}B concentration and the relative biological effectiveness (RBE) factors for the different dose components associated with BNCT. Because there is still no worldwide agreement on RBE values, more often than not, average values for these parameters are used. It turns out that the RBE-problem can be circumvented by taking into account all imaginable parameter values. Approaching this quest from another angle: the outcome will also provide the parameters (and values) which influence the optimal source neutron energy. For brain tumours it turns out that the {sup 10}B concentration, the RBE factors for {sup 10}B as well as fast neutrons, together with the dose limit set for healthy tissue, affect the optimal BNCT source neutron energy. By using source neutrons of a few keV together with neutrons of a few eV, it ensures that, under all imaginable circumstances, a maximum of alpha (and lithium) particles can be delivered in the tumour.

  6. ANALYSIS OF THE EFFICIENCY OF A THERAPEUTIC PROGRAM USING 10.2-MEV FAST NEUTRONS. OPTIMIZATION AND PROSPECTS OF THE DEVELOPMENT OF A PROCEDURE FOR COMBINED PHOTON-NEUTRON THERAPY. THE EXPERIENCE OF THE URAL CENTER FOR NEUTRON THERAPY

    Directory of Open Access Journals (Sweden)

    E. Yu. Kandakova

    2013-01-01

    Full Text Available The Ural Center for Neutron Therapy performs combined photon-neutron therapy for cancer patients, by applying an ELLIT-80 gamma unit and a NG-12I neutron generator. After modernization of the NG-12I generator, there was a need for redetermination of the relative biological efficiency (RBE to optimize radiotherapy for the patients. An exotest was used to experimentally estimate RBE according to the survival criteria for stem hematopoietic cells in CBA mice after modernization of the equipment generated by the NG-12I unit with respect to the gamma radiation generated by the ELLIT-80 unit. The investigation established that the RBE factor of NG-12I unit-induced radiation determined as the ratio of equally effective doses (our study used D0 was 1.53 for an acute radiation regimen. During fractional radiation, the RBE factor of neutron radiation was 3.05. That is to say, the total neutron radiation dose replacing 20 % gamma radiation (13 Gy in the used photon-neutron therapy regimen is 4.26 Gy. The experimental findings have led us to conclude that the previously described neuron therapy regimen may be optimized, by increasing the contribution of neutrons to the total course of radiotherapy in a definite category of patients with radioresistant tumors of the head and neck.

  7. Boron neutron capture therapy (BNCT) for glioblastoma multiforme using the epithermal neutron beam at the Brookhaven Medical Research Reactor

    International Nuclear Information System (INIS)

    Capala, J.; Diaz, A.Z.; Chadha, M.

    1997-01-01

    The abstract describes evaluation of boron neutron capture therapy (BNCT) for two groups of glioblastoma multiforme patients. From September 1994 to February 1996 15 patients have been treated. In September 1997 another 34 patients were examined. Authors determined a safe starting dose for BNCT using epithermal neutrons and BPA-F. They have also evaluated adverse effects of BNCT at this starting dose. Therapeutic effectiveness of this starting dose has been evaluated. No significant side effects from BPA-F infusion or BNCT treatment were observed in normal brains

  8. Boron neutron capture therapy (BNCT) for glioblastoma multiforme using the epithermal neutron beam at the Brookhaven Medical Research Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Capala, J. [Brookhaven National Lab., Upton, NY (United States); Diaz, A.Z.; Chadha, M. [Univ. Hospital, State Univ. of New York, NY (United States)] [and others

    1997-12-31

    The abstract describes evaluation of boron neutron capture therapy (BNCT) for two groups of glioblastoma multiforme patients. From September 1994 to February 1996 15 patients have been treated. In September 1997 another 34 patients were examined. Authors determined a safe starting dose for BNCT using epithermal neutrons and BPA-F. They have also evaluated adverse effects of BNCT at this starting dose. Therapeutic effectiveness of this starting dose has been evaluated. No significant side effects from BPA-F infusion or BNCT treatment were observed in normal brains.

  9. Primary study for boron neutron capture therapy uses the RSG-GAS beam tube facility

    International Nuclear Information System (INIS)

    Suroso

    2000-01-01

    The minimum epithermal neutron flux as one of the prerequisite of Boron Neutron Capture Therapy (BNCT) is 1.0 x 10 9 n/(cm 2 s) RSG-GAS have 6 beam tube facilities for neutron source, which is one of the beam tube S-2 has a possibility to utilization for BNCT facility. The totally flux neutron measurement in the front of S-2 beam tube is 1.8 x 10 7 n/(cm 2 s). The neutron flux measurement was less than for BNCT minimum prerequisite. Concerning to the flux neutron production in the reactor, which is reach to 2.5 x 10 14 n/(cm 2 s), there for the S-2 beam tube could be used beside collimator modification

  10. Neutron reflector design with Californium 252 neutron for Boron neutron chapter therapy facility using MCNP5 simulation method

    International Nuclear Information System (INIS)

    Muhammad Fakhrurreza; Kusminanto; Y Sardjono

    2014-01-01

    In this research has made a reflector design to provide beams of Neutron for BNCT with Californium-252 radioactive source. This collimator is useful to obtain optimum epithermal neutron flux with the smallest impurity radiation (thermal neutron, fast neutron, and gamma). The design process is done using Monte Carlo N-Particle simulation version 5 (MCNP5) code to calculate the neutron flux tally form. The chosen reflector design is the reflectors which use material such as BeO ceramic with 13 cm thick. Moderator use sulfur material with the slope angle of the cone is 30°. From the calculation result, it is obtained that Reflector with 1 gram Californium-252 source can produce a neutron output thermal which has thermal neutron specification 2.23189 x 10 9 n/s.cm 2 , epithermal neutron 3.51548 x 10 9 n/s.cm 2 , and fast neutron 4.82241 x 10 9 n/s.cm 2 From the result, it needs additional collimator because the BNCT requirement. (author)

  11. Long-term prognosis of maxillary sinus malignant tumor patients treated by fast neutron radiation therapy

    Energy Technology Data Exchange (ETDEWEB)

    Kishi, Hirohisa; Numata, Tsutomu; Yuza, Jun; Suzuki, Haruhiko; Konno, Akiyoshi [Chiba Univ. (Japan). School of Medicine; Miyamoto, Tadaaki

    1995-03-01

    From 1976 through 1990, 19 patients with maxillary sinus malignant tumor were treated with combination therapy consisting of maxillectomy and radiation of fast neutron. Fast neutron radiotherapy was performed at National Institute of Radiological Sciences. Eight patients had adenoid cystic carcinomas, three patients squamous cell carcinomas, one patient a carcinoma in pleomorphic adenoma, four patients fibrosarcomas, one patient osteosarcoma, one patient chondrosarcoma and one patient rhabdomyosarcoma. Fast neutron therapy after/before surgery was effective in fresh cases with T2-3N0M0 adenoid cystic carcinomas and sarcomas (except for fibrosarcoma). Nine patients were alive more than three years after treatment. And serious complications of fast neutron radiation therapy appeared in six of these nine patients. Visual impairment of opposite side occurred in four patients. Bone necrosis occured in one patient and brain dysfunction in one patient. (author).

  12. Long-term prognosis of maxillary sinus malignant tumor patients treated by fast neutron radiation therapy

    International Nuclear Information System (INIS)

    Kishi, Hirohisa; Numata, Tsutomu; Yuza, Jun; Suzuki, Haruhiko; Konno, Akiyoshi; Miyamoto, Tadaaki.

    1995-01-01

    From 1976 through 1990, 19 patients with maxillary sinus malignant tumor were treated with combination therapy consisting of maxillectomy and radiation of fast neutron. Fast neutron radiotherapy was performed at National Institute of Radiological Sciences. Eight patients had adenoid cystic carcinomas, three patients squamous cell carcinomas, one patient a carcinoma in pleomorphic adenoma, four patients fibrosarcomas, one patient osteosarcoma, one patient chondrosarcoma and one patient rhabdomyosarcoma. Fast neutron therapy after/before surgery was effective in fresh cases with T2-3N0M0 adenoid cystic carcinomas and sarcomas (except for fibrosarcoma). Nine patients were alive more than three years after treatment. And serious complications of fast neutron radiation therapy appeared in six of these nine patients. Visual impairment of opposite side occurred in four patients. Bone necrosis occured in one patient and brain dysfunction in one patient. (author)

  13. Development of fast neutron therapy worldwide. Radiobiological, clinical and technical aspects

    International Nuclear Information System (INIS)

    Wambersie, A.; Richard, F.; Breteau, N.

    1994-01-01

    Radiobiological data indicate that fast neutrons could bring a benefit in the treatment of some tumour types, and suggest mechanisms through which this benefit could be achieved. However, radiobiology also clearly indicates that there is a need for patient selection as well as for a high-physical selectivity. The main difficulty when interpreting the results of neutron therapy are the poor technical conditions in which the first treatments were applied. This explains why the value and the place of neutron therapy are not universally recognized, although more than 15000 patients have been treated so far worldwide. There are, however, clinical indications of fast neutrons bringing a benefit for the following tumour sites: salivary glands, paranasal sinuses, soft tissue sarcomas, prostatic adenocarcinomas, palliative treatment of melanoma and rectum. These tumours represent about 10-15% of all patients currently referred to the radiation therapy departments. (orig.)

  14. Neutrons in active proton therapy. Parameterization of dose and dose equivalent

    Energy Technology Data Exchange (ETDEWEB)

    Schneider, Uwe; Haelg, Roger A. [Univ. of Zurich (Switzerland). Dept. of Physics; Radiotherapy Hirslanden AG, Aarau (Switzerland); Lomax, Tony [Paul Scherrer Institute, Villigen (Switzerland). Center for Proton Therapy

    2017-08-01

    One of the essential elements of an epidemiological study to decide if proton therapy may be associated with increased or decreased subsequent malignancies compared to photon therapy is an ability to estimate all doses to non-target tissues, including neutron dose. This work therefore aims to predict for patients using proton pencil beam scanning the spatially localized neutron doses and dose equivalents. The proton pencil beam of Gantry 1 at the Paul Scherrer Institute (PSI) was Monte Carlo simulated using GEANT. Based on the simulated neutron dose and neutron spectra an analytical mechanistic dose model was developed. The pencil beam algorithm used for treatment planning at PSI has been extended using the developed model in order to calculate the neutron component of the delivered dose distribution for each treated patient. The neutron dose was estimated for two patient example cases. The analytical neutron dose model represents the three-dimensional Monte Carlo simulated dose distribution up to 85 cm from the proton pencil beam with a satisfying precision. The root mean square error between Monte Carlo simulation and model is largest for 138 MeV protons and is 19% and 20% for dose and dose equivalent, respectively. The model was successfully integrated into the PSI treatment planning system. In average the neutron dose is increased by 10% or 65% when using 160 MeV or 177 MeV instead of 138 MeV. For the neutron dose equivalent the increase is 8% and 57%. The presented neutron dose calculations allow for estimates of dose that can be used in subsequent epidemiological studies or, should the need arise, to estimate the neutron dose at any point where a subsequent secondary tumour may occur. It was found that the neutron dose to the patient is heavily increased with proton energy.

  15. Feasibility of boron neutron capture therapy for malignant spinal tumors

    International Nuclear Information System (INIS)

    Nakai, Kei; Kumada, Hiroaki; Yamamoto, Tetsuya; Tsurubuchi, Takao; Zaboronok, Alexander; Matsumura, Akira

    2009-01-01

    Treatment of malignant spinal cord tumors is currently ineffective. The characteristics of the spine are its seriality, small volume, and vulnerability: severe QOL impairment can be brought about by small neuronal damage. The present study aimed to investigate the feasibility of BNCT as a tumor-selective charged particle therapy for spinal cord tumors from the viewpoint of protecting the normal spine. A previous report suggested the tolerance dose of the spinal cord was 13.8 Gy-Eq for radiation myelopathy; a dose as high as 11 Gy-Eq demonstrated no spinal cord damage in an experimental animal model. We calculated the tumor dose and the normal spinal cord dose on a virtual model of a spinal cord tumor patient with a JAEA computational dosimetry system (JCDS) treatment planning system. The present study made use of boronophenylalanine (BPA). In these calculations, conditions were set as follows: tumor/normal (T/N) ratio of 3.5, blood boron concentration of 12 ppm, tumor boron concentration of 42 ppm, and relative biological effectiveness (RBE) values for tumor and normal spinal cord of 3.8 and 1.35, respectively. We examined how to optimize neutron irradiation by changing the beam direction and number. In our theoretical example, simple opposed two-field irradiation achieved 28.0 Gy-Eq as a minimum tumor dose and 7.3 Gy-Eq as a maximum normal spinal dose. The BNCT for the spinal cord tumor was therefore feasible when a sufficient T/N ratio could be achieved. The use of F-BPA PET imaging for spinal tumor patients is supported by this study.

  16. A large animal model for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gavin, P.R.; Kraft, S.L.; DeHaan, C.E.; Moore, M.P.; Griebenow, M.L.

    1992-01-01

    An epithermal neutron beam is needed to treat relatively deep seated tumors. The scattering characteristics of neutrons in this energy range dictate that in vivo experiments be conducted in a large animal to prevent unacceptable total body irradiation. The canine species has proven an excellent model to evaluate the various problems of boron neutron capture utilizing an epithermal neutron beam. This paper discusses three major components of the authors study: (1) the pharmacokinetics of borocaptate sodium (NA 2 B 12 H 11 SH or BSH) in dogs with spontaneously occurring brain tumors, (2) the radiation tolerance of normal tissues in the dog using an epithermal beam alone and in combination with borocaptate sodium, and (3) initial treatment of dogs with spontaneously occurring brain tumors utilizing borocaptate sodium and an epithermal neutron beam

  17. Dosimetric properties of the fast neutron therapy beams at TAMVEC

    International Nuclear Information System (INIS)

    Almond, P.R.; Smith, A.R.; Smathers, J.R.; Otte, V.A.

    1975-01-01

    In October 1972, M.D. Anderson Hospital and Tumor Institute of the University of Texas System Cancer Center initiated a clinical trial of fast neutron radiotherapy using the cyclotron at Texas A and M University. Initially, the study used neutrons produced by bombarding beryllium with 16 MeV deuterons, but since March, 1973, neutrons from 50 MeV deuterons have been used. The dosimetric properties of the 30 MeV beams have also been measured for comparison with the neutron beams from D-T generators. The three beams are compared in terms of dose rate, skin sparing, depth dose and field flatness. Isodose curves for treatment planning were generated using the decrement line method and compared to curves measured by a computer controlled isodose plotter. This system was also used to measure the isodose curves for wedge fields. Dosimetry checks on various patients were made using silicon diodes as in vivo fast neutron dosimeters

  18. Feasibility of sealed D-T neutron generator as neutron source for liver BNCT and its beam shaping assembly.

    Science.gov (United States)

    Liu, Zheng; Li, Gang; Liu, Linmao

    2014-04-01

    This paper involves the feasibility of boron neutron capture therapy (BNCT) for liver tumor with four sealed neutron generators as neutron source. Two generators are placed on each side of the liver. The high energy of these emitted neutrons should be reduced by designing a beam shaping assembly (BSA) to make them useable for BNCT. However, the neutron flux decreases as neutrons pass through different materials of BSA. Therefore, it is essential to find ways to increase the neutron flux. In this paper, the feasibility of using low enrichment uranium as a neutron multiplier is investigated to increase the number of neutrons emitted from D-T neutron generators. The neutron spectrum related to our system has a proper epithermal flux, and the fast and thermal neutron fluxes comply with the IAEA recommended values. Copyright © 2014 Elsevier Ltd. All rights reserved.

  19. High energy astrophysics

    International Nuclear Information System (INIS)

    Engel, A.R.

    1979-01-01

    High energy astrophysical research carried out at the Blackett Laboratory, Imperial College, London is reviewed. Work considered includes cosmic ray particle detection, x-ray astronomy, gamma-ray astronomy, gamma and x-ray bursts. (U.K.)

  20. High energy positron imaging

    International Nuclear Information System (INIS)

    Chen Shengzu

    2003-01-01

    The technique of High Energy Positron Imaging (HEPI) is the new development and extension of Positron Emission Tomography (PET). It consists of High Energy Collimation Imaging (HECI), Dual Head Coincidence Detection Imaging (DHCDI) and Positron Emission Tomography (PET). We describe the history of the development and the basic principle of the imaging methods of HEPI in details in this paper. Finally, the new technique of the imaging fusion, which combined the anatomical image and the functional image together are also introduced briefly

  1. Investigation of dose distribution in mixed neutron-gamma field of boron neutron capture therapy using N isopropylacrylamide gel

    Energy Technology Data Exchange (ETDEWEB)

    Bavarmegin, Elham; Sadremomtaz, Alireza [Nuclear Science and Technology Research Institute (NSTRI), Tehran (Iran, Islamic Republic of); Khalafi, Hossein; Kasesaz, Yaser [Dept. of Physics, University of Guilan, Rasht (Iran, Islamic Republic of); Khajeali, Azim [Medical Education Research Center, Tabriz (Iran, Islamic Republic of)

    2017-02-15

    Gel dosimeters have unique advantages in comparison with other dosimeters. Until now, these gels have been used in different radiotherapy techniques as a reliable dosimetric tool. Because dose distribution measurement is an important factor for appropriate treatment planning in different radiotherapy techniques, in this study, we evaluated the ability of the N-isopropylacrylamide (NIPAM) polymer gel to record the dose distribution resulting from the mixed neutron-gamma field of boron neutron capture therapy (BNCT). In this regard, a head phantom containing NIPAM gel was irradiated using the Tehran Research Reactor BNCT beam line, and then by a magnetic resonance scanner. Eventually, the R2 maps were obtained in different slices of the phantom by analyzing T2-weighted images. The results show that NIPAM gel has a suitable potential for recording three-dimensional dose distribution in mixed neutron-gamma field dosimetry.

  2. Review of clinical results of fast neutron therapy in the USA

    International Nuclear Information System (INIS)

    Peters, L.J.; Maor, M.H.; Laramore, G.E.; Griffin, T.W.; Hendrickson, F.R.

    1986-01-01

    Fast neutron radiotherapy in the United States is entering a new era in which dedicated hospital-based generators with isocentric beam capability are replacing treatment facilities based on fixed beams extracted from physics accelerators. All available clinical data, however, come from the older facilities. The majority of randomized trials conducted in the U.S. have used neutrons in a mixed schedule with photons, in which the aim was to deliver two-fifths of the total dose with neutrons; the neutron dose per fraction was set as the estimated equivalent of 2 Gy photons in terms of late normal tissue injury. Overall treatment time was held constant compared with the control photon therapy regimens (usually 6-8 weeks). Random studies of this type showed no evidence of a therapeutic gain in the treatment of advanced primary carcinomas of the head and neck, lung, uterine cervix, or pancreas. Based on a reassessment of all the available clinical and radiobiological data, and taking advantage of the greater technical flexibility offered by hospital-based facilities, the strategy of fast neutron therapy for future trials has been changed. In these trials neutrons are being used in a 12 fraction, 4 week regimen to treat gross disease, with elective therapy given wherever possible using low LET irradiation. Concomitantly, research is proceeding to define predictors of tumor response to high LET radiations in order to better select patients for fast neutron radiotherapy

  3. Boron neutron capture therapy of malignant brain tumors at the Brookhaven Medical Research Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Joel, D.D.; Coderre, J.A.; Chanana, A.D. [Brookhaven National Lab., Upton, NY (United States). Medical Dept.

    1996-12-31

    Boron neutron capture therapy (BNCT) is a bimodal form of radiation therapy for cancer. The first component of this treatment is the preferential localization of the stable isotope {sup 10}B in tumor cells by targeting with boronated compounds. The tumor and surrounding tissue is then irradiated with a neutron beam resulting in thermal neutron/{sup 10}B reactions ({sup 10}B(n,{alpha}){sup 7}Li) resulting in the production of localized high LET radiation from alpha and {sup 7}Li particles. These products of the neutron capture reaction are very damaging to cells, but of short range so that the majority of the ionizing energy released is microscopically confined to the vicinity of the boron-containing compound. In principal it should be possible with BNCT to selectively destroy small nests or even single cancer cells located within normal tissue. It follows that the major improvements in this form of radiation therapy are going to come largely from the development of boron compounds with greater tumor selectivity, although there will certainly be advances made in neutron beam quality as well as the possible development of alternative sources of neutron beams, particularly accelerator-based epithermal neutron beams.

  4. Boron neutron capture therapy of malignant brain tumors at the Brookhaven Medical Research Reactor

    International Nuclear Information System (INIS)

    Joel, D.D.; Coderre, J.A.; Chanana, A.D.

    1996-01-01

    Boron neutron capture therapy (BNCT) is a bimodal form of radiation therapy for cancer. The first component of this treatment is the preferential localization of the stable isotope 10 B in tumor cells by targeting with boronated compounds. The tumor and surrounding tissue is then irradiated with a neutron beam resulting in thermal neutron/ 10 B reactions ( 10 B(n,α) 7 Li) resulting in the production of localized high LET radiation from alpha and 7 Li particles. These products of the neutron capture reaction are very damaging to cells, but of short range so that the majority of the ionizing energy released is microscopically confined to the vicinity of the boron-containing compound. In principal it should be possible with BNCT to selectively destroy small nests or even single cancer cells located within normal tissue. It follows that the major improvements in this form of radiation therapy are going to come largely from the development of boron compounds with greater tumor selectivity, although there will certainly be advances made in neutron beam quality as well as the possible development of alternative sources of neutron beams, particularly accelerator-based epithermal neutron beams

  5. Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.; Clement, S.D.; Harling, O.K.; Brenner, J.F.; Wazer, D.E.; Madoc-Jones, H.; Yanch, J.C.

    1990-01-01

    Monte Carlo based dosimetry and computer-aided treatment planning for neutron capture therapy have been developed to provide the necessary link between physical dosimetric measurements performed on the MITR-II epithermal-neutron beams and the need of the radiation oncologist to synthesize large amounts of dosimetric data into a clinically meaningful treatment plan for each individual patient. Monte Carlo simulation has been employed to characterize the spatial dose distributions within a skull/brain model irradiated by an epithermal-neutron beam designed for neutron capture therapy applications. The geometry and elemental composition employed for the mathematical skull/brain model and the neutron and photon fluence-to-dose conversion formalism are presented. A treatment planning program, NCTPLAN, developed specifically for neutron capture therapy, is described. Examples are presented illustrating both one and two-dimensional dose distributions obtainable within the brain with an experimental epithermal-neutron beam, together with beam quality and treatment plan efficacy criteria which have been formulated for neutron capture therapy. The incorporation of three-dimensional computed tomographic image data into the treatment planning procedure is illustrated. The experimental epithermal-neutron beam has a maximum usable circular diameter of 20 cm, and with 30 ppm of B-10 in tumor and 3 ppm of B-10 in blood, it produces a beam-axis advantage depth of 7.4 cm, a beam-axis advantage ratio of 1.83, a global advantage ratio of 1.70, and an advantage depth RBE-dose rate to tumor of 20.6 RBE-cGy/min (cJ/kg-min). These characteristics make this beam well suited for clinical applications, enabling an RBE-dose of 2,000 RBE-cGy/min (cJ/kg-min) to be delivered to tumor at brain midline in six fractions with a treatment time of approximately 16 minutes per fraction

  6. SU-E-T-274: Radiation Therapy with Very High-Energy Electron (VHEE) Beams in the Presence of Metal Implants

    Energy Technology Data Exchange (ETDEWEB)

    Jensen, C; Palma, B; Qu, B; Maxim, P; Loo, B; Bazalova, M [Department of Radiation Oncology, Stanford University, Stanford, CA (United States); Hardemark, B; Hynning, E [RaySearch Laboratories, Stockholm (Sweden)

    2014-06-01

    Purpose: To evaluate the effect of metal implants on treatment plans for radiation therapy with very high-energy electron (VHEE) beams. Methods: The DOSXYZnrc/BEAMnrc Monte Carlo (MC) codes were used to simulate 50–150MeV VHEE beam dose deposition and its effects on steel and titanium (Ti) heterogeneities in a water phantom. Heterogeneities of thicknesses ranging from 0.5cm to 2cm were placed at 10cm depth. MC was also used to calculate electron and photon spectra generated by the VHEE beams' interaction with metal heterogeneities. The original VMAT patient dose calculation was planned in Eclipse. Patient dose calculations with MC-generated beamlets were planned using a Matlab GUI and research version of RayStation. VHEE MC treatment planning was performed on water-only geometry and water with segmented prostheses (steel and Ti) geometries with 100MeV and 150MeV beams. Results: 100MeV PDD 5cm behind steel/Ti heterogeneity was 51% less than in the water-only phantom. For some cases, dose enhancement lateral to the borders of the phantom increased the dose by up to 22% in steel and 18% in Ti heterogeneities. The dose immediately behind steel heterogeneity decreased by an average of 6%, although for 150MeV, the steel heterogeneity created a 23% increase in dose directly behind it. The average dose immediately behind Ti heterogeneities increased 10%. The prostate VHEE plans resulted in mean dose decrease to the bowel (20%), bladder (7%), and the urethra (5%) compared to the 15MV VMAT plan. The average dose to the body with prosthetic implants was 5% higher than to the body without implants. Conclusion: Based on MC simulations, metallic implants introduce dose perturbations to VHEE beams from lateral scatter and backscatter. However, when performing clinical planning on a prostate case, the use of multiple beams and inverse planning still produces VHEE plans that are dosimetrically superior to photon VMAT plans. BW Loo and P Maxim received research support from

  7. SU-E-T-274: Radiation Therapy with Very High-Energy Electron (VHEE) Beams in the Presence of Metal Implants

    International Nuclear Information System (INIS)

    Jensen, C; Palma, B; Qu, B; Maxim, P; Loo, B; Bazalova, M; Hardemark, B; Hynning, E

    2014-01-01

    Purpose: To evaluate the effect of metal implants on treatment plans for radiation therapy with very high-energy electron (VHEE) beams. Methods: The DOSXYZnrc/BEAMnrc Monte Carlo (MC) codes were used to simulate 50–150MeV VHEE beam dose deposition and its effects on steel and titanium (Ti) heterogeneities in a water phantom. Heterogeneities of thicknesses ranging from 0.5cm to 2cm were placed at 10cm depth. MC was also used to calculate electron and photon spectra generated by the VHEE beams' interaction with metal heterogeneities. The original VMAT patient dose calculation was planned in Eclipse. Patient dose calculations with MC-generated beamlets were planned using a Matlab GUI and research version of RayStation. VHEE MC treatment planning was performed on water-only geometry and water with segmented prostheses (steel and Ti) geometries with 100MeV and 150MeV beams. Results: 100MeV PDD 5cm behind steel/Ti heterogeneity was 51% less than in the water-only phantom. For some cases, dose enhancement lateral to the borders of the phantom increased the dose by up to 22% in steel and 18% in Ti heterogeneities. The dose immediately behind steel heterogeneity decreased by an average of 6%, although for 150MeV, the steel heterogeneity created a 23% increase in dose directly behind it. The average dose immediately behind Ti heterogeneities increased 10%. The prostate VHEE plans resulted in mean dose decrease to the bowel (20%), bladder (7%), and the urethra (5%) compared to the 15MV VMAT plan. The average dose to the body with prosthetic implants was 5% higher than to the body without implants. Conclusion: Based on MC simulations, metallic implants introduce dose perturbations to VHEE beams from lateral scatter and backscatter. However, when performing clinical planning on a prostate case, the use of multiple beams and inverse planning still produces VHEE plans that are dosimetrically superior to photon VMAT plans. BW Loo and P Maxim received research support from

  8. Power Burst Reactor Facility as an epithermal neutron source for brain cancer therapy

    International Nuclear Information System (INIS)

    Wheeler, F.J.

    1986-01-01

    The Power Burst Facility (PBF) reactor is considered for modification to provide an intense, clean source of intermediate-energy (epithermal) neutrons desirable for clinical studies of neutron capture therapy (NCT) for malignant tumors. The modifications include partial replacement of the reflector, installation of a neutron-moderating, shifting region, additional shielding, and penetration of the present concrete shield with a collimating (and optionally) filtering region. The studies have indicated that the reactor, after these modifications, will be safely operable at full power (28 MW) within the acceptable limits of the plant protection systems. The neutron beam exiting from the collimator port is predicted to be of sufficient intensity (approx.10 10 neutrons/cm 2 -s) to provide therapeutic doses in very short irradiation times. The beam would be relatively free of undesirable fast neutrons, thermal neutrons and gamma rays. The calculated neutron energy spectrum and associated gamma rays in the beam were provided as input in simulation studies that used a computer model of a patient with a brain tumor to determine predicted dose rates to the tumor and healthy tissue. The results of this conceptual study indicate an intense, clean beam of epithermal neutrons for NCT clinical trials is attainable in the PBF facility with properly engineered design modifications. 9 refs., 11 figs., 3 tabs

  9. Possible alternation of the blood-brain barrier by boron-neutron capture therapy

    International Nuclear Information System (INIS)

    Hatanaka, H.; Moritani, M.; Camillo, M.

    1991-01-01

    In the course of re-assessment of boron-neutron capture therapy (BNCT) for malignant brain tumors, fractionation of neutron irradiation has been proposed. The authors have used BNCT with a single fraction technique during the past 21 years and now decided to study some effects of fractionation. Twenty-two healthy mouse brains were irradiated with thermal neutrons after boron-10 injection (mercaptoundecahydrododecaborate). A second dose of boron-10 was administered and its uptake in the boron-neutron-capture-irradiated brains was determined. A tendency towards increased boron uptake in the moderately BNCT-treated brains was noticed, which may result in increased brain damage if fractionated neutron irradiation is used. (orig.)

  10. Assessment of doses due to secondary neutrons received by patient treated by proton therapy

    International Nuclear Information System (INIS)

    Sayah, R.; Martinetti, F.; Donadille, L.; Clairand, I.; Delacroix, S.; De Oliveira, A.; Herault, J.

    2010-01-01

    Proton therapy is a specific technique of radiotherapy which aims at destroying cancerous cells by irradiating them with a proton beam. Nuclear reactions in the device and in the patient himself induce secondary radiations involving mainly neutrons which contribute to an additional dose for the patient. The author reports a study aimed at the assessment of these doses due to secondary neutrons in the case of ophthalmological and intra-cranial treatments. He presents a Monte Carlo simulation of the room and of the apparatus, reports the experimental validation of the model (dose deposited by protons in a water phantom, ambient dose equivalent due to neutrons in the treatment room, absorbed dose due to secondary particles in an anthropomorphic phantom), and the assessment with a mathematical phantom of doses dues to secondary neutrons received by organs during an ophthalmological treatment. He finally evokes current works of calculation of doses due to secondary neutrons in the case of intra-cranial treatments

  11. SU-E-T-75: Commissioning Optically Stimulated Luminescence Dosimeters for Fast Neutron Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Young, L [UniversityWashington, Seattle, WA (United States); Yang, F; Sandison, G [University of Washington, Seattle, WA (United States); Woodworth, D [University of California, Santa Barbara, Santa Barbara, CA (United States); McCormick, Z [University of Nevada - Reno, Reno, Nevada (United States)

    2014-06-01

    Purpose: Fast neutrons therapy used at the University of Washington is clinically proven to be more effective than photon therapy in treating salivary gland and other cancers. A nanodot optically stimulated luminescence (OSL) system was chosen to be commissioned for patient in vivo dosimetry for neutron therapy. The OSL-based radiation detectors are not susceptible to radiation damage caused by neutrons compared to diodes or MOSFET systems. Methods: An In-Light microStar OSL system was commissioned for in vivo use by radiating Landauer nanodots with neutrons generated from 50.0 MeV protons accelerated onto a beryllium target. The OSLs were calibrated the depth of maximum dose in solid water localized to 150 cm SAD isocenter in a 10.3 cm square field. Linearity was tested over a typical clinical dose fractionation range i.e. 0 to 150 neutron-cGy. Correction factors for transient signal fading, trap depletion, gantry angle, field size, and wedge factor dependencies were also evaluated. The OSLs were photo-bleached between radiations using a tungsten-halogen lamp. Results: Landauer sensitivity factors published for each nanodot are valid for measuring photon and electron doses but do not apply for neutron irradiation. Individually calculated nanodot calibration factors exhibited a 2–5% improvement over calibration factors computed by the microStar InLight software. Transient fading effects had a significant impact on neutron dose reading accuracy compared to photon and electron in vivo dosimetry. Greater accuracy can be achieved by calibrating and reading each dosimeter within 1–2 hours after irradiation. No additional OSL correction factors were needed for field size, gantry angle, or wedge factors in solid water phantom measurements. Conclusion: OSL detectors are a useful for neutron beam in vivo dosimetry verification. Dosimetric accuracy comparable to conventional diode systems can be achieved. Accounting for transient fading effects during the neutron beam

  12. High energy radiation detector

    International Nuclear Information System (INIS)

    Vosburgh, K.G.

    1975-01-01

    The high energy radiation detector described comprises a set of closely spaced wedge reflectors. Each wedge reflector is composed of three sides forming identical isoceles triangles with a common apex and an open base forming an equilateral triangle. The length of one side of the base is less than the thickness of the coat of material sensitive to high energy radiation. The wedge reflectors reflect the light photons spreading to the rear of the coat in such a way that each reflected track is parallel to the incident track of the light photon spreading rearwards. The angle of the three isosceles triangles with a common apex is between 85 and 95 deg. The first main surface of the coat of high energy radiation sensitive material is in contact with the projecting edges of the surface of the wedge reflectors of the reflecting element [fr

  13. High-energy detector

    Science.gov (United States)

    Bolotnikov, Aleksey E [South Setauket, NY; Camarda, Giuseppe [Farmingville, NY; Cui, Yonggang [Upton, NY; James, Ralph B [Ridge, NY

    2011-11-22

    The preferred embodiments are directed to a high-energy detector that is electrically shielded using an anode, a cathode, and a conducting shield to substantially reduce or eliminate electrically unshielded area. The anode and the cathode are disposed at opposite ends of the detector and the conducting shield substantially surrounds at least a portion of the longitudinal surface of the detector. The conducting shield extends longitudinally to the anode end of the detector and substantially surrounds at least a portion of the detector. Signals read from one or more of the anode, cathode, and conducting shield can be used to determine the number of electrons that are liberated as a result of high-energy particles impinge on the detector. A correction technique can be implemented to correct for liberated electron that become trapped to improve the energy resolution of the high-energy detectors disclosed herein.

  14. Commissioning optically stimulated luminescence in vivo dosimeters for fast neutron therapy

    Energy Technology Data Exchange (ETDEWEB)

    Young, Lori A., E-mail: layoung@uw.edu; Sandison, George [Department of Radiation Oncology, University of Washington, Seattle, Washington 98115 (United States); Yang, Fei [Sylvester comprehensive Cancer Center, University of Miami, Miami, Florida 33124 (United States); Woodworth, Davis [Department of Physics, University of Reno, Reno, Nevada 89557 (United States); McCormick, Zephyr [Department of Physics, University of California, Santa Barbara, California 93106 (United States)

    2016-01-15

    Purpose: Clinical in vivo dosimeters intended for use with photon and electron therapies have not been utilized for fast neutron therapy because they are highly susceptible to neutron damage. The objective of this work was to determine if a commercial optically stimulated luminescence (OSL) in vivo dosimetry system could be adapted for use in fast neutron therapy. Methods: A 50.5 MeV fast neutron beam generated by a clinical neutron therapy cyclotron was used to irradiate carbon doped aluminum oxide (Al{sub 2}O{sub 3}:C) optically simulated luminescence dosimeters (OSLDs) in a solid water phantom under standard calibration conditions, 150 cm SAD, 1.7 cm depth, and 10.3 × 10.0 cm field size. OSLD fading and electron trap depletion studies were performed with the OSLDs irradiated with 20 and 50 cGy and monitored over a 24-h period to determine the optimal time for reading the dosimeters during calibration. Four OSLDs per group were calibrated over a clinical dose range of 0–150 cGy. Results: OSLD measurement uncertainties were lowered to within ±2%–3% of the expected dose by minimizing the effect of transient fading that occurs with neutron irradiation and maintaining individual calibration factors for each dosimeter. Dose dependent luminescence fading extended beyond the manufacturer’s recommended 10 min period for irradiation with photon or electron beams. To minimize OSL variances caused by inconsistent fading among dosimeters, the observed optimal time for reading the OSLDs postirradiation was between 30 and 90 min. No field size, wedge factor, or gantry angle dependencies were observed in the OSLDs irradiated by the studied fast neutron beam. Conclusions: Measurements demonstrated that uncertainties less than ±3% were attainable in OSLDs irradiated with fast neutrons under clinical conditions. Accuracy and precision comparable to clinical OSL measurements observed with photons can be achieved by maintaining individual OSLD calibration factors and

  15. Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT).

    Science.gov (United States)

    Seki, Ryoichi; Wakisaka, Yushi; Morimoto, Nami; Takashina, Masaaki; Koizumi, Masahiko; Toki, Hiroshi; Fukuda, Mitsuhiro

    2017-12-01

    The physics of epi-thermal neutrons in the human body is discussed in the effort to clarify the nature of the unique radiologic properties of boron neutron capture therapy (BNCT). This discussion leads to the computational method of Monte Carlo simulation in BNCT. The method is discussed through two examples based on model phantoms. The physics is kept at an introductory level in the discussion in this tutorial review.

  16. SU-E-T-566: Neutron Dose Cloud Map for Compact ProteusONE Proton Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Syh, J; Patel, B; Syh, J; Rosen, L; Wu, H [Willis-Knighton Medical Center, Shreveport, LA (United States)

    2015-06-15

    Purpose: To establish the base line of neutron cloud during patient treatment in our new compact Proteus One proton pencil beam scanning (PBS) system with various beam delivery gantry angles, with or without range shifter (RS) at different body sites. Pencil beam scanning is an emerging treatment technique, for the concerns of neutron exposure, this study is to evaluate the neutron dose equivalent per given delivered dose under various treatment conditions at our proton therapy center. Methods: A wide energy neutron dose equivalent detector (SWENDI-II, Thermo Scientific, MA) was used for neutron dose measurements. It was conducted in the proton therapy vault during beam was on. The measurement location was specifically marked in order to obtain the equivalent dose of neutron activities (H). The distances of 100, 150 and 200 cm at various locations are from the patient isocenter. The neutron dose was measured of proton energy layers, # of spots, maximal energy range, modulation width, field radius, gantry angle, snout position and delivered dose in CGE. The neutron dose cloud is reproducible and is useful for the future reference. Results: When distance increased the neutron equivalent dose (H) reading did not decrease rapidly with changes of proton energy range, modulation width or spot layers. For cranial cases, the average mSv/CGE was about 0.02 versus 0.032 for pelvis cases. RS will induce higher H to be 0.10 mSv/CGE in average. Conclusion: From this study, neutron per dose ratio (mSv/CGE) slightly depends upon various treatment parameters for pencil beams. For similar treatment conditions, our measurement demonstrates this value for pencil beam scanning beam has lowest than uniform scanning or passive scattering beam with a factor of 5. This factor will be monitored continuously for other upcoming treatment parameters in our facility.

  17. Theoretical high energy physics

    International Nuclear Information System (INIS)

    Lee, T.D.

    1991-01-01

    This report discusses theoretical research in high energy physics at Columbia University. Some of the research topics discussed are: quantum chromodynamics with dynamical fermions; lattice gauge theory; scattering of neutrinos by photons; atomic physics constraints on the properties of ultralight-ultraweak gauge bosons; black holes; Chern- Simons physics; S-channel theory of superconductivity; charged boson system; gluon-gluon interactions; high energy scattering in the presence of instantons; anyon physics; causality constraints on primordial magnetic manopoles; charged black holes with scalar hair; properties of Chern-Aimona-Higgs solitons; and extended inflationary universe

  18. Epithermal neutron beam adoption for lung and pancreatic cancer treatment by boron neutron capture therapy

    International Nuclear Information System (INIS)

    Matsumoto, Tetsuo; Fukushima, Yuji

    2001-01-01

    The depth-dose distributions were evaluated for possible treatment of both lung and pancreatic cancers using an epithermal neutron beam. The Monte Carlo Neutron Photon (MCNP) calculations showed that physical dose in tumors were 6 and 7 Gy/h, respectively, for lung and pancreas, attaining an epithermal neutron flux of 5 x 10 8 ncm -2 s -1 . The boron concentrations were assumed at 100 ppm and 30 ppm, respectively, for lung and pancreas tumors and normal tissues contains 1/10 tumor concentrations. The dose ratios of tumor to normal tissue were 2.5 and 2.4, respectively, for lung and pancreas. The dose evaluation suggests that BNCT using an epithermal neutron beam could be applied for both lung and pancreatic cancer treatment. (author)

  19. The neutron therapy facility at the University of Pennsylvania-Fox Chase Cancer Center

    International Nuclear Information System (INIS)

    Bloch, P.; Chu, J.; Larsen, R.

    1983-01-01

    The fusion of deuterium and tritium nuclei results in the formation of a helium-4 nucleus and a 14 MEV neutron. This reaction readily takes place when deuterium and tritium ions are accelerated to potentials between 150-200 kV. These energy ions can be obtained in a moderate size accelerator. A DT neutron facility has been installed in the radiation therapy department of the University of Pennsylvania Hospital-Fox Chase Cancer Center. The system is being commissioned in a hospital setting to test the efficacy of fast neutron radiotherapy

  20. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax

    OpenAIRE

    Wang, Peng; Zhen, Haining; Jiang, Xinbiao; Zhang, Wei; Cheng, Xin; Guo, Geng; Mao, Xinggang; Zhang, Xiang

    2010-01-01

    Abstract Background Boron neutron capture therapy (BNCT) is an alternative treatment modality for patients with glioma. The aim of this study was to determine whether induction of apoptosis contributes to the main therapeutic efficacy of BNCT and to compare the relative biological effect (RBE) of BNCT, γ-ray and reactor neutron irradiation. Methods The neutron beam was obtained from the Xi'an Pulsed Reactor (XAPR) and γ-rays were obtained from [60Co] γ source of the Fourth Military Medical Un...

  1. Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells

    Energy Technology Data Exchange (ETDEWEB)

    Faiao-Flores, F. [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)] [Faculty of Medicine, University of Sao Paulo, 455 Doutor Arnaldo Avenue, Sao Paulo (Brazil); Coelho, P.R.P. [Institute for Nuclear and Energy Research, 2242 Lineu Prestes Avenue, Sao Paulo (Brazil); Arruda-Neto, J. [Physics Institute, University of Sao Paulo, 187 Matao Street, Sao Paulo (Brazil)] [FESP, Sao Paulo Engineering School, 5520 Nove de Julho Avenue, Sao Paulo (Brazil); Maria, Durvanei A., E-mail: durvaneiaugusto@yahoo.br [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)

    2011-12-15

    The melanoma is a highly lethal skin tumor, with a high incidence. Boron Neutron Capture Therapy (BNCT) is a radiotherapy which combines Boron with thermal neutrons, constituting a binary system. B16F10 melanoma and L929 fibroblasts were treated with Boronophenylalanine and irradiated with thermal neutron flux. The electric potential of mitochondrial membrane, cyclin D1 and caspase-3 markers were analyzed. BNCT induced a cell death increase and cyclin D1 amount decreased only in B16F10 melanoma. Besides, there was not caspase-3 phosphorylation.

  2. Neutron shielding verification measurements and simulations for a 235-MeV proton therapy center

    International Nuclear Information System (INIS)

    Newhauser, W.D.; Titt, U.; Dexheimer, D.; Yan, X.; Nill, S.

    2002-01-01

    The neutron shielding at the Massachusetts General Hospital's 235-MeV proton therapy facility was investigated with measurements, analytical calculations, and realistic three-dimensional Monte Carlo simulations. In 37 of 40 cases studied, the analytical calculations predicted higher neutron dose equivalent rates outside the shielding than the measured, typically by more than a factor of 10, and in some cases more than 100. Monte Carlo predictions of dose equivalent at three locations are, on average, 1.1 times the measured values. Except at one location, all of the analytical model predictions and Monte Carlo simulations overestimate neutron dose equivalent

  3. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial

    Energy Technology Data Exchange (ETDEWEB)

    Maor, Moshe H; Errington, R Douglas; Caplan, Richard J; Griffin, Thomas W; Laramore, George E; Parker, Robert G; Burnison, Michele; Stetz, Joann; Zink, Sandra; Davis, Lawrence W; Peters, Lester J

    1995-06-15

    Purpose: To compare the efficacy of fast-neutron radiotherapy with that of conventionally fractionated photon therapy in the management of patients with locally advanced squamous cell carcinoma of the head and neck. Methods and Materials: Patients with Stage III or IV disease were randomized to receive either 20.4 Gy/12 fractions/4 weeks of neutrons or 70 Gy/35 fractions/7 weeks of photons (control). Between April 1986 and March 1991, 178 patients were entered, 169 of whom were eligible for analysis. The treatment arms were balanced for age, stage, and performance status, but not for primary site of origin. Results: Complete response occurred in 70 and 52% with neutrons and photons, respectively (p = 0.006). Local regional failure at 3 years for all patients was 63% for neutrons and 68% for photons. Actuarial overall survival curves were virtually identical in both study arms, falling to 27% at 3 years. Acute toxicity was similar in the two arms, but late grade 3-5 toxicity was 40% with neutrons compared to 18% with photons (p = 0.008). Conclusion: Although the initial response rate was higher with neutrons, permanent local control and survival were not improved, and the incidence of late normal tissue toxicity was increased. As a result, fast-neutron therapy for advanced squamous cell carcinoma of the head and neck can only be recommended for patients in whom the logistic benefit of treatment in 12 sessions over 4 weeks outweighs the increased risk of late toxicity.

  4. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial

    International Nuclear Information System (INIS)

    Maor, Moshe H.; Errington, R. Douglas; Caplan, Richard J.; Griffin, Thomas W.; Laramore, George E.; Parker, Robert G.; Burnison, Michele; Stetz, Joann; Zink, Sandra; Davis, Lawrence W.; Peters, Lester J.

    1995-01-01

    Purpose: To compare the efficacy of fast-neutron radiotherapy with that of conventionally fractionated photon therapy in the management of patients with locally advanced squamous cell carcinoma of the head and neck. Methods and Materials: Patients with Stage III or IV disease were randomized to receive either 20.4 Gy/12 fractions/4 weeks of neutrons or 70 Gy/35 fractions/7 weeks of photons (control). Between April 1986 and March 1991, 178 patients were entered, 169 of whom were eligible for analysis. The treatment arms were balanced for age, stage, and performance status, but not for primary site of origin. Results: Complete response occurred in 70 and 52% with neutrons and photons, respectively (p = 0.006). Local regional failure at 3 years for all patients was 63% for neutrons and 68% for photons. Actuarial overall survival curves were virtually identical in both study arms, falling to 27% at 3 years. Acute toxicity was similar in the two arms, but late grade 3-5 toxicity was 40% with neutrons compared to 18% with photons (p = 0.008). Conclusion: Although the initial response rate was higher with neutrons, permanent local control and survival were not improved, and the incidence of late normal tissue toxicity was increased. As a result, fast-neutron therapy for advanced squamous cell carcinoma of the head and neck can only be recommended for patients in whom the logistic benefit of treatment in 12 sessions over 4 weeks outweighs the increased risk of late toxicity

  5. Feasibility of the utilization of BNCT in the fast neutron therapy beam at Fermilab

    International Nuclear Information System (INIS)

    Langen, Katja; Lennox, Arlene J.; Kroc, Thomas K.; DeLuca, Paul M. Jr.

    2000-01-01

    The Neutron Therapy Facility at Fermilab has treated cancer patients since 1976. Since then more than 2,300 patients have been treated and a wealth of clinical information accumulated. The therapeutic neutron beam at Fermilab is produced by bombarding a beryllium target with 66 MeV protons. The resulting continuous neutron spectrum ranges from thermal to 66 MeV in neutron energy. It is clear that this spectrum is not well suited for the treatment of tumors with boron neutron capture therapy (BNCT) only However, since this spectrum contains thermal and epithermal components the authors are investigating whether BNCT can be used in this beam to boost the tumor dose. There are clinical scenarios in which a selective tumor dose boost of 10 - 15% could be clinically significant. For these cases the principal treatment would still be fast neutron therapy but a tumor boost could be used either to deliver a higher dose to the tumor tissue or to reduce the dose to the normal healthy tissue while maintaining the absorbed dose level in the tumor tissue

  6. High energy magnetic excitations

    International Nuclear Information System (INIS)

    Endoh, Yasuo

    1988-01-01

    The report emphasizes that the current development in condensed matter physics opens a research field fit to inelastic neutron scattering experiments in the eV range which is easilly accessed by spallation neutron sources. Several important subjects adopted at thermal reactors are shown. It is desired to extend the implementation of the spectroscopic experiments for investigation of higher energy magnetic excitations. For La 2 CuO 4 , which is the mother crystal of the first high Tc materials found by Bednortz and Muller, it seems to be believed that the magnetism is well characterized by the two-dimensional Heisenberg antiferromagnetic Hamiltonian, and it is widely accepted that the magnetism is a most probable progenitor of high Tc superconductors. The unusual properties of spin correlations in this crystal have been studied extensively by standard neutron scattering techniques with steady neutrons at BNL. FeSi is not ordered magnetically but shows a very unique feature of temperature induced magnetism, which also has been studied extensively by using the thermal neutron scattering technique at BNL. In these experiments, polarized neutrons are indispensable to extract the clean magnetic components out of other components of non-magnetic scattering. (N.K.)

  7. Antitumor potential induction and free radicals production in melanoma cells by Boron Neutron Capture Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Faiao-Flores, F. [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)] [Faculty of Medicine, University of Sao Paulo, 455 Doutor Arnaldo Avenue, Sao Paulo (Brazil); Coelho, P.R.P.; Muniz, R.O.R.; Souza, G.S. [Institute for Nuclear and Energy Research, 2242 Lineu Prestes Avenue, Sao Paulo (Brazil); Arruda-Neto, J. [Physics Institute, University of Sao Paulo, 187 Matao Street, Sao Paulo (Brazil)] [FESP, Sao Paulo Engineering School, 5520 Nove de Julho Avenue, Sao Paulo (Brazil); Maria, Durvanei A., E-mail: durvaneiaugusto@yahoo.com.br [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)

    2011-12-15

    Antiproliferative and oxidative damage effects occurring in Boron Neutron Capture Therapy (BNCT) in normal fibroblasts and melanoma cell lines were analyzed. Melanoma cells and normal fibroblasts were treated with different concentrations of Boronophenylalanine and irradiated with thermal neutron flux. The cellular viability and the oxidative stress were determined. BNCT induced free radicals production and proliferative potential inhibition in melanoma cells. Therefore, this therapeutic technique could be considered efficient to inhibit growth of melanoma with minimal effects on normal tissues. - Highlights: Black-Right-Pointing-Pointer Boron Neutron Capture Therapy (BNCT) induces melanoma cell death. Black-Right-Pointing-Pointer BNCT stimulates free radicals production and proliferative inhibition in melanoma cells. Black-Right-Pointing-Pointer It produces tumor membrane degeneration and destruction with apoptotic bodies formation. Black-Right-Pointing-Pointer This therapy damages tumor cells selectively, with minimum effects on normal adjacent tissue.

  8. Structural refinement and extraction of hydrogen atomic positions in polyoxymethylene crystal based on the first successful measurements of 2-dimensional high-energy synchrotron X-ray diffraction and wide-angle neutron diffraction patterns of hydrogenated and deuterated species

    International Nuclear Information System (INIS)

    Tashiro, Kohji; Hanesaka, Makoto; Ohhara, Takashi; Kurihara, Kazuo; Tamada, Taro; Kuroki, Ryota; Fujiwara, Satoru; Ozeki, Tomoji; Kitano, Toshiaki; Nishu, Takashi; Tanaka, Ichiro; Niimura, Nobuo

    2007-01-01

    2-Dimensional X-ray and neutron diffraction patterns have been successfully measured for deuterated and hydrogenated polyoxymethylene (POM) samples obtained by γ-ray induced solid-state polymerization reaction. More than 700 reflections were collected from the X-ray diffraction data at -150degC by utilizing a high-energy synchrotron X-ray beam at SPring-8, Japan, from which the crystal structure of POM has been refined thoroughly including the extraction of hydrogen atomic positions at clearly seen in the difference Fourier synthesis map. As the first trial the nonuniform (9/5) helical model was analyzed with the reliability factor (R factor) 6.9%. The structural analysis was made also using the X-ray reflections of about 400 observed at room temperature (R 8.8%), and the thermal parameters of constituent atoms were compared between the low and high temperatures to discuss the librational thermal motion of the chains. The 2-dimensional neutron diffraction data, collected for the deuterated and hydrogenated POM samples using an imaging plate system specifically built-up for neutron scattering experiment, have allowed us to pick up the D and H atomic positions clearly in the Fourier synthesis maps. Another possible model, (29/16) helix, which was proposed by several researches, has been also investigated on the basis of the X-ray diffraction data at -150degC. The direct method succeeded in extracting this (29/16) model straightforwardly. The R factor was 8.6%, essentially the same as that of (9/5) helical model. This means that the comparison of the diffraction intensity between the data collected from the full-rotation X-ray diffraction pattern and the intensity calculated for both the (9/5) and (29/16) models cannot be used for the unique determination of the superiority of the model, (9/5) or (29/16) helix. However, we have found the existence of 001 and 002 reflections which give the longer repeating period 55.7 A. Besides there observed a series of meridional

  9. Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA.

    Directory of Open Access Journals (Sweden)

    Chaeyeong Lee

    Full Text Available Proton therapy is a rapidly progressing field for cancer treatment. Globally, many proton therapy facilities are being commissioned or under construction. Secondary neutrons are an important issue during the commissioning process of a proton therapy facility. The purpose of this study is to model and validate scanning nozzles of proton therapy at Samsung Medical Center (SMC by Monte Carlo simulation for beam commissioning. After the commissioning, a secondary neutron ambient dose from proton scanning nozzle (Gantry 1 was simulated and measured. This simulation was performed to evaluate beam properties such as percent depth dose curve, Bragg peak, and distal fall-off, so that they could be verified with measured data. Using the validated beam nozzle, the secondary neutron ambient dose was simulated and then compared with the measured ambient dose from Gantry 1. We calculated secondary neutron dose at several different points. We demonstrated the validity modeling a proton scanning nozzle system to evaluate various parameters using FLUKA. The measured secondary neutron ambient dose showed a similar tendency with the simulation result. This work will increase the knowledge necessary for the development of radiation safety technology in medical particle accelerators.

  10. Theoretical high energy physics

    International Nuclear Information System (INIS)

    Lee, T.D.

    1992-01-01

    This progress report discusses research by Columbia University staff in high energy physics. Some of the topics discussed are as follows: lattice gauge theory; quantum chromodynamics; parity doublets; solitons; baryon number violation; black holes; magnetic monopoles; gluon plasma; Chern-Simons theory; and the inflationary universe

  11. High energy astrophysics

    International Nuclear Information System (INIS)

    Shklorsky, I.S.

    1979-01-01

    A selected list of articles of accessible recent review articles and conference reports, wherein up-to-date summaries of various topics in the field of high energy astrophysics can be found, is presented. A special report outlines work done in the Soviet Union in this area. (Auth.)

  12. High energy battery. Hochenergiebatterie

    Energy Technology Data Exchange (ETDEWEB)

    Boehm, H.; Beyermann, G.; Bulling, M.

    1992-03-26

    In a high energy battery with a large number of individual cells in a housing with a cooling medium flowing through it, it is proposed that the cooling medium should be guided so that it only affects one or both sides of the cells thermally.

  13. High energy beam cooling

    International Nuclear Information System (INIS)

    Berger, H.; Herr, H.; Linnecar, T.; Millich, A.; Milss, F.; Rubbia, C.; Taylor, C.S.; Meer, S. van der; Zotter, B.

    1980-01-01

    The group concerned itself with the analysis of cooling systems whose purpose is to maintain the quality of the high energy beams in the SPS in spite of gas scattering, RF noise, magnet ripple and beam-beam interactions. Three types of systems were discussed. The status of these activities is discussed below. (orig.)

  14. High energy colliders

    International Nuclear Information System (INIS)

    Palmer, R.B.; Gallardo, J.C.

    1997-02-01

    The authors consider the high energy physics advantages, disadvantages and luminosity requirements of hadron (pp, p anti p), lepton (e + e - , μ + μ - ) and photon-photon colliders. Technical problems in obtaining increased energy in each type of machine are presented. The machines relative size are also discussed

  15. High Energy Physics

    Science.gov (United States)

    Untitled Document [Argonne Logo] [DOE Logo] High Energy Physics Home Division ES&H Personnel Collider Physics Cosmic Frontier Cosmic Frontier Theory & Computing Detector R&D Electronic Design Mechanical Design Neutrino Physics Theoretical Physics Seminars HEP Division Seminar HEP Lunch Seminar HEP

  16. An accelerator-based epithermal photoneutron source for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Mitchell, Hannah E. [Georgia Inst. of Technology, Atlanta, GA (United States)

    1996-04-01

    Boron neutron capture therapy is an experimental binary cancer radiotherapy modality in which a boronated pharmaceutical that preferentially accumulates in malignant tissue is first administered, followed by exposing the tissue in the treatment volume to a thermal neutron field. Current usable beams are reactor-based but a viable alternative is the production of an epithermal neutron beam from an accelerator. Current literature cites various proposed accelerator-based designs, most of which are based on proton beams with beryllium or lithium targets. This dissertation examines the efficacy of a novel approach to BNCT treatments that incorporates an electron linear accelerator in the production of a photoneutron source. This source may help to resolve some of the present concerns associated with accelerator sources, including that of target cooling. The photoneutron production process is discussed as a possible alternate source of neutrons for eventual BNCT treatments for cancer. A conceptual design to produce epithermal photoneutrons by high photons (due to bremsstrahlung) impinging on deuterium targets is presented along with computational and experimental neutron production data. A clinically acceptable filtered epithermal neutron flux on the order of 107 neutrons per second per milliampere of electron current is shown to be obtainable. Additionally, the neutron beam is modified and characterized for BNCT applications by employing two unique moderating materials (an Al/AlF3 composite and a stacked Al/Teflon design) at various incident electron energies.

  17. An accelerator-based epithermal photoneutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Mitchell, H.E.

    1996-04-01

    Boron neutron capture therapy is an experimental binary cancer radiotherapy modality in which a boronated pharmaceutical that preferentially accumulates in malignant tissue is first administered, followed by exposing the tissue in the treatment volume to a thermal neutron field. Current usable beams are reactor-based but a viable alternative is the production of an epithermal neutron beam from an accelerator. Current literature cites various proposed accelerator-based designs, most of which are based on proton beams with beryllium or lithium targets. This dissertation examines the efficacy of a novel approach to BNCT treatments that incorporates an electron linear accelerator in the production of a photoneutron source. This source may help to resolve some of the present concerns associated with accelerator sources, including that of target cooling. The photoneutron production process is discussed as a possible alternate source of neutrons for eventual BNCT treatments for cancer. A conceptual design to produce epithermal photoneutrons by high photons (due to bremsstrahlung) impinging on deuterium targets is presented along with computational and experimental neutron production data. A clinically acceptable filtered epithermal neutron flux on the order of 10 7 neutrons per second per milliampere of electron current is shown to be obtainable. Additionally, the neutron beam is modified and characterized for BNCT applications by employing two unique moderating materials (an Al/AlF 3 composite and a stacked Al/Teflon design) at various incident electron energies

  18. Nominal effective radiation doses delivered during clinical trials of boron neutron capture therapy

    International Nuclear Information System (INIS)

    Capala, J.; Diaz, A.Z.; Chanana, A.D.

    1997-01-01

    Boron neutron capture therapy (BNCT) is a binary system that, in theory, should selectively deliver lethal, high linear energy transfer (LET) radiation to tumor cells dispersed within normal tissues. It is based on the nuclear reaction 10-B(n, α)7-Li, which occurs when the stable nucleus of boron-10 captures a thermal neutron. Due to the relatively high cross-section of the 10-B nucleus for thermal neutron capture and short ranges of the products of this reaction, tumor cells in the volume exposed to thermal neutrons and containing sufficiently high concentration of 10-B would receive a much higher radiation dose than the normal cells contained within the exposed volume. Nevertheless, radiation dose deposited in normal tissue by gamma and fast neutron contamination of the neutron beam, as well as neutron capture in nitrogen, 14-N(n,p)14-C, hydrogen, 1-H(n,γ)2-H, and in boron present in blood and normal cells, limits the dose that can be delivered to tumor cells. It is, therefore, imperative for the success of the BNCT the dosed delivered to normal tissues be accurately determined in order to optimize the irradiation geometry and to limit the volume of normal tissue exposed to thermal neutrons. These are the major objectives of BNCT treatment planning

  19. Production of fast neutron beams for therapy: The application of and need for nuclear data

    International Nuclear Information System (INIS)

    Chaudhri, M.A.

    1987-01-01

    A brief review of the historical development of the production of therapy neutron beams is presented, with special reference to the author's contribution, using the available nuclear data. Different nuclear reactions and target systems have been critically examined regarding their suitability for cyclotrons of different sizes. A few current problems in this field, especially relating to the nonavailability of appropriate nuclear data, where the nuclear physics and nuclear data communities can greatly contribute, are highlighted. Specific recommendations are made as to what sort of nuclear data need to be acquired/compiled that would be most useful in the neutron therapy programme. (author). 28 refs

  20. Reactor-moderated intermediate-energy neutron beams for neutron-capture therapy

    International Nuclear Information System (INIS)

    Less, T.J.

    1987-01-01

    One approach to producing an intermediate energy beam is moderating fission neutrons escaping from a reactor core. The objective of this research is to evaluate materials that might produce an intermediate beam for NCT via moderation of fission neutrons. A second objective is to use the more promising moderator material in a preliminary design of an NCT facility at a research reactor. The evaluations showed that several materials or combinations of materials could produce a moderator source for an intermediate beam for NCT. The best neutron spectrum for use in NCT is produced by Al 2 O 3 , but mixtures of Al metal and D 2 O are also attractive. Using the best moderator materials, results were applied to the design of an NCT moderator at the Georgia Institute of Technology Research Reactor's bio-medical facility. The amount of photon shielding and thermal neutron absorber were optimized with respect to the desired photon dose rate and intermediate neutron flux at the patient position

  1. [A clinical trial of neutron capture therapy for brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.

    1989-01-01

    This report describes accomplishments by this laboratory concerning development of high-resolution alpha-autoradiography design of an optimized epithermal neutron beam dosimetry and treatment planning Using Monte Carlo techniques development of a prompt-gamma 10 B analysis facility

  2. [A clinical trial of neutron capture therapy for brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.

    1990-01-01

    This document briefly describes recent advances in the author's laboratory. Topics described include neutron beam design, high- resolution autoradiography, boronated phenylalanine (BPA) distribution and survival studies in glioma bearing mice, computer- aided treatment planning, prompt gamma boron 10 analysis facility at MITI-II, non-rodent BPA toxicity studies, and preparations for clinical studies

  3. High energy nuclear physics

    International Nuclear Information System (INIS)

    Meyer, J.

    1988-01-01

    The 1988 progress report of the High Energy Nuclear Physics laboratory (Polytechnic School, France), is presented. The Laboratory research program is focused on the fundamental physics of interactions, on the new techniques for the acceleration of charged particles and on the nuclei double beta decay. The experiments are performed on the following topics: the measurement of the π 0 inclusive production and the photons production in very high energy nuclei-nuclei interactions and the nucleon stability. Concerning the experiments under construction, a new detector for LEP, the study and simulation of the hadronic showers in a calorimeter and the H1 experiment (HERA), are described. The future research programs and the published papers are listed [fr

  4. High energy medical accelerators

    International Nuclear Information System (INIS)

    Mandrillon, P.

    1990-01-01

    The treatment of tumours with charged particles, ranging from protons to 'light ions' (carbon, oxygen, neon), has many advantages, but up to now has been little used because of the absence of facilities. After the successful pioneering work carried out with accelerators built for physics research, machines dedicated to this new radiotherapy are planned or already in construction. These high energy medical accelerators are presented in this paper. (author) 15 refs.; 14 figs.; 8 tabs

  5. Theoretical high energy physics

    International Nuclear Information System (INIS)

    Lee, T.D.

    1990-05-01

    This report discusses progress on theoretical high energy physics at Columbia University in New York City. Some of the topics covered are: Chern-Simons gauge field theories; dynamical fermion QCD calculations; lattice gauge theory; the standard model of weak and electromagnetic interactions; Boson-fermion model of cuprate superconductors; S-channel theory of superconductivity and axial anomaly and its relation to spin in the parton model

  6. High energy nuclear excitations

    International Nuclear Information System (INIS)

    Gogny, D.; Decharge, J.

    1983-09-01

    The main purpose of this talk is to see whether a simple description of the nuclear excitations permits one to characterize some of the high energy structures recently observed. The discussion is based on the linear response to different external fields calculated using the Random Phase Approximation. For those structure in heavy ion collisions at excitation energies above 50 MeV which cannot be explained with such a simple approach, we discuss a possible mechanism for this heavy ion scattering

  7. Monte Carlo calculations on efficiency of boron neutron capture therapy for brain cancer

    International Nuclear Information System (INIS)

    Awadalla, Galaleldin Mohamed Suliman

    2015-11-01

    The search for ways to treat cancer has led to many different treatments, including surgery, chemotherapy, and radiation therapy. Among these treatments, boron neutron capture therapy (BNCT) has shown promising results. BNCT is a radiotherapy treatment modality that has been proposed to treat brain cancer. In this technique, cancerous cells are being injected with 1 0B and irradiated by thermal neutrons to increase the probability of 1 0B (n, a)7 L i reaction to occur. This reaction can potentially deliver a high radiation dose sufficient to kill cancer cells by concentrating boron in them. The short rang of 1 0B (n, a) 7 L i reaction limits the damage to only cancerous cells without affecting healthy tissues. The effectiveness and safety of radiotherapy are dependent on the radiation dose delivered to the tumor and healthy tissues. In this thesis, after reviewing the basics and working principles of boron neutron capture therapy (BNCT), monte Carlo simulations were carried out to model a thermal neutron source suitable for BNCT and to examine the performance of proposed model when used to irradiate a sample of boron containing both 1 0B and 1 1B isotopes. MCNP5 code was used to examine the modeled neutron source through different shielding materials. The results were presented, analyzed and discussed at the end of the work. (author)

  8. Phantom experiment of depth-dose distributions for gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Matsumoto, T.; Kato, K.; Sakuma, Y.; Tsuruno, A.; Matsubayashi, M.

    1993-01-01

    Depth-dose distributions in a tumor simulated phantom were measured for thermal neutron flux, capture gamma-ray and internal conversion electron dose rates for gadolinium neutron capture therapy. The results show that (i) a significant dose enhancement can be achieved in the tumor by capture gamma-rays and internal conversion electrons but the dose is mainly due to capture gamma-rays from the Gd(n, γ) reactions, therefore, is not selective at the cellular level, (ii) the dose distribution was a function of strongly interrelated parameters such as gadolinium concentrations, tumor site and neutron beam size (collimator aperture size), and (iii) the Gd-NCT by thermal neutrons appears to be a potential for treatment of superficial tumor. (author)

  9. Design study of a medical reactor for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Sasaki, M.; Hirota, J.; Tamao, S.; Kanda, K.; Mishima, Y.

    1992-01-01

    A new design study of a medical reactor for Boron Neutron Capture Therapy (BNCT) has been carried out. The reactor is to be used exclusively for the treatment of malignant melanoma and other cancers as well as for the further biomedical research. Main specifications of the reactor are as follows; thermal power of 2 MW, water cooling by natural convection, semitight core of triangular lattice, UO 2 fuel rod of 9.5 mm diameter and no refueling in the reactor-life. Three horizontal and one vertical neutron beam hole are to be provided to deliver thermal and epithermal neutrons. N-γ coupling Sn transport calculations indicate that the patient treatment period will be about 30 minutes with minimal fast neutron and gamma contaminants. (author)

  10. Progress in study of a medical reactor for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Sasaki, Makoto; Hirota, Jitsuya; Tamao, Shigeo; Kanda, Keiji; Mishima, Yutaka.

    1993-01-01

    A design study of a medical reactor for Boron Neutron Capture Therapy has made progress. Main specifications of the reactor are as follows; thermal power of 2 MW, water cooling by natural convection, semitight core of hexagonal lattice, UO 2 fuel rod of 9.5 mm diameter and no refueling in the reactor-life. Three horizontal and one vertical neutron beam holes are to be provided for simultaneous treatments by thermal and epithermal neutrons and for further biomedical research. The design objectives for the beam holes are to deliver the therapeutic doses in a modest time (30 to 60 min) with minimal fast neutron and gamma contaminants. The n-γ coupling Sn transport calculations have been carried out using n-21 and γ-9 group cross sections on 2-dim. practical models. The calculated results indicate that the design objectives will be achievable even if the thermal power of the reactor is reduced to 1 MW. (author)

  11. Nuclear data for fast neutron and proton therapy

    International Nuclear Information System (INIS)

    Chadwick, M.B.; Jones, D.T.L.; Barschall, H.H.

    2001-01-01

    ICRU Report 63 entitled 'Nuclear Data for Neutron and Proton Radiotherapy and for Radiation Protection' has recently been published. The present paper presents an overview of this report, along with examples of some of the results obtained for evaluated nuclear cross sections and kerma coefficients. These cross sections are evaluated using a combination of measured data and the GNASH nuclear model code for elements of importance for biological, dosimetric, beam modification and shielding purposes. In the case of hydrogen both R-matrix and phase-shift scattering theories are used. Neutron cross sections and kerma coefficients were evaluated up to 100 MeV and proton cross sections up to 250 MeV. (author)

  12. A colorimetric determination of boron in biological sample for boron neutron capture therapy (BNCT)

    International Nuclear Information System (INIS)

    Camillo, M.A.P.; Tomac Junior, U.

    1990-01-01

    The boron neutron capture therapy (BNCT) has shown better prognosis in the treatment of glyemas and gluoblastomas grade III and IV than other therapies. During the treatment the levels of Na 2 10 B 12 H 11 SH must be known in several compartiments of the organism and with this purpose the method of colorimetric determination of boron using curcumine was established. This method is simple, reprodutible and adequate sensitivity for this control. (author) [pt

  13. A colorimetric determination of boron in biological sample for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Camilo, M.A.P.; Tomac Junior, U.

    1989-01-01

    The boron neutron capture therapy (BNCT) has shown better prognosis in the treatment of gliomas and glioblastomas grade III and IV than other therapies. During the treatment of levels of Na 2 10 B 12 H 11 S H must be known in several compartments of the organism and with this purpose the method of colorimetric determination of boron using curcumin was established. This method is simples, reproducible and has adequate sensitivity for this control. (author). 7 refs, 3 figs, 1 tab

  14. Viability of neutron brachytherapy technique using Cf252 for tumors of salivary glands therapy

    International Nuclear Information System (INIS)

    Andrade, Lidia M.; Campos, Tarcisio P.R.

    2000-01-01

    Gland salivary tumors, although uncommon, present significant characteristics such as distant metastasis, recurrence and average survive of five year for treated patients. Those tumors presents low response to a conventional radiotherapy, photon and electron therapy; thus, this modality is associated with surgery. Fast neutron therapy has been presented better results in controlling the local tumor in comparison with conventional radiotherapy. Brachytherapy with Cf-252 presents an alternative treatment for tumors. Those radiotherapy technique are discussed and analyzed. (author)

  15. Dysphagia after fast neutron therapy to the head and neck

    International Nuclear Information System (INIS)

    Alexander, M.S.M.; Edelman, G.M.; Man, Kate; Randall, C.J.

    1989-01-01

    Nine patients presenting with dysphagia following successful treatment for head and neck cancer with neutron radiotherapy are reviewed. Combined clinical and videofluoroscopic investigation is used to analyse their deficits and provide indications for management. All patients show impairment of both the oral and pharyngeal phases of the swallow, with the exception of one subject who shows signs of focal neurological damage. It is suggested that fibrosis is the underlying cause of dysphagia in the remainder. (author)

  16. Improved apparatus for neutron capture therapy of rat brain tumors

    International Nuclear Information System (INIS)

    Liu, Hungyuan B.; Joel, D.D.; Slatkin, D.N.; Coderre, J.A.

    1994-01-01

    The assembly for irradiating tumors in the rat brain at the thermal neutron beam port of the Brookhaven Medical Research Reactor was redesigned to lower the average whole-body dose from different components of concomitant radiation without changing the thermal neutron fluence at the brain tumor. At present, the tumor-bearing rat is positioned in a rat holder that functions as a whole-body radiation shield. A 2.54 cm-thick collimator with a centered conical aperture, 6 cm diameter tapering to 2 cm diameter, is used to restrict the size of the thermal neutron field. Using the present holder and collimator as a baseline design, Monte Carlo calculations and mixed-field dosimetry were used to assess new designs. The computations indicate that a 0.5 cm-thick plate, made of 6 Li 2 CO 3 dispersed in polyethylene (Li-poly), instead of the existing rat holder, will reduce the whole-body radiation dose. Other computations show that a 10.16 cm-thick (4 inches) Li-poly collimator, having a centered conical aperture of 12 cm diameter tapering to 2 cm diameter, would further reduce the whole-body dose. The proposed irradiation apparatus of tumors in the rat brain, although requiring a 2.3-fold longer irradiation time, would reduce the average whole-body dose to less than half of that from the existing irradiation assembly. 7 refs., 4 figs., 7 tabs

  17. Further development of thermal neutron capture therapy for metastatic and deeply-invasive human malignant melanoma

    International Nuclear Information System (INIS)

    Mishima, Yutaka

    1995-03-01

    This issue is the collection of the papers presented thermal neutron capture therapy for metastatic and deeply-invasive human malignant melanoma. Separate abstracts were prepared for 2 of the papers in this report. The remaining 32 papers were considered outside the subject scope of INIS. (J.P.N.)

  18. Proceedings of workshop on 'boron science and boron neutron capture therapy'

    Energy Technology Data Exchange (ETDEWEB)

    Kitaoka, Y. [ed.

    1998-12-01

    This volume contains the abstracts and programs of the 8th (1996), 9th (1997) and 10th (1998) of the workshop on 'the Boron Science and Boron Neutron Capture Therapy' and the recent progress reports especially subscribed. The 11 of the presented papers are indexed individually. (J.P.N.)

  19. Evaluation of conditions of radiation protection of medical personnel in intracavitary neutron therapy of cervical cancer

    International Nuclear Information System (INIS)

    Kostromina, K.N.; Korenkov, I.P.; Bocharov, A.L.; Gladkikh, N.N.

    1991-01-01

    Combined radiation therapy was provided to cervical cancer patients. Working conditions of personnel were examined, the rate of exposure doses and flows of neutrons at working places were measured, dose exposures of the personnel were evaluated. It has been concluded that occupational conditions for the medical personnel are considered to be relatively safe

  20. Contemporary state of neutron capture therapy in the Czech Republic - (Part 2)

    Czech Academy of Sciences Publication Activity Database

    Dbalý, V.; Tovaryš, F.; Honová, H.; Petruželka, L.; Prokeš, K.; Burian, J.; Marek, M.; Honzátko, Jaroslav; Tomandl, Ivo; Kříž, O.; Janků, I.; Mareš, Vladislav

    2003-01-01

    Roč. 66, č. 1 (2003), s. 60-63 ISSN 1210-7859 Institutional research plan: CEZ:AV0Z5011922; CEZ:AV0Z1048901 Keywords : boron neutron therapy * radiotherapy Subject RIV: FH - Neurology Impact factor: 0.047, year: 2003

  1. The Boron Neutron Capture Therapy (BNCT) Project at the TRIGA Reactor in Mainz, Germany

    DEFF Research Database (Denmark)

    Hampel, G.; Grunewald, C.; Schütz, C.

    2011-01-01

    The thermal column of the TRIGA reactor in Mainz is being used very effectively for medical and biological applications. The BNCT (boron neutron capture therapy) project at the University of Mainz is focussed on the treatment of liver tumours, similar to the work performed at Pavia (Italy) a few ...

  2. Gastrocutaneous fistula as a late complication of fast neutron therapy for carcinoma of the stomach

    International Nuclear Information System (INIS)

    Griffith, C.D.M.; Arnott, S.J.

    1984-01-01

    A brief report is presented of a case of gastrocutaneous fistula in a 36-year-old housewife, who had been treated a year previously for carcinoma of the stomach with fast neutron therapy at a dose of 1500 cGy delivered in 20 daily treatments. The maximum tissue dose delivered to the skin surface was 1780 cGy. (U.K.)

  3. Current status of high energy nucleon-meson transport code

    Energy Technology Data Exchange (ETDEWEB)

    Takada, Hiroshi; Sasa, Toshinobu [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-03-01

    Current status of design code of accelerator (NMTC/JAERI code), outline of physical model and evaluation of accuracy of code were reported. To evaluate the nuclear performance of accelerator and strong spallation neutron origin, the nuclear reaction between high energy proton and target nuclide and behaviors of various produced particles are necessary. The nuclear design of spallation neutron system used a calculation code system connected the high energy nucleon{center_dot}meson transport code and the neutron{center_dot}photon transport code. NMTC/JAERI is described by the particle evaporation process under consideration of competition reaction of intranuclear cascade and fission process. Particle transport calculation was carried out for proton, neutron, {pi}- and {mu}-meson. To verify and improve accuracy of high energy nucleon-meson transport code, data of spallation and spallation neutron fragment by the integral experiment were collected. (S.Y.)

  4. HIGH ENERGY HADRON POLARIMETRY

    International Nuclear Information System (INIS)

    BUNCE, G.

    2007-01-01

    Proton polarimetry at RHIC uses the interference of electromagnetic (EM) and hadronic scattering amplitudes. The EM spin-flip amplitude for protons is responsible for the proton's anomalous magnetic moment, and is large. This then generates a significant analyzing power for small angle elastic scattering. RHIC polarimetry has reached a 5% uncertainty on the beam polarization, and seem capable of reducing this uncertainty further. Polarized neutron beams ax also interesting for RHIC and for a polarized electron-polarized proton/ion collider in the fume. In this case, deuterons, for example, have a very small anomalous magnetic moment, making the approach used for protons impractical. Although it might be possible to use quasielastic scattering from the protons in the deuteron to monitor the polarization. 3-He beams can provide polarized neutrons, and do have a large anomalous magnetic moment, making a similar approach to proton polarimetry possible

  5. High energy ion implantation

    International Nuclear Information System (INIS)

    Ziegler, J.F.

    1985-01-01

    High energy ion implantation offers the oppertunity for unique structures in semiconductor processing. The unusual physical properties of such implantations are discussed as well as the special problems in masking and damage annealing. A review is made of proposed circuit structures which involve deep implantation. Examples are: deep buried bipolar collectors fabricated without epitaxy, barrier layers to reduce FET memory sensitivity to soft-fails, CMOS isolation well structures, MeV implantation for customization and correction of completed circuits, and graded reach-throughs to deep active device components. (orig.)

  6. Theoretical High Energy Physics

    Energy Technology Data Exchange (ETDEWEB)

    Christ, Norman H.; Weinberg, Erick J.

    2014-07-14

    we provide reports from each of the six faculty supported by the Department of Energy High Energy Physics Theory grant at Columbia University. Each is followed by a bibliography of the references cited. A complete list of all of the publications in the 12/1/2010-04/30/2014 period resulting from research supported by this grant is provided in the following section. The final section lists the Ph.D. dissertations based on research supported by the grant that were submitted during this period.

  7. High energy physics

    International Nuclear Information System (INIS)

    Fortney, L.R.; Goshaw, A.T.; Walker, W.D.

    1991-01-01

    This progress report presents a review of research done over the past five years by the Duke High Energy Physics Group. This research has been centered at Fermilab where we have had a continuing involvement with both the Tevatron collider and fixed-target programs. In 1988 we began extensive detector R ampersand D for the SSC through its Major Subsystem Program. Duke has been an active member of the Solenoidal Detector Collaboration (SDC) since its formation. These last five years has also been used to finish the analysis of data from a series of hybrid bubble chamber experiments which formed the core of Duke's research program in the early 1980's

  8. High energy cosmic rays

    CERN Document Server

    Stanev, Todor

    2010-01-01

    Offers an accessible text and reference (a cosmic-ray manual) for graduate students entering the field and high-energy astrophysicists will find this an accessible cosmic-ray manual Easy to read for the general astronomer, the first part describes the standard model of cosmic rays based on our understanding of modern particle physics. Presents the acceleration scenario in some detail in supernovae explosions as well as in the passage of cosmic rays through the Galaxy. Compares experimental data in the atmosphere as well as underground are compared with theoretical models

  9. The Biological Effect of Fast Neutrons and High-Energy Protons; Effets Biologiques des Neutrons Rapides et des Protons de Haute Energie; Biologicheskoe dejstvie bystrykh nejtronov i protonov vysokikh ehnergii; Efectos Biologicos de los Neutrones Rapidos y de los Protones de Elevada Energia

    Energy Technology Data Exchange (ETDEWEB)

    Moskalev, Ju. I.; Petrovich, I. K.; Strel' cova, V. N.

    1964-03-15

    The paper gives the results of comparative experiments on the effects of fast neutrons and high-energy protons (500 MeV) on life expectancy, peripheral blood, incidence and rate of appearance of tumours in the rat as a function of administered dose and time of observation. The neutron experiment was performed on 573 and the proton experiment on 490 white rats. The animals irradiated with fast neutrons were given doses between 8.5 and 510 rad, and those irradiated with protons received doses between 28 and 1008 rad. The effective doses for the acute, sub-acute and chronic forms of sickness were established for fast neutrons and for protons. LD{sub 50/30} for neutrons was 408 and for protons 600 rad, and the corresponding LD{sub 50}/{sub 120} values were 380 and 600 rad. The conditions governing rat mortality were analysed both in the early and the later stages of the experiment. It is shown that the average life expectancy of rats irradiated with fast neutrons does not depend on sex. The shape of the dose-effect curve for the various peripheral-blood indexes is strongly dependent not only on the radiosensitivity of the blood cells in question but also on the time of observation. It may change greatly in time for one and the same index. A considerable time after irradiation with either fast neutrons or protons, benign and malignant tumours appear in different tissues of the rats, including the haemopoeitic tissues, mammary glands, pituitary, uterus, ovaries, prostate gland, testicles, liver, kidneys, lungs, gastro-intestinal tract, subcutaneous tissue, lymph nodes, urinary bladder, etc. The over-all incidence of tumours and the number of cases of multi centred neoplasms in females are two to three times higher than in males. The minimum tumour dose for the mammary glands with neutron irradiation is apparently rather less than 42.5 rad. The maximum incidence of tumours of the pituitary is found after irradiation with a dose of 42.5 rad.- At this same dose leucosis and

  10. Simulation of silicon microdosimetry spectra in fast neutron therapy using the GEANT4 Monte Carlo toolkit

    International Nuclear Information System (INIS)

    Cornelius, I.M.; Rosenfeld, A.B.

    2003-01-01

    Microdosimetry is used to predict the biological effects of the densely ionizing radiation environments of hadron therapy and space. The creation of a solid state microdosimeter to replace the conventional Tissue Equivalent Proportional Counter (TEPC) is a topic of ongoing research. The Centre for Medical Radiation Physics has been investigating a technique using microscopic arrays of reverse biased PN junctions. A prototype silicon-on-insulator (SOI) microdosimeter was developed and preliminary measurements have been conducted at several hadron therapy facilities. Several factors impede the application of silicon microdosimeters to hadron therapy. One of the major limitations is that of tissue equivalence, ideally the silicon microdosimeter should provide a microdosimetry distribution identical to that of a microscopic volume of tissue. For microdosimetry in neutron fields, such as Fast Neutron Therapy, it is important that products resulting from neutron interactions in the non tissue equivalent sensitive volume do not contribute significantly to the spectrum. Experimental measurements have been conducted at the Gershenson Radiation Oncology Center, Harper Hospital, Detroit by Bradley et al. The aim was to provide a comparison with measurements performed with a TEPC under identical experimental conditions. Monte Carlo based calculations of these measurements were made using the GEANT4 Monte Carlo toolkit. Agreement between experimental and theoretical results was observed. The model illustrated the importance of neutron interactions in the non tissue equivalent sensitive volume and showed this effect to decrease with sensitive volume size as expected. Simulations were also performed for 1 micron cubic silicon sensitive volumes embedded in tissue equivalent material to predict the best case scenario for silicon microdosimetry in Fast Neutron Therapy

  11. Calculations of neutron source at the KYIV research reactor for the boron neutron capture therapy aims

    International Nuclear Information System (INIS)

    Gritzay, O.; Kalchenko, O.; Klimova, N.; Razbudey, V.; Sanzhur, A.

    2006-01-01

    Calculation results of an epithermal neutron source which can be created at the Kyiv Research Reactor (KRR) by means of placing of specially selected moderators, filters, collimators, and shielding into the 10-th horizontal experimental tube (so-called thermal column) are presented. The general Monte-Carlo radiation transport code MCNP4C [1], the Oak Ridge isotope generation code ORIGEN2 [2] and the NJOY99 [3] nuclear data processing system have been used for these calculations

  12. Proceedings of the third specialists` meeting on high energy nuclear data

    Energy Technology Data Exchange (ETDEWEB)

    Fukahori, Tokio [ed.

    1998-11-01

    This report is the Proceedings of the Third Specialists` Meeting on High Energy Nuclear Data. The meeting was held on March 30-31, 1998, at the Tokai Research Establishment of Japan Atomic Energy Research Institute with the participation of forty-odd specialists, who were the evaluators, theorists, experimentalists and users of high energy nuclear data including the members of the Japanese Nuclear Data Committee. The need of the high energy nuclear data up to a few Gev has been stressed in the meeting for many applications, such as spallation neutron sources for radioactive waste treatment, accelerator shielding design, medical isotope production, radiation therapy, the effects of space radiation on astronauts and their equipments, and the cosmic history of meteorites and other galactic substances. Since the Second Specialists` Meeting in 1995, such an evaluation activity in Japan has been grown and the results are accumulated. Foreign activities of high energy nuclear data evaluation are also being increased. According to the above situation, with the view point of reviewing and validating an evaluated high energy nuclear data file, project of high energy nuclear data file production, differential and integral experiments, status of evaluation and reviewing methods, processing and transport calculation methods, benchmark tests, international trends, etc. were discussed. The 16 of the presented papers are indexed individually. (J.P.N.)

  13. A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part II: gadolinium neutron capture therapy models and therapeutic effects.

    Science.gov (United States)

    Wangerin, K; Culbertson, C N; Jevremovic, T

    2005-08-01

    The goal of this study was to evaluate the COG Monte Carlo radiation transport code, developed and tested by Lawrence Livermore National Laboratory, for gadolinium neutron capture therapy (GdNCT) related modeling. The validity of COG NCT model has been established for this model, and here the calculation was extended to analyze the effect of various gadolinium concentrations on dose distribution and cell-kill effect of the GdNCT modality and to determine the optimum therapeutic conditions for treating brain cancers. The computational results were compared with the widely used MCNP code. The differences between the COG and MCNP predictions were generally small and suggest that the COG code can be applied to similar research problems in NCT. Results for this study also showed that a concentration of 100 ppm gadolinium in the tumor was most beneficial when using an epithermal neutron beam.

  14. Local control of murine melanoma xenografts in nude mice by neutron capture therapy

    International Nuclear Information System (INIS)

    Allen, B.J.; Corderoy-Buck, S.; Moore, D.E.; Mishima, Y.; Ichihashi, M.

    1992-01-01

    In recent years considerable progress has been made in the development and implementation of neutron capture therapy (NCT) for the treatment of cancer. In particular, the boron analogue of the melanin precursor phenylalanine, i.e., DL-p-boronophenylalanine (BPA), has been used to demonstrate the regression and cure of Harding-Passey (HP) melanoma in syngeneic mice. However, 18 to 25% cures were obtained for neutron irradiations without boron, suggesting that the neutron dose alone plays an important role. Neutron capture therapy of B-16 melanoma xenografts in nude mice showed substantial tumor regression over 35 days, but the survival rate of NCT treated mice after 7 weeks was only 40-60%. In this paper the authors demonstrate the equivalence of the nude mouse model with a syngeneic model, using the same Harding-Passey murine melanoma line, and delineate the conditions required for maximum differential response between neutron irradiation with and without BPA administration, with complete local control as the end point

  15. Perspectives of boron-neutron capture therapy of malignant brain tumors

    Science.gov (United States)

    Kanygin, V. V.; Kichigin, A. I.; Krivoshapkin, A. L.; Taskaev, S. Yu.

    2017-09-01

    Boron neutron capture therapy (BNCT) is characterized by a selective effect directly on the cells of malignant tumors. The carried out research showed the perspective of the given kind of therapy concerning malignant tumors of the brain. However, the introduction of BNCT into clinical practice is hampered by the lack of a single protocol for the treatment of patients and the difficulty in using nuclear reactors to produce a neutron beam. This problem can be solved by using a compact accelerator as a source of neutrons, with the possibility of installation in a medical institution. Such a neutron accelerator for BNCT was developed at Budker Institute of Nuclear Physics, Novosibirsk. A neutron beam was obtained on this accelerator, which fully complies with the requirements of BNCT, as confirmed by studies on cell cultures and experiments with laboratory animals. The conducted experiments showed the relative safety of the method with the absence of negative effects on cell cultures and living organisms, and also confirmed the effectiveness of BNCT for malignant brain tumors.

  16. Clinical experience of therapy with cyclotron neutrons at the University of Washington

    International Nuclear Information System (INIS)

    Parker, R.G.; Gerdes, A.J.; Berry, H.C.; Soronen, M.D.

    1975-01-01

    Proper clinical evaluation of fast neutron teletherapy of human cancers will be difficult and time-consuming and will require extension over many years. Fast neutron teletherapy may not have significant advantage over modern conventional supervoltage/megavoltage radiation therapy. A negative answer will be acceptable only if based on sound evidence. If fast neutron teletherapy has an advantage over modern conventional radiation therapy, the advantage may be small and tumor- and site-specific. Detection of a small advantage will require study of a large number of patients and this will be possible only in carefully planned cooperative clinical trials. The study of a large number of patients over a long period will require installation of dedicated neutron generators in research-oriented medical centers. Cooperative clinical trials must be preceded by careful definition of target tumors, normal tissue tolerances, reasonable doses and advantageous patterns of application. Any improvement in local tumor control attributed to fast neutron teletherapy might be dissipated by a concurrent increase in treatment-related sequelae. Much related physics and radiobiology remains to be done and must be supported concurrent with the clinical programs

  17. Distribution of exogenous porphyrins in vivo; implications for neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Gabel, D.; Hillman, M.; Watts, K.

    1982-01-01

    Endogenous porphyrins (HpD) are already in clinical use for phototherapy, in which red light is used to stimulate a cytotoxic response in tumors. The evident success, at least with superficial cancers, gives biological evidence of selective concentrations of porphyrins in tumors adequate for therapy. The authors have investigated, in addition, the biodistribution of a synthetic porphyrin (tetraphenylporphinesulfonate, or TPPS) in seven different animal tumor models. Their data, as well as those of others, indicate abundant accumulations of TPPS in tumor. If boronated analogs behave in the same way, boron concentrations would be up to 10 times that needed for therapy. Utilization of such porphyrin analogs in the neutron capture therapy (NCT) procedure is similar in concept to phototherapy currently being used clinically, with the distinct advantage of deeper tissue penetration produced by the activating neutrons

  18. Cf-252 neutron brachytherapy: an advance for bulky localized cancer therapy

    International Nuclear Information System (INIS)

    Maruyama, Y.

    1984-01-01

    The physical and radiobiogical basis as well as the rationale for neutron brachytherapy, using Cf-252, in human cancer therapy is reviewed. Cf-252 brachytherapy represents an economical and effective form of neutron radiotherapy that is readily and safely applied clinically. It can be used anywhere in the world without unusual personnel, equipment or facilities, or prohibitive expenses or maintenance costs. Used on bulky head and neck, thoracic, abdominal, pelvic, brain and appendage cancers, it overcomes hypoxic radioresistance and produces remarkable rates of tumor clearance. It is easily combined with photon radiotherapy and in proper schedules and doses, it can control advanced but still localized regional cancers to produce tumor cure. It will clear the local manifestations of recurrent or metastatic tumors or advanced stages of primary tumors and therefore in conjunction with other adjuvant therapies offers much more effective tumor control and palliation than present conventional therapy. (Auth.)

  19. Medical aspects of boron-slow neutron capture therapy

    International Nuclear Information System (INIS)

    Sweet, W.H.

    1986-01-01

    Earlier radiations of patients with cerebral tumors disclosed the need: (1) to find a carrier of the boron compound which would leave the blood and concentrate in the tumor, (2) to use a more penetrating neutron beam, and (3) to develop a much faster method for assaying boron in blood and tissue. To some extent number1 has been accomplished in the form of Na 2 B 12 H 11 SH, number2 has yet to be achieved, and number3 has been solved by the measurement of the 478-keV gamma ray when the 10 B atom disintegrates following its capture of a slow neutron. The hitherto unreported data in this paper describe through the courtesy of Professor Hiroshi Hatanaka his studies on the pharmacokinetics and quality control of Na 2 B 12 H 11 SH based on 96 boron infusions in 86 patients. Simultaneous blood and tumor data are plotted here for 30 patients with glioblastomas (Grade III-IV gliomas), illustrating remarkable variability. Detailed autopsy findings on 18 patients with BNCT showed radiation injury in only 1. Clinical results in 12 of the most favorably situated glioblastomas reveal that 5 are still alive with a 5-year survival rate of 58% and the excellent Karnofsky performance rating of 87%. For the first time evidence is presented that slow-growing astrocytomas may benefit from BNCT. 10 references, 8 figures, 5 tables

  20. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma

    International Nuclear Information System (INIS)

    Kageji, Teruyoshi; Nagahiro, Shinji; Kitamura, Katsushi; Nakagawa, Yoshinobu; Hatanaka, Hiroshi; Haritz, Dietrich; Grochulla, Frank; Haselsberger, Klaus; Gabel, Detlef

    2001-01-01

    Purpose: A cooperative study in Europe and Japan was conducted to determine the pharmacokinetics and boron uptake of sodium borocaptate (BSH: Na 2 B 12 H 11 SH), which has been introduced clinically as a boron carrier for boron neutron capture therapy in patients with glioblastoma. Methods and Materials: Data from 56 patients with glioblastoma who received BSH intravenous infusion were retrospectively reviewed. The pharmacokinetics were evaluated in 50 patients, and boron uptake was investigated in 47 patients. Patients received BSH doses between 12 and 100 mg/kg of body weight. For the evaluation, the infused boron dose was scaled linearly to 100 mg/kg BSH. Results: In BSH pharmacokinetics, the average value for total body clearance, distribution volume of steady state, and mean residence time was 3.6±1.5 L/h, 223.3±160.7 L, and 68.0±52.5 h, respectively. The average values of the boron concentration in tumor adjusted to 100 mg/kg BSH, the boron concentration in blood adjusted to 100 mg/kg BSH, and the tumor/blood boron concentration ratio were 37.1±35.8 ppm, 35.2±41.8 ppm, and 1.53±1.43, respectively. A good correlation was found between the logarithmic value of T adj and the interval from BSH infusion to tumor tissue sampling. About 12-19 h after infusion, the actual values for T adj and tumor/blood boron concentration ratio were 46.2±36.0 ppm and 1.70±1.06, respectively. The dose ratio between tumor and healthy tissue peaked in the same interval. Conclusion: For boron neutron capture therapy using BSH administered by intravenous infusion, this work confirms that neutron irradiation is optimal around 12-19 h after the infusion is started

  1. Boron Neutron Capture Therapy activity of diffused tumors at TRIGA Mark II in Pavia

    Energy Technology Data Exchange (ETDEWEB)

    Bortolussi, S.; Stella, S.; De Bari, A.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy)]|[National Institute of Nuclear Physics (INFN), Pavia (Italy); Bruschi, P.; Bakeine, J.G. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Clerici, A.; Ferrari, C.; Zonta, C.; Zonta, A. [Department of Surgery, University of Pavia, Pavia (Italy); Nano, R. [Department of Animal Biology, University of Pavia, Pavia (Italy)

    2008-10-29

    The Boron neutron Capture Therapy research in Pavia has a long tradition: it begun more than 20 years ago at the TRIGA Mark II reactor of the University. A technique for the treatment of the hepatic metastases was developed, consisting in explanting the liver treated with {sup 10}B, irradiating it in the thermal column of the reactor, and re-implanting the organ in the patient. In the last years, the possibility of applying BNCT to the lung tumours using epithermal collimated neutron beams and without explanting the organ, is being explored. The principal obtained results of the BNCT research will be presented, with particular emphasis on the following aspects: a) the project of a new thermal column configuration to make the thermal neutron flux more uniform inside the explanted liver, b) the Monte Carlo study by means of the MCNP code of the thermal neutron flux distribution inside a patient's thorax irradiated with epithermal neutrons, and c) the measurement of the boron concentration in tissues by (n,{alpha}) spectroscopy and neutron autoradiography. (authors)

  2. Development of the JAERI computational dosimetry system (JCDS) for boron neutron capture therapy. Cooperative research

    CERN Document Server

    Kumada, H; Matsumura, A; Nakagawa, Y; Nose, T; Torii, Y; Uchiyama, J; Yamamoto, K; Yamamoto, T

    2003-01-01

    The Neutron Beam Facility at JRR-4 enables us to carry out boron neutron capture therapy with epithermal neutron beam. In order to make treatment plans for performing the epithermal neutron beam BNCT, it is necessary to estimate radiation doses in a patient's head in advance. The JAERI Computational Dosimetry System (JCDS), which can estimate distributions of radiation doses in a patient's head by simulating in order to support the treatment planning for epithermal neutron beam BNCT, was developed. JCDS is a software that creates a 3-dimentional head model of a patient by using CT and MRI images, and that generates a input data file automatically for calculation of neutron flux and gamma-ray dose distributions in the brain with the Monte Carlo code MCNP, and that displays these dose distributions on the head model for dosimetry by using the MCNP calculation results. JCDS has any advantages as follows; By using CT data and MRI data which are medical images, a detail three-dimensional model of patient's head is...

  3. Boron Neutron Capture Therapy activity of diffused tumors at TRIGA Mark II in Pavia

    International Nuclear Information System (INIS)

    Bortolussi, S.; Stella, S.; De Bari, A.; Altieri, S.; Bruschi, P.; Bakeine, J.G.; Clerici, A.; Ferrari, C.; Zonta, C.; Zonta, A.; Nano, R.

    2008-01-01

    The Boron neutron Capture Therapy research in Pavia has a long tradition: it begun more than 20 years ago at the TRIGA Mark II reactor of the University. A technique for the treatment of the hepatic metastases was developed, consisting in explanting the liver treated with 10 B, irradiating it in the thermal column of the reactor, and re-implanting the organ in the patient. In the last years, the possibility of applying BNCT to the lung tumours using epithermal collimated neutron beams and without explanting the organ, is being explored. The principal obtained results of the BNCT research will be presented, with particular emphasis on the following aspects: a) the project of a new thermal column configuration to make the thermal neutron flux more uniform inside the explanted liver, b) the Monte Carlo study by means of the MCNP code of the thermal neutron flux distribution inside a patient's thorax irradiated with epithermal neutrons, and c) the measurement of the boron concentration in tissues by (n,α) spectroscopy and neutron autoradiography. (authors)

  4. Comparison of the radiobiological effects of Boron neutron capture therapy (BNCT) and conventional Gamma Radiation

    International Nuclear Information System (INIS)

    Dagrosa, Maria A.; Carpano, Marina; Perona, Marina; Thomasz, Lisa; Juvenal, Guillermo J.; Pisarev, Mario; Pozzi, Emiliano; Thorp, Silvia

    2009-01-01

    BNCT is an experimental radiotherapeutic modality that uses the capacity of the isotope 10 B to capture thermal neutrons leading to the production of 4 He and 7 Li, particles with high linear energy transfer (LET). The aim was to evaluate and compare in vitro the mechanisms of response to the radiation arising of BNCT and conventional gamma therapy. We measured the survival cell fraction as a function of the total physical dose and analyzed the expression of p27/Kip1 and p53 by Western blotting in cells of colon cancer (ARO81-1). Exponentially growing cells were distributed into the following groups: 1) BPA (10 ppm 10 B) + neutrons; 2) BOPP (10 ppm 10 B) + neutrons; 3) neutrons alone; 4) gamma-rays. A control group without irradiation for each treatment was added. The cells were irradiated in the thermal neutron beam of the RA-3 (flux= 7.5 10 9 n/cm 2 sec) or with 60 Co (1Gy/min) during different times in order to obtain total physical dose between 1-5 Gy (±10 %). A decrease in the survival fraction as a function of the physical dose was observed for all the treatments. We also observed that neutrons and neutrons + BOPP did not differ significantly and that BPA was the more effective compound. Protein extracts of irradiated cells (3Gy) were isolated to 24 h and 48 h post radiation exposure. The irradiation with neutrons in presence of 10 BPA or 10 BOPP produced an increase of p53 at 24 h maintain until 48 h. On the contrary, in the groups irradiated with neutrons alone or gamma the peak was observed at 48 hr. The level of expression of p27/Kip1 showed a reduction of this protein in all the groups irradiated with neutrons (neutrons alone or neutrons plus boron compound), being more marked at 24 h. These preliminary results suggest different radiobiological response for high and low let radiation. Future studies will permit establish the role of cell cycle in the tumor radio sensibility to BNCT. (author)

  5. SBNCT plan: A 3-dimensional treatment planning system for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Reinstein, L.E.; Ramsay, E.B.; Gajewski, J.; Ramamoorthy, S.; Meek, A.G.

    1993-01-01

    The need for accurate and comprehensive 3-dimensional treatment planning for boron neutron capture therapy (BNCT) has been debated for the past several years. Although many argue against the need for elaborate and expensive treatment planning programs which mimic conventional radiotherapy planning systems, it is clear that in order to realize significant gains over conventional fractionated radiation therapy, patients must be treated to the edge of normal tissue tolerance. Just how close to this edge is dictated by the uncertainties in dosimetry. Hence the focus of BNCT planning is the determination of dose distribution throughout normal tissue volumes. Although precise geometric manipulation of the epithermal neutron beam is not achievable, the following variables play an important role in BNCT optimization: patient orientation, dose fractionation, number of fields, megawatt-minutes per fraction, use of surface bolus, and use of collimation. Other variables which are not as easily adjustable and would not, therefore, be part of treatment planning optimization, include external patient contour, internal patient heterogeneities, boron compound distributions, and RBE's. The boron neutron capture therapy planning system developed at SUNY Stony Brook (SBNCT-Plan) was designed as an interactive graphic tool to assist the radiation oncologist in generating the optimum plan for a neutron capture treatment

  6. A new target concept for proton accelerator driven boron neutron capture therapy applications

    International Nuclear Information System (INIS)

    Powell, J.R.; Ludewig, H.; Todosow, M.; Reich, M.

    1998-01-01

    A new target concept termed Discs Incorporating Sector Configured Orbiting Sources (DISCOS), is proposed for spallation applications, including BNCT (Boron Neutron Capture Therapy). In the BNCT application a proton beam impacts a sequence of ultra thin lithium DISCOS targets to generate neutrons by the 7 Li(p,n) 7 Be reaction. The proton beam loses only a few keV of its ∼MeV energy as it passes through a given target, and is re-accelerated to its initial energy, by a DC electric field between the targets

  7. Biological Tests for Boron Neutron Capture Therapy Research at the TRIGA Mark II Reactor in Pavia

    Energy Technology Data Exchange (ETDEWEB)

    Protti, N.; Ballarini, F.; Bortolussi, S.; De Bari, A.; Stella, S.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Nuclear Physics National Institute (INFN), Pavia (Italy); Bruschi, P. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Bakeine, J.G.; Cansolino, L.; Clerici, A.M. [Laboratory of Experimental Surgery, Department of Surgery, University of Pavia, Pavia (Italy)

    2011-07-01

    The thermal column of the TRIGA Mark II reactor of the Pavia University is used as an irradiation facility to perform biological tests and irradiations of living systems for Boron Neutron Capture Therapy (BNCT) research. The suitability of the facility has been ensured by studying the neutron flux and the photon background in the irradiation chamber inside the thermal column. This characterization has been realized both by flux and dose measurements as well as by Monte Carlo simulations. The routine irradiations concern in vitro cells cultures and different tumor animal models to test the efficacy of the BNCT treatment. Some results about these experiments will be described. (author)

  8. Validation of dose planning calculations for boron neutron capture therapy using cylindrical and anthropomorphic phantoms

    Energy Technology Data Exchange (ETDEWEB)

    Koivunoro, Hanna; Seppaelae, Tiina; Uusi-Simola, Jouni; Merimaa, Katja; Savolainen, Sauli [Department of Physics, POB 64, FI-00014 University of Helsinki (Finland); Kotiluoto, Petri; Seren, Tom; Auterinen, Iiro [VTT Technical Research Centre of Finland, Espoo, POB 1000, FI-02044 VTT (Finland); Kortesniemi, Mika, E-mail: hanna.koivunoro@helsinki.f [HUS Helsinki Medical Imaging Center, University of Helsinki, POB 340, FI-00029 HUS (Finland)

    2010-06-21

    In this paper, the accuracy of dose planning calculations for boron neutron capture therapy (BNCT) of brain and head and neck cancer was studied at the FiR 1 epithermal neutron beam. A cylindrical water phantom and an anthropomorphic head phantom were applied with two beam aperture-to-surface distances (ASD). The calculations using the simulation environment for radiation application (SERA) treatment planning system were compared to neutron activation measurements with Au and Mn foils, photon dose measurements with an ionization chamber and the reference simulations with the MCNP5 code. Photon dose calculations using SERA differ from the ionization chamber measurements by 2-13% (disagreement increased along the depth in the phantom), but are in agreement with the MCNP5 calculations within 2%. The {sup 55}Mn(n,{gamma}) and {sup 197}Au(n,{gamma}) reaction rates calculated using SERA agree within 10% and 8%, respectively, with the measurements and within 5% with the MCNP5 calculations at depths >0.5 cm from the phantom surface. The {sup 55}Mn(n,{gamma}) reaction rate represents the nitrogen and boron depth dose within 1%. Discrepancy in the SERA fast neutron dose calculation (of up to 37%) is corrected if the biased fast neutron dose calculation option is not applied. Reduced voxel cell size ({<=}0.5 cm) improves the SERA calculation accuracy on the phantom surface. Despite the slight overestimation of the epithermal neutrons and underestimation of the thermal neutrons in the beam model, neutron calculation accuracy with the SERA system is sufficient for reliable BNCT treatment planning with the two studied treatment distances. The discrepancy between measured and calculated photon dose remains unsatisfactorily high for depths >6 cm from the phantom surface. Increasing discrepancy along the phantom depth is expected to be caused by the inaccurately determined effective point of the ionization chamber.

  9. Theoretical high energy physics

    International Nuclear Information System (INIS)

    Lee, T.D.

    1993-01-01

    Brief reports are given on the work of several professors. The following areas are included: quantum chromodynamics calculations using numerical lattice gauge theory and a high-speed parallel computer; the ''spin wave'' description of bosonic particles moving on a lattice with same-site exclusion; a high-temperature expansion to 13th order for the O(4)-symmetric φ 4 model on a four-dimensional F 4 lattice; spin waves and lattice bosons; superconductivity of C 60 ; meson-meson interferometry in heavy-ion collisions; baryon number violation in the Standard Model in high-energy collisions; hard thermal loops in QCD; electromagnetic interactions of anyons; the relation between Bose-Einstein and BCS condensations; Euclidean wormholes with topology S 1 x S 2 x R; vacuum decay and symmetry breaking by radiative corrections; inflationary solutions to the cosmological horizon and flatness problems; and magnetically charged black holes

  10. High energy astrophysical techniques

    CERN Document Server

    Poggiani, Rosa

    2017-01-01

    This textbook presents ultraviolet and X-ray astronomy, gamma-ray astronomy, cosmic ray astronomy, neutrino astronomy, and gravitational wave astronomy as distinct research areas, focusing on the astrophysics targets and the requirements with respect to instrumentation and observation methods. The purpose of the book is to bridge the gap between the reference books and the specialized literature. For each type of astronomy, the discussion proceeds from the orders of magnitude for observable quantities. The physical principles of photon and particle detectors are then addressed, and the specific telescopes and combinations of detectors, presented. Finally the instruments and their limits are discussed with a view to assisting readers in the planning and execution of observations. Astronomical observations with high-energy photons and particles represent the newest additions to multimessenger astronomy and this book will be of value to all with an interest in the field.

  11. Prospects at high energies

    International Nuclear Information System (INIS)

    Quigg, C.

    1988-11-01

    I discuss some possibilities for neutrino experiments in the fixed-target environment of the SPS, Tevatron, and UNK, with their primary proton beams of 0.4, 0.9, and 3.0 TeV. The emphasis is on unfinished business: issues that have been recognized for some time, but not yet resolved. Then I turn to prospects for proton-proton colliders to explore the 1-TeV scale. I review the motivation for new physics in the neighborhood of 1 TeV and mention some discovery possibilities for high-energy, high-luminosity hadron colliders and the implications they would have for neutrino physics. I raise the possibility of the direct study of neutrino interactions in hadron colliders. I close with a report on the status of the SSC project. 38 refs., 17 figs

  12. High energy physics problems

    International Nuclear Information System (INIS)

    Arbuzov, B.A.

    1977-01-01

    Described are modern views on the particle structure and particle interactions at high energies. According to the latest data recieved, all particles can be classified in three groups: 1) strong interacting hadrons; 2) leptons, having no strong interactions; 3) photon. The particle structure is described in a quark model, and with the use of gluons. The elementary particle theory is based on the quantum field theory. The energy increase of interacting particles enables to check the main theory principles, such as conventions for causality, relativistic invariance and unitarity. Investigations of weak interactions are of great importance. The progress in this field is connected with unified gauge theories of weak and electromagnetic interactions. For weak interactions promissing are the experiments with colliding electron-proton rings. The new data, especially at higher energies, will lead to a further refinement of the nature of particles and their interactions

  13. Design study of a medical proton linac for neutron therapy

    International Nuclear Information System (INIS)

    Machida, S.; Raparia, D.

    1988-01-01

    This paper describes a design study which establishes the physical parameters of the low energy beam transport, radiofrequency quadrupole, and linac, using computer programs available at Fermilab. Beam dynamics studies verify that the desired beam parameters can be achieved. The machine described here meets the aforementioned requirements and can be built using existing technology. Also discussed are other technically feasible options which could be attractive to clinicians, though they would complicate the design of the machine and increase construction costs. One of these options would allow the machine to deliver 2.3 MeV protons to produce epithermal neutrons for treating brain tumors. A second option would provide 15 MeV protons for isotope production. 21 refs., 33 figs

  14. Nuclear Physics meets Medicine and Biology: Boron Neutron Capture Therapy

    CERN Document Server

    F. Ballarini, F; S. Bortolussi, S; P. Bruschi, P; A.M. Clerici, A M; A. De Bari, A; P. Dionigi, P; C. Ferrari, C; M.A. Gadan, M A; N. Protti, N; S. Stella, S; C. Zonta, C; A. Zonta, A; S. Altieri, S

    2010-01-01

    BNCT is a tumour treatment based on thermal-neutron irradiation of tissues enriched with 10B, which according to the 10B(n, )7Li reaction produces particles with high Linear Energy Transfer and short range. Since this treatment can deliver a therapeutic tumour dose sparing normal tissues, BNCT represents an alternative for diffuse tumours and metastases, which show poor response to surgery and photontherapy. In 2001 and 2003, in Pavia BNCT was applied to an isolated liver, which was infused with boron, explanted, irradiated and re-implanted. A new project was then initiated for lung tumours, developing a protocol for Boron concentration measurements and performing organ-dose Monte Carlo calculations; in parallel, radiobiology studies are ongoing to characterize the BNCT effects down to cellular level. After a brief introduction, herein we will present the main activities ongoing in Pavia including the radiobiological ones, which are under investigation not only experimentally but also theoretically, basing on...

  15. Control system specification for a cyclotron and neutron therapy facility

    International Nuclear Information System (INIS)

    Jacky, J.; Risler, R.; Kalet, I.; Wootton, P.; Barke, A.; Brossard, S.; Jackson, R.

    1991-01-01

    It is usually considered an essential element of good practice in engineering to produce a specification for a system before building it. However, it has been found to be quite difficult to produce useful specifications of large software systems. The authors have nearly completed a comprehensive specification for the computer control system of a cyclotron and treatment facility that provides particle beams for cancer treatments with fast neutrons, production of medical isotopes, and physics experiments. They describe the control system as thoroughly as is practical using standard technical English, supplemented by tables, diagrams, and some algebraic equations. This specification comprises over 300 single-spaced pages. A more precise and compact specification might be achieved by making greater use of formal mathematical notations instead of English. They have begun work on a formal specification of the system, using the Z and Petri net notations

  16. Gadolinium as an element for neutron capture therapy

    International Nuclear Information System (INIS)

    Brugger, R.M.; Liu, H.B.; Laster, B.H.; Gordon, C.R.; Greenberg, D.D.; Warkentien, L.S.

    1992-01-01

    At BNL, preparations are being made to test in vitro compounds containing Gd and compare their response to the response of GD-DTPA to determine if one or several compounds can be located that enter the cells and enhance the Auger effect. Two similar rotators with positions for cell vials that have been constructed for these tests. The first rotator is made of only paraffin which simulates healthy tissue and provides control curves. The second rotator has 135 ppM of Gd-157 in the paraffin to simulate a Gd loaded tumor. Cells are irradiated in vials in the paraffin rotator and in the Gd-paraffin rotator at the epithermal beam of the Brookhaven Medical Research Reactor (BMRR). This produces an irradiation similar to what a patient would receive In an actual treatment. A combination of irradiations are made with both rotators; with no Gd compound or IdUrd In the cell media, with only Gd compound in the cell media and with both Gd compound and IdUrd in the cell media. The first set shows the effects of gamma rays from the H(n,gamma) reaction and the prompt gamma rays from capture of neutrons by Gd. The second set shows if there is any effect of Gd being in the cell media or inside the cells, i.e., an Auger effect. The third set shows the effect of enhancement by the IdUrd produced by the gamma rays from neutrons captured by either H or Gd. The fourth set combines all of the reactions and enhancements. Preliminary calculations and physical measurements of the doses that the cells will receive In these rotators have been made

  17. CYCLONE. Neutron therapy facility at Louvain-la-Neuve

    International Nuclear Information System (INIS)

    Meulders, J.P.; Saedeleer, G. de; Winant, M.; Wambersie, A.

    1979-01-01

    The neutrontherapy program at Louvain-la-Neuve is carried out with the cyclotron CYCLONE of the Catholic University. This isochronous variable energy cyclotron, produced by CSF (Corbeville, France), accelerates different types of charged particles; in particular, deuterons can be accelerated at energies ranging from 13 to 50 MeV. Neutrons used for therapeutic applications are produced by bombarding a thick (10 mm) water cooled, Beryllium target with 50 MeV deuterons. A beam current of about 5 μA is used for patient treatments, which produces dose rates of about 0,5 Gy/min at a target-skin-distance (TSD) of 157 cm. The treatment room, and related medical facilities, are located one level below the main level of the cyclotron. This permits the use of a vertical therapeutic neutron beam by bending the deuteron beam at 90 0 . This vertical beam appears to be more adequate for positioning the majority of the patients. The collimation system consists of a fixed shielding and of a series of interchangeable inserts. The inserts are cylindrical in shape; their height is 80 cm and their external diameter 40 cm. The proximal part (50 cm) is a mixture of iron (equivalent thickness 22 cm) and epoxy, and the distal part (30 cm) is a mixture (50%) of borax and epoxy. The emphasis is made on the radioprotection conditions. A series of measurements made in the treatment room and in the entry maze have shown that their special configuration provides a satisfactory protection of the staff. (author)

  18. Fast neutron therapy for squamous cell carcinoma in the head and neck region: results of a randomized trial

    International Nuclear Information System (INIS)

    Duncan, W.; Orr, J.A.; Arnott, S.J.; Jack, W.J.; Kerr, G.R.; Williams, J.R.

    1987-01-01

    A randomized trial of fast neuron therapy compared with 4MV photons for patients with head and neck cancer is reported. One hundred and sixty-eight patients were recruited between 1977 and 1984. The minimum follow-up is 2 years. Three patients were withdrawn before treatment began. Eighty-five were allocated to neutron therapy and 80 to receive photon therapy. All patients had squamous cell cancers in one of four primary sites: oral cavity, oropharynx, larynx, and hypopharynx. Local tumor control was similar in both groups: 44.7% after neutrons and 45.0% after photons. Salvage surgery was performed on 18 patients in each treatment group for residual or recurrent cancer. Acute radiation reactions of the mucous membranes were significantly more severe after photons. The number of patients with serious late reactions was greater after neutron therapy but the difference was not statistically significant. There were six deaths related to late morbidity after neutron therapy but none after photon therapy. Survival was better after photon therapy but the difference compared with the neutron group failed to reach statistical significance. When intercurrent deaths are excluded, the difference is less marked. Photon therapy was clearly better in terms of disease-free survival giving a 2-year local disease-free rate of 41.3% (s.e. 5.5%) compared with 29.4% (s.e. 4.9%) after neutrons

  19. Analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer

    International Nuclear Information System (INIS)

    Duncan, W.; Williams, J.R.; Kerr, G.R.; Arnott, S.J.; Quilty, P.M.; Rodger, A.; MacDougall, R.H.; Jack, W.J.

    1986-01-01

    This report is an analysis of the morbidity in the bladder and bowel observed in a randomized trial of d(15)+Be neutrons versus megavoltage photons in the treatment of bladder cancer. Acute reactions in the bladder and bowel were significantly worse after photon therapy. Of the patients treated with photons 45.7% had severe reactions in the bladder compared with 10.6% after neutron therapy (p less than 0.001). Severe acute bowel reactions were observed in 8.5% of the patients after photon therapy compared with 3.8% after neutron therapy (p less than 0.05). Late reactions were significantly worse after neutrons. Severe late reactions in the bladder were seen in 58.5% of patients after neutron therapy and in 40.5% after photon therapy (p less than 0.05). In the bowel they were observed in 53.3% of patients after neutron therapy compared with 8% after photon therapy (p less than 0.0001). The disparity in the degree of early and late complications makes assessment of RBE values difficult. It is estimated that for bladder morbidity the RBE value, for photon dose fractions of 2.75 Gy, is less than 3.3 for early reactions and equal to 3.4 for late effects. The respective RBE values for early and late effects in the bowel are less than 3.4 and 3.8

  20. Clinical application of in vivo treatment delivery verification based on PET/CT imaging of positron activity induced at high energy photon therapy

    Science.gov (United States)

    Janek Strååt, Sara; Andreassen, Björn; Jonsson, Cathrine; Noz, Marilyn E.; Maguire, Gerald Q., Jr.; Näfstadius, Peder; Näslund, Ingemar; Schoenahl, Frederic; Brahme, Anders

    2013-08-01

    The purpose of this study was to investigate in vivo verification of radiation treatment with high energy photon beams using PET/CT to image the induced positron activity. The measurements of the positron activation induced in a preoperative rectal cancer patient and a prostate cancer patient following 50 MV photon treatments are presented. A total dose of 5 and 8 Gy, respectively, were delivered to the tumors. Imaging was performed with a 64-slice PET/CT scanner for 30 min, starting 7 min after the end of the treatment. The CT volume from the PET/CT and the treatment planning CT were coregistered by matching anatomical reference points in the patient. The treatment delivery was imaged in vivo based on the distribution of the induced positron emitters produced by photonuclear reactions in tissue mapped on to the associated dose distribution of the treatment plan. The results showed that spatial distribution of induced activity in both patients agreed well with the delivered beam portals of the treatment plans in the entrance subcutaneous fat regions but less so in blood and oxygen rich soft tissues. For the preoperative rectal cancer patient however, a 2 ± (0.5) cm misalignment was observed in the cranial-caudal direction of the patient between the induced activity distribution and treatment plan, indicating a beam patient setup error. No misalignment of this kind was seen in the prostate cancer patient. However, due to a fast patient setup error in the PET/CT scanner a slight mis-position of the patient in the PET/CT was observed in all three planes, resulting in a deformed activity distribution compared to the treatment plan. The present study indicates that the induced positron emitters by high energy photon beams can be measured quite accurately using PET imaging of subcutaneous fat to allow portal verification of the delivered treatment beams. Measurement of the induced activity in the patient 7 min after receiving 5 Gy involved count rates which were about

  1. Report of a randomized trial of d(15)+Be neutrons compared with megavoltage X ray therapy of bladder cancer

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Jack, W.J.; MacDougall, R.H.; Quilty, P.M.; Rodger, A.; Kerr, G.R.; Williams, J.R.

    1985-01-01

    The results of a randomized trial of d(15)+Be neutrons compared with 4 or 6 MV photons for the treatment of transitional cell carcinoma of the bladder. Between December 1978 and December 1981, 113 patients were accrued, 53 allocated to be treated by neutrons and 60 by photons. Complete local tumor regression was observed in 64% of patients treated by neutrons and 62% treated by photons. Recurrent cancer was subsequently confirmed in 31% of patients, similar in both treatment groups. There was no significant difference in the control rates by T stage between the two treatment groups. Late morbidity was significantly worse in patients treated by neutrons. Following neutron therapy, 78% of patients had serious late morbidity in at least one tissue compared with 38% in the group treated by photons. Survival was significantly better in the photon treated group 45.3% (+/- 11%) at 5 years compared with 12% (+/- 6%) after neutron therapy

  2. Novel technologies and theoretical models in radiation therapy of cancer patients using 6.3 MeV fast neutrons produced by U-120 cyclotron

    Energy Technology Data Exchange (ETDEWEB)

    Musabaeva, L. I., E-mail: musabaevaLI@oncology.tomsk.ru; Lisin, V. A., E-mail: Lisin@oncology.tomsk.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); Startseva, Zh. A., E-mail: zhanna.alex@rambler.ru; Gribova, O. V., E-mail: gribova79@mail.ru; Velikaya, V. V., E-mail: viktoria.v.v@inbox.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); National Research Tomsk Polytechnic University, Lenin Avenue 30, Tomsk, 634050 (Russian Federation)

    2016-08-02

    The analysis of clinical use of neutron therapy with 6 MeV fast neutrons compared to conventional radiation therapy was carried out. The experience of using neutron and mixed neutron and photon therapy in patients with different radio-resistant malignant tumors shows the necessity of further studies and development of the novel approaches to densely-ionizing radiation. The results of dosimetry and radiobiological studies have been the basis for planning clinical programs for neutron therapy. Clinical trials over the past 30 years have shown that neutron therapy successfully destroys radio-resistant cancers, including salivary gland tumors, adenoidcystic carcinoma, inoperable sarcomas, locally advanced head and neck tumors, and locally advanced prostate cancer. Radiation therapy with 6.3 MeV fast neutrons used alone and in combination with photon therapy resulted in improved long-term treatment outcomes in patients with radio-resistant malignant tumors.

  3. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Zamenhof, R.G.; Lin, K.; Ziegelmiller, D.; Clement, S.; Lui, C.; Harling, O.K.

    Monte Carlo simulations of thermal neutron flux distributions in a mathematical head model have been compared to experimental measurements in a corresponding anthropomorphic gelatin-based head phantom irradiated by a thermal neutron beam as presently available at the MITR-II Research Reactor. Excellent agreement between Monte Carlo and experimental measurements has encouraged us to employ the Monte Carlo simulation technique to approach treatment planning problems in neutron capture therapy. We have also implemented a high-resolution alpha-track autoradiography technique originally developed in our laboratory at MIT. Initial autoradiograms produced by this technique meet our expectations in terms of the high resolution available and the ability to etch tracks without concommitant destruction of stained tissue. Our preliminary results with computer-aided track distribution analysis indicate that this approach is very promising in being able to quantify boron distributions in tissue at the subcellular level with a minimum amount of operator effort necessary.

  4. Neutron, Proton, and Photonuclear Cross Sections for Radiation Therapy and Radiation Protection

    International Nuclear Information System (INIS)

    Chadwick, M.B.

    1998-01-01

    The authors review recent work at Los Alamos to evaluate neutron, proton, and photonuclear cross section up to 150 MeV (to 250 MeV for protons), based on experimental data and nuclear model calculations. These data are represented in the ENDF format and can be used in computer codes to simulate radiation transport. They permit calculations of absorbed dose in the body from therapy beams, and through use of kerma coefficients allow absorbed dose to be estimated for a given neutron energy distribution. For radiation protection, these data can be used to determine shielding requirements in accelerator environments, and to calculate neutron, proton, gamma-ray, and radionuclide production. Illustrative comparisons of the evaluated cross section and kerma coefficient data with measurements are given

  5. Boron neutron capture therapy for malignant brain tumor and future potential

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Hatanaka, Hiroshi.

    1994-01-01

    This paper presents therapeutic experience with boron neutron capture therapy (BNCT) for malignant brain tumors. Nine patients who survived for 10 years or more as of 1986 are given in a table. A review of the 9 patients concluded that physical dose of 15 Gy is required. In addition, the following factors are defined to be the most important: (1) to determine tumor size and depth as accurately as possible, (2) to measure neutron doses in the deepest site of the tumor during irradiation, (3) to measure the content of boron within the tumor, and to deliver neutron beams as deeply as possible. Finally, the importance of knowing RBE of alpha particles for tumor cells of the human brain is emphasized. (N.K.)

  6. Design status of an intense 14 MeV neutron source for cancer therapy

    CERN Document Server

    Yao, Z E; Cheng, S W; Jia, W B

    2002-01-01

    Design and development of an intense 14 MeV neutron source for cancer therapy is in progress at the Institute of Nuclear Research of Lanzhou University. The neutrons from the T(d,n) sup 4 He reaction are produced by bombarding a rotating titanium tritide target with a 40 mA deuteron beam at 600 keV. The designed neutron yield is 8x10 sup 1 sup 2 n/s and the maximum dose rate at a 100 cm source-to-skin distance is 25 cGy/min. The HV terminal, accelerating column and HV power supply are enclosed inside a stainless steel pressure vessel containing 6 atm SF sub 6 gas to provide the electrical insulation.

  7. FSU High Energy Physics

    Energy Technology Data Exchange (ETDEWEB)

    Prosper, Harrison B. [Florida State Univ., Tallahassee, FL (United States); Adams, Todd [Florida State Univ., Tallahassee, FL (United States); Askew, Andrew [Florida State Univ., Tallahassee, FL (United States); Berg, Bernd [Florida State Univ., Tallahassee, FL (United States); Blessing, Susan K. [Florida State Univ., Tallahassee, FL (United States); Okui, Takemichi [Florida State Univ., Tallahassee, FL (United States); Owens, Joseph F. [Florida State Univ., Tallahassee, FL (United States); Reina, Laura [Florida State Univ., Tallahassee, FL (United States); Wahl, Horst D. [Florida State Univ., Tallahassee, FL (United States)

    2014-12-01

    The High Energy Physics group at Florida State University (FSU), which was established in 1958, is engaged in the study of the fundamental constituents of matter and the laws by which they interact. The group comprises theoretical and experimental physicists, who sometimes collaborate on projects of mutual interest. The report highlights the main recent achievements of the group. Significant, recent, achievements of the group’s theoretical physicists include progress in making precise predictions in the theory of the Higgs boson and its associated processes, and in the theoretical understanding of mathematical quantities called parton distribution functions that are related to the structure of composite particles such as the proton. These functions are needed to compare data from particle collisions, such as the proton-proton collisions at the CERN Large Hadron Collider (LHC), with theoretical predictions. The report also describes the progress in providing analogous functions for heavy nuclei, which find application in neutrino physics. The report highlights progress in understanding quantum field theory on a lattice of points in space and time (an area of study called lattice field theory), the progress in constructing several theories of potential new physics that can be tested at the LHC, and interesting new ideas in the theory of the inflationary expansion of the very early universe. The focus of the experimental physicists is the Compact Muon Solenoid (CMS) experiment at CERN. The report, however, also includes results from the D0 experiment at Fermilab to which the group made numerous contributions over a period of many years. The experimental group is particularly interested in looking for new physics at the LHC that may provide the necessary insight to extend the standard model (SM) of particle physics. Indeed, the search for new physics is the primary task of contemporary particle physics, one motivated by the need to explain certain facts, such as the

  8. Conception of a New Recoil Proton Telescope for Real-Time Neutron Spectrometry in Proton-Therapy

    Science.gov (United States)

    Combe, Rodolphe; Arbor, Nicolas; el Bitar, Ziad; Higueret, Stéphane; Husson, Daniel

    2018-01-01

    Neutrons are the main type of secondary particles emitted in proton-therapy. Because of the risk of secondary cancer and other late occurring effects, the neutron dose should be included in the out-of-field dose calculations. A neutron spectrometer has to be used to take into account the energy dependence of the neutron radiological weighting factor. Due to its high dependence on various parameters of the irradiation (beam, accelerator, patient), the neutron spectrum should be measured independently for each treatment. The current reference method for the measurement of the neutron energy, the Bonner Sphere System, consists of several homogeneous polyethylene spheres with increasing diameters equipped with a proportional counter. It provides a highresolution reconstruction of the neutron spectrum but requires a time-consuming work of signal deconvolution. New neutron spectrometers are being developed, but the main experimental limitation remains the high neutron flux in proton therapy treatment rooms. A new model of a real-time neutron spectrometer, based on a Recoil Proton Telescope technology, has been developed at the IPHC. It enables a real-time high-rate reconstruction of the neutron spectrum from the measurement of the recoil proton trajectory and energy. A new fast-readout microelectronic integrated sensor, called FastPixN, has been developed for this specific purpose. A first prototype, able to detect neutrons between 5 and 20 MeV, has already been validated for metrology with the AMANDE facility at Cadarache. The geometry of the new Recoil Proton Telescope has been optimized via extensive Geant4 Monte Carlo simulations. Uncertainty sources have been carefully studied in order to improve simultaneously efficiency and energy resolution, and solutions have been found to suppress the various expected backgrounds. We are currently upgrading the prototype for secondary neutron detection in proton therapy applications.

  9. Computing in high energy physics

    Energy Technology Data Exchange (ETDEWEB)

    Watase, Yoshiyuki

    1991-09-15

    The increasingly important role played by computing and computers in high energy physics is displayed in the 'Computing in High Energy Physics' series of conferences, bringing together experts in different aspects of computing - physicists, computer scientists, and vendors.

  10. Monte Carlo assessment of boron neutron capture therapy for the treatment of breast cancer

    Directory of Open Access Journals (Sweden)

    Mundy Daniel W.

    2005-01-01

    Full Text Available For a large number of women who are diagnosed with breast cancer every year the avail able treatment options are effective, though physically and mentally taxing. This work is a starting point of a study of the efficacy of boron neutron capture therapy as an alternative treatment for HER-2+ breast tumors. Using HER-2-specific monoclonal anti bodies coupled with a boron-rich oligomeric phosphate diester, it may be possible to deliver sufficient amounts of 10B to a tumor of the breast to al low for selective cell destruction via irradiation by thermal neutrons. A comprehensive computational model (MCNP for thermal neutron irradiation of the breast is described, as well as the results of calculations made using this model, in order to determine the optimum boron concentration within the tumor for an effective boron neutron capture therapy treatment, as compared with traditional X-ray radiotherapy. The results indicate that a boron concentration of 50-60 mg per gram of tumor tissue is optimal when considering treatment times, dose distributions and skin sparing. How ever these results are based upon best-guess assumptions that must be experimentally verified.

  11. Monte Carlo calculations of lung dose in ORNL phantom for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Krstic, D.; Markovic, V.M.; Jovanovic, Z.; Milenkovic, B.; Nikezic, D.; Atanackovic, J.

    2014-01-01

    Monte Carlo simulations were performed to evaluate dose for possible treatment of cancers by boron neutron capture therapy (BNCT). The computational model of male Oak Ridge National Laboratory (ORNL) phantom was used to simulate tumours in the lung. Calculations have been performed by means of the MCNP5/X code. In this simulation, two opposite neutron beams were considered, in order to obtain uniform neutron flux distribution inside the lung. The obtained results indicate that the lung cancer could be treated by BNCT under the assumptions of calculations. The difference in evaluated dose in cancer and normal lung tissue suggests that BNCT could be applied for the treatment of cancers. The difference in exposure of cancer and healthy tissue can be observed, so the healthy tissue can be spared from damage. An absorbed dose ratio of metastatic tissue-to-the healthy tissue was ∼5. Absorbed dose to all other organs was low when compared with the lung dose. Absorbed dose depth distribution shows that BNC therapy can be very useful in the treatments for tumour. The ratio of the tumour absorbed dose and irradiated healthy tissue absorbed dose was also ∼5. It was seen that an elliptical neutron field was better irradiation choice. (authors)

  12. Comparison of Out-Of-Field Neutron Equivalent Doses in Scanning Carbon and Proton Therapies for Cranial Fields

    DEFF Research Database (Denmark)

    Athar, B.; Henker, K.; Jäkel, O.

    2010-01-01

    Purpose: The purpose of this analysis is to compare the secondary neutron lateral doses from scanning carbon and proton beam therapies. Method and Materials: We simulated secondary neutron doses for out-of-field organs in an 11-year old male patient. Scanned carbon and proton beams were simulated...

  13. High energy physics

    International Nuclear Information System (INIS)

    Kernan, A.; Shen, B.C.; Ma, E.

    1997-01-01

    This proposal is for the continuation of the High Energy Physics program at the University of California at Riverside. In hadron collider physics the authors will complete their transition from experiment UA1 at CERN to the DZERO experiment at Fermilab. On experiment UA1 their effort will concentrate on data analysis at Riverside. At Fermilab they will coordinate the high voltage system for all detector elements. They will also carry out hardware/software development for the D0 muon detector. The TPC/Two-Gamma experiment has completed its present phase of data-taking after accumulating 160 pb - 1 of luminosity. The UC Riverside group will continue data and physics analysis and make minor hardware improvement for the high luminosity run. The UC Riverside group is participating in design and implementation of the data acquisition system for the OPAL experiment at LEP. Mechanical and electronics construction of the OPAL hadron calorimeter strip readout system is proceeding on schedule. Data analysis and Monte Carlo detector simulation efforts are proceeding in preparation for the first physics run when IEP operation comenses in fall 1989

  14. High energy physics

    International Nuclear Information System (INIS)

    Kernan, A.; Shen, B.C.; Ma, E.

    1997-01-01

    This proposal is for the continuation of the High Energy Physics Program at the University of California, Riverside. In 1990, we will concentrate on analysis of LEP data from the OPAL detector. We expect to record 10 5 Z's by the end of 1989 and 10 6 in 1990. This data will be used to measure the number of quark-lepton families in the universe. In the second half of 1990 we will also be occupied with the installation of the D-Zero detector in the Tevatron Collider and the preparation of software for the 1991 run. A new initiative made possible by generous university support is a laboratory for detector development at UCR. The focus will be on silicon strip tracking detectors both for the D-Zero upgrade and for SSC physics. The theory program will pursue further various mass-generating radiative mechanisms for understanding small quark and lepton masses as well as some novel phenomenological aspects of supersymmetry

  15. High energy plasma accelerators

    International Nuclear Information System (INIS)

    Tajima, T.

    1985-05-01

    Colinear intense laser beams ω 0 , kappa 0 and ω 1 , kappa 1 shone on a plasma with frequency separation equal to the electron plasma frequency ω/sub pe/ are capable of creating a coherent large longitudinal electric field E/sub L/ = mc ω/sub pe//e of the order of 1GeV/cm for a plasma density of 10 18 cm -3 through the laser beat excitation of plasma oscillations. Accompanying favorable and deleterious physical effects using this process for a high energy beat-wave accelerator are discussed: the longitudinal dephasing, pump depletion, the transverse laser diffraction, plasma turbulence effects, self-steepening, self-focusing, etc. The basic equation, the driven nonlinear Schroedinger equation, is derived to describe this system. Advanced accelerator concepts to overcome some of these problems are proposed, including the plasma fiber accelerator of various variations. An advanced laser architecture suitabl